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Abstract 
 The rich coordination chemistry of transition metals renders them of interest for 
broad applications in energy conversion. For example, there is increasing interest in 
molecular light absorbers such as dye-sensitized photoelectrochemical solar cells (DSSCs) 
and hybrid inorganic/organic devices. Additionally, the properties of light emitting 
molecules are the subject of intense research, with applications in organic light emitting 
diodes (OLEDs) and photosensitisers of energy- and electron-transfer for solar energy 
conversion.  
 This thesis can be broadly separated into two sections; (1) the study of a macrocyclic 
cobalt complex and its potential as a catalyst for the conversion of protons into H2 and (2) 
the synthesis and study of transition metal complexes as phosphorescent dopants for 
OLEDs. 
 In part 1, the synthesis and characterisation of a series of cobalt compounds 
coordinated by the macrocyclic biquinazoline ligand, Mabiq, is presented. The solution and 
solid-state structures of the compounds were examined, alongside the electronic 
structures of paramagnetic 2 and 3. Electrochemistry data reveals that the reduction of 4 
is possible to form a formally Co0 species, which shows promise in its activity with respect 
to H2 production. 
 In part 2, the synthesis and characterisation of a range of mono- and bimetallic Pt(II) 
and Ir(III) complexes is presented. A series of readily synthesised tridentate proligands and 
their resulting complexes is presented that include pseudo-cyclometallating units to allow 
for mild reaction conditions. The complexes are weakly emissive, with PLQYs in the range 
0.1 – 4%, attributed to varying rates of non-radiative decay. Two successful strategies in 
decreasing non-radiative decay are reported: the replacement of the chloride ancillary 
ligand with a stronger field acetylide ligand and the development of tetradentate 
proligands to improve the rigidity of the square planar complexes. The synthesis of 
hydrazone-based proligands, which offer two N^N^O-coordination sites bridged by a 
central pyrimidine ring is also reported. Coordination of a second Ir(III) centre results in a 
6-fold enhancement of the PLQYs.  
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Part I - Cobalt Complexes Containing 
a Redox Active Macrocyclic 
Biquinazoline Ligand 
 
 
 
 
Our children will enjoy in their homes electrical energy too cheap to 
meter.... Transmutation of the elements, unlimited power, ability to 
investigate the working of living cells by tracer atoms, the secret of 
photosynthesis about to be uncovered, these and a host of other 
results, all in about fifteen short years. 
Lewis Strauss – 1954 
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1.1 Introduction 
1.1.1 The Current Energy Crisis 
As the modern world develops, so does its need for energy. Alongside our growing 
population and technological advances, the global demand for energy is steadily increasing. 
In 1993 the world’s energy consumption was 9.5 TW, in 2011 this increased by 48% to 14 
TW.1 It is estimated that by 2050 our demand for energy will increase at least two-fold due 
to population and economic growth and will have tripled by 2100.2 This increase in demand 
for energy comes not only from our expanding population, which is set to increase to 9.4 
billion by 2050, but from the rising standard of living in areas across the globe.2 
Our reliance on finite resources, such as fossil fuels, has led to our reserves 
depleting at an alarming rate. It is well documented1–5 that our current energy resources 
are insufficient to meet our growing appetite. Our current reserves of oil and natural gas 
are set to become critically low in 40 years. Despite being our most plentiful source of fossil 
fuels, even our coal reserves are only projected to last 114 years if we continue at our 
current rate of production.6 Continuing to irreversibly burn our fossil fuels at this rate has 
implications beyond energy production; these reserves have a huge host of useful industrial 
applications. Oil is used for lubricants, dyes, plastics and synthetic rubber, natural gas is 
used in ammonia, glass and plastic production and coal is used to make creosote oil, 
benzene, toluene, ammonium nitrate, soap, aspirin and solvents.3 A further hot topic in the 
employment of fossil fuels as an energy source is the consequence on the environment. 
Although the real consequences of increased greenhouse gases cannot be accurately 
predicted, it is now generally accepted that human activities are largely causing climate 
change by releasing CO2 and other heat-trapping gases into the atmosphere.7 Society, with 
its ever increasing awareness of the strains we place on the environment, demands a 
solution that is both sustainable and ‘green’. 
Solar power is the most plentiful resource available to humankind and a large 
amount of focus has been placed on this energy source. More energy from sunlight hits the 
earth in 1 hour, than all of the energy consumed by humans in an entire year.8 Even taking 
into account that 19% of solar power is absorbed by clouds and 30% is reflected back into 
space, the available power is still 5000 times the current world energy needs.3  
A key challenge in the exploitation of solar energy is the ability to store and dispatch 
energy upon demand. Society relies on a continual energy supply and solar energy is 
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intermittent due to variable atmospheric conditions, therefore an inexpensive storage 
mechanism is needed for solar energy to become our primary energy supply.2 A viable 
approach to this is to develop a process which can capture and convert solar energy 
through the formation of chemical bonds, i.e., to generate high-energy molecules as nature 
accomplishes in a photosynthetic process. Current schemes aim to split water into oxygen 
and a fuel such as hydrogen, methanol or other hydrocarbons.8 This is by no means a new 
idea, indeed the first instance may be credited to science fiction: Jules Verne, “Vingt mille 
lieues sous les mers: Tour dumonde sous-marin” (twenty thousand leagues under the sea), 
1870.9  
Hydrogen is an odourless, colourless, tasteless and non-poisonous gas which 
produces water when burned. Hydrogen has already proven a useful fuel, an interesting 
example being in the space program, providing electrical power to shuttles and allowing 
the crew to consume the water by-product!10 Hydrogen is a useful ‘feedstock’ to a variety 
of industrial activities and has the potential to become a fuel sufficient to energize virtually 
every aspect of society; from homes to electrical utilities to business and industry.11 There 
is often a perception of danger surrounding hydrogen fuel cells that can give pause to 
sceptics12 but for more than half a century hydrogen has been used, stored and transported 
in the U.S. industrial sector. Like any fuel, safe handling procedures have made this 
possible.13 
The production of hydrogen from solar energy devices is a sought-after process, as 
hydrogen can be produced by using solar energy to split water molecules into H2 and O2 in 
a process termed ‘artificial photosynthesis’. The chemical community has stepped up to 
the challenge, and many have joined the race to produce cost-effective, efficient and 
robust catalysts for artificial photosynthesis. 
1.1.2 Artificial Photosynthesis 
Interest in photosynthesis stems from the fact that all of the raw materials and 
power needed for the synthesis of biomass are available in almost unlimited amounts. In 
natural photosynthesis, the energy of the sun is harnessed; water is split into oxygen, 
protons and electrons. The oxygen is released into the environment and the electrons are 
used to reduce CO2 to sugar and other molecules, creating an energy store which we 
release when we burn fuels such as fossil and biomass; thus creating a renewable cycle 
(Scheme 1.1).14 
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Scheme 1.1: A representation of the energy flow in the biological cycle of photosynthesis 
and respiration.14 
In artificial photosynthesis, the protons and electrons are recombined to produce 
hydrogen. The splitting of water requires two individual multi-electron redox processes; 
water oxidation to dioxygen (or the oxygen evolution reaction, OER) and proton reduction 
to dihydrogen (or the hydrogen evolution reaction, HER)15 as displayed in Scheme 1.2. 
2H2O
hv
catalyst
O2 + 4H+ + 4e-
4H+ + 4e-
catalyst
2H2
 
Scheme 1.2: Water oxidation and proton reduction equations. 
This process is highly desirable as 4.92 eV is stored when two water molecules are 
split into two molecules of H2 and one of O2.15 However, in order to achieve water splitting 
sizable kinetic and thermodynamic energy barriers must be overcome.8 These barriers are 
overcome in nature by a very complex series of reactions which are still not fully 
understood.14 
One example of a water oxidation catalyst used in natural photosynthesis is 
Photosystem Two (PSII). PSII is a multi-subunit complex embedded within the thylakoid 
membrane inside chloroplasts of green plants. Due to its importance to understanding the 
water splitting reaction there has been a wide range of techniques used to probe the 
mechanisms involved and also to determine the structure of the catalytic centre (Figure 
1.1).16 
combustion 
solar energy 
O2 
2 H2O 4 H+ + 4e- (CH2O)n 
organic 
molecules, 
biomass, 
food, fossil 
fuels 
dark reactions 
CO2 
CO2 
photosynthesis 
light reactions 
respiration 
O2 
energy 
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Figure 1.1: A side view of PSII, inset with the oxygen evolving centre, CaMn4. PSII consists 
of two monomers, related by a two-fold rotation axis. The protein subunits shown in orange and 
yellow compose the reaction centre.1  
 
PSII is nature’s oxygen evolution catalyst and many groups strive to synthesise 
oxygen-evolving catalysts. In an artificial system, successful water oxidation will be 
followed by proton reduction to form dihydrogen. To reduce a proton using a single 
electron has an energy cost of 2.3V vs NHE. A H• radical is formed, which can be reduced 
using a second electron to yield H2 with the release of 2.3V. Thus, the reaction is overall 
thermoneutral, but there is a need for a catalyst to lower the energetic requirements of 
the first reduction.2 
1.1.3 Hydrogen Evolution Catalysts 
The photocatalytic evolution of hydrogen is an area of artificial photosynthesis that 
has enjoyed its share of success and great developments in the past 10 years.9 The HER is 
a well-studied reaction, a driving force of this being the key role hydrogen plays in many 
industrial reactions.17 Many advances have been made in the drive for noble-metal-free 
molecular catalysts for light-driven hydrogen evolution. The catalytic performances of the 
noble-metal group for hydrogen production are unrivalled, but the limited supply and high 
                                                          
1 Reprinted with permission from Science, 2004, 303, 1831, Copyright (2004), American Association for the 
Advancement of Science. 
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costs of noble metals would not sustain a wide-scale production of such devices. In biology, 
the hydrogenase enzymes are able to catalyse both proton reduction and hydrogen 
oxidation with efficiencies comparable to platinum particles.18 Hydrogenases are large 
molecules (98 kDa) that contain a buried bimetallic active site composed of only nickel and 
iron. These are situated in a sulphur- and carbon-rich environment.19 There are two distinct 
types of hydrogenases, according to the identity of their binuclear active sites, either Fe-Fe 
or Ni-Fe (Figure 1.2).18 
 
Figure 1.2: Structure of the active sites of the hydrogenases. X = H-, H2O or H2. 
By examining these structures and pathways, a bio-inspired catalysis approach has 
been undertaken to generate functional models of hydrogenases, that make use of first-
row transition metals.18 In recent years, intense work has been directed at biomimetic 
models of the Fe-only hydrogenase; retaining the sulfur environment, the nature and 
number of metal ions as well as the diatomic carbonyl and cyanide ligands found at the 
active site. The activities displayed by some compounds are noteworthy20 but generally 
there is a lack of functioning hydrogenase mimics,8 suggesting that the large protein 
environment of the hydrogenases plays a significant role in activity and that simply 
replicating the active site alone will not succeed. Moreover, biomimics can suffer from 
instability as they generally lack chelating ligands, which help stabilise the coordination 
sphere during catalysis.20  
A different approach to replicating the hydrogenases ability is therefore required to 
successfully develop a proton reduction catalyst. The HER at metal electrodes has been well 
studied and the generally accepted mechanism in acidic media consists of three steps. The 
first step is the discharge step where a proton is adsorbed to the surface of the electrode: 
 
This is followed by recombination of two Hads to generate H2 and/or by protonation of Hads 
coupled to a single electron transfer: 
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The strength of the proton adsorption to the metal plays a key role in determining 
the catalytic activity of the metal electrode. The strength of the M–H bond against the log 
of the current exchange density for several metals is displayed in Figure 1.3.2 Metals on the 
left side of the volcano peak, which form relatively weak bonds, exhibit a slow initial 
adsorption rate and hence the rate of hydrogen evolution is limited. The metals that lie on 
the right side of the volcano peak form very strong M–H bonds and hence the final 
desorption step and evolution of hydrogen is limited. 
 
 
 
 
 
 
 
 
Figure 1.3: Volcano curve displaying the relationship between M–H bond strength and the 
current exchange density.2 
The metals situated at the peak of the volcano plot have the optimum M–H bond 
strength for efficient adsorption and desorption and therefore are the pre-eminent 
hydrogen evolution catalysts. However, these metals are rare and expensive and so, as 
previously discussed, their implementation is not viable on a wide scale. 
In an effort to move away from precious metals, numerous studies have focused on 
metals such as Co, Fe and Ni in mono, bi- or multi-metallic systems in order to tune the 
strength of the M-H bond and thereby increase electrocatalytic activity. These molecular 
                                                            
2 Reprinted with permission from J. Electroanal. Chem., 1972, 39, 163, Copyright (1972), Elsevier B.V. 
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catalysts are bio-inspired rather than biomimetic, taking inspiration from biological systems 
and exploiting this knowledge to design original catalysts. 
First row transition metals are earth-abundant and inexpensive, but can facilitate 
multi-electron reactions due to the availability of multiple oxidations states. A synthetic 
approach allows chemists to exploit in creative ways the versatile and modular character 
of coordination chemistry to develop efficient photosensitizers.18 The intention would be 
to replace the platinum electrode with a molecular complex able to catalyse the reaction, 
i.e., to lower the activation potential for hydrogen evolution.21 
Despite having no biological relevance in terms of water splitting and being 
significantly less abundant than Fe, Ni or Mn22, cobalt has received considerable attention 
in the field over the past 10 years.23 Its catalytic power for hydrogen evolution was 
recognised some time ago and to date numerous efficient systems have been reported.23 
1.1.4 Mechanism of Hydrogen Evolution 
There has been considerable experimental and theoretical investigation into the 
mechanism of cobalt-catalysed hydrogen evolution. Naturally, understanding the 
fundamental mechanisms of electrocatalytic hydrogen evolution will assist in the design of 
better catalysts.24 It is generally accepted that the mechanism begins with the reduction of 
CoII to CoI which is then protonated to form CoIII-H (Scheme 1.3).15   
 
 
 
 
 
 
 
Scheme 1.3: H2 evolution pathways3 
                                                            
3 Adapated with permission from Acc. Chem. Res., 2009, 42, 1995-2004, Copyright (2009), American 
Chemical Society. 
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Hydrogen evolution then can occur via a homolytic or heterolytic pathway. The CoIII-
H can react in a bimolecular step with another CoIII-H to eliminate H2 (homolytic, bimetallic 
pathway, red) or it can be protonated, generating H2 and a CoIII species which can then be 
reduced (heterolytic, monometallic pathway, blue).15 A further possibility is the reduction 
of CoIII-H to yield CoII-H, which can then react via a similar homolytic (orange) or heterolytic 
(purple) pathway. A final possibility is that the CoI species is not protonated but reduced to 
a Co0 species which is then protonated to form CoII-H and can react in the manner stated 
above.15 
The different pathways available to cobalt-catalysed evolution would imply 
different optimum operating conditions.24 Baffert et. al. (2007) carried out in-depth 
analysis of the mechanism of hydrogen evolution by the complex [Co(dmgBF2)2L] (dmgBF2-
= (difluoroboryl)dimethylglyoximatio anion, L = CH3CN, DMF, H2O). They concluded that the 
pathway followed is also reliant on the strength of the acid used as the proton source. They 
listed three possible mechanisms, involving: (i) CoIII-H as the active species, (ii) both CoIII-H 
and CoII-H as intermediates and (iii) CoII-H as the active species (Scheme 1.4).21 
Hydrogen evolution proceeds via pathway (i) if the acid used is strong enough to 
protonate both CoI and CoIII-H species, meaning a heterolytic pathway is more probable. 
With lower strength acids, CoIII-H cannot be protonated and therefore is further reduced 
to CoII-H which then can react via parallel homolytic and heterolytic pathways. Finally, very 
weak acids (e.g. Et3NH+) are unable to protonate the CoI species, and hence require further 
reduction of the CoI species to a “Co0” species before protonation can occur. This leads to 
a CoII-H intermediate which evolves hydrogen through parallel homolytic and heterolytic 
pathways.21 
Detailed mechanistic work has suggested that the homolytic pathway predominates 
and the heterolytic pathway is only competitive at low catalyst or high acid concentrations. 
The low-barrier homolytic pathway is generally limited by diffusion of two hydride species 
together in solution, which could be elimated by the covalent linking of cobalt centres in a 
single catalyst.15 Recent work by Dempsey et. al. (2010) examined the mechanism of 
hydrogen evolution from a photogenerated hydridocobaloxime and reported that reaction 
via protonation of CoII-H is favoured under certain conditions, such as in solution where 
CoIII-H is in low concentrations.25  
10 
 
Overall, the pathway can be optimised by both judicious choice of operating 
conditions and careful design of the cobalt catalyst. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.4: Possible mechanisms for hydrogen evolution based on acid strength 
1.1.5 Cobalt Catalysts for Hydrogen Evolution 
Most of the catalytically active cobalt systems are square-planar macrocyclic or 
pseudo-macrocyclic complexes, such as 1 and other cobaloxime derivatives 2-4 (Figure 
1.4).22 Cobaloximes have been extensively studied and were initially proposed as models 
of the B12 co-enzyme, but have now acquired an independent research field because of 
their rich coordination chemistry and potential application in organic synthesis.26 
Cobaloximes have the general formula RCo(L)2B, where R is an organic group σ-bonded to 
11 
 
cobalt, B is an axial base trans to the organic group and L is a monoanionic dioxime ligand 
(e.g. glyoxime (gH), Dimethylglyoxime (dmgH), diphenylglyoxime (dpgH)).27 
 
Figure 1.4: Structures of some cobaloximes. (dmg = dimethylglyoxime, dpg =  
diphenylglyoxime, do = N2,N2’-propanediylbis(2,3-butandione 2-imine 
3-oxime). 
It is proposed that the fine combination of soft ligands found at the active site of 
hydrogenases helps in making the iron centre both nucleophilic and easily reducible which 
stabilises an open coordination site for substrate binding. As some of these features can be 
found in cobaloximes, these compounds are interesting potential electrocatalysts for 
hydrogen evolution in terms of both cost and working potential.20 In the reduced Co(I) state 
the cobaloximes are powerful nucleophiles which can be protonated to yield cobalt(III)-
hydride species which can evolve dihydrogen either through protonation or binuclear 
reductive elimination.28 
One of the first examples of catalytic activity for hydrogen evolution using a 
cobaloxime was reported by P. Connolly and J. Espenson in 1986. The CoII macrocycle 
CoII(dmgBF2)2 (Figure 1.5) was mixed with acidic solutions (pH 2) of EuCl2/CrCl2 and shown 
to evolve copious amounts of H2. It was noted that a trace amount of catalyst caused the 
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reaction to proceed until the supply of MCl2 was exhausted, suggesting a mechanism 
involving electron donation from Cr2+/Eu2+ (Scheme 1.5).29 
 
Figure 1.5: CoII macrocycle CoII(dmgBF2)2 investigated by P. Connolly and J. Espenson. 
Cl- + Cr2+ + CoII(dmgBF2)2 [Cr-Cl-Co(dmgBF2)2]
+
[Cr-Cl-Co(dmgBF2)2]+ Co
I(dmgBF2)2- + CrCl2+
Co(dmgBF2)2 + H
+ HCoIII(dmgBF2)2
2HCo(dmgBF2)2 2Co(dmgBF2)2 + H2
HCo(dmgBF2)2 + H
+ H2 + Co
III(dmgBF2)2
+
CoIII(dmgBF2)2+ + Cr2+ + Cl- CrCl
2+ + Co(dmgBF2)2
Homolytic
Heterolytic
 
Scheme 1.5: Proposed mechanism of hydrogen elimination.  
The proposed mechanism begins with the formation of a bridged intermediate [Cr-
Cl-Co(dmgBF2)2]+, which enables an inner-sphere electron transfer from CrII to CoII. This 
electron transfer has slightly unfavourable thermodynamics and therefore is thought to be 
responsible for a slow overall rate of catalysis.29 
In 2005, Hu et al. reasoned that this system might be well suited to electrocatalytic 
hydrogen evolution, as the CoII/I transition may be rapid and the process should occur at 
relatively positive potentials. He further reasoned that modification of the diglyoxime 
framework should allow tuning of the CoII/I redox potential and hence the potential at 
which hydrogen evolution occurs. Hu et al. investigated two related complexes, 5 and 6 
which can be seen in Figure 1.6.30 It was established that both 5 and 6 serve as catalysts for 
hydrogen evolution, with complex 6 mediating hydrogen evolution at -0.28 V vs. SCE in 
CH3CN. This was one of the most positive potentials recorded at the time (until that date 
others were the range of -1 V to -2 V in organic solvents). 
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Figure 1.6: Complex 5 and 6 studied by Hu et al. 
A recent breakthrough in hydrogen evolution catalysed by cobalt cobaloxime based 
complexes is the work by Kaeffer et al. (2015)31 which contributes to the development of a 
second generation of catalysts utilising cobalt diamine-dioxime complexes. These 
tetradentate ligands (see Figure 1.7) form cobalt complexes which are more stable to 
hydrolysis under strongly acidic conditions than the first generation cobaloximes. H2 
evolution involves the oxime bridge as a protonation site, reproducing the mechanism in 
the active sites of hydrogenase enzymes, allowing modest overpotentials at a wide range 
of acid-base conditions in non-aqueous solutions.  
 
Figure 1.7: Cobalt Diimine-Dioxime complex (X = Br, Cl, …). 
Another promising candidate in the field of cobalt hydrogen evolution are Co(II)-
octahedral complexes with polypyridyl ligands. The first catalyst of this nature, 7 (Figure 
1.8), was reported by Chang and co-workers.32 This tetradentate system was designed to 
stabilise the CoII centre while allowing two open coordination sites on which binding and 
catalysis may occur. 
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Figure 1.8: Tetradentate polypyridyl CoII complex reported by Chang and co-workers. 
Chang and co-workers found this system was able to electrocatalytically reduce 
protons to hydrogen and again implicated a CoI species in the catalytic cycle. However, the 
catalyst is not soluble in water in the millimolar range and subsequently second generation 
complexes have looked at modifying the ligand in order to address this problem.33 A 
number of polypyridyl catalysts have since been reported and the robustness of the 
coordination sphere towards reduction, hydrolysis and ligand exchange under reductive 
conditions has allowed light-driven hydrogen evolution under fully aqueous conditions.23   
Interestingly, a number of ligand-assisted catalytic processes are emerging for this 
class of compounds. Ligand-centred redox processes have been characterised for 
complexes 8 and 9a-b (Figure 1.9), with ligands bearing redox-active moieties in the 
backbone.34,35  
 
Figure 1.9: Complexes bearing redox active moieties in the ligand backbone. 
The cyclic voltammograms of 8 and 9a-b both reveal a CoII/CoI couple and two 
further reduction processes assigned as ligand-centred. In electrocatalytic studies, the 
CoII/CoI couple is still observed at all pH values and hydrogen evolution occurs at more 
cathodic potentials, likely triggered by a ligand-centred reduction process. These redox 
active moieties are thought to stabilise the reduced cobalt centre through π-back-bonding, 
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shifting the CoII/CoI couple to a more positive potential and reducing the nucleophilicity of 
the CoI state.  
Great progress has been made in the last few decades on catalytic hydrogen 
evolution by Co complexes, showing earth-abundant metals are a viable approach to 
artificial photosynthesis. Of course, challenges still remain in the development of materials 
for solar driven hydrogen evolution. Many systems suffer from low aqueous solubility, 
stability or do not exhibit sufficiently high turnover numbers (TON) at low catalyst 
concentrations. Due to the wealth of studies into water splitting with cobalt, this field is 
reaching maturity and it is reasonable to say that a fully molecular photoelectrocatalytic 
system for water splitting will be a reality in the near future.22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
1.1.6 Current Strategy 
In an attempt to develop a cost-effective H2-producing catalyst, research during the 
first part of my doctoral studies was focused on metal complexes containing the N4-
macrocyclic biquinazoline ligand, HMabiq (Scheme 1.6). This ligand offers two binding sites 
for metals and a key part of the research has focused on the development of cobalt 
complexes where either one or both of these sites are occupied.  
This potential hydrogen evolution catalyst has several benefits. Firstly, the use of 
cobalt eradicates the need for expensive metals such as platinum, helping meet the 
demand for a cost-effective catalyst. This builds upon the considerable promise that has 
been shown by cobaloxime catalysts, which feature macrocyclic cavities with cobalt 
centres. 
Secondly, the HMabiq ligand is able to participate in redox processes by storing and 
donating electrons as needed. The redox non-innocence of the HMabiq ligand has been 
established previously,36,37 the π* orbitals of the diketiminate unit are capable of accepting 
one electron. 
Most ligands used in inorganic chemistry are not redox-active, the energy needed 
to oxidize or reduce them by one electron is much greater than the energy needed to 
change the oxidation state at the metal; hence changes in the electronic structure occur at 
the metal. “Non-innocence”, as it is often known, can occur when ligands have 
energetically accessible levels that allow redox reactions to change their charge state. Thus, 
the ligands are ‘redox active’.38  The coordination between a metal My/y+1 and a redox active 
ligand (RALx/x-1) may either exist as a resonance situation with delocalised valences, or as 
an equilibrium between two different redox isomeric species: 
 
During reactions, non-innocent ligands can cooperate with the metal centre and 
react synergistically to facilitate chemical processes. The ligand is able to act as an electron 
sink, allowing the metal to store and accept electron density while retaining its original 
oxidation state, avoiding unfavourable, high energy states of the metal. The employment 
of redox active ligands opens up a whole new range of reactions which would otherwise 
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not be possible for first row transition metals. Multi-electron reactions, such as hydrogen 
evolution, tend to be catalysed most effectively by precious metals since they typically 
undergo 2e- oxidation state changes, whereas common metals tend to undergo 1e- 
reactions. It is therefore thought that redox active ligands allow base metals to mimic 
precious metals, by combining 1e- redox change at the ligand with a 1e- redox change at 
the metal, for an overall oxidation change of 2e- (Scheme 1.6).39 The use of the redox active 
Mabiq ligand may bypass the unfavourable Co0 species which is implicated in the hydrogen 
evolution mechanism, allowing for reactivity to be seen even with weak acids. 
N N
N N
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Scheme 1.6: 1e- reduction of Mabiq ligand. 
Finally, the second binding site provided by HMabiq may allow us to add a sensitiser 
to the system. A particularly interesting system which used this method was described by 
Hawecker et al. in 1983. Hydrogen evolution was achieved in organic or aqueous organic 
media using the photosensitiser/relay-catalyst/donor system of 
Ru(bipy)3Cl2/Co(dmgH)2/tertiary amine. The photosensitiser allowed visible light 
irradiation to drive the hydrogen evolution, producing the most active photochemical 
process that had been reported at the time. The overall hydrogen generation process was 
proposed to involve two catalytic cycles; the photochemical ruthenium cycle and the 
thermal cobalt cycle, as well as two irreversible reactions; the formation of hydrogen and 
the oxidative decomposition of the tertiary amine. A schematic representation of the 
reactions is given in Scheme 1.7.40 
The feasibility of efficient hydrogen production is displayed by this work, and has 
spurred on the search for stable components, photosensitisers of larger spectral domain 
and alternative electron donor species.40 
The addition of a sensitizer would allow us to harness solar energy directly, making 
our system solar driven. This is an exciting feature which may allow us to create a system 
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that can drive H2 evolution and oxygen formation with the only inputs being water and 
sunlight. 
D
decomposition
RuI
RuII
*RuII Ru CoI
CoIII-H
CoII
visible light irradiation
Co
H2
H+
D
 
Scheme 1.7: Schematic representation of photochemical hydrogen generation in the 
ruthenium(II)-cobaloxime supramolecular complex reported by Hawecker et al. D = tertiary amine. 
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1.2 Results and discussion 
1.2.1 Synthesis of Cobalt Mabiq complexes 
The target macrocyclic ligand, HMabiq, was synthesised according to the synthesis 
previously published by E. Müller et. al37, as shown in Scheme 1.8.  
 
Scheme 1.8: HMabiq Synthesis 
Following successful synthesis of the HMabiq ligand, a series of Co-Mabiq 
complexes was synthesised, as detailed in Scheme 1.9. Complex 1 and 2 were first 
synthesised by Priyabrata Banerjee. Complex 3 was first synthesised by Liam Drennen. 
The CoIII complex Co(Mabiq)Cl2 (1) was initially synthesised in the presence of 
hydrogen peroxide as an oxidant, following the protocol established for the synthesis of 
Co(Mabiq)(CN)2.37 However, carrying out the reaction in an aerated CH2Cl2 solution  
resulted in higher product yields. 1 is dark brown in colour in the solid form, dissolving 
readily in DCM and less so in MeOH to form an amber solution.  The diamagnetic nature of 
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1 is confirmed by the 1H NMR spectrum which displays no broadening of peaks compared 
to those on the spectrum of the free ligand (Figure 1.10). Furthermore, there is an upfield 
shift of both the aromatic protons and the diketiminate C-H proton when compared to the 
spectrum of the free HMabiq ligand, which can be attributed to the coordination of the CoIII 
ion on the macrocyclic cavity.  
Although von Zelewskys’s original motivation for the synthesis of HMabiq was to 
design a bimetallic complex with photocatalytic properties, the binuclear complexes 
targeted by both von Zelewsky and Hess were never reported.36,37 We have successfully 
generated both monometallic CoII complex Co(Mabiq)Cl (2) and the bimetallic CoII complex 
Co2(Mabiq)Cl3 (3) which can be formed with one or two equivalents of anhydrous CoCl2, 
respectively. Both 2 and 3 are dark green in colour, with 2 dissolving readily in DCM and 
less so in MeOH whereas 3 is only soluble in MeOH.  
The CoI complex Co(Mabiq) (4) can be formed on reduction of 2 using 1 equivalent 
of cobaltocene in THF. 4 is a deep purple colour and dissolves readily in THF. The 1H NMR 
spectrum (Figure 1.10) shows a further upfield shift of the diketiminate C-H proton signal, 
which now appears at 7.54 ppm. This shift is significantly higher than that of the 
corresponding signal in the spectrum of the CoIII-, FeII-, and ZnII-Mabiq complexes.36 
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Scheme 1.9: Synthesis of cobalt complexes. 
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Figure 1.10: 1H NMR spectra of HMabiq (top, CDCl3), 1 (middle, CDCl3), and 4 (bottom, 
THF-d8), showing the aromatic protons and the diketiminate proton (*).41 
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1.3 Characterisation of Cobalt Mabiq Complexes 
1.3.1 Solution State Characterisation 
 
 
Figure 1.11: Electronic absorption spectra of 1 (red, CH2Cl2), 2 (green, CH3OH), 3 (blue, 
CH3OH), and 4 (purple, THF). Inset: NIR region of the spectrum of 4.41 
Absorption bands at λmax = 484 and 514 nm can be seen in the UV-Visible electronic 
absorption spectrum of 1 (Figure 1.11). These features are reminiscent of those seen for 
Co(Mabiq)CN2 (λmax = 502 and 536 nm) and Zn(Mabiq)Cl (λmax = 471 and 502 nm).36,37 von 
Zelewsky attributed these features in the visible region to Mabiq π-π* transitions by 
comparing the low energy features to those of dicyanocobalamin, and the energy of the 
lowest energy absorption band is related to the net charge of the coordinated central atom, 
with increasing charge resulting in a move to higher energy.37 This conclusion appears to 
be consistent with the position of these absorptions bands in the above spectra and 
FeIII(Mabiq)Cl2 (λmax = 524 nm).  
The trio of peaks which can be seen in 2 and 3 (λmax = 576, 618 and 668 nm) are 
assigned as charge-transfer bands due to their high molar extinction coefficients, 
distinguishing them from spin-forbidden metal centred d-d transitions. Remarkably, the 
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solution absorption spectra of 2 and 3 are only distinguishable by their extinction 
coefficients. The spectra are superimposable and exhibit identical transitions (Figure 1.11). 
The similarity in the two spectra may be an indication that the outer CoCl2 moiety is labile 
and therefore dissociates in solution. 
In order to further explore the dissociation of CoCl2 from 3, the solid-state UV-Vis 
for 2 and 3 were recorded, as can be seen in Figure 1.12. We can see that the spectrum of 
3 maintains its trio of peaks, whereas the spectrum of 2 appears to have retained two of 
the three. The λmax of both 2 and 3 are at a lower energy than in the solution state.  
 
Figure 1.12: Solid state electronic spectra of 2 (green) and 3 (blue). 
Further to this, the solid-state IR spectra (Figure 1.13) exhibit several distinctive 
bands in the fingerprint region. The differences in the spectra confirms that in the solid 
state there are clear differences between 2 and 3. 
 
Figure 1.13: Comparison of IR spectra of 2 (green) and 3 (blue). 
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The UV-Visible absorption spectrum of low-valent Co(Mabiq) 4 in THF exhibits the 
π-π* transitions (λmax = 392 and 403 nm) as seen for 1 and discussed earlier, as well as 
absorption bands at λmax = 523 and 533 nm as seen for 2 and 3 which are again assigned to 
metal-to-ligand charge transfer. In addition, multiple features can be seen in the NIR region 
(inlaid, Figure 1.11), which closely resembles the absorption bands seen for CoI 
cobalamin.42 In the superreduced vitamin B12 the low-energy transitions are assigned as Co 
3d -> corrin π* excitations, with the relevant π* orbitals localised on the diketimate group 
of the corrin ring. It is proposed that a similar Co -> Mabiq transition involving the π* 
orbitals on the diketimate group may account for these transitions in the spectrum of 4. 
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1.3.2 Solid State Structures 
Co(Mabiq)Cl2 (1) 
Crystals of 1 were obtained via slow evaporation of a solution of crude product in 
DCM, with >90% yields. The structure obtained for 1 from X-ray diffraction of a suitable 
crystal is shown in Figure 1.14. 
 
Figure 1.14: Molecular structure of 1. Hydrogen atoms and solvent molecules omitted for clarity. T 
= 120K. 
Table 1.1: Selected bond lengths and bond angles for Complex 1. 
Bond Lengths (Å) Bond Angles (°) 
Co1-Cl1 2.2640(12) Cl2-Co1-Cl1 179.1(5) 
Co1-Cl2 2.2451(12) N1-Co1-N2 83.8(13) 
Co1-N1 1.920(3) N2-Co1-N3 91.6(13) 
Co1-N2 1.928(3) N3-Co1-N4 92.7(13) 
Co1-N3 1.902(3) N4-Co1-N1 92.0(13) 
Co1-N4 1.891(3)   
 
Complex 1 displays a CoIII ion coordinated by four nitrogen atoms in the macrocyclic 
cavity. The coordination about the metal is pseudooctahedral; the CoIII ion lies within the 
plane of the macrocyclic N-donors with two axial chloride ligands. The cobalt ion in the 
macrocyclic cavity is asymmetrically coordinated, with a slightly longer bond (1.92 Å) to the 
bipyrimidine nitrogen atoms in comparison to the shorter (1.90 Å) bond to the pyrrole 
nitrogen atoms (Table 1.1). This is a phenomenon noted in the related complex 
[CoIII(Mabiq)(CN)2]37, which is attributed to the different donor strength/basicity of the two 
N1 
Cl2 
Co1 
N2 N3 
N4 Cl1 
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types of nitrogen donors, although it could be due to the different bite angles. One CH2Cl2 
molecule per Co is located in the crystal structure of 1. 
Co(Mabiq)Cl2 (2) 
Crystals of 2 were obtained via slow evaporation of a solution of crude product in 
DCM. The structure obtained for 2 from X-ray diffraction of a suitable crystal is shown in 
Figure 1.15. 
 
Figure 1.15: Molecular structure of 2. Hydrogen atoms and solvent molecules omitted for 
clarity. T = 120K. 
Table 1.2: Selected bond lengths and bond angles for Complex 2. 
Bond Lengths (Å) Bond Angles (°) 
Co1-Cl1 2.4458(7) N1-Co1-N2 84.2(9) 
Co1-N1 1.918(2) N2-Co1-N3 91.3(9) 
Co1-N2 1.911(2) N3-Co1-N4 92.5(9) 
Co1-N3 1.892(2) N4-Co1-N1 92.2(9) 
Co1-N4 1.891(2)   
 
Complex 2 displays a CoII ion situated within the macrocyclic cavity. The 
coordination about the metal is square pyramidal; the CoII ion sits 0.114 Å above the N4-
plane that compromises the macrocyclic cavity. As with 1, the cobalt ion in the macrocyclic 
cavity is asymmetrically coordinated. The M-N distances show little variation, although 
there is a slight decrease in the bond length to the pyrrole nitrogen’s in comparison to 1, 
as expected due to the increase in metal-to-ligand π-backbonding of CoII vs. CoIII centre 
Cl1 
Co1 
N1 
N2 N3 
N4 
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(Table 1.2). Solvent molecules are located in the structure in a ratio of two CH2Cl2 per Co 
molecule. 
Co2(Mabiq)Cl3 (3) 
Crystals of 3 were obtained via vapour diffusion of ether into a solution of the crude 
product in MeOH, although the crystal structure was too disordered for the data to be 
refined to a publishable level. The structure obtained for 3 from X-ray diffraction of a 
suitable crystal is shown in Figure 1.16. 
 
Figure 1.16: Molecular structure of 3. Hydrogen atoms and solvent molecules omitted for 
clarity. T = 120K. 
Table 1.3: Selected bond lengths and bond angles for Complex 3. 
Bond Lengths (Å) Bond Angles (°) 
Co1-Cl1 2.541(2) N1-Co1-N2 85.3(2) 
Co1-N1 1.933(6) N2-Co1-N3 90.6(3) 
Co1-N2 1.923(6) N3-Co1-N4 94.0(3) 
Co1-N3 1.906(6) N4-Co1-N1 90.1(3) 
Co1-N4 1.896(6) N5-Co2-N6 81.3(2) 
Co2-Cl2 2.216(3) Cl4-Co2-Cl5 120.6(12) 
Co2-Cl3 2.231(3) Cl4-Co2-N5 111.7(16) 
Co2-N5 2.069(6)   
Co2-N6 2.061(6)   
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Complex 3 displays a CoII ion coordinated by four nitrogen atoms in the macrocyclic 
cavity. The coordination about the inner Co is again square pyramidal whereas the 
coordination about the outer CoII is tetrahedral, although this is slightly distorted.  As in 1 
and 2, the cobalt ion in the macrocyclic cavity of 3 is asymmetrically coordinated. 
Co(Mabiq) (4) 
Crystals of 4 were obtained via vapour diffusion of ether into a solution of the crude 
product in THF. The structure obtained for 4 from X-ray diffraction at the Diamond Light 
Source is shown in figure 18. 
 
Figure 1.17: Molecular structure of 4. Hydrogen atoms and solvent molecules omitted for 
clarity. T = 120K. 
Table 1.4: Selected bond lengths and bond angles for Complex 4. 
Bond Lengths (Å) Bond Angles (°) 
Co1-N1 1.877(3) N1-Co1-N2 84.8(13) 
Co1-N2 1.878(3) N2-Co1-N3 91.2(13) 
Co1-N3 1.857(3) N3-Co1-N4 92.6(13) 
Co1-N4 1.864(3) N4-Co1-N1 91.4(13) 
 
The coordination about the metal in 4 is square planar; the CoI ion sits within the 
plane of the macrocyclic N-donor atoms. As with the other complexes, the cobalt ion in the 
macrocyclic cavity is asymmetrically coordinated. The M-N distances are the shortest of the 
four complexes, going against the expected trend of decreasing bond lengths with each 
reduction; this is attributed to π-backbonding from the electron rich CoI. It is interesting to 
Co1 
N1 
N2 N3 
N4 
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note the bond lengths of the diketiminate unit; the average C-C bond distance is slightly 
shorter than seen in the previous complexes, whereas the C-N bonds are considerably 
longer. This effect has been observed previously, with similar bond distances seen in the 
reduced FeII(Mabiq•) complex.36 This calls into question the most accurate description of 
the low-valent complex 4: whether CoI(Mabiq) or CoII(Mabiq•). 
The dihydropyrrole rings in all four complexes are considerably puckered; the sum 
of the five bond angles are on average in the range of 533-535° instead of the ideal 547.5°.37 
The rings are the least puckered in 3, which has angles of 533° and 538° whereas they are 
the most puckered in 4 having angles of 529° and 531°. In the case of all four complexes, 
the sum of the six angles in each of the pyrimidine rings is 720°, showing them all to be 
completely flat.37 However, there are varying degrees of distortion of the bipyrimidine unit 
among the compounds, with 4 again being the most distorted with a difference of ~6° in 
coplanarity between to two pyrimidine groups. In all four complexes the bond lengths of 
the diketiminate unit lie in between the theoretical values for single and double bonds43,  
indicating a fully conjugated system. 
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1.3.3 Electronic Structure 
 The electronic structures of paramagnetic complexes 2 and 3 were examined using 
EPR spectroscopy4 and SQUID magnetometry5.  
The solid-state magnetic susceptibility data of 2 was measured from 2 – 300 K and 
the results are shown in Figure 1.18 as a plot of magnetic moment vs. temperature. The 
data affords a temperature independent magnetic moment of 1.88 µB, consistent with an 
S = 1/2 ground state for the CoII complex. The low spin assignment is confirmed by the X-
band EPR spectrum recorded in a CH2Cl2/toluene solution at ambient temperature (Figure 
1.19), which produces an eight-line hyperfine splitting of the electron-spin resonance. 
When measured at 30 K, the frozen solution spectrum has a richly detailed hyperfine 
structure (Figure 1.20). The magnitude of the g anisotropy supports a five-coordinate low-
spin CoII and is markedly different from that of a four-coordinate species.41 
The solid-state magnetic susceptibility data of 3 was measured from 2 – 300 K and 
the results are shown in Figure 1.21 as a plot of magnetic moment vs. temperature. The 
data affords a temperature independent magnetic moment of 4.3 µB from 50 – 300 K, which 
decreases below 50 K to a value of µeff ~ 3.8 µB. The data supports the presence of two CoII 
ions in 3 with S = 1/2 and S = 3/2 ground states (the spin only value is µeff = 4.24 µB for g = 2). 
The fluid-solution EPR spectrum of 3 in methanol essentially identical to that of 2; the 
hyperfine pattern can arise from a single spin only, presumably that of the S = ½ CoII ion 
(Figure 1.22). When measured at 10 K, the frozen solution spectrum consists of a broad 
signal at ~120 mT attributed to an S = 3/2 and a second signal at ~300 mT is consistent with 
the assumed spin doublet observed at room temperature (Figure 1.23). This spectrum is 
additional evidence for the dissociation of the bimetallic 3 in solution; the high-field signal 
at 120 mT is generated by dissociation of the high-spin CoII.  
 
 
 
 
                                                            
4 Measurements and analysis performed by Dr. Stephen Sproules at the University of Glasgow.   
5 Measurements performed by Andreas Göbels and analysis by Dr. Eckhard Bill at the MPI for Bioinorganic 
Chemistry. 
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Figure 1.18: Temperature dependence of the magnetic moment µeff, µB, (2 – 300 K, 1T) of a 
crystalline sample of 2. S1 = ½; g1 = 2.17; TIP = 61 x 10-6 cm3 mol-1. 
 
 
 
 
 
 
Figure 1.19: X-band EPR spectrum of 2 recorded in CH2Cl2/toluene at 293 K (experimental  
conditions: frequency, 9.4338 GHz; modulation, 0.7 mT; power, 20 mW). Experimental spectrum  
shown in black and simulation depicted by the red trace: giso = 2.204; Aiso = 55 × 10–4 cm–1. 
 
  
 
 
 
 
Figure 1.20: X-band EPR spectrum of 2 recorded in CH2Cl2/toluene at 30 K (experimental 
conditions: frequency, 9.3668 GHz; modulation, 0.5 mT; power, 0.63 mW). The experimental 
spectrum is shown in black and the simulation depicted by the red trace: g = (2.280, 2.280, 2.002); 
A{59Co} = (35, 36, 111) × 10−4 cm−1; A{35,37Cl} = (0, 0, 25) × 10−4 cm−1. 
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Figure 1.21: Temperature dependence of the magnetic moment μeff, μB, of a powdered sample of 
3. S1 = 3/2; S2 =1/2; g1 = 2.05; g2 = 2.0; J12 = 0.47 cm−1; |D2| = 20.37 cm−1; TIP = 1500 × 10−6 cm3 mol−1. 
 
 
 
 
 
Figure 1.22: X-band EPR spectrum of 3 recorded in CH3OH at 293 K (experimental 
conditions: frequency, 9.8079 GHz; modulation, 0.4 mT; power, 20 mW). Experimental spectrum 
shown in black and simulation depicted by the red trace: giso = 2.196; Aiso = 49 × 10–4 cm–1. 
 
 
 
 
 
Figure 1.23: X-band EPR spectra of 3 recorded in CH3OH/toluene at 10 K (experimental 
conditions: frequency, 9.3352 GHz; modulation, 0.6 mT; power, 0.63 mW). Experimental data are 
depicted by the solid line. Simulation of an S = 3/2 spectrum of a tetrahedral CoII centre with D >> 
hν is shown by the dashed line: g = (2.35, 2.35, 2.58); E/D = 0.03; W = (450, 450, 1000) × 10–4 cm–1; 
σE/D = 0.22. 
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1.3.4 Electrochemistry 
 
The cyclic voltammograms (CV) for complexes 1-4 are shown in Figure 1.24. 
 
Figure 1.24:  CVs of 1−4 (0.2 V s−1; 0.1 M [N(n-Bu)4]PF6; that of 4 in THF and all others in 
CH3OH). 
The CV’s for 1 and 2 are remarkably similar and show three individual redox 
processes. An irreversible redox couple can be seen at E1/2 = ~0.1 V which is assigned to the 
CoIII/CoII couple. Although on first glance the redox couple may appear to be reversible, a 
peak separation of 280 mV and 190 mV and a peak current ratio of 1.08 and 1.47 for 1 and 
2 respectively rules out this assignment.44 The redox couple at E1/2 = ~0.1 V is followed by 
a reversible one electron reduction at E1/2 = ~-0.9 V and a second irreversible reductive 
event at Ea = ~-1.5 V (Table 1.5).  
All three redox events can be seen in the CV of 4 but are shifted to more negative 
potentials. Interestingly, all three events are fully reversible showing that the presence of 
the axial ligand clearly has a substantial effect on the electrochemical properties. The peak-
to-peak separation for these redox processes is 125 – 150 mV; however, the peak-to-peak 
separation for the Fc+/0 couple was also determined to be 134 mV in THF. The reversible 
nature of the redox events observed for complex 4 is further confirmed by peak currents 
in the range of 0.9 – 1.  
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Ligand centred reduction has been observed for the Zn- and Fe-Mabiq complexes 
and occurred at potentials of -0.9 V and -1.5 V, respectively.36 The second redox process in 
the CVs of 1, 2 and 4 may therefore formally correspond to the CoII/CoI couple but could 
also be attributed to a CoII(Mabiq•) species. Thus, the ensuing redox event would likely 
entail the formation of CoI(Mabiq•), where both the metal and the ligand are one-electron 
reduced, rather than the formal Co0 species. 
Table 1.5: Reduction Potentials (V vs Fc+/0) of 1-4 (the Oxidation State Represents the Formal Metal 
Valency) 
 E1/2 (CoIII/CoII) E1/2 (CoII/CoI) E1/2 (CoI/Co0) 
1 0.14 -0.86 Ea = -1.53; Ec = -1.33 
2 0.11 -0.88 Ea = -1.51; Ec = -1.22 
3 0.12 -0.85  
4 -0.22 -1.27 -1.78 
 
The CV for the bimetallic 3 displays only two individual redox processes; though the 
presence of an additional CoII ion appears to have little other discernible effect. The 
potentials of the CoIII/CoII and CoII/CoI couples are in line with those seen for 1 and 2. The 
redox event assigned to the CoI/Co0 couple is no longer present and scanning at potentials 
more negative than -1.2 V led to the appearance of new redox waves (Figure 1.25). Redox 
deactivation by a neighbouring metal ion has been reported previously45 and may be 
occurring in this system. However, if CoCl2 is indeed dissociating from the ligand as 
postulated from the solution-state characterisation, this would also complicate the 
electrochemistry. At present, we cannot confirm the solution-state composition of 3 and 
are unable to draw any further conclusions from the CV. 
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Figure 1.25: CV of 3 in CH3OH, showing the effect of scanning at potentials <-1.2V; 0.2 V 
s−1; 0.1 M [N(n-Bu)4]PF6. 
The use of cyclic voltammetry enables electrolysis to provide electrons rather than 
chemical reductants and restricts the system to very few components. Cyclic voltammetry 
is a fascinating technique as catalytic turnover reactions lead to deviations from the ideal 
reversible behaviour of the redox curves, which allow qualitative and quantitative 
information to be inferred. This includes but is not limited to; the amount of H2 evolved, 
the turnover numbers (TONs) per mole and mechanistic information such as the rate-
determining step.  
When a proton source is added to a solution of a molecular catalyst, an increase of 
the anodic current accompanied by the loss of the reverse oxidation peak is indicative of a 
catalytic wave.46 Molecular cobalt complexes have been studied extensively as catalysts for 
electrochemical H2 production, with formation of a CoI species and subsequently a CoIII-H 
intermediate as a typical mechanism. To this end, we have used cyclic voltammetry to 
explore the potential of these complexes as hydrogen evolution catalysts, focusing on the 
CoII/CoI couple. 
The effect of adding a proton source to 1 was observed by cyclic voltammetry 
(Figure 1.26). A current increase is observed on addition of trifluoroacetic acid (TFA). At 1 
equivalent, there is an increase of the anodic current with no loss of the cathodic current, 
whereas with increasing equivalents we see a broadening of the anodic peak accompanied 
by an increase in current, a reduction of the return wave and a new cathodic peak. It may 
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be that a catalytic wave (although there is no true loss of the return wave) is being obscured 
by the appearance of a new redox couple, likely CoIII-H/CoII-H. This phenomenon has been 
observed previously by Hu et al., who reported the appearance of a new quasi-reversible 
wave when investigating catalytic hydrogen production with the complex 
Co(dmfBF2)2(CH3CN)2.47  
 
Figure 1.26: Cyclic voltammogram for 1 increasing equivalents of trifluoroacetic acid. Glassy 
carbon electrode, 0.5mM solution in CH3OH; 0.2 V s−1; 0.1 M [N(n-Bu)4]PF6. 
  When increasing equivalents of tosic acid are added to a DCM solution of 2, a 
similar effect can be observed (Figure 1.27). 
 
Figure 1.27: Cyclic voltammogram for 2 with increasing equivalents of tosic acid. Glassy carbon 
electrode, 0.5mM solution in DCM; 0.2 V s−1; 0.1 M [N(n-Bu)4]PF6. 
On addition of one equivalent of tosic acid, a new reduction event can be seen at  
Ea = ~-1.0 with the retention of the CoII/CoI couple. With increasing equivalents, a 
37 
 
broadening of the reduction event is observed with an appreciable loss of the return wave. 
Again, although less pronounced, this may be indicative of a catalytic wave with more than 
one process occurring.  
Typically, electrolysis is performed at a potential less negative than that of the direct 
electrochemical reduction.48 However, this is not the case seen here; the apparent catalytic 
wave appears at a potential more negative than that of the CoII/CoI couple. Similar 
behaviour was observed by Razavet et al. who reported catalytic hydrogen production with 
the complex [Co(dmgH)2(py)Cl]. This complex displayed a catalytic wave with high acid 
concentrations at more negative potentials than the CoII/CoI reversible wave. Razavet et al. 
assigned this catalytic wave to proton electroreduction.20 
It is worth noting that the presence of axial chloride in both 1 and 2 may be 
interfering with the catalytic process; in order for CoIII-H to be formed a vacant coordination 
site must be available for coordination.  
The effect of adding acid to 3 was also measured by cyclic voltammetry; no catalytic 
activity was observed (Figure 1.28). Although an increase of the anodic current is observed, 
this is also accompanied by an increase in the cathodic current. This does not indicate the 
irreversible loss of hydrogen as is seen for complex 1 and 2 but rather suggests that a new 
reversible Co(II/I) species may be formed in solution. 
 
Figure 1.28: Cyclic voltammogram for 3 with increasing equivalents of tosic acid. Glassy carbon 
electrode, 0.5mM solution in CH3OH; 0.2 V s−1; 0.1 M [N(n-Bu)4]PF6. 
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In order to explore the behaviour of 4 on addition of a proton source, the complex 
was first oxidised using FeCp2*PF6 to form the complex [CoII(mabiq)]PF6 (4-ox). This allowed 
us to obtain a CoII complex of Mabiq without the complication of axial chloride.  
The effect of adding a proton source to 4-ox can be seen in Figure 1.29. Addition of 
increasing equivalents of triflic acid triggers the appearance of a new catalytic irreversible 
anodic wave near the CoII/CoI couple. The CoII/CoI couple appears to be completely lost and 
there is no evidence of additional redox couples forming at this concentration. Due to time 
constraints, only very preliminary experiments were carried out on 4-ox but this is a 
promising result and suggests that the axial chloride anions do indeed cause the 
complicated processes occuring in both 1 and 2.  
 
Figure 1.29: Cyclic voltammogram for 4-ox with increasing equivalents of triflic acid. Glassy carbon 
electrode, 0.5mM solution in CH3OH; 0.2 V s−1; 0.1 M [N(n-Bu)4]PF6. 
 
 
 
 
 
 
 
39 
 
1.4 Conclusions and Further Work 
 The molecular structure of HMabiq is such that it is able to bind through the four 
nitrogen donors in the macrocyclic cavity, allowing the isolation of a three-electron series 
of monometallic compounds 1, 2, and 4.  
Despite the functionalities of Mabiq appearing well suited to the coordination of a 
second metal ion, this phenomenon was previously unreported. Complex 3 offers the first 
evidence of the ability of HMabiq to bind to a second metal. Based on the solution-state 
spectroscopic data, we conclude that the outer CoCl2 moiety is only weakly bound and 
readily removed from the bipyrimidine unit.   
Electrochemical data confirms the ability of monometallic Co(Mabiq) compounds 
to be further reduced yielding formally Co0 monoanionic species, likely resulting from the 
reduced form of the macrocycle. The removal of all axial chloride anions in complex 4 
introduces full electrochemical reversibility into the system. 
Preliminary studies into the suitability of these complexes as hydrogen evolution 
show promising results. Complex 1 and 2 show promising activity towards proton sources 
with both complexes exhibiting a current increase, however neither cyclic voltammogram 
appears clear cut with broad peaks and the emergence of new redox couples. Removing 
the axial chloride anions again appears to improve the system, the addition of a proton 
source to the cyclic voltammogram of complex 4-ox displayed the typical behaviour for 
total catalysis and was uncomplicated by broadening or additional redox couples. 
An unfortunate feature of complex 4 and indeed 4-ox is the increase in air sensitivity 
of these complexes. Complex 1 is air stable and while complex 2 shows some air sensitivity 
it is stable for a period of days. Complex 4 however is extremely air sensitive and is affected 
by air on a sub-second timescale. It may be beneficial to replace the chloride anion with a 
more labile ligand and hence increase the ease of access to the coordination site rather 
than removing the chloride anion altogether.  
The cyclic voltammetry of complex 3 only exhibited two redox couples, assigned to 
the CoIII/CoII  and CoII/CoI couple. This is a somewhat surprising result; due to the lability of 
the outer CoCl2 moiety we expected to see behaviour similar to that of complex 2. 
Disappointingly, the addition of a proton source to the CV of 3 showed no evidence of 
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catalytic activity. It is possible that at the higher concentrations of cyclic voltammetry there 
is little to no loss of the outer CoCl2 moiety.  
Now that the ability of HMabiq to coordinate two metal ions has been verified, 
exploration of this phenomenon is warranted. The effect of coordination of a second metal 
ion may be explored by the complexation of Zn into the macrocyclic cavity followed by the 
coordination of CoCl2 into the bipyrimidine unit. Modification to enhance the chelating 
ability of the external unit may be advantageous to this end. 
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Part 2 – New Tridentate and 
Tetradentate Ligands for Photoactive 
Metal Complexes 
 
 
 
 
 
 
 
 
 
PHOSPHORESCENCE. Now there’s a word to light your hat to… to 
find that phosphorescence, that light within, that’s the genius 
behind poetry. 
Emily Dickinson  
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2 Introduction 
 Since 1959 and the first report of phosphorescence resulting from a charge transfer 
state in the transition metal complex [Ru(bpy)3]2+, interest in photoactive metal complexes 
has grown exponentially.49 This explosion of interest has been driven by the many 
applications these complexes offer; phosphors for organic light-emitting devices (OLEDs) 
and light-emitting electrochemical cells (LEECs), light-harvesting units or ‘dyes’ for dye-
sensitised solar cells (DSSCs) and energy and/or electron donors in artificial photosynthesis 
to name but a few.50–53 The past two decades have seen thousands of transition-metal 
complexes synthesised and extensive studies have been reported on their 
photochemistry.54 The factors that govern the luminescence efficiencies of heavy metal 
complexes are now better understood; high-efficiency emission and systematic colour 
tuning are possible with a wide range of ligands.55  This review will consider the factors 
governing the luminescent properties of a compound and the strategies for the rational 
design of highly emissive transition-metal complexes. 
2.1 Luminescence 
 When light energy is absorbed by a molecule to form an excited electronic state, 
the molecule tends to try to lower its energy back to the ground state. Generally this is 
achieved by transferring the energy into vibrations and rotations known as non-radiative 
decay.56 However, in some molecules the energy may be lost radiatively, as a photon of 
light, in a process known as photoluminescence. This mode of decay of the excited state 
can be broadly divided into two categories: fluorescence and phosphorescence.  
 Fluorescence is the emission of light from a spin-allowed transition, i.e. from an 
excited state whose spin multiplicity is the same as that of the ground state (e.g. S1  S0). 
Emission from this pathway is relatively fast, being characterised by a high radiative rate 
constant krs of the order of 108-109 s-1, leading to emission lifetimes in the nanosecond 
range.57 When a molecule has been promoted to a singlet excited state, intersystem 
crossing (ISC) can occur, changing the spin multiplicity to a triplet excited state. Emission 
from this state is a spin-forbidden process (ΔS ≠ 0), referred to as phosphorescence. For 
purely organic molecules, the rate constant for this process is as low as 0.1-100 s-1 but 
incorporation of a heavy metal (such as platinum or iridium) into a molecule increases spin-
orbit coupling (SOC), which relaxes the spin selection rule and increases the rate constant 
of phosphorescence. Radiative decay through this pathway is still significantly slower than 
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fluorescence, leading to longer emission lifetimes on the order of microseconds. The 
pertinent states related to this process are represented with a classical Jabłoński diagram 
(Figure 2.1), first proposed by Professor Alexander Jabłoński in 1935.58  
 
 
 
 
 
 
 
 
 
Figure 2.1: A simplified Jabłoński diagram illustrating the rate constants for key processes. 
‘IC’ represents internal conversion followed by vibrational relaxation; ‘ISC’ represents 
intersystem crossing followed by vibrational relaxation.  
2.1.1 Quantum Yield 
 The efficiency of emission from a given excited state is quantified in terms of the 
photoluminescence quantum yield, φlum, which is simply the ratio of the number of photons 
emitted to the number of photons absorbed (assuming all the absorbed light led to the 
emitting state). This is determined by the relative rate constants of radiative decay (kr) and 
non-radiative decay (knr), according to equation 2.1. 
ɸ௟௨௠ =
௡ಶ
௡ಲ
 =  ௞ೝ
௞ೝ ା௞೙ೝ
                                                          (2.1) 
 Triplet states are generally not populated directly through absorption of light due 
to the spin selection rule; rather the T1 state is formed indirectly from the S1 state through 
ISC. However, for complexes with small ligands and heavy metals, ISC is usually much faster 
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than the rate of emission from the singlet excited state and so equation 2.1 can often still 
be applied. 
2.1.2 Electronic Transitions 
 In an organometallic compound, the molecular orbitals can be crudely 
approximated as either metal- or ligand-based. This results in the excited state generally 
being described as one of four transitions: metal centred (MC), metal-to-ligand charge 
transfer (MLCT), ligand-to-metal charge transfer (LMCT) and ligand centred (LC). These are 
illustrated schematically in Figure 2.2. It is important to note that although broadly 
classified in these states, if they are similar in energy, mixing of the states can occur and 
emission may be the result of a combination of transitions. 
 
 
 
 
 
 
 
  
Figure 2.2: An energy level diagram to illustrate the various possible excited states of octahedral 
metal complexes. 
2.1.3 Promoting Luminescence 
 It is clear that in order to design molecules which are brightly luminescent, a high kr 
and low knr value are desirable. The phosphorescence quantum yield also depends on the 
efficiency of formation of the triplet state, which is determined by the magnitude of the 
rate constant of ISC. The high-spin orbit coupling of a heavy metal nucleus facilitates both 
the ISC process and emission from the triplet state. As a result, the degree of metal 
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character in the excited state is important in determining the efficiency of emission; kr 
should be highest for excited states with a high degree of metal character, e.g. MLCT states.  
However, a d-d (MC) excited state with solely metal character typically leads to 
population of antibonding orbitals, causing an elongation of M-L bonds and significant 
distortion of the molecule in the excited state and therefore a large knr due to the 
isoenergetic crossing point lying at thermally accessible energies (Figure 2.3a). Bearing this 
in mind, a careful balance of energy levels must be achieved; if the MLCT state and the d-d 
states are quite close in energy, the d-d states can be thermally populated, i.e. if ΔE is 
comparable to kT (Figure 2.3b).  This offers a non-radiative decay pathway and renders a 
complex non-emissive at room temperature.  
 
 
 
 
 
 
 
Figure 2.3: (a) The displaced potential energy surface of the d-d excited state formed by 
population of an antibonding metal centred orbital. (b) The d-d state can provide a thermally 
activated decay pathway for other, lower-lying excited states if ΔE is comparable to kT. Thick 
arrows represent absorption of light; thin ones indicate vibrational relaxation and non-radiative 
decay. 
 Therefore, we can conclude that the most emissive complexes will be those in which 
(1) the lowest lying excited state is not a MC d-d state and (2) the energy gap between the 
lowest lying excited state and the d-d state is large enough to prevent thermally activated 
decay. 
 The higher spin-orbit coupling of the third-row metals promotes S1  T1 
intersystem crossing and promotes the T1  S0 phosphorescence process, making metals 
such as Pt and Ir a popular choice for emissive complexes. However, caution must be taken 
to ensure that the metal ion ‘participates’ in the excited state; the relative energies of MLCT 
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and LC states depend on the combination of ligand, metal and metal oxidation state. We 
shall now consider some of the main classes of Pt(II) and Ir(III) complexes that are 
luminescent under ambient temperatures. After reviewing some important and 
informative early examples, we will focus on advances from the past few years.  
2.2 Platinum(II) complexes of aromatic bidentate ligands 
 There are many Pt(II) complexes based on the Pt(N^N)X2 structure where N^N is a 
bidentate diamine ligand such as bipyridine or phenanthroline and their derivatives. X must 
provide a strong ligand-field to ensure the d-d state is not the lowest energy or thermally 
accessible from a lower-lying CT or LC state. For example, those where X = Cl are rarely 
significantly emissive. 
 An early example of a luminescent bidentate Pt(II) complex was reported by 
Kunkely et. al. where X = -C≡N in the complex Pt(dpphen)(CN)2, 1 (Figure 2.4).59 The strong-
field cyanide lowers the energy of the highest-occupied metal-centred orbitals and raises 
the vacant dx2-y2 orbitals, such that the Pt(N^N)(CN)2 emits from the π-π* state. The 
complex emits green light centred at 520 nm in dilute CH2Cl2 solution. At higher 
concentrations an association to an excimer takes place. The excimer emits at lower 
energy, with emission of red light centred at 615 nm. The excimer is reported as being 
characterised by a metal-metal bond which promotes dimerization and emission originates 
from the interaction of an excited monomer with a ground-state monomer.  
 Organometallic carbon derivatives that incorporate Pt-aryl bonds have also seen 
success. The high degree of covalency in Pt-C bonds and a good match between the 
energies of the highest filled metal and ligand-based orbitals frequently leads to the excited 
state having a significant degree of MLCT character.53 The bis-mesityl complex, 2 (Figure 
2.4), reported by Dungey et al. emits at 660nm in dilute toluene solution from a 3MLCT 
state. The colour of emission from these complexes can be readily tuned, for example 
related compounds containing perfluorinated aryl rings, reported by Nishida et al.,60 emit 
at substantially blue shifted wavelengths compared to the mesityl compound 2. This is 
rationalised by the electron-withdrawing influence of the fluorine substituents in lowering 
the energy of the metal-centred HOMO.  
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Figure 2.4: Representative Pt(II) complexes with bidentate ligands. 
 A further success in the preparation of luminescent bidentate Pt(II) complexes 
comes from the use of ‘pseudo-cyclometallates’. This replaces the neutral two-electron ‘L’ 
donors such as pyridines and quinolines by heterocycles such as pyrazoles, indazoles, 
imidazoles and triazoles. These systems can either coordinate via a neutral nitrogen atom 
or through deprotonation of a ‘pyrrolic’ nitrogen. In the latter case, the coordination 
offered to the metal is essentially analogous to that of a cyclometallating ligand; hence 
‘pseudo-cyclometallating’. These ligands again exert a strong ligand field, giving a beneficial 
effect on luminescence. An interesting example of this type of ligand was reported by Chi 
and co-workers when exploring the chemistry of Pt(II) with a series of 3-(2-pyridyl)pyrazole, 
3-(pyrazyl)pyrazole and 3-(2-pyridyl)triazole ligands.61 It was noted that PLQY in solution 
varied widely according to the substituents on the ring; the tert-butyl substituted 
complexes 3 and 4 are amongst the most efficient Pt(II) emitters known (φ = 0.82 and 0.86, 
respectively), whereas the analogues 5a and 5b display very weak emission under the same 
conditions (Figure 2.4).  
Another important class of Pt(II) bidentate complexes are those which incorporate 
a bidentate N^C cyclometallating ligand. The coordination pattern for Pt(II) complexes of 
this type may be type I or type II (Figure 2.5). Type I contains a bidentate cyclometallating 
ligand with two monodentate ligands and type II contains two bidentate ligands with at 
least one being cyclometallating. Depending on the nature of the ligands, the complexes 
can either be neutral or ionic.  
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Figure 2.5: Types of cyclometallated Pt(II) complexes. 
 In general, the emission of type I complexes tend to be inferior to type II complexes 
and are instead typically used as intermediates in the preparation of type II complexes.62 
The archetypal complex is one based upon 2-phenylpyridine (Hppy) and its analogues, 
modifications of which are mainly focused on colour tuning and improving PLQY. An 
interesting example of this modification is a series of lepidine-based ligands reported by 
Velusamy et al.63 The complexes 6 - 12 (Figure 2.6) contain 1 lepidine-based ligand and one 
O^O acac ligand and emit in the orange-to-red region with a wide range of PLQYs (φPL = 
0.15 – 0.99) (Table 2.1). The O^O ligand is easily introduced and normally does not influence 
the excited state energy significantly, so that the properties are essentially those associated 
with the N^C ligand.57 Electron-withdrawing substituents in the aryl ring lower the HOMO, 
leading to a shift to the blue, whereas extending the conjugation in the heterocycle shifts 
the emission to the red. 
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Figure 2.6: Lepidine-based Pt(II) complexes. 
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Table 2.1: Data for Lepidine-based Pt(II) Complexes in degassed toluene at 298 K. 
 Emission (nm) Q.Y. 
6 619 0.35 
7 617 0.70 
8 597 0.87 
9 593 0.99 
10 641 0.15 
11 600 0.74 
12 588 0.60 
 
 Schiff bases have provided a C^N cyclometallated alternative to 2-phenylpyridine; 
these complexes usually show intense phosphorescence in the solid state which is less 
efficient in solution.64 Komiya et al. reported a series of complexes bearing iminophenyl 
and iminophenoxy ligands, with an absolute quantum efficiency up to 0.29 in the crystalline 
state (Figure 2.7).64 The complexes show extraordinarily wide chromogenic change; 
emission occurs over a range of 99nm when simply introducing methoxy groups at different 
positions on the rings (R1 – R4).  
 
Figure 2.7: Cyclometallated Pt(II) complexes based on Schiff base ligands. 
2.3 Platinum(II) complexes of aromatic tridentate ligands 
 In an effort to further increase PLQY, researchers have turned their attention to 
tridentate ligands. The d-d excited states of Pt(II) complexes with bidentate ligands are  
susceptible to distortion away from the D4h symmetry of the ground state towards a D2d 
symmetry, in which the plane of the bidentate ligand is twisted relative to that containing 
the other two ligands.65 As discussed previously, excited state distortion is associated with 
an increase in non-radiative decay causing an adverse effect on PLQYs. Tridentate ligands 
which are able to bind via three sites rather than two in a planar conformation should 
inhibit such distortion owing to a more rigid binding.  
50 
 
2.3.1 N^N^N-Coordinated Ligands 
 The N^N^N-coordinated platinum terpyridyl  complex of Pt(II) [Pt(tpy)Cl]+ (14, 
Figure 2.8) was first synthesised by Morgan et al. in 1934.66 The photophysical properties 
were not explored until the 1990s when it was found that room temperature luminescence 
was not observed. The coordination bite angle around Pt(II) is smaller than the favourable 
180° about the N-Pt-N.67 This strain results in a weaker ligand field compared to that which 
is expected, such that the anti-bonding dx2-y2 orbital lies at a similar energy to the ligand π*. 
In order to enable room temperature luminescence, the ligand field strength must be 
increased to raise the dx2-y2 orbital so it can no longer be populated, or the MLCT radiative 
excited state lowered to an extent where population of the dx2-y2 orbital is no longer possible. 
 
Figure 2.8: Terpyridyl Pt(II) complex, [Pt(tpy)Cl]+. 
 Systematic exploration of substituent effects has led to the preparation of 
[Pt(tpy)Cl]+ derivatives that are luminescent at room temperature. Introduction of 
substituents in the 4 position of the central pyridine ring was shown to produce 
luminescent compounds by McMillin et al.68 As shown in Figure 2.9, the introduction of the 
electron-withdrawing substituent inhibits thermal population of the d-d excited states by 
lowering the MLCT state further than the d-d states and increasing the energy gap. The 
introduction of an electron-donating substituent stabilises the MLCT state in relation to the 
deactivating d-d states, due to the lone pairs on the substituents conjugating with the π-
system of the terpyridine ligand. A new π-π* state is formed with intra-ligand charge-
transfer (ILCT) character which increases the gap between the emissive and non-radiative 
states. 
Replacement of the chloride ancillary ligand with a stronger-field ligand can also 
increase ligand field splitting, increasing the energy of the d-d states and reducing the 
likelihood of their population. A good example of this is an acetylide ligand and a wide range 
of emissive complexes based on [Pt(tpy)(-C≡C-R)]+ have been reported.69–71 Other studies 
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have shown that increasing the size of the chelate ring from a 5 to 6 membered can relieve 
ring strain in the system, giving a bite angle closer to 180° which gives a stronger ligand 
field and promotes the d-d energy.72  
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Molecular orbital diagram for the proposed excited state energies of 4-substituted 
Pt(II) tpy complexes for electron-withdrawing and electron-donating substituents.6 
2.3.2 N^N^C-Coordinated Ligands 
Replacing one of the nitrogen atoms in the terpyridine ligand by a cyclometallating 
aryl ring has a profound effect on the luminescence. Constable et al. first reported the 
cycloplatinated complex of 6-phenyl-2,2’-bypridine (phbpyH) shown in Figure 2.1073. In 
contrast to [Pt(tpy)Cl]+, the N^N^C complex 18 shows modest room temperature 
luminescence (λmax = 565 nm, φPL = 0.025)74. The strong σ-donating power of the 
deprotonated carbon and the extended π-system creates a very strong ligand field, 
increasing the energy difference between the d-d states and MLCT states.  
                                                            
6 Adapted with permission from Coord. Chem. Rev., 2002, 229, 113, Copyright (2002), Elsevier Science B.V. 
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Figure 2.10: N^N^C-coordinated complex Pt(phbpy)Cl. 
Che and co-workers have provided an in-depth study into the cyclometallated Pt(II) 
complex with the N^N^C-coordinating ligand, 6-phenyl-2,2’-bypridine (phbpyH) and its 
derivatives, providing around 30 examples with σ-alkynyl ligands in the fourth coordination 
site rather than chloride.75 Most of the reported complexes were emissive in solution at 
room temperature and emission was attributed to a 3MLCT(dPtπ*NNC) state. Structural 
modification of the N^N^C ligand and the acetylide can be used to influence the emission 
properties, tuning the colour emitted from green-yellow to saturated red. For example, 
electron-withdrawing substituents on the acetylide ligand shift the emission maxima to 
higher energy as the metal-based HOMO is lowered in energy (Figure 2.11). Introduction 
of substituents into the 4-position of the pyridyl rings is also an effective method of colour 
tuning, whilst substituents on the cyclometallating phenyl ring were found to have very 
little influence. However, changing from phenyl to thienyl or furanyl rings led to substantial 
red shift due to the more electron-rich nature of these heterocycles (Figure 2.12).57 
Interestingly, Harris et al. found a decrease in emission efficiency by increasing the 
size of one of the 5-membered chelate rings to a 6-membered ring (Figure 2.13).76 Although 
this change brings the complex closer to the ideal square planar geometry for a Pt(II) 
complex, the accompanying increase in flexibility of the molecule has a detrimental effect 
on the quantum efficiency.   
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Figure 2.11: Normalised emission spectra for N^N^C-Pt(II) complex with various R substituents 
shown. Spectra were taken at 298 K in DCM solution.7  
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Figure 2.12: Structures and emission properties of N^N^C-coordinated Pt(II) complexes with 
various cyclometallated heterocycles. Measurements taken at 298 K in DCM solution.75 
 
 
 
 
 
 
 
Figure 2.13: Structures and emission properties of N^N^C-coordinated Pt(II) complexes reported by 
Harris et al. Measurements taken at 298 K in DCM solution.76 
                                                          
7 Adapted with permission from J. Am. Chem. Soc., 2004, 126, 4958–4971. Copyright (2004) American 
Chemical Society. 
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2.3.3 N^N^O-Coordinated Ligands 
 The aryl ring of N^N^C Pt(II) complexes can be replaced by a phenolate, giving a 
range of luminescent [(N^N^O)PtX] complexes (where X = Cl, Br, I or -C≡C-Ph and Y = H, Me 
or t-Bu; Z=H or F) as reported by Kwok et al. (Figure 2.14).77 For complex 26, broad orange-
red emission (λmax = 593-618 nm) originates from triplet excited state with mixed 3MLCT 
and 3[l  π*(diamine)] (l = lone pair/phenoxide) parentage. Unfortunately, the PLQYs were 
too low to be measured; this was attributed to quenching by DMF.  
 
Figure 2.14: N^N^O-coordinated Pt(II) complex. 
2.3.4 N^C^N-Coordinated Ligands 
 Changing the position of the cyclometallating ring can lead to significant differences 
in the chemistry and properties of Pt(II) complexes. The N^C^N-coordinated complex 
(Figure 2.15) was first reported by Cárdenas et al. in a study investigating the complexation 
chemistry of 1,3-di(2-pyridyl)-benzene with Pt(II) and Pd(II).78 Williams et al. carried out the 
first photophysical study of the Pt(II) complex 27 (Y = Z = H) and reported intense 
luminescence; φlum = 0.60 and τ = 7.2 μs in  degassed DCM.79 This is an order of magnitude 
higher than the isomeric N^N^C-coordinated compound Pt(phbpy)Cl. The unexpectedly 
high luminescence is attributed to the Pt-C bond in Pt(dpyb)Cl being significantly shorter 
than in Pt(phbpy)Cl, and hence the ligand-field strength being higher. The emission is highly 
structured and is scarcely shifted upon cooling to 77K, indicating emission from a primarily 
LC π-π* state, the contribution of the metal is nevertheless sufficient to promote efficient 
triplet emission.  
 
Figure 2.15: N^C^N-coordinated Pt(dpyb)Cl 
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 The N^C^N-coordinated complex offers a versatile approach to colour tuning of 
emission.55 DFT calculations reveal that the HOMO spans across the cyclometallating ring, 
the metal and the chloride co-ligand whereas the LUMO is localised on the pyridine rings. 
This accounts for the influence of substituents at the 4-position of the phenyl ring on 
emission energy. For example, the introduction of electron-donating aryl groups shifts the 
emission increasingly to the red while a blue shift is caused by electron-withdrawing groups 
(Figure 2.16).51  
It is interesting to note that the complex incorporating the strongly electron-
donating pendant R = -C6H4NMe2 displays a broad, structureless emission band with a high 
degree of positive solvatochromism not displayed by the other complexes (Figure 2.16). 
This behaviour suggests a switch in the nature of the lowest-energy excited state towards 
one of primarily ILCT, due to the high degree of stabilisation of the emissive excited state. 
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Figure 2.16: Normalised emission spectra of the Pt(dpyb)Cl complexes measured in DCM at 298 K 
(right) and emission spectra of R = -C6H4NMe2 in solvents of differing polarity at 298 K (left).8 
 Increasing the two 5-membered chelate rings of the complex to two 6-membered 
chelates was found to have a dramatic effect on emission efficiency (Figure 2.17, far right 
complex). The resulting complex 30, reported by Williams and co-workers, was found to 
have severely diminished emission despite having a bite angle close to the desired 180°.72 
                                                          
8 Reprinted with permission from Inorg. Chem., 2005, 44, 9690–9703, Copyright (2005) American Chemical 
Society. 
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The PLQY was reduced to 1.6% in DCM from 60% and the λmax was shifted to 645 from 491 
nm. Williams and co-workers attributed this to emission originating from a predominately 
LC triplet state, making the radiative transition less allowed. 
 Interestingly, inserting an amino linker between the pyridine and phenyl units gives 
a modest increase in emission efficiency: complex 29 (Figure 2.17) emits green light with a 
65% PLQY, despite the shift of λmax to a longer wavelength of 506 nm.80 As seen for other 
Pt(II) complexes, substitution of the chloride ligand for an acetylide monodentate ligand 
can also lead to somewhat superior PLQY for the resulting complexes. 
 
Figure 2.17: Chelate ring sizes of N^C^N-coordinated Pt(II) complexes.  
2.3.5 C^N^C-Coordinated Ligands 
 The introduction of a second cyclometallating ring to produce Pt(II) complexes 
based on 2,6-diphenylpyridine (31, Figure 2.18) are only weakly emissive in solution, 
although modest PLQYs have been achieved with the introduction of thiophene, fluorene 
and carbazole groups as anionic carbon donors.81  
Kui et al. reported a series of such modified ligands (Figure 2.19) and observed 
emission in solution at room temperature with λmax at 564 – 619 nm and φ = 0.02 – 0.26.81 
Emission was attributed to excited states with mixed 3MLCT and 3IL character.  
 
Figure 2.18: Bis-cyclometallated Pt(II) complex based on 2,6-diphenylpyridine. 
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Figure 2.19: Pt(II) C^N^C-coordinated complexes reported by Kui et al. 
2.4 Platinum(II) complexes of aromatic tetradentate ligands 
 In efforts to develop suitable triplet emitters to be used in OLEDs, the development 
of phosphorescent Pt(II) complexes with tetradentate ligands is a rapidly growing field. 
Inspiration for this class of emitters was the unfavourable photophysical properties 
displayed by bis-bidentate bis-cyclometallated Pt(II) complexes such as cis-[Pt(ppy)2], ( non-
emissive at room temperature) and cis-[Pt(thpy)2] (Hthpy = 2-(2-thienyl)pyridine), which is 
emissive but unstable towards sublimation. The poor PLQYs displayed by such complexes 
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are at least in part attributed to the flexibility of the complexes.62 The rigidity can be 
improved by linking the two ligands together to form a ligand which can offer tetradentate 
coordination and a structure closer to planarity might be anticipated. Depending on how 
the C-Pt and N-Pt bonds are arranged, there is a possibility of four different coordination 
patterns as shown in Figure 2.20. 
 
Figure 2.20: Schematic representation of various coordination modes. 
 In 2009, Feng et al. investigated the first bis-cyclometallated tetradentate platinum 
complexes, preparing C^N*N^C complexes 41 and 42 (Figure 2.21).82 Both complexes 
emitted at λmax = 492nm with PLQYs of 0.54 (41) and 0.58 (42). Vezzu et al. later showed 
the effect of functionalisation by using an amine linker to offer high modularity in ligand 
design.83 Interestingly, DFT calculations show the HOMO is based on the phenyl rings and 
the metal while the LUMO is localised on the pyridine rings (Figure 2.22). The complexes 
43 and 44 both showed high PLQYs of 0.74 and 0.75, respectively, although the emission 
wavelength was blue shifted from λmax = 512 nm to λmax = 488 nm with the presence of 
fluorine in the complex. 
 
Figure 2.21: C^N*N^C Pt(II) complexes 41 and 42. 
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Figure 2.22: ΔE comparison between Pt(II) complexes 43 and 44. 
 Vezzu et al. also studied the influence of the coordination pattern on the 
photophysical properties, reporting a series of N^C*C^N Pt(II) complexes (45 – 48, Figure 
2.23).84 DFT calculations showed the HOMO was again localised on the phenyl rings and the 
metal and the LUMO localised on the pyridine/pyrazole rings. Replacement of the pyridine 
rings by pyrazole rings causes a bathochromic shift from λmax = 613 nm to λmax = 474 – 516 
nm (Figure 2.24). The more electron rich pyrazole raises the LUMO level causing the blue 
shift in complexes 46 – 48. 
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Figure 2.23: N^C*C^N Pt(II) complexes. Room temperature emission spectra of 45 – 48 in degassed 
THF at 298K.9 
In 2013, Huo et al. investigated the C^C*N^N coordination pattern with complexes 
containing a pyridyl ring and a pyrazole ring (complexes 49 and 50, Figure 2.24).85 Careful 
design of the proligand scaffold was required to restrict rotation, due to the preferential 
formation of C^N^N-coordinated complexes. Complex 49 is weakly emissive in the red 
                                                          
9 Adapted with permission from Inorg. Chem., 2010, 49, 5107–5119. Copyright 2010 American Chemical 
Society. 
ΔE ΔE 
LUMO 
LUMO 
HOMO 
HOMO 
45 
46
47 
48 
60 
 
region (λmax = 660 nm, φPL = 0.001), but 50 emits bright yellow light in DCM at 298K (λmax = 
555 nm, φPL = 0.17). This increase in PLQY is unsurprising, PLQYs are generally highest in 
the green region; they fall off towards the blue because of the role of higher-lying states 
and towards the red because of vibrational deactivation. The emission is attributed to a 
primarily ligand centred transition (ILCT) with admixture of MLCT.  
 
Figure 2.24: C^C*N^N Pt(II) complexes 49 and 50. 
  Pseudo-cyclometallation has also seen some success in the preparation of 
tetradentate complexes. Oxygen ligands on their own are usually unsuitable for forming 
stable complexes with the soft Pt(II) ion but stable complexes can be formed when 
combined with other ligands such as diimines.57 Shagisultanova reported in 1998 that the 
well-known proligand, N,N’-bis(salicylidine)-1,2-ethylenediamine or salen forms a highly 
luminescent Pt(II) complex, 51 (Figure 2.25).86 The emissive state is assigned to one of 
d(Pt)/π(O)π*(Schiff base) character, giving a PLQY of 0.19 in MeCN. Che and co-workers 
explored the luminescence of the related ligand based on dpphen appended with ortho-
phenoxy groups, finding the resulting Pt(II) complex, 52 (Figure 2.25) to be superior in terms 
of solution PLQY, reporting an impressive φPL = 0.6 in MeCN. 
 
Figure 2.25: Pseudocyclometallated Pt(II) complexes. 
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 Charge neutral O^C^C^N complexes, where the two carbon donors are from neutral 
carbene species, were recently reported by Li et al (Figure 2.26).87 Complexes 53 to 57 emit 
in the region λmax = 443 – 461 nm with φPL = 3 – 18%. Complex 58 however does not emit 
at room temperature, owing to severe structural distortion in the T1 excited-state and the 
resulting increase in knr, revealed by DFT calculations. 
 
Figure 2.26: Pt(II) complexes 53 – 58 bearing a tetradentate O^C^C^O ligand. 
Impressive PLQYs have been reported by Kui et al. for a series of O^N^C^N-
coordinated Pt(II) complexes, which feature one 6-membered metallacycle and two 5-
membered metallacycles (Figure 2.27).88 All complexes displayed green-blue emission, with 
high PLQYs, φlum = 0.72 to 0.93 and long luminescence lifetimes (τ = 11 to 28 μs). 
 
Figure 2.27: Tetradentate Pt(II) O^N^C^N complexes 59 – 63. 
 A number of closely related O^N^C^N-coordinated Pt(II) complexes with two 6-
membered metallacycles and one 5-membered metallacycle have been reported by Cheng 
et al., utilising a bridging tertiary amine (64) or a biphenyl group with a spiro linkage (65) 
(Figure 2.28).89 Both complexes are efficient emitters; 64 emits at 551 nm with a PLQY of 
0.9 and 65 emits at 517 nm with a PLQY of 0.8. The emission is tentatively assigned to 
excited states having mixed 3MLCT and 3[l  π*(N^C^N)] (l = lone pair of phenoxide) 
parentage.  
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Figure 2.28: O^N^C^N-coordinated Pt(II) complexes with two 6-membered metallacycles and one 
5-membered metallacycle. 
2.5 Iridium(III) complexes of aromatic ligands 
 Although once less studied than the other platinum group metals, iridium has 
become of intense interest in the past 20 years.90 Most studies have focused on tris-
bidentate complexes; the complex [Ir(ppy)3] (66) (Figure 2.29) and its derivatives have been 
at the centre of many OLED studies. The related cationic systems, of which [Ir(ppy)2(bpy)]+ 
(67) is representative (Figure 2.29), have also seen much interest; with applications in light-
emitting electrochemical cells (LEECs), as probes and sensors for biomolecules and as 
photocatalysts for water splitting.90 The area has been extensively reviewed and the reader 
can refer to a number of comprehensive reviews listed in the references.91–95 
 
Figure 2.29: Two key tris-bidentate Ir(III) complexes; fac-[Ir(N^C-ppy)3] (left) and [Ir(N^C-
ppy)2(N^N-bpy)]+. 
 Despite the increase in interest, only a limited number of groups world-wide have 
studied Ir(III) complexes with tridentate ligands. As discussed for Pt(II) complexes, 
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tridentate ligands can lead to different properties and excited states when compared with 
bidentate analogues. Interestingly, for Ir(III) complexes, C2-symmetrical tridentate ligands 
produce achiral complexes as opposed to the tris-bidentate complexes which are 
intrinsically chiral; the latter form as a racemic mixture of Ʌ and Δ isomers.  
 In contrast with the archetypical [Pt(tpy)Cl]+, the parent complex [Ir(tpy)2]+ (68, 
Figure 2.30) shows structured emission with maxima at 458, 491 and 523 nm and a PLQY 
of 0.02 – 0.06 depending on counter anion and solvent.96 The highly structured emission 
profile, with a vibrational spacing of ~1400 cm-1 that is typical of coupling with aromatic 
C=C vibrations, is characteristic of emission from states with relatively little involvement of 
the metal and the emission is attributed to LC π-π* excited states.90 The preparation and 
purification of these complexes was described as ‘ardous’ in the first reports; this difficult 
chemistry was once a hallmark of Ir(III) complexation chemistry.90 However, an optimised 
synthesis of these complexes has been developed and the milder, stepwise route allows 
for the introduction of two differently substituted terpyridines into the coordination 
sphere.97 Taking inspiration from the method commonly used for the preparation of 
asymmetric terpyridine complexes of Ru(III), tpy is reacted with IrCl3.nH2O in ethylene 
glycol to give [Ir(tpy)Cl3] as an intermediate, which is then reacted with a second tridentate 
ligand to produce the target complex (Scheme 2.1). 
 
Figure 2.30: [Ir(tpy)2](PF6)3 
 
Scheme 2.1: The synthesis of [Ir(tpy)2](PF6)3 via [Ir(tpy)Cl3]. 
 Cyclometallation has also proven successful in the chemistry of Ir(III) with tridentate 
ligands. Wilkinson et al. sought to introduce 1,3-di(2-pyridyl)benzene (dpyb) into the 
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coordination sphere of Ir(III) to bind in an N^C^N fashion (Figure 2.31, binding mode I).98 
However, reaction of dpybH with IrCl3.3H2O resulted primarily in complexation through 
binding mode II. Interestingly, cyclometallation at the C4 position is kinetically favoured 
over reaction at the more hindered C2 position. This can be overcome by using the xylene 
derivative, 1,3-di(2-pyridyl)-4,6-dimethylbenzene (dpyxH), to block cyclometallation in 
binding mode II and give the chloro-bridged dimer [Ir(dpyx)Cl(μ-Cl)]2, 69 (Scheme 2.2, 
centre). Reaction of the intermediate dimer with a wide range of proligands successfully 
forms a diverse selection of bis-tridentate Ir(III) complexes with varied coordination 
spheres, as seen in Scheme 4.3. 
 
Figure 2.31: N^C^N and N^C binding modes of dpyb. 
 The emission colour of these Ir(III) bis-tridentate complexes can be tuned in an 
analogous manner to the Pt(II) complexes discussed, and the selection of these chelates 
mainly focuses on achieving diverse emission colour.  
Introduction of one cyclometallating ligand alongside tpy, as in the case of 70 and 
71, does not favourably affect the emission properties; indeed, these complexes display 
only very weak emission, on the order of φ = <10-4.90 DFT calculations reveal that the metal 
character of the lowest energy excited state is not significantly increased; the HOMO is 
localised on the N^C^N ligand with a small contribution from the metal and the LUMO is 
localised on the N^N^N ligand, again with a small contribution from the metal.90 As 
discussed in previous sections, given the small contribution of metal character to the 
excited state, the radiative rate constant kr is expected to be small. 
The introduction of a second cyclometallating carbon atom, as seen for complexes 
72 and 73, increases the PLQY appreciably. These complexes, with a cis arrangement of the 
cyclometallating carbons in different ligands, have PLQYs of 0.023 (73) and 0.063 (72). An 
interesting difference in such complexes emerges, according to whether the carbon atoms 
are mutually cis or trans to one another. In the case of complexes containing trans 
cyclometallated carbons within the same ligand, such as complexes 79 and 80 (Figure 2.32), 
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we observe a decrease in the radiative rate constant by at least an order of magnitude, 
giving rather small radiative rate constants on the order of 104 s-1. This difference is again 
explained by DFT calculations, showing that the cis complex HOMO and LUMO has some 
contribution from the metal whereas in the trans complex the HOMO and LUMO are 
located on the ligands. Despite this difference in radiative rate constant, the PLQYs of the 
two classes remain remarkedly similar, presumably because the non-radiative decay 
constants increase by a roughly comparable factor.90 
The introduction of a third anionic ligand into the coordination sphere has a 
dramatic effect on the PLQY, giving a uniformly beneficial effect. This effect can primarily 
be attributed to the increase in radiative rate constant kr.90 The PLQYs of such complexes 
exceed 0.2 in almost all cases. 
Bernhard and co-workers reported the related homoleptic complex [Ir(phbpy)2]+ 
(81, Figure 2.33), which has a similar coordination environment to that of the highly 
versatile [Ir(C^N)2(N^N)]+ (82, Figure 2.33).99 Complex 81 has an increased excited-state 
lifetime (τ) of 548 ns compared to the 385 ns lifetime of complex 82; this longer lifetime is 
attributed to the increased rigidity of complex 81. It is interesting to note that the deviation 
from octahedral geometry resulting from the use of the tridentate ligand in complex 81 
lowers the PLQY (φ = 3.9%) from that of complex 82 (φ = 7.3%). 
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Scheme 2.2: Structures of a range of Ir(III) complexes containing the N^C^N-bound dpyx ligand. 
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Figure 2.32: Examples of trans bis-cyclometallated complexes containing the C^N^C-coordinating 
ligand, 2,6-diphenylpyridine (bottom) or one of its derivatives (top). 
 
Figure 2.33: [Ir(phbpy)2]+ and the related [Ir(ppy)2(bpy)]+. 
2.6 Concluding Remarks 
In conclusion, this review has sought to highlight the factors that influence the 
excited state energies of luminescent Pt(II) and Ir(III) complexes. The continued design and 
development of these complexes has shown the importance of radiative decay versus non-
radiative decay. Ligand design plays a crucial role in controlling the excited state properties 
and new synthetic strategies will play an increasingly valuable role. Cyclometallating 
chelates have shown considerable promise in the assembly of luminescent metal 
complexes and provide a promising route to achieving high PLQYs across a broad spectrum 
of emission wavelengths.  
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3 Synthesis of Mononuclear Pt(II) and Ir(III) complexes 
3.1 Background and objectives of the work 
In the field of luminescent Pt(II) complexes, it has been found that tri-/tetradentate 
ligands can sometimes offer advantages over bidentate analogues in that they rigidify the 
square-planar Pt(II) complexes, reducing non-radiative excited-state decay and thus 
enhancing luminescence.100 Bidentate complexes can undergo a distortion from square 
planar towards tetrahedral in the excited state, a process not open to a complex with a 
tri/tetradentate ligand. However, the synthesis of such multidentate ligands is often 
arduous, relying on costly metallo-organic precursors, Pd(0) catalysts, and extensive 
column chromatography.52 
As discussed in Chapter 2, anionic, tridentate proligands such as 1,3-di(2-
pyridyl)benzene (dpybH) have been shown to form complexes with outstanding 
luminescence efficiencies – the Pt(II) complexes of these ligands are amongst the brightest 
platinum emitters known.52 In contrast to Pt(II), Ir(III) binds to dpybH at the C4 position, 
giving bidentate coordination (Figure 3.1). Appropriate ligand modification must be used 
to block this reaction and direct the metalation to the C2 position to give N^C^N 
coordination.52 
 
Figure 3.1: N^C^N and N^C binding modes of dpybH. 
The combination of σ-donating nitrogen atoms and π-accepting heterocycles leads 
to relatively low energy charge-transfer (CT) states and thus helps to ensure these 
complexes absorb and emit in the visible region. The closely related N^N^C-binding ligand 
6-phenyl-2,2’-bipyridine (phbpyH) also shares these properties but the different position 
of the cyclometallating phenyl ring can lead to significant differences in coordination 
chemistry and properties.  
The work presented in this chapter focuses on the quest for highly luminescent Pt(II) 
and Ir(III) complexes using tridentate ligands that are more readily synthesised. We have 
developed a series of ligands which retain the key desirable features of dpybH and phbpyH 
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(imparting rigidity on resulting complexes) but removes the need for cross coupling in their 
formation. We have also included pseudo-cyclometallating units in order to retain the 
favourable properties whilst dispensing of the need for the harsh conditions required for 
cyclometallation (Figure 3.2). 
 
Figure 3.2: The conceptual link between dpyb and phbpy ligands and those reported in this 
chapter offering an anion N^N-^N and N^N^O- donor set. 
We have also explored tetradentate analogues of some of these tridentate ligands. 
As discussed in chapter 2, an increasing number of complexes with tetradentate ligands in 
the literature have shown greatly increased emission efficiencies, probably owing to the 
greater rigidity.53 It is also well reported that the chloride ligand in tridentate Pt(II) 
complexes is somewhat labile and can be replaced with other ligands.53 This may call into 
question the nature of these complexes in solution, especially in coordinating solvents.  
3.2 Synthesis of tridentate ligands 
3.2.1 N^N^O ligands 
Imine-based N^N^O Ligands 
 Since their discovery by Hugo Schiff in 1864101, Schiff bases have been extensively 
studied as an important class of ligands for metal coordination, with ligands based on the 
famous tetradentate proligand N,N’-bis(salicylidene)-1,2-ethylenediamine (H2Salen) 
having been studied in a number of research areas (Figure 3.3).102 Such ligands feature a 
combination of imine nitrogen and phenolic oxygen donors. However, study of this 
important class of ligands remains surprisingly limited in terms of excited state 
chemistry.103 The small amount of research that has examined Schiff base complexes for 
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photochemical applications102–108 has largely focused on complexes of the H2Salen parent 
ligand and its analogues.  
 
Figure 3.3: Proligand H2Salen. 
Schiff bases are formed by a condensation reaction between an aldehyde and a 
primary amine, requiring very mild conditions and no catalysis. Imine formation is 
traditionally carried out in an anhydrous organic solvent, which helps to push the 
equilibrium towards the condensation product.109 
We sought to prepare new proligands offering an N^N^O- coordination set, in which 
the central N atom would be an imine. Such ligands can be considered analogues of N^N^C- 
cyclometallation ligands such as phbpy, but their synthesis should be achievable through 
Schiff base chemistry rather than requiring C-C bonding forming cross-coupling. 
Preparation of proligands HL1, HL2 and HL4 have been described previously.110,111 The 
synthetic route to HL1 – HL4 is depicted in Scheme 3.1. The proligands were prepared in the 
absence of solvent using a ‘melt’. The aldehyde and amine were mixed and heated with 
stirring to 65°C under vacuum and the reaction progress was monitored by 1H NMR; a near 
unity conversion was observed. Due to the sensitivity of the product to hydrolysis, the 
ligands were used directly for complexation without any formal isolation or 
characterisation. 
 
Scheme 3.1: Synthetic route to Imine bridged N^N^O- proligands HL1-HL4. 
 Hydrazone-based N^N^O Ligands  
 Given the susceptibility of the imine-based N^N^O proligands to hydrolysis, we 
reasoned that a hydrazone linker might offer an attractive alternative to generate a more 
hydrolytically stable analogue (Scheme 3.2). Preparation of proligands HL5 and some of its 
derivatives have been reported previously.112 The synthetic routes to HL5 – HL13 are 
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depicted in Scheme 3.2. The ligand precursor, 2-hydrazinopyridine, was prepared in an 85% 
yield by refluxing 2-bromopyridine and hydrazine hydrate to yield a pale orange solid. The 
proligand, HL5, was prepared by reaction of the precursor and salicyladehyde, in methanol, 
at reflux for 30 minutes. A wide number of substitutions can be made on the phenol; the 
series of ligands HL6 to HL13 were prepared in the same way as HL5, using the appropriate 
salicylaldehyde. The reaction invariably produces a fine powder which can be isolated in 
good yield by filtration without need for further purification. 
  
Scheme 3.2: Synthetic routes to hydrazone bridged N^N^O ligands, HL6-HL13. Conditions: (i) 110°C, 
4 h; (ii) 70°C, MeOH, 1 h. 
 Condensation of a hydrazine and an aldehyde results in a significant upfield shift of 
the N=C-H proton in the 1H NMR spectra. For instance, the O=C-H proton in salicylaldehyde 
has a chemical shift of 9.89 ppm (in CDCl3), while the N=C-H proton in HL5 has a shift of 7.94 
ppm (in CDCl3). The aromatic protons and the phenolic proton are largely unaffected.  
 Crystals of HL5 were obtained by slow evaporation of the methanol filtrates from 
the reaction (Figure 3.4). The structure obtained confirms the identity of the compound; 
interestingly there is hydrogen bonding within the molecules (N3–H1, 1.904 Å) and to 
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neighbouring molecules (N1–H2, 2.185 Å) but the packing adopted by this molecule shows 
no evidence of π-π interactions between the sheets.113  
 
Figure 3.4: Crystal structure and illustration of the packing adopted by HL5. Crystallised from 
MeOH. T = 120 K. 
We have also explored the replacement of the N-H functionality with a N-Me moiety 
(Scheme 3.3). The ligand precursor, 2-(1-methylhydrazinyl)pyridine is prepared in an 
analogous manner to 2-hydrazinopyridine, by refluxing 2-bromopyridine and 
methylhydrazine. The resulting yellow oil was used to prepare proligand HL14 by reaction 
with salicylaldehyde. Again, a range of substitutions can be made on the phenol by 
employing different salicylaldehydes. In this case, we also prepared some derivatives 
incorporating different substituents on the pyridine ring by preparing the appropriate 
pyridylhydrazines.  
Condensation of a methylhydrazine and an aldehyde again results in a significant 
upfield shift of the N=C-H proton in the 1H NMR spectra. For instance, in HL14 this proton 
resonates at 7.80 ppm in CDCl3 compared to 9.89 ppm for salicylaldehyde. The aromatic 
and phenolic protons are largely unaffected nor is there a significant shift of the N-Me 
protons.  
N3 
H1 
N1 
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Scheme 3.3: Synthetic routes to hydrazone N-Me bridged N^N^O ligands, HL14-HL20. 
Conditions: (i) 110°C, 4 h; (ii) 70°C, MeOH, 1 h. 
Pyrazole Based N^N^O Ligand 
 The N-N=C unit of the above proligand is reminiscent of part of a pyrazole ring. In 
order to explore the effect of rigidification of this part of the structures the pyrazole-based 
proligand HL21 (Figure 3.5) was targeted. 
 
Figure 3.5: Pyrazole bridged N^N^O ligand, HL21. 
In order to synthesise HL23, we first prepared the intermediate 3-(dimethylamino)-
1-(2-hydroxyphenyl)prop-2-enone (Scheme 3.4, a) by replicating the synthesises reported 
by Li et al.114 2-Hydroxyacetophenone and N,N-dimethylformamide dimethyl acetal 
(DMFDMA) were heated to 70°C in DMF for 30 minutes. The desired product ‘a’ was 
obtained by precipitation from saturated brine. 
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Scheme 3.4: Synthetic route to HL21. Conditions: (i) DMFDMA, DMF, 75°C, 30 min; (ii) N2H4.H2O, 
EtOH, reflux, 6 h; (iii) CuI, trans-1,2-diaminocyclohexane, K2CO3, 1,4-dioxane, reflux, 24 h 
Intermediate b was then synthesised by replicating the synthesis reported by 
Seubert et al.115 Hydrazine monohydrate and intermediate a were dissolved in ethanol and 
refluxed for 6 hours to afford the pure product after work up in a 62% yield.  
 Proligand HL21 was subsequently obtained from ‘b’ by using the general conditions 
for the copper-diamine catalysed N-arylation of pyrazoles reported by Buchwald and co-
workers.116 A mixture of intermediate ‘b’ (1.0 equiv), 2-bromopyridine (1.2 equiv), trans-
1.2-cyclohexanediamine (20 mol%), CuI (5 mol%) and K2CO3 (2.1 equiv) in anhydrous 1,4-
dioxane was degassed via 3 freeze-pump-thaw cycles before being refluxed for a period of 
24 hours. The reaction gave HL21 in a 55% yield. As observed by Buchwald and co-
workers,116 the reaction selectively forms the product in which the less hindered nitrogen 
is arylated. The 1H and 13C NMR study of the structure of pyrazoles reported by Yranzo and 
co-workers makes the identification of the H1 and H2 trivial (refer to Scheme 3.4 for 
numbering); H2 is consistently downfield from H1.117 1H-1H NOESY is useful for determining 
which protons are close to each other in space rather than through bonds; the NOESY 
spectrum  shows  a correlation between H2 and H3 confirming arylation of the less hindered 
nitrogen.  
3.2.2 N^N^N ligands 
 Due to the higher QYs typically exhibited by N^C^N-coordinated dpyb complexes 
compared to their N^N^C-coordinated phbpy analogues, we were eager to explore closely 
related ligands which offered a central position for the anionic ligating atom.  
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Hydrazide-based N^N^N Ligands 
2-Picolinoylhydrazides which possess a coordinating substituent at the C(imine) 
atom (Scheme 3.5) could be promising candidates for the design of N^N-^N ligands, with a 
number of different donor atoms in the molecule.  The ligand synthesis has been described 
previously.118 The commercially available ethyl 2-picolinate was completely converted into 
the intermediate 2-picolylhydrazine ‘a’ by refluxing with hydrazine monohydrate in 
ethanol.  HL22 was then synthesised by the reaction of equimolar amounts of 2-
picolylhydrazine and 2-pyridine carboxaldehyde in methanol at reflux for 2 hours before 
cooling to ambient temperature. The product was unsuitable for separation by column 
chromatography due to streaking of the compound but successive recrystallization from 
DCM/Hexane afforded the target compound in a 44% yield.  
There are two possible isomers of the proligand HL22, the E and Z forms. These 
isomers are expected to have different capabilities for binding to metals, owing to the 
relative arrangement of the donor atoms; the Z-form is able to bind in the desired 
tridentate fashion. As previously reported by Hecht and co-workers, the reaction invariably 
produces the highly pure E-isomer.118 Compounds containing a carbon-nitrogen C=N 
double bond may undergo photochemical and thermal cis-trans isomerisation;119 we 
anticipate this isomerisation will occur during complexation of the proligand. 
 
Scheme 3.5: Synthesis of hydrazide-based N^N^N proligand, HL22. Conditions:(i) N2H4, EtOH, reflux, 
12 h; (ii) MeOH, reflux, 2 h. 
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Imide and Amide-based Ligands 
 In order to further explore the possibility of N^N-^N ligands without the 
conformational ambiguity of E/Z isomers, we turned our attention to the synthesis of both 
imide and amide ligands (Figure 3.6). 
 
Figure 3.6: Imide and Amide based N^N^N ligands, HL23 – HL25  
 The first structurally characterised imide complex was reported in 1976 by Lerner 
and Lippard.120 Since then, many studies have focused on imide coordination chemistry 
with the ligand bis(2-pyridylcarbonyl)amide (Hbpca, HL23) and related ligands such as 
Hbpcam (HL24) for applications such as; catalysts for the reduction of carbon dioxide, 
building blocks for the construction of single molecule magnets and to generate polymeric 
complexes with interesting structural features including ladders, helicates and 
clusters.121121,122 As noted for hydrazide bridged ligands, there are a number of different 
donor atoms in the molecule allowing for some interesting coordination chemistry. 
 HL23 and HL24 were originally obtained as unexpected products of metal-catalysed 
hydrolysis of 2,4,6-tris(2-pyridyl)-1,3,4-triazine (tpyt) and its pyrimidine analogue (tpymt) 
(Scheme 3.6). 
 
Scheme 3.6: Route by which HL25 and HL26 were originally obtained. 
Tpyt is easy readily obtained from commercial sources but this is not the case for 
the pyrimidine analogue, tpymt. The first reported synthesis of tpymt (X = N) was by Case 
and Koft in 1959, with a yield of less than 6% on standing of 2-cyanopyrimidine for several 
months.123 This disappointing result prevented extensive studies of this ligand until much 
later, when in 1976 Lerner and Lippard reported a crude yield of 84% by the trimerization 
of 2-cyanopyrimidine.120 The pyrimidine was heated in a sealed vessel at 150°C for 48 h; 
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the solidified product was then ground to a fine powder and washed with ether to remove 
any unreacted starting material. A laborious purification followed, reducing the yield to 
65%. We replicated this synthesis with great success, the trimerization proceeded with a 
yield of 80% and after washing with ether the crude material was of sufficient purity that 
no further purification was required.  
 Although tpyt and tpymt are stable in boiling water and hydrochloric acid, their 
hydrolysis is extensively promoted by CuII salts resulting in the formation of copper 
complexes of HL25 and HL26. Cu(NO3)2.3H2O is added to a suspension of tpyt or tpymt in 
water and the resulting green slurry is refluxed for a period of two hours. Slow evaporation 
of the solvent results in bright blue, needle like crystals. The free ligand can then be isolated 
by treating the CuII complexes with Na2EDTA to scavenge the metal. On examination of the 
crystal structures of the CuII complexes, it was initially proposed that coordination causes 
an angular strain which allows nucleophilic attack at the carbon atoms of the triazine ring 
by water resulting in hydrolysis.124 However, a later study coordinated tpyt to rhodium(III) 
and ruthenium(II) but only the Ru(II) complex generated the hydrolysis product despite the 
angular strain being comparable in across the Cu(II), Ru(II) and Rh(III) complexes. These 
results allowed further investigation into the nature of the hydrolysis and established that 
an electron-withdrawing effect was the major factor responsible for metal ion promoted 
hydrolysis.122  
 The synthesis of the amide bridged ligand HL25 has been reported previously.125 The 
synthetic route to HL25 is depicted in Scheme 3.7. Ethyl 2-picolinate and 2-picolylamine 
were dissolved in anhydrous 1,4-dioxane and heated in a microwave reactor at 180°C for 1 
hour. The crude material was extracted into DCM and purified by column chromatography 
to give the desired product in a 45% yield. 
 
Scheme 3.7: Synthetic route to HL25. Conditions: (i) 1,4-dioxane, MW 180°C, 1 h. 
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3.3 Synthesis of tetradentate ligands 
3.3.1 C^N^N^O ligands 
Hydrazone-based Ligands 
 Due to the readily synthesised nature and the ease of substitution around the 
heterocyclic rings of the hydrazone bridged ligands discussed in section 3.2.1, we chose to 
extend this system into a series of tetradentate proligands (Figure 3.7). HL26 and HL27 offer 
a C^N^N^O- coordination set, whilst HL28 is isomeric with HL26, giving a N^C^N^O- 
coordination set. 
 
Figure 3.7: Hydrazone bridged tetradentate ligands HL26-HL28 
The synthesis of proligands HL26 and HL27 proved to be relatively straightforward 
due to the activated nature of the 2- and 4- positions of a pyridine towards nucleophilic 
substitution (Scheme 3.8).126 This allows a hydrazine unit to be readily installed into the 
pyridine ring of the phenyl pyridine precursor.  
 
Scheme 3.8: Synthetic route for HL26 and HL27. R = H or Me. Conditions: (i) BuLi-LiDMAE, 
CBr4, hexane, 0°C; (ii) N2H4 (R = H) or MeN2H3 (R = Me), reflux, 22 h; (iii) salicylaldehyde, methanol, 
70°C, 5 h. 
The synthesis of proligands HL26 and HL27 is a multistep procedure, beginning with 
the commercially available 2-phenyl pyridine. We successfully replicated the synthesis 
reported by Gros et al.,127 by halogenating the commercially available 2-phenylpyridine, 
beginning with lithiation with BuLi-LIDMAE in hexane at 0°C and then carried out 
condensation with the electrophile CBr4 to give the desired 2-bromo-6-phenylpyridine. 
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Column chromatography successfully isolated the pure product in a 62% yield. 2-bromo-6-
phenylpyridine was then converted to the desired ligands HL26 and HL27 in the same manner 
as the analogous tridentate proligands.  
The proligand HL28 proved much more synthetically challenging due to the 
unreactive nature of the benzene ring towards nucleophilic substitution.126 Unlike HL26 and 
HL27, the hydrazine intermediate cannot be formed by simple nucleophilic substitution on 
a bromobenzene. We initially proposed the synthetic route outlined in Scheme 3.9. 
 
 
 
 
Scheme 3.9: Proposed synthetic route for HL28. Conditions: (i) LiCl, 3-bromoaniline, 2-
(tributylstannyl)pyridine, Pd(PPh3)4, toluene, reflux, 24 h; (ii) NaNO2, HCl, SnCl2, H2O, 0°C, 1 h; (iii) 
salicylaldehyde, methanol, 70°C, 5 h.  
We successfully synthesised intermediate ‘a’, 3-(2-pyridinyl)benzenamine, using 
Stille cross coupling conditions. A mixture of LiCl, 3-bromoaniline, 2-
(tributylstannyl)pyridine and Pd(PPh3)4 in toluene was degassed via 3 freeze-pump-thaw 
cycles and then refluxed under an inert atmosphere for 48 hours. The crude product was 
purified by column chromatography which yielded the desired product in an 80% yield.     
We next attempted to form the hydrazine intermediate ‘b’ via diazotisation and 
reduction by SnCl2 of the diazo intermediate, however we encountered difficulties with 
side products and instability of the product. This is perhaps somewhat unsurprising, since 
Lednicer and co-workers encountered similar difficulties when preparing polycyclic 
aromatic hydrazines via this procedure and there are few examples in the literature of 
these derivatives.128 
In order to synthesise the desired ligand HL28 we instead proposed the alternative 
pathway in Scheme 3.10, in which the pyridine ring is incorporated in the last step and the 
diazotisation is carried out on 3-bromoaniline. 
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Scheme 3.10: Alternative synthesis of HL28. Conditions: (i) NaNO2, HCl, SnCl2, H2O, 0°C, 1 h; 
(ii) salicylaldehyde, methanol, 70°C, 5 h; (iii) LiCl, 3-bromoaniline, 2-(tributylstannyl)pyridine, 
Pd(PPh3)4, toluene, reflux, 24 h. 
The hydrazine intermediate ‘c’ was successfully synthesised although we did 
encounter some difficulties with product stability and so the crude material was used 
without further purification to form the hydrazone bridged intermediate ‘d’ in a 60% yield. 
HL28 was then successfully synthesised using Stille cross coupling conditions, in the same 
manner as discussed previously, to give the purified product in a 19% yield.  
Pyrazole-based Ligands 
In order to further investigate the effects on rigidifying the ligand scaffold we turned 
our attention to extending the N^N^O pyrazole bridged proligand reported earlier into a 
tetradentate proligand of the type C^N^N^O (Figure 3.8).  
 
Figure 3.8: Pyrazole bridged ligands HL29-HL32. 
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The synthesis of proligands HL29-HL31 was achieved via the synthetic route depicted 
in Scheme 3.11. The appropriate pyrazole intermediate ‘a’ was prepared using the 
conditions reported by Develay et al.129 (discussed in section 3.2.1) and the appropriate 2-
bromo-6-phenyl pyridine analogue was prepared using the conditions reported by Gros et 
al.127 (discussed earlier in this section). 
 
Scheme 3.11: Synthetic route for HL29 – HL30. Conditions: (i) DMFDMA, DMF, 75°C, 30 min; (ii) 
N2H4.H2O, EtOH, reflux, 6 h; (iii) BuLi-LIDMAE, CBr4, hexane, 0°C; (iv) CuI, trans-1,2-
diaminocyclohexane, K2CO3, 1,4-dioxane, reflux, 24 h. 
For the synthesis of HL31, the 2-bromo-6-tert-butyl pyridine starting material was 
not readily available. This was instead prepared from 2-bromopyridine and 4-tert-
butylphenyl boronic acid using Suzuki cross-coupling conditions (Scheme 3.12). A mixture 
of 2-bromopyridine, 4-tert-butylphenylboronic acid, sodium carbonate and Pd(PPh3)4 in 
toluene/water/ethanol (4:4:1) was degassed via freeze-pump-thaw and refluxed for 24 
hours. The crude product was purified by column chromatography to give the desired 
compound in a 90% yield.  
 
Scheme 3.12: Synthetic route to 2-bromo-6-tert-butyl pyridine. 
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Synthesis of proligand HL32 was achieved via a 2-bromo-6-phenoxypyridine 
intermediate ‘b’ (Scheme 3.13).  
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Scheme 3.13: Synthetic route for HL32. (i) DMFDMA, DMF, 75°C, 30 min; (ii) N2H4.H2O, 
EtOH, reflux, 6 h; (iii) NaH, DMF, 0 - 100°C, 12 h; (iv) CuI, trans-1,2-diaminocyclohexane, K2CO3, 
1,4-dioxane, reflux, 24 h. 
The 2-bromo-6-phenoxypyridine intermediate was prepared following the 
procedure reported by Arai et al.130 A mixture of phenol (3 equivs.), NaH (3 equivs.) and 
DMF was stirred over ice for 10 minutes, before slow addition of a solution of 2,6-
dibromopyridine (1 equiv.) in DMF. The solution was stirred overnight at 100°C before work 
up and purification to give the desired compound in an 89% yield. 
The copper catalysed coupling of HL32 proceeded with relatively poor yields, a 
maximum yield of 30% was achieved. This is presumably due to the deactivating influence 
of the oxygen and the lower reactivity of bromo compared to iodo substrates. 
Small crystals, suitable for X-ray diffraction, were obtained of HL29 and HL30 (Figure 
3.9). The structures obtained confirm the identities of the compounds. Interestingly both 
structures contain antiparallel π-π linked dimers. In HL29 there is hydrogen bonding 
between the phenolic OH and the pyrazole N which is absent in HL30 (OMe in place of OH), 
this has resulted in a 180° rotation of the pyrazole.  
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Figure 3.9: Crystal structure and packing of HL29(above) and HL30(below). T = 120 K. 
3.3.2 C^N^N^N ligands 
 Again, due to the more favourable emission properties of dpybH complexes over 
phbpyH complexes we were eager to explore closely related ligands which offer a different 
position for the pseudo-cyclometallating atom whilst rigidifying the system into a 
tetradentate ligand. 
 Owing to the exciting properties of the hydrazine bridged ligands offering multiple 
coordination modes, we chose to extend this system into a tetradentate ligand. The ligand 
HL33 was synthesised via the route shown in Scheme 3.14. 
The intermediate ester, methyl-6-phenyl-2-pyridine carboxylate ‘a’, was 
synthesised by a Suzuki cross-coupling in 94% yield. The ester was then reacted with 
hydrazine monohydrate to give quantative conversion into the hydrazine intermediate. 
Finally, the hydrazine intermediate was reacted with an equimolar amount of 2-pyridine 
carboxyaldehyde to give a 17% yield of HL33 after successive recrystallizations. 
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Scheme 3.14: Synthetic route to ligand HL33. 
1H NMR of the isolated product showed the presence of both the Z- and E- isomer, 
in approximately a 3:1 (Z:E) mixture (Figure 3.10). Inspection of the 1H NMR spectrum 
reveals the N-H proton in the Z isomer resonates at 15.97 ppm (CDCl3) vs. 11.21 ppm (CDCl3) 
in the E isomer. This behaviour observed for the related ligand quinoline-2-carbaldehyde 
(pyridine-2-carbonyl)-hydrazone reported by Mori et al.131, a significant downfield chemical 
shift was observed for the N-H proton in the Z-isomer; a chemical shift of 16.76 ppm (CDCl3) 
compared to 11.24 ppm in the E-isomer.  
The Z and E isomer were successively separated using HPLC, although we were only 
able to obtain enough of the Z isomer for characterisation (Figure 3.11).  These species can 
interconvert in solution; evidence of the E isomer beginning to form in the purified HL35 (Z 
isomer) sample was observed when the 1H NMR spectra was collected again after one week 
standing in the presence of light.  
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Figure 3.10: 400 MHz 298K  1H NMR spectrum of the as-prepared HL33showing a roughly 
3:1 mixture of the Z and E isomers. 
 
 
 
 
 
 
 
 
Figure 3.11: 400 MHz 298K 1H NMR Spectrum of HL33 (Z isomer) in CDCl3 separated from 
the mixture of isomers by HPLC.  
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3.4 Synthesis of Pt(II) complexes of Tridentate Ligands 
3.4.1 Synthesis of N^N^O complexes 
Imine-based Ligands 
The Pt(II) complexes of ligands L1-L4 were all prepared by reaction of the 
corresponding proligands HL1-HL4 with dichloro(1,5-cyclooctadiene)platinum(II) 
(Pt(COD)Cl2) (Figure 3.12).  
 
Figure 3.12: Pt(II) complexes of imine based N^N^O ligands. 
Pt(COD)Cl2 is widely used as an entry point to other Pt(II) complexes since the 1,5-
cycloocatdiene moiety is readily displaced by other ligands.132 Pt(COD)Cl2 can be obtained 
from commercial sources but it is easily prepared within the laboratory from K2PtCl4 and 4 
equivs. of 1,5-cyclooctadiene.133  
Due to the susceptibility towards hydrolysis of the imine bridged N^N^O ligands, 
the complex was prepared directly from the corresponding crude proligand without any 
formal isolation. The ligands were prepared by a melt (as discussed in 3.2.1), after 2 hours 
under vacuum at 65°C the vessel was filled with argon and a mixture of Pt(COD)Cl2, 
anhydrous NEt3 (excess) and anhydrous acetonitrile was added. The mixture was refluxed 
overnight and the precipitated products were collected by filtration with no purification 
required.  
The identity of the complexes was confirmed by 1H and 13C NMR spectroscopy and 
electrospray ionisation (ESI) mass spectrometry. Successful complexation of the ligand 
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showed the absence of the OH proton in the 1H NMR spectrum and high-resolution mass 
spectrometry also confirmed the identity of the species.  
Small crystals of PtL1Cl suitable for X-ray diffraction, were obtained by slow 
evaporation of DCM (Figure 3.12). The structure contains one molecule of DCM per PtL1Cl. 
A summary of important bond lengths and angles is shown in Table 3.1. PtL1Cl shows a 
nearly planar environment around the Pt atom with only very slight twisting out of the 
plane (max displacement = 0.018 Å), in fact the whole molecule is essentially planar. The 
Pt-Cl bond is elongated with respect to the other bonds (2.3264(14) Å), the Pt-O and Pt-
N(qui) bonds are approximately equal (1.992(4) and 1.998(5) Å, respectively) and the 
central Pt-N(imine) bond is somewhat shorter at 1.971(5) Å. Related species of the type 
[Pt(typ)Cl]+ display a very similar structure: an elongated Pt-Cl bond (average 2.303 Å), Pt-
Ncis bonds approximately equal at 2.02 Å and the Pt-Ntrans being slightly shorter at 1.93 Å. 
The PtL1Cl molecules form pair-wise Pt...Pt interactions which leads to head-to-tail 
orientation of dimers with a short/long Pt…Pt distance of 3.600 and 5.618 Å, respectively. 
The interplanar separation between ligands for PtL1Cl of 3.564 Å is sufficiently close for π-
π interactions to occur.113 
 
 
 
 
 
 
Figure 3.12: Crystal structure and packing of Pt(L1)Cl. T = 120 K. 
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Table 3.1: Selected bond lengths and bond angles for PtL1Cl. 
Bond Lengths (Å) Bond Angles (°) Distances (Å) 
Pt-N(qui) 1.998(5) N-Pt-O 177.43(19) Pt…Pt 3.600 
Pt-N(imine) 1.971(5) N-Pt-Cl 178.12(15) Pt…Pt 5.618 
Pt-O 1.992(4) N-Pt-N 82.8(2)   
Pt-Cl 2.3264(14) N-Pt-O 94.85(18)   
C=N 1.299(7)     
C-N 1.433(7)     
 
Substitution of the chloride ancillary ligand for one which exerts a stronger ligand-
field would be expected to raise the energy of destabilising d-d states, which involve the 
population of the strongly anti-bonding dx2-y2 orbital, displacing them to higher energies not 
accessible at room temperature.72 Substitution of this ligand for an acetylide group is a well 
reported strategy for improving the emission efficiency of a range of Pt(II) and Ir(III) 
complexes.72,134–139    
The chloride ancillary ligand of PtL1Cl was substituted for an acetylide using  the 
technique reported by Cárdenas and co-workers for N^N^C-coordinated Pt(II) 
complexes.134 The chemical structure of the new complex PtL1C≡C-Ar is shown in Figure 
3.13. A mixture of PtL1Cl, acetylene, CuI and excess NEt3 were stirred in anhydrous DCM at 
40°C for 48 hours under argon. The resulting mixture was filtered and the crude product 
purified by column chromatography to give the desired product in a 49% yield as a red 
solid.  
 
Figure 3.13: The chemical structure of PtL1C≡C-Ar 
The identity of the complex was confirmed by 1H and 13C NMR spectroscopy and 
electrospray ionisation (ESI) mass spectrometry. Crystals suitable for X-ray diffraction were 
obtained from cooling a concentrated DMSO solution (Figure 3.14). The structure contains 
two molecules of DMSO per PtL1C≡C-Ar. A summary of important bond lengths and angles 
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is shown in Table 3.2. As with PtL1Cl we observe an essentially planar environment around 
Pt, with only a maximum displacement of 0.005 Å from the N^N^O plane. The Pt-C≡C-Ar 
bond is much shorter than the Pt-Cl bond in PtL1Cl (1.966(3) vs. 2.3264(14) Å) and the Pt-
N(imine) bond opposite is noticeably longer at 2.013(2) vs 1.971(5) Å, presumably due to 
the stronger trans influence exerted by the acetylide. The Pt-O and Pt-N(qui) bonds remain 
essentially unchanged. Related species of the type [Pt(typ)C≡C-Ar]+ displays a very similar 
effect on the structure when the chloride ligand is replaced with an acetylide, a lengthening 
on the Pt-Ntrans bond (1.93 to 1.97 Å) and a shortening of the Pt-C2Ar bond with respect to 
the Pt-Cl bond (2.303 to 1.98 Å).140  
The molecules once again form pair-wise Pt...Pt interactions which leads to head-to-
tail orientation of dimers with a short/long Pt…Pt distance of 3.587 and 7.216 Å, 
respectively. The interplanar separation between ligands for PtL1C≡C-Ar of 3.457 Å is 
sufficiently close for π-π interactions to occur.113 
Figure 3.14: Crystal structure and packing of PtL1C≡C-Ar. T = 120 K. 
Table 3.2: Selected bond lengths and bond angles for PtL1C≡C-Ar 
Bond Lengths (Å) Bond Angles (°) Distances (Å) 
Pt-N(qui) 1.9925(19) N-Pt-O 175.83(8) Pt…Pt 3.587 
Pt-N(imine) 2.013(2) N-Pt-Cl 178.47(9) Pt…Pt 7.216 
Pt-O 1.9970(16) N-Pt-N 82.01(8)   
Pt-C2Ar 1.966(3) N-Pt-O 93.83(8)   
C=N 1.299(3)     
C-N 1.419(3)     
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Hydrazone-based Ligands 
The Pt(II) complexes of ligands L5-L13 were all prepared by reaction of the 
corresponding proligands HL5-HL13 with K2PtCl4 (Figure 3.15).  
 
Figure 3.15: Pt(II) complexes of hydrazone (N-H) based N^N^O ligands. 
The synthesis of PtL1Cl, PtL8Cl and PtL10Cl have been reported previously.141 The 
complexes PtL5Cl – PtL13Cl were synthesised by refluxing the corresponding proligand and 
K2PtCl4 in an EtOH:H2O mixture for a period of 2 hours. The resulting mixture was cooled to 
ambient temperature and filtered to yield the crude product. The target complex was 
obtained by recrystallization in hot DMF in all instances.  
The identity of the complexes was confirmed by 1H and 13C NMR spectroscopy and 
electrospray ionisation (ESI) mass spectrometry. Complexation causes a small down field 
shift of the N=C-H proton; for instance, HL5 has a shift of 8.29 ppm (DMSO-d6), while in the 
complex PtL5Cl the imine proton resonates at 8.61 ppm (DMSO-d6). Upon complexation, 
the N-H proton is shifted significantly upfield and becomes very broad. For instance, the N-
H proton resonates at 10.50 ppm (DMSO-d6) in the proligand HL5 while the N-H proton 
resonates at 13.73 ppm (DMSO-d6) in the corresponding PtL5Cl. Crystals suitable for X-ray 
diffraction were obtained from the DMF recrystallization in the case of PtL6Cl and PtL12Cl 
and from a solution of PtL8Cl in DMSO. The crystal structure and packing can be seen in 
Figure 3.16 and a summary of important bond lengths and angles in Table 3.3. PtL6Cl has 
one molecule of DMF in the crystal structure and PtL8Cl has one unit of DMSO whereas 
PtL12Cl has no solvent molecules in the crystal structure. 
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Table 3.3: Selected bond lengths, bond angles and distances for PtL6Cl, PtL8Cl and PtL12Cl 
  PtL6Cl PtL8Cl PtL12Cl 
Bond Lengths (Å) Pt-N(py) 1.995(4) 1.992(4) 1.994(2) 
 P-N(imine) 1.953(4) 1.951(4) 1.941(2) 
 Pt-O 1.981(3) 1.993(3) 1.9903(18) 
 Pt-Cl 2.3097(13) 2.2947(12) 2.303(7) 
Bond Angles (°) N-Pt-O 175.64(16) 175.38(15) 175.69(7) 
 N-Pt-Cl 178.25(13) 177.33(12) 177.61(6) 
 N-Pt-N 81.62(17) 81.22(17) 81.13(9) 
 N-Pt-O 94.04(16) 94.42(16) 94.57(8) 
Distances (Å) Pt…Pt 5.948 5.07 5.222 
 
 We observe an essentially planar environment around Pt in all of the structures, 
with a maximum of 0.027 Å displacement from the N^N^O plane in PtL8Cl and as little as 
0.002 Å in PtL12Cl. There appears to be little to differentiate between the complexes with 
regards to bond lengths and angles. The central Pt-N(imine) bond is shorter than observed 
for the analogous N^N^O imine bridged Pt(II) complexes discussed earlier (~1.948 vs. 1.971 
Å in PtL1Cl), there is also a shortening of the Pt-Cl bond (~2.304 vs. 2.326 Å in PtL1Cl) 
although it is less significant. It is noteworthy that the hydrazone bridged complex is closer 
to the values reported for related species of the type [Pt(typ)Cl]+ than the imine bridged 
complex. The Pt-Cl bond is elongated (average 2.303 Å), Pt-Ncis bonds approximately equal 
at 2.02 Å and the Pt-Ntrans being slightly shorter at 1.93 Å.  
In all structures, there is once again a head-to-tail orientation of molecules although 
with distances of >4 Å in all cases there is no Pt…Pt interactions. The interplanar separation 
between ligands for PtL8Cl of 3.746 Å is sufficiently close for π-π interactions to occur,113 
however the distance in PtL6Cl (4.648 Å) and PtL12Cl (4.358 Å) is too large for π-π 
interactions to occur. 
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Figure 3.16: Crystal structure and packing of Pt(L7)Cl (top), Pt(L9)Cl (middle) and Pt(L13)Cl 
(bottom). T = 120 K. 
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The Pt(II) complexes of the N-Me hydrazone based ligands L14-L20 (Figure 3.17) were 
all prepared by reaction of the corresponding proligands HL14-HL20 with K2PtCl4 using the 
same procedure as for the preparation of complexes PtL4Cl – PtL13Cl. 
 
Figure 3.17: Pt(II) complexes of hydrazone (N-Me) based N^N^O ligands. 
The identity of the complexes was confirmed by 1H and 13C NMR spectroscopy and 
electrospray ionisation (ESI) mass spectrometry. Complexation causes a larger down field 
shift of the N=C-H proton than seen for the N-H complexes; for instance, the N=C-H proton 
in HL14 resonates at 8.05 ppm (DMSO-d6) which shifts to 8.94 ppm upon complexation 
(compared to PtL5Cl which shifts from 8.29 to 8.61 ppm). Crystals suitable for X-ray 
diffraction were obtained from the DMF recrystallization of PtL14Cl, PtL17Cl and PtL19Cl. The 
crystal structure and packing can be seen in Figure 3.18 and a summary of important bond 
lengths and angles in Table 3.4. PtL17Cl has one molecule of DMF in the crystal structure 
whereas PtL14Cl and PtL19Cl have no solvent molecules in the crystal structure. 
Table 3.4: Selected bond lengths, bond angles and distance for PtL14Cl, PtL17Cl and PtL19Cl 
    PtL14Cl PtL17Cl PtL19Cl 
Bond Lengths (Å) Pt-N(py) 1.9883(14) 1.977(2) 1.986(3) 
  P-N(imine) 1.9518(13) 1.960(2) 1.956(3) 
  Pt-O 1.9758(12) 1.9852(19) 1.99(2) 
  Pt-Cl 2.3047(4) 2.3071(8) 2.3105(9) 
Bond Angles (°) N-Pt-O 176.61(5) 176.49(8) 176.28(11) 
  N-Pt-Cl 177.59(4) 177.05(6) 177.60(9) 
  N-Pt-N 81.02(6) 80.92(9) 81.07(13) 
 N-Pt-O 95.58(5) 95.57(8) 95.42(11) 
Distances (Å) Pt…Pt 5.117 4.398 4.733 
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Figure 3.18: Crystal structure and packing of PtL14Cl (top), PtL17Cl (middle) and PtL19Cl 
(bottom). T = 120 K. 
We observe an essentially planar environment around Pt in all of the structures, 
with a maximum of 0.022 Å displacement from the N^N^O plane in PtL19Cl, 0.002 Å in 
PtL17Cl and zero displacement in PtL14Cl. Again, there appears to be little to differentiate 
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between the complexes with regards to bond lengths and angles, although the central Pt-
N(imine) bond is slightly longer than seen for the N-H complexes (~1.956 vs. 1.948 Å).  
In all structures, there is once again a head-to-tail orientation of molecules, 
although with distances of >4 Å in each of the complexes there is no Pt…Pt interactions. The 
interplanar separation between the tridentate ligands in PtL14Cl is too large for π-π 
interactions to occur, however the interplanar separation between ligands for PtL17Cl 
(3.595 Å) and PtL19Cl (3.652 Å) are sufficiently close for π-π interactions.113 
The chloride ancillary ligand of PtL14Cl was substituted for an acetylide using the 
technique reported by Cárdenas and co-workers for N^N^C-coordinated Pt(II) 
complexes.134 The chemical structure of the new complex PtL14C≡C-Ar is shown in Figure 
3.19. A mixture of PtL14Cl, acetylide, CuI and excess NEt3 were stirred in anhydrous DCM at 
40°C for 48 hours under argon. The resulting mixture was filtered and the crude product 
purified by column chromatography to give the desired product in a 38% yield as a yellow 
solid.  
 
Figure 3.19: The chemical structure of PtL14C≡C-Ar 
The identity of the complex was confirmed by 1H and 13C NMR spectroscopy and 
electrospray ionisation (ESI) mass spectrometry.  
Pyrazole-based Ligands 
The Pt(II) complex of ligand L21 was prepared by reaction with of the proligand HL21 
with K2PtCl4 (Figure 3.20) using the method reorted by Mohan et al.141 HL21 and K2PtCl4 
were refluxed in a EtOH:H2O mixture for a period of 2 hours. The resulting mixture was 
cooled to ambient temperature and filtered to give the pure complex in a 90% yield.  
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Figure 3.20: Pt(II) complex of pyrazole bridged N^N^O ligand L21 
The identity of the complex was confirmed by 1H and 13C NMR spectroscopy and 
electrospray ionisation (ESI) mass spectrometry. Successful complexation of the ligand 
showed the absence of the OH proton in the 1H NMR spectrum and high resolution mass 
spectrometry also confirmed the identity of the species. There is a down field shift of the 
pyrazole protons H1 and H2, which resonate at 7.83 and 9.43 ppm in DMSO-d6, respectively. 
These protons resonate at 7.19 (H1) and 8.72 ppm (H2) in DMSO-d6 in the proligand HL21. 
3.4.2 Synthesis of N^N^N complexes 
Hydrazide bridged Ligands 
The Pt(II) complex of ligand L22 was prepared by reaction with Pt(COD)Cl2 in an 
analogous manner to that reported by Mori et al.142 HL22, Pt(COD)Cl2 and excess NEt3 were 
refluxed in MeCN for a period of 48 hours before filtration to yield a dark purple solid. 1H 
NMR revealed this as a mixture of two Pt(II) complexes which could be separated by column 
chromatography. The proposed structures can be seen in Figure 3.21.  
The complexes a-PtL22Cl and b-PtL22Cl were isolated in a 35% and 40% yield, 
respectively. The complex a-PtL22Cl is burnt orange in colour and is appreciably soluble in 
DCM, chloroform and DMSO, whereas b-PtL22Cl is a dark purple solid with limited solubility 
in DCM, chloroform and DMSO. 
 
Figure 3.21: Pt(II) complexes of hydrazide bridged N^N^N ligand H22 
 The formation of the complexes indicates that E to Z isomerisation occurs during 
the reaction, although no isomerisation occurs at room temperature for the free ligand, 
suggesting that the Pt(II) ion assists the E to Z conversion of the ligand. This assisted 
97 
 
isomerisation was also reported by Mori et al. for related compounds [PdCl-(Z-L-ĸ2N,N’)] 
and [PdCl2(E-HL’-ĸ2N,N’)] where L = quinoline-2-carbaldehyde (pyridine-2-
carbonyl)hydrazone.142 
The introduction of platinum satellites can clearly be seen in the 1H NMR spectrum 
of a-PtL22Cl (Figure 3.22). On comparison with the 1H NMR spectrum of HL22, an upfield shift 
can be observed for the N=C-H imine proton in a-PtL22Cl, from 8.38 ppm (CDCl3) to 7.60 
ppm; interestingly in b-PtL22Cl complexation does not cause a shift of this proton (Figure 
3.23).  
 The complex b-PtL22Cl is the kinetically formed product and in solution is gradually 
converted under room light to yield a-PtL22Cl. Mori et al. reported that this process took 
several days for the Pd(II) complex of L22 and suggested both thermal and photochemical 
coordination structure conversion in solution could take place via the proposed mechanism 
show in Figure 3.24.142  
 
Figure 3.22: 400 MHz 298 K 1H NMR spectrum of a-PtL22Cl in CDCl3.
 
Figure 3.23: 400 MHz 298 K 1H NMR spectrum of b-PtL22Cl in CDCl3. 
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Figure 3.24: Plausible mechanism for photochemical structure conversion. 
 
Imide and Amide-based Ligands 
The Pt(II) complexes of ligands L23 and L25 were prepared by reaction of the 
corresponding proligand with Pt(COD)Cl2 (Figure 3.25). The synthesis of PtL23Cl has been 
reported previously.143 The Pt(II) complexes of L25 and L27 were synthesised by reaction with 
Pt(COD)Cl2 with NEt3 in MeCN. This proceeded in yields of 65% and 40%, respectively, with 
no need for purification in either instance. The identity of the complexes was confirmed by 
1H and 13C NMR spectroscopy and electrospray ionisation (ESI) mass spectrometry.  
 
Figure 3.25: Chemical structure of imide and amide-based complexes 
An alternative route was required for the Pt(II) complex of L24. We used the 
conditions reported by Lippert and co-workers, originally for the synthesis of PtL23Cl (with 
lower yields of around 50%).143 HL26 and K2PtCl4 were heated at 60°C for a period of 24 
hours. The resulting mixture was filtered, and the filtrates extracted into DCM to give an 
orange solid. The resulting material was extremely insoluble in all common organic 
solvents. Analysis of the 1H NMR in DMSO-d6 at 80°C showed an approximate 3:1 ratio of 
ligand to complex and a small amount of aromatic impurity (Figure 3.26). The crude product 
was recrystallized in hot DMSO to give the target complex as a bright yellow solid.  
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Figure 3.26: 400 MHz 353 K 1H NMR of the crude product PtL24Cl in DMSO-d6. The ligand 
protons are indicated by *. 
3.5 Synthesis of Pt(II) Complexes of Tetradentate Ligands  
3.5.1 Synthesis of C^N^N^O complexes 
Hydrazone-based Ligands 
 The Pt(II) complex of L27 (Figure 3.27) was synthesised using the well reported 
method of cyclometallation in acetic acid with K2PtCl4.78,79,129,144,145 HL29 and K2PtCl4 were 
refluxed in acetic acid for 3 days before cooling to ambient temperature. Filtration resulted 
in the crude product which was purified by DMF recrystallization to give the desired 
product in a 30% yield. 
 
Figure 3.27: Chemical Structure of PtL27 
* 
* 
* 
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It is interesting to note that the crude 1H NMR revealed the possible formation of a 
dimer alongside the desired PtL27 complex (Figure 3.28). 
Figure 3.28: 400 MHz 298 K 1H NMR spectrum of PtL27 (above) and the crude product 
(below) in DMSO-d6 
DOSY NMR spectroscopy (diffusion-ordered spectroscopy) was used in order to 
shed light on the species present (Figure 3.29). DOSY seeks to separate the NMR signals of 
different components of a mixture according to their diffusion coefficient which is inversely 
related to the molecular weight/size.146 
Figure 3.29: DOSY NMR spectrum of the crude product. 
Comparison of the DOSY and the 1H NMR spectrum suggests that the isolated PtL27 
has the smaller molecular weight of the two species, since it has the higher diffusion 
coefficient. We note that the two species otherwise appear very similar, with each 1H NMR 
signal of PtL27 having a closely related signal of similar splitting and chemical shift. 
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Crystals suitable for X-ray diffraction were obtained from the DMF recrystallization 
of PtL27. The structure contains one molecule of DMF per PtL27. The crystal structure and 
packing can be seen in Figure 3.30 and a summary of important bond lengths and angles in 
Table 3.5. We observe an essentially planar environment around Pt, with only a 0.01 Å 
displacement from the C^N^N^O plane. The square planar geometry of the Pt(II) is quite 
distorted, presumably due to the steric constraints of the ligand. We note the central Pt-
N(imine) bond (2.024(4) Å) is longer than seen for any of the tridentate complexes, likely due 
to the strong trans influence of the cyclometallated phenyl ring. The Pt-N(py) bond is 
significantly shorter than observed for the analogous tridentate complex PtL14Cl (1.924(4) 
vs 1.9758(12)).  
To the best of our knowledge, there are no reports of a C^N^N^O tetradentate Pt(II) 
complex in the literature.147 We instead note the similarities to the C^N^N^C tetradentate 
complex reported by Vezzu et al. (Figure 3.31).84 They report a Pt-C bond length of 2.004 Å 
which is very similar to the Pt-C bond length of 2.007(5) Å observed in PtL27 however the 
Pt-N bond length is somewhat longer at 2.051 Å than the observed 2.019 Å for Pt-N(py) in 
PtL27.  
The molecules are again aligned in a head-to-tail orientation, with no evidence of 
π-π stacking and Pt…Pt distances of > 4Å indicating there is no Pt…Pt interactions. 
 
 
 
 
 
 
 
 
 
 
Figure 3.30: Crystal structure and packing of PtL27. T = 120 K. 
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Table 3.5: Selected bond lengths, bond angles and distances for PtL27 
Bond Lengths (Å) Bond Angles (°) Distances (Å) 
Pt-N(py) 1.924(4) N(py)-Pt-O 176.00(17) Pt…Pt 4.54 
Pt-N(imine) 2.024(4) N(imine)-Pt-C 162.8(2)    
Pt-O 2.006(4) N-Pt-N 80.86(19)    
Pt-C 2.007(5) N(imine)-Pt-O 95.15(17)    
    C-Pt-N(py) 82.0(2)     
    C-Pt-O 101.9(2)     
 
 
Figure 3.31: Chemical Structure of C^N^N^C complex reported by Vezzu et al. 
Repeated attempts to synthesis Pt(II) complexes of L26 and L28 were unsuccessful. 
Due to the instability of the N-H hydrazone bridge towards acid148, we were unable to  
cyclometalate in acetic acid. We attempted to use the conditions reported by Williams et 
al.79 for cyclometallation: an aqueous solution of K2PtCl4 was added to a solution of HL26 in 
acetonitrile and the aerated mixture was refluxed for 3 days. Unfortunately, this method 
yielded only the ligand and some decomposition products. We also attempted synthesis 
using the common starting material for cycloplatination PtCl2(DMSO)2 in toluene145 
however similar results were obtained. Due to the instability of the N-H hydrazone bridged 
ligands no further attempts were made to synthesise these complexes. 
Pyrazole-based Ligands 
 We synthesised the Pt(II) complexes of L29-L32 by reacting K2PtCl4 and the 
corresponding proligand in acetic acid for 3 – 5 days. Characterisation of the complexes 
revealed a surprising tridentate complexation mode for all four of the ligands (Figure 3.32). 
 Inspection of the 1H NMR of PtL29Cl shows the presence of the OH proton, indicating 
that the oxygen is not coordinated to the Pt(II) (Figure 3.33). We investigated the effect of 
adding sodium tert-butoxide to the 1H NMR sample in order to deprotonate the OH and 
encourage coordination (Figure 3.33). We initially believed the loss of the OH proton and 
resulting shift of some signals in the 1H NMR spectrum to be a consequence of formation 
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of the tetradentate complex rather than simply deprotonation. Mass spectroscopy was 
unable to shed light upon this phenomenon; due to the lability of the chloride ancillary 
ligand we often observe the [M-Cl]+ ion rather than [M]+. 
 
Figure 3.32: Chemical structures of PtL29Cl – PtL32Cl. 
Figure 3.33: 400 MHz 298K 1H NMR of PtL29Cl before (top) and after (bottom) adding 
sodium t-butoxide in DMSO-d6. 
In order to rationalise this unexpected behaviour, we synthesised the related 
complex PtL30Cl. This would allow us to characterise the complex where coordination 
through the O-Me is not anticipated and relate this to the PtL29Cl complex. The 1H NMR 
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looks remarkedly similar to the PtL29Cl spectrum (Figure 3.34). We also observe the [M-Cl]+ 
ion in the mass spectrum for PtL30Cl.  
Figure 3.34: 400 MHz 298 K 1H NMR spectrum of PtL30Cl in DMSO-d6. 
Due to the insoluble nature of complex PtL29Cl we synthesised the related complex 
PtL31Cl, the t-butyl substituent was anticipated to increase the solubility of the complex 
allowing us to probe the coordination of the Pt(II) further. 
Crystals suitable for X-ray diffraction were obtained from the acetic acid filtrates of 
the reaction mixture. The structure contains three molecules of acetic acid per PtL31Cl. The 
crystal structure and packing can be seen in Figure 3.35 and a summary of important bond 
lengths and angles in Table 3.6. We observe an essentially planar environment around Pt, 
with only a 0.036 Å displacement from the C^N^N plane. The square planar geometry of 
the Pt(II) is significantly distorted as indicated by the small bite angle of C-Pt-N(pyrazole) 
(160.3(2)°), presumably due to the steric constraints of the ligand. We note the similarities 
to the tridentate N^N^C pyrazole Pt(II) complex reported by Harris et al.149 (Figure 3.36). 
The Pt-C bond (1.973(6) Å) is comparable to that reported by Harris et al. (1.989 Å) and the 
Pt-C bond (2.007(5) Å) in PtL27. The Pt-N(pyrazole) which is trans to the Pt-C is bond is 
significantly longer (2.163(5) Å) than the Pt-N(py) bond (1.961(5) Å), indicating the strong 
structural trans effect.  
The molecules take a head-to-tail orientation and there is evidence of π-π 
interactions with an interplanar distance of 3.754 Å. There is no Pt…Pt interaction. The 
phenol ring is perpendicular to coordination plane. 
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Figure 3.35: Crystal structure and packing of PtL31Cl. T = 120 K. 
Table 3.6: Selected bond lengths, bond angles and distances for PtL31Cl 
Bond Lengths (Å) Bond Angles (°) Distances (Å) 
Pt-N(py) 1.961(5) C-Pt-N(pyrazole) 160.3(2) Pt…Pt 5.208 
Pt-N(pyrazole) 2.163(5) N(py)-N-Cl 175.40(14)    
Pt-C 1.973(6) C-Pt-N(py) 81.8(2)    
Pt-Cl 2.3027(14) N-Pt-N 78.62(19)     
 
NN
N Pt
Cl  
Figure 3.36: Chemical Structure of N^N^C Pt(II) complex reported by Harris et al. 
In order to encourage coordination of the O-H moiety in PtL29Cl we removed the 
chloride ancillary ligand using silver triflate (AgOTf). A downfield shift can be observed in 
the 1H NMR spectrum of the resulting product, however we note the presence of the O-H 
proton suggesting the Pt(II) is still not coordinated (Figure 3.37).  
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Figure 3.37: 400 MHz 298 K 1H NMR spectrum of PtL29Cl (top) and [PtL29]OTf (bottom) in DMSO-d6. 
Crystals suitable for X-ray diffraction were obtained from the slow evaporation of 
an acetone solution. The crystal structure and packing can be seen in Figure 3.38 and a 
summary of important bond lengths and angles in Table 3.7. We note the successful 
removal of the chloride ancillary ligand, although we observe its replacement with an 
acetone molecule rather than binding of the O-H moiety. There is an essentially planar 
environment around Pt, with only a 0.019 Å displacement from the C^N^N plane. The 
square planar geometry of the Pt(II) remains significantly distorted as indicated by the small 
bite angle of C-Pt-N(pyrazole) (161.3(3)°). We observe some notable differences in bond 
lengths from PtL31Cl; the Pt-C bond is longer (1.995(8) vs. 1.973(6) Å), the opposite bond 
Pt-N(pyrazole) is shorter (2.109(6) vs. 2.163(5) Å), the Pt-O(acetone) is 2.055(5) Å, which is 
significantly shorter than the Pt-Cl bond in PtL31Cl (2.3027(14) Å) and the Pt-N(py) is also 
shorter (1.942(7) vs. 1.961(5) Å).  
The molecules take a head-to-tail orientation and there is evidence of π-π 
interactions with an interplanar distance of 3.657 Å. There is no Pt…Pt interaction. The 
phenol ring is again perpendicular to coordination plane. 
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Figure 3.38: Crystal structure and packing of [PtL29]OTf. T = 120 K. 
Table 3.7: Selected bond lengths, bond angles and distances for [PtL29]OTf 
Bond Lengths (Å) Bond Angles (°) Distances (Å) 
Pt-N(py) 1.942(7) C-Pt-N(pyrazole) 161.3(3) Pt…Pt 6.155 
Pt-N(pyrazole) 2.109(6) N(py)-N-O(acetone) 175.4(3)    
Pt-C 1.995(8) C-Pt-N(py) 82.6(3)    
Pt-O(acetone) 2.055(5) N-Pt-N 78.7(3)     
 
The increase in chelate ring size for the Pt(II) complex of L34 was intended to 
decrease the strain from complexation on the ligand and allow binding to the O-H moiety 
Figure 3.39).   
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Figure 3.39: Comparison of the chelate ring sizes of PtL29 and PtL32 
Analysis of the 1H NMR spectrum once again shows the O-H proton is present and 
remains unbound (Figure 3.40). 
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Figure 3.40: 400 MHz 298 K 1H NMR spectrum of PtL32Cl in DMSO-d6. 
3.6 Synthesis of Tridentate coordinated Ir(III) complexes  
3.6.1 Synthesis of N^N^O complexes 
Hydrazone-based Ligands 
The Ir(III) complexes of ligands L15-L18 (Figure 3.41) were all prepared by reaction of 
the corresponding proligands with an intermediate iridium dimer [Ir(dpyx)Cl(μ-Cl)2]2. 
 
Figure 3.41: Chemical Structure of Ir(III) complexes of L14 – L17. dpyx = 1,3-Di(2-pyridyl)-4,6-
dimethylbenzene (dpyx). 
The synthetic route is displayed in Scheme 3.15. The tridentate proligand dpyxH is 
known to react with IrCl3.3H2O in ethoxyethanol/water to give a dichloro-bridged dimer 
[Ir(dpyx)Cl(μ-Cl)2]2.98 Reaction of the di-chloro bridged iridium dimer with proligands HL14 
– HL17 was carried out in ethylene glycol at 195°C for 90 minutes, leading to the 
corresponding complexes. The chloride counter anion was exchanged for PF6 by 
precipitation in aq. sat. KPF6. The complexes were purified by recrystallization in 
acetonitrile/ether.  
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Scheme 3.15: Synthetic route to complexes [Ir(dpyx)L14]PF6 - [Ir(dpyx)L17]PF6. 
 The identity of the complexes was confirmed by 1H NMR and 13C NMR spectroscopy 
and electrospray ionisation (ESI) mass spectrometry. Successful complexation of the ligand 
showed the absence of the OH proton in the 1H NMR spectrum and high resolution mass 
spectrometry also confirmed the identity of the species. 
Small crystals, suitable for X-ray diffraction, were obtained of [Ir(dpyx)L15]PF6 by 
slow evaporation of a MeCN solution. There is one molecule of MeCN per [Ir(dpyx)L15]PF6. 
The crystal structure and packing can be seen in Figure 3.42 and a summary of important 
bond lengths and angles in Table 3.8. The desired (N^C^N)(N^N^O) coordination is evident. 
The iridium(III) centre exhibits a distorted octahedral geometry due to the geometric 
constraints of the tridentate binding of dpyx. The Ir-C bond (1.9483(16) Å) is shortened with 
respect to analogous bonds in [Ir(dpyx)(DMSO)Cl2] (1.975(4) Å).150 The Pt-N distances of 
the flanking pyridine rings (2.0352(14) and 2.0527(14) Å) are also shortened with respect 
to those in [Ir(dpyx)(DMSO)Cl2] (2.067(3) and 2.087(3) Å).  
The molecules take a head-to-tail orientation and there is evidence of π-π 
interactions with an interplanar distance of 3.729 Å. 
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Figure 3.42: Crystal structure and packing of [Ir(dpyx)L15]PF6. T = 120 K. 
Table 3.8: Selected bond lengths, bond angles and distances for [Ir(dpyx)L15]PF6 
Bond Lengths (Å) Bond Angles (°) Distances (Å) 
Ir-C 1.9483(16) N5-Ir-N4 161.42(6) Ir…Ir 8.804 
Ir-N4 2.0352(14) C-Ir-N3 175.57(6)    
Ir-N5 2.0527(14) O-Ir-N1 171.70(5)    
Ir-N1 2.0190(14) C-Ir-N4 80.80(6)    
Ir-N3 2.0782(13) N1-Ir-N3 78.79(5)    
Ir-O 2.0334(12) O-Ir-N3 93.03(5)     
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4 Photophysical Characterisation 
4.1 Tridentate Pt(II) Complexes 
4.1.1 Imine-based complexes 
Electronic Absorption Spectra 
 The absorption spectra of complexes PtL1-4Cl (Figure 4.1) and Pt(L1)C≡C-Ar (Figure 
4.2) were recorded in DCM at room temperature. The complexes show bands with high 
extinction coefficients in the far UV, moderately intense bands at ~400 nm and less intense 
bands at 500-600 nm.  
The electronic spectra resemble those of the dioxovanadium(v) schiff-base 
complexes reported by Asgedom et al. using ligand HL1 and a series of derivatives.151 The 
very intense bands at wavelengths below 300 nm are assigned to 1π-π* transitions as they 
also appear in the ligand spectra.151 We assign the multiple absorption bands centred 
around ~400 nm and 500/550 nm as charge-transfer transitions which involve the metal, 
and/or the chloride ligand and/or the imine ligand in line with the assignments of Asgedom 
et al. and Williams et al.79  
The absorption wavelengths are very similar in each of the complexes but there is 
a significant red shift of the lowest energy band for PtL2Cl; the lowest energy band has a 
λmax of 550 nm, compared to 511nm for PtL1Cl. The –OMe substituent on PtL2Cl is strongly 
electron-donating; the red shift suggests the substituent is affecting the HOMO. This 
behaviour is indicative of transitions with an appreciable degree of charge-transfer 
character.55 
Although the exchange of the chloride ligand for the phenylacetylide ligand does 
not change the spectral profile substantially, we do observe a significant increase in 
extinction coefficients for the higher energy absorption bands of Pt(L1)C2Ar. This is due to 
transitions within the Ar-C≡C unit and possibly also the introduction of additional charge-
transfer transitions involving the acetylide. 
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Figure 4.1: UV-Vis electronic absorption spectra of PtL1-4Cl in DCM at 298 K. 
 
 
Figure 4.2: UV-Vis electronic absorption spectra of PtL1Cl and PtL1C≡C-Ar in DCM at 298 K. 
 
Emission 
 The emission spectra of the complexes PtL1-4Cl and PtL1C≡C-Ar were recorded in 
degassed DCM at room temperature. Complexes PtL1Cl, PtL3Cl and PtL4Cl displayed highly 
structured emission bands in the range 635 – 720 nm. The component band of highest 
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intensity is the 0-0 transition, suggesting little difference in geometry between the ground 
states and the emissive excited electronic states.55 In contrast, weaker, structureless 
emission is displayed by complex PtL2Cl in the far-red region (Figure 4.3). The parent 
complex PtL1Cl emits light with a PLQY of 4%, whereas PtL3Cl has a PLQY of 2.2%, PtL4Cl has 
a PLQY of 2.9% and PtL2Cl has a PLQY of 0.5%. 
 
 
 
 
Figure 4.3: Normalised emission spectra of PtL1-4Cl and PtL1C≡C-Ar in deoxygenated 
dichloromethane at 298 K. 
The emission lifetime (τ) of the complexes are reported in Table 4.1, all complexes 
show susceptibility to quenching by dioxygen confirming that emission originates from a 
triplet state. The emission bimolecular rate constants for quenching by O2 (kq) of PtL1-4Cl 
and PtL1C≡C-Ar are similar to the kq values (~108 to 109 mol-1 dm3 s-1) of luminescent Pt(II) 
complexes reported in the literature.89 The radiative (kr) and nonradiative (knr) constants 
were estimated from the PLQYs (φ) and lifetimes (τ) of the phosphorescent complexes 
according to eq. 4.1 and 4.2, respectively. The non-radiative rate constants are significantly 
higher than the radiative rate constants for all of the complexes.  
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Table 4.1: Photophysical data for Complexes Pt(L1-4)Cl and Pt(L1)C2Ar 
 298 K    77 K 
Complex λ(abs) (nm) λ(em) (nm)  τ* 
(μs)a 
ɸb  
(%) 
kr 
(103 s-1) 
knr 
(105 s-1) 
kqd 
(mol-1 dm3 s-1) 
λ(em) 
 (nm) 
τ (μs) 
PtL1Cl 281, 334, 346, 376, 402, 511 635, 700 6.8 (0.6) 4b 5.9 1.4 6.8 x 108 615, 677, 755 14 
PtL2Cl 318, 334, 353, 385, 403, 550 735 1.8 (0.3) 0.5c 2.8 5.5 1.3 x 109 677, 737 13 
PtL3Cl 280, 334, 346, 377, 401, 512 645, 710 4.5 (0.4) 2.2b 4.9 2.2 1.0 x 109 619, 686, 762 11 
PtL4Cl 284, 334, 348, 379, 403, 524 660, 720 4.8 (0.4) 2.9b 6.0 2.0 1.0 x 109 626, 689, 768 13 
PtL1C≡C-Ar 279, 320, 334, 378, 406, 505 629, 686 11 (0.4) 4.6b 4.3 0.9 1.1 x 109 607, 667, 741 20 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±10%. c ±20% 
d Bimolecular rate constant for quenching by O2. *Χ2 values are located in appendix 7.3 
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𝑘௥ = 𝜙𝜏ିଵ                                                           (4.1) 
𝑘௡௥ = 𝑘௥(𝜙ିଵ − 1)                                                   (4.2) 
 The weaker emission of PtL2Cl may be explained by considering the general trend 
in knr for this series; as the energy of emission decreases the nonradiative rate increases. 
Exchanging the chloride for the more strongly donating acetylide ligand only causes a small 
increase in PLQY (to 4.6%), which is attributed to the decrease in knr rather than any 
beneficial effect of the acetylide on kr. 
All complexes show increased emission at 77K in frozen EPA glass (EPA = diethyl 
ether, isopentane and ethanol 2/2/1 by volume) and the estimated lifetimes of the 
emissions remain in the range of microseconds, indicating phosphorescent emission. All of 
the complexes displayed highly structured spectra, with an approximate 500 cm-1 blue shift 
of the 0,0 band from the room temperature emission (Figure 4.4). PtL2Cl appears to be 
shifted more significantly towards the blue by 1166 cm-1 however it is difficult to identify 
the 0,0 band in the room temperature spectra. The component band of highest intensity 
appears to be the 0,0 band in each of the spectra, indicating a small degree of distortion of 
the excited state.  
 
Figure 4.4: Normalised emission spectra of imine based complexes in EPA rigid glass at77 K. 
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DFT calculations 
In order to further understand the molecular orbitals and the nature of excited 
states, density functional theory (DFT) calculations and time-dependent DFT (TDDFT) were 
performed using the B3LYP152–154 method and LANL2DZ basis set for all atoms, with the 
Gaussian09 program. The orbital densities for the HOMO and LUMO are depicted in Figure 
4.5. The HOMOs are spread over the phenol ring, the platinum, the chloride and the imine 
unit, with very little contribution from the quinoline unit. However, the LUMO is spread 
over the whole ligand with relatively little contribution from the Pt and the chloride.  
It is important to note that the 4-position on the phenol ring appears to make a 
significant contribution to the HOMO and very little contribution to the LUMO, giving an 
insight into the substituent effects seen on the photophysical properties of the complexes. 
This spacial separation of the HOMO and the LUMO allows us to tune the HOMO-LUMO 
gap by using different substituents in the 4-position which can exert inductive or 
mesomeric effects that result in an electron donating or withdrawing character.155 The 
electronic character of substituents can be quantified according to Hammett values (σmeta 
or σpara); more negative (positive) values are associated with more electron-donating 
(withdrawing) groups.156 Complex PtL2Cl displays a red shift in both its UV-Vis absorption 
and emission spectra. This reflects the electron-donating effect of the 4-OMe group (σp = -
0.27), which destabilises the HOMO, decreasing the HOMO-LUMO gap.  
Exchanging the 4-position substituent for 4-OCF3 and 4-F in PtL3Cl and PtL4Cl, 
respectively, has a less pronounced effect. TDDFT calculations reveal that both the HOMO 
and LUMO are lowered by approximately the same extent in complexes PtL3Cl and PtL4Cl, 
resulting in very little deviation in ΔE from the parent complex PtL1Cl. Although there 
appears to be a node in the LUMO at the 4-position on the phenyl ring, an inductive effect 
on the LUMO may be anticipated through the meta position of the phenyl ring (4-OCF3 and 
4-F σm = 0.38 and 0.34, respectively). Similarly, exchanging the chloride ligand for the 
acetylide (1-Ethynyl-3,5-bis(trifluoromethyl)benzene) causes a blue shift in the emission 
wavelength (λem) due to stabilisation of the HOMO, presumably also through an inductive 
effect from the CF3 groups. 
TDDFT calculations gave emission wavelengths in good agreement with the 
experimental data and revealed in all complexes the emission is mainly from HOMO  
LUMO (70%) transitions. For all the complexes, the lowest energy absorption (S0  S1) is 
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derived primarily (by 70% contribution) from the HOMO  LUMO transition. Interestingly, 
the S0  S1 transition is not observed in the absorption spectra of any of the complexes, 
however the calculated S2 state and subsequent transitions match well with the 
experimentally observed absorption spectra. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Calculated orbital density for the LUMO (top) and HOMO (bottom) of PtL1-4Cl and 
PtL1C≡C-Ar at their optimised S0 geometries.  
PtL1Cl 
R = H 
PtL2Cl 
R = OMe
PtL3Cl 
R = OCF3
PtL4Cl 
R = F
PtL1C≡C-Ar 
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4.1.2 Hydrazone based complexes 
Electronic Absorption Spectra of N-H complexes 
 The absorption spectra of PtL5-13Cl were recorded in MeCN at room temperature. 
We noted difficulties in obtaining consistent extinction coefficient values for each of the 
complexes; we observed a change in the ratio of various absorption bands upon dilution 
and the appearance and absence of other absorption bands. 
 We postulated that we may have a mixture of protonated and deprotonated 
complex causing the spectral changes we observed (Scheme 4.1). It is well documented 
that deprotonation of uncoordinated hydrazones occurs only in highly basic conditions but 
coordination to a metal ion causes a significant enhancement in acidity of the N-H 
proton.157 The complexes of substituted hydrazones R1HNN=CHR2 are known as 
colorimetric reagents and their acid-base behaviour is accompanied by remarkable colour 
changes.158 It was reported by Bacchi et al. that the palladium complex of 2-
(diphenylphosphino)benzaldehyde 2-pyridylhydrazone (Hpbph) coexisted in both the 
protonated and deprotonated forms in the crystal.159  
N
H
N
N
OPt
Cl
N
N
N
OPt
Cl
H
H
 
Scheme 4.1: Deprotonation of PtL5Cl. 
 To investigate this phenomenon in our Pt-N^N^O- complexes we measured the 
electronic absorption spectra of PtL9Cl in the presence of various concentrations of acid or 
base in MeCN (Figure 4.6). The protonated complex shows moderately intense charge-
transfer absorption bands at 349 and 430 nm. Addition of NEt3 causes a loss of the 349 nm 
band and the appearance of two new absorption bands at 358 and 377 nm. We also 
observe that the absorption band at 430 nm increases in intensity and a new, more intense 
absorption band emerges at 448 nm. This red shift in absorption is likely due to the 
extension of π-conjugation in the deprotonated form. We see a colour change from pale 
yellow in the protonated form to bright yellow in the deprotonated form. The isosbestic 
points were maintained at 355, 306 and 297nm, indicating that the deprotonation reaction 
proceeds without any decomposition in this system. The original spectrum can be 
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recovered completely by addition of an acid such as acetic acid. We repeated this 
investigation with PtL8Cl and observed the same acid-base response (Figure 4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: UV-Vis electronic absorption of PtL9Cl at various concentrations of acid and base in 
MeCN 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: UV-Vis electronic absorption of PtL6Cl at various concentrations of acid and base in 
MeCN 
 
excess base 
excess acid 
excess base 
excess acid 
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The extinction coefficients of complexes PtL5-13Cl in the protonated and 
deprotonated form are listed in Table 4.2. We assign the intense transitions <300 nm as 
1π-π*, due to the presence of these bands in the ligand spectra. The transitions between 
the regions of 325 to 360 nm are assigned as metal-to-ligand charge transfer, in line with 
the original assignment by Mohan et al for PtL1Cl, PtL6Cl, PtL8Cl and PtL10Cl.141 The lowest 
energy transitions in the region of 400 - 500 nm are somewhat influenced by the R group 
on the phenyl ring, although no clear trend emerges with respect to electron-
donating/withdrawing ability. 
During the course of our investigation we observed some sensitivity of the 
complexes to light exposure when in solution. We recorded the spectral changes in a 
solution of PtL9Cl when exposed to sunlight over a period of 6 hours (Figure 4.8). A gradual 
loss of absorption across the whole of the spectrum was observed and a rise in the baseline 
suggesting the precipitation of an insoluble degradation product. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: UV-Vis electronic absorption of PtL9Cl in MeCN on exposure to sunlight, measurements 
taken at hourly intervals. 
 
T = 0 hours 
T = 6 hours  
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Table 4.2: Extinction coefficients for complexes PtL5-13Cl under acidic and basic conditions. 
 
Complex Absorption λmax / nm (a) 
(ε/ M-1 cm-1) 
excess acid 
Absorption λmax / nm (a) 
(ε/ M-1 cm-1) 
excess base 
PtL5Cl 
 
268 (28831), 280 (20472), 346 (9883), 417 (6747) 297 (14434), 358 (9395), 375 (10164), 423 (16350), 447 (22866) 
PtL6Cl 
 
262 (24728), 285 (19663), 349 (12858), 417 (12641) 
 
298 (13303), 358 (12008), 377 (12856), 425 (19787), 448 (25635) 
 
PtL7Cl 
 
257 (25908), 285 (17955), 351 (11842), 429 (9712) 
 
297 (14429), 359 (7735), 377 (8111), 428 (18810), 454 (33917) 
 
PtL8Cl 
 
279 (21100), 338 (18715), 410 (15047), 448 (7632) 
 
287 (11893), 351 (22078), 369 (25715), 426 (16881), 449 (23762) 
 
PtL9Cl 
 
259 (18763), 284 (16792), 349 (10985), 430 (10234) 
 
295 (12653), 361 (8499), 379 (9448), 427 (19159), 453 (31693) 
 
PtL10Cl 
 
261 (26190), 284 (19986), 348 (12558), 426 (9282) 
 
297 (14641), 358 (9146), 377 (9625), 426 (19480), 452 (32111) 
 
PtL11Cl 
 
264 (21486), 289 (15741), 351 (10975), 409 (14474) 
 
291 (15428), 357 (13589), 376 (13904), 430 (18819), 449 (18077) 
 
PtL12Cl 
 
270 (20397), 287 (18363), 349 (13115), 442 (8185) 
 
302 (14179), 365 (8861), 384 (10041), 433 (16646), 458 (26468) 
 
PtL13Cl 269 (33055), 334 (12388), 353 (11961), 441 (14829) 297 (22967), 378 (7842), 399 (8498), 441 (21893), 470 (32967) 
 
(a)Absorption maxima >250nm 
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Electronic Absorption Spectra of N-Me Complexes  
 The absorption spectra of complexes PtL14-20Cl (Figure 4.9) and PtL14C≡C-Ar (Figure 
4.10) were recorded in DCM at room temperature. The complexes show bands with high 
extinction coefficients in the far UV and moderately intense bands at ~350 nm and 
400-500 nm. We note the similarity of the spectra to the protonated N-H hydrazone 
bridged complexes and assign the transitions in the same manner (Figure 4.11). The lowest 
energy transitions in the region of 475 - 525 nm are again somewhat influenced by the R 
group on the phenyl ring, although no clear trend emerges with respect to electron-
donating/withdrawing ability. 
 
Figure 4.9: UV-Vis electronic absorption spectra of PtL14-20Cl.  
 Although the substitution of the chloride ligand in PtL14Cl by the phenylacetylide 
ligand in PtL14C≡C-Ar does not change the spectral profile substantially, there is a general 
red shift of the lower energy absorption bands (Figure 4.10). The strong σ-donation from 
the phenylacetylide ligand is expected to render the platinum centre more electron-rich 
and hence raise the dπ(Pt) orbital energy, leading to a lower energy MLCT absorption.160  
We investigated the effect of both acid and base on the absorption profile of the N-
Me complexes and observed no spectral changes. This verifies the origin of the spectral 
changes observed in the complexes PtL5-13Cl as being due to deprotonation of the N-H. The 
N-Me complexes did not show any evidence of decomposition, even when solutions were 
exposed to sunlight during the daylight hours for a period of one week. 
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Figure 4.10: UV-Vis electronic absorption spectra of PtL14Cl and PtL14C≡C-Ar.
 
Figure 4.11: UV-Vis electronic absorption spectra of PtL14Cl and PtL5Cl. 
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Emission of Hydrazone Based Pt(II) Complexes 
 The emission spectra of the hydrazone based Pt(II) complexes were recorded in 
degassed MeCN PtL5-13Cl or degassed DCM PtL14-20Cl at room temperature.  
For all of the N-Me hydrazone based Pt(II) complexes PtL14-20Cl we observed weak 
luminescence in solution at room temperature; the PLQYs in a degassed solution are of the 
order of 0.4 — 2.1%. This is in contrast to the related complex [Pt(tpy)Cl]+ which is 
essentially non emissive under these conditions. The lack of emission from [Pt(tpy)Cl]+ is 
attributed to the presence of low-lying d-d excited states that provide a thermally activated 
non-radiative decay pathway for the MLCT state.51 The introduction of the pseudo-
cyclometallating O- atom probably increases the ligand-field strength and hence the energy 
of the d-d state, reducing the accessibility of this pathway. 
The emission spectra of the N-Me complexes are poorly structured and broad, 
typical of luminescence from states with a high degree of charge-transfer character (Figure 
4.12). The emission maxima are affected by substituents on the phenyl ring, although no 
clear trend emerges with respect to electron-donating/withdrawing ability. The ‘parent’ 
complex PtL14Cl emits light with a PLQY of 1.7% and substitution of the R group causes very 
little variation in the PLQY (1.5-1.2%). Substitutions on the pyridine have a much less 
pronounced effect on the wavelength of emission (Figure 4.13) and again the PLQY shows 
little variation (1.7 – 2.1%).  
The component band of highest intensity appears to be the 0—1 transition, with 
the 0 – 0 transition appearing as a shoulder, indicating a more significant difference in 
geometry between the ground and excited electronic state compared to the earlier series 
of complexes.55 This geometrical distortion of the molecule in the excited state can lead to 
efficient pathways to non-radiative decay. 
Exchanging the chloride in PtL14Cl for the more strongly donating acetylide ligand 
results in a significant increase in the PLQY of PtL14C≡C-Ar to 11% from 1.7%. The emission 
spectrum is quite similar to that of the parent complex (Figure 4.14), although the 
vibrational structure is better defined and the emission is marginally blue shifted (approx. 
20 nm). Changing the co-ligand to an acetylide also causes an increase in the luminescence 
lifetime, which is raised to 9.3 vs. 2.1 in the parent complex PtL14Cl. The PLQY and lifetime 
are both increased by a comparable factor suggesting that the increase in PLQY in the 
acetylide complex is indeed due to a reduction in nonradiative decay pathways. 
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Figure 4.12: Normalised emission spectra of PtL14-18Cl in degassed DCM at 298 K.
 
Figure 4.13: Normalised emission spectra of PtL14Cl and PtL19-20Cl in degassed DCM at 298 K. 
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Figure 4.14: Relative emission spectra of PtL14Cl vs. PtL14C≡C-Ar in degassed DCM at 298 K. 
The emission lifetime (τ) of the complexes are reported in Table 4.3, all complexes 
show susceptibility to quenching by dioxygen confirming that emission originates from a 
triplet state. The emission bimolecular rate constants for quenching by O2 (kq) of PtL14-20Cl 
and PtL14C≡C-Ar are similar to the kq values (~108 to 109 mol-1 dm3 s-1) of luminescent Pt(II) 
complexes reported in the literature.89 The radiative (kr) and nonradiative (knr) constants 
were estimated from the PLQY (φ) and lifetime (τ) of the phosphorescent complexes 
according to eq. 4.1 and 4.2, respectively. The non-radiative rate constants are significantly 
higher than the radiative rate constants for all of the complexes. It is interesting to note 
that the radiative rate constant for the hydrazone based NMe ‘parent’ complex, PtL14Cl (8.1 
x 103 s-1) is higher than the earlier discussed imine based parent complex, PtL1Cl (5.9 x 103 
s-1), as might be expected if the excited state has more MLCT character. However, the non-
radiative rate constant is significantly higher in the hydrazone based complex (4.7 vs 1.4 x 
105 s-1) resulting in a lower PLQY (1.7 vs 4%). Inspection of the crystal structures of the 
imine and hydrazone based complexes reveals an insight into this difference, the bite angle 
in the imine based complex is closer to 180° which gives a stronger ligand field and 
promotes the d-d energy, reducing knr. Exchanging the chloride co-ligand for an acetylide 
ligand increases the radiative rate constant by a small degree but significantly reduces the 
non radiative decay, resulting in the increased luminescence life time and PLQY. 
Replacement of the phenol with a naphthol unit causes a significant reduction in PLQY 
(PtL18Cl, 0.4%), due to a reduction in the radiative decay accompanied by an increase in the 
non-radiative decay. 
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Table 4.3: Photophysical data for Complexes PtL14-20Cl and PtL14C≡C-Ar 
  298 K   77 K 
Complex λ(abs) (nm) λ(em) (nm) τ*  
(μs)a  
Φ  
(%) 
kr 
(103 s-1) 
knr 
(105 s-1) 
kqe 
(mol-1 dm3 s-1) 
λ(em) 
 (nm) 
τ (μs) 
PtL14Cl 261, 292, 333, 350, 399 (sh), 423 597 2.1 (0.4) 1.7b 8.1 4.7 9.2 x 108 529, 575, 628 36 
PtL15Cl 274, 294, 339, 351, 448 637 3.4 (0.2) 1.5b 4.4 2.9 2.1 x 109 564, 614, 674 39 
PtL16Cl 261, 286, 335, 351, 403 (sh), 427 609 2.3 (0.4) 1.4b 6.1 4.3 9.4 x 108 540, 589, 645 40 
PtL17Cl 261, 293, 338, 354, 412 (sh), 434 614 2.3 (0.3) 1.2b 5.2 4.3 1.2 x 109 545, 594, 653 36 
PtL18Cl 257, 274, 330, 340, 357, 422, 444 641 1.5 (0.4) 0.4c 2.7 6.6 8.3 x 108 575, 628, 689 23 
PtL19Cl 259, 294, 304, 349, 410 (sh), 435 598 1.8 (0.3) 1.7b 9.4 5.4 1.3 x 109 528, 573, 627 41 
PtL20Cl 261, 283, 331, 346, 398 (sh), 422 589 2.0 (0.3) 2.1d 11 4.9 1.3 x 109 529, 576, 629 49 
PtL14C≡C-Ar 260, 297, 338, 353, 399 (sh), 420 540 (sh), 578 9.3 (0.4) 11d 12 0.9 1.1 x 109 523, 568, 620 55 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±20%.c ±30% d ±10% 
 eBimolecular rate constant for quenching by O2. *Χ2 values are located in appendix 7.3 
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All complexes show more intense emission at 77K in frozen EPA glass (EPA = diethyl 
ether, isopentane and ethanol 2/2/1 by volume) and the estimated lifetimes of the 
emissions remain in the range of microseconds, indicating phosphorescent emission. All of 
the complexes displayed highly structured emission, with an approximate 500 cm-1 blue 
shift from the room temperature emission (Figure 4.15). The component band of highest 
intensity is the 0 – 1 transition in all of the complexes, indicating a larger degree of 
distortion in the excited state in comparison to the earlier discussed imine based 
complexes.  
 
 
Figure 4.15: Normalised emission spectra of hydrazone (NMe) based complexes in EPA rigid glass 
at 77 K. Top left: PtL15Cl – PtL18Cl; top right: PtL14Cl and PtL19Cl – PtL20Cl; bottom: PtL14Cl and 
PtL14C≡C-Ar. 
 Due to the sensitivity to light of the N-H hydrazone bridged complexes the series 
was deemed unsuitable for detailed luminescence studies. PtL6Cl was chosen as a 
representative complex for limited emission studies. The emission spectra of PtL6Cl (R = 5-
Me) was recorded under acidic and basic conditions in degassed acetonitrile at room 
temperature (Figure 4.16). Regardless of the pH, the complex was only weakly luminescent 
in solution at room temperature.  
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The protonated form of the complex showed broad (half-height width of 145 nm), 
orange emission (λmax = 597 nm) with a PLQY of 0.003. Close inspection of the emission 
profile reveals the presence of poorly resolved vibronic structure; the component band of 
highest intensity appears to be the 0—1 transition, with the 0 – 0 transition appearing as a 
shoulder, suggesting a reasonably significant difference in geometry between the ground 
and excited electronic states.55 
The deprotonated form of the complex showed more structured emission with 
better resolved vibronic coupling. The emission is red shifted with lowest energy emission 
band 0—0 and the 0—1 band approximately equal in intensity.  The PLQY is reduced to 
0.001.  
 
 
 
 
 
 
 
 
 
 
Figure 4.16: Normalised emission spectra of PtL6Cl in degassed MeCN at 298 K with the addition of 
acetic acid (red) and NEt3 (blue) 
DFT calculations 
In order to further understand the molecular orbitals and the nature of excited 
states, density functional theory (DFT) calculations and time-dependent DFT (TDDFT) were 
performed using the B3LYP152–154 method and LANL2DZ basis set for all atoms, with the 
Gaussian09 program. The orbital densities for the HOMO and LUMO of complex PtL14Cl are 
depicted in Figure 4.17. The HOMO and LUMO are both spread over the whole ligand and 
the platinum however only the HOMO has contribution from the chloride atom. The lack 
of spatial separation of the HOMO and LUMO gives an insight into the unpredictable 
substituent effects seen on the photophysical properties of the complexes. 
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Figure 4.17: Calculated orbital density for the LUMO (left) and the HOMO (right) of PtL14Cl 
at its optimised S0 geometry. 
4.1.3 Pyrazole based complex 
Photophysical Properties 
 The absorption spectrum of PtL21Cl was recorded in DCM at room temperature, it 
shows strong absorption in the high-energy region and slightly weaker absorption in the 
low-energy region (Figure 4.18). The high energy, intense absorptions can be assigned as 
ligand based 1π – π* transitions. There is a broad low energy band at 429 nm with a 
shoulder at 410 nm, attributed to charge transfer bands due to the similarity of the spectra 
to previously discussed complexes. There is no observable emission at ambient 
temperature in solution or in the solid state. 
 
Figure 4.18: UV-Vis electronic absorption spectra of PtL21Cl in DCM at 298K. 
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4.1.4 Hydrazide based complexes 
Electronic Absorption Spectra 
 The absorption spectra of a-PtL22Cl and b-PtL22Cl2 were recorded in DCM at room 
temperature (Figure 4.19). The transitions below 400 nm are assigned as ligand-centred 
due to the presence of these bands in the ligand spectra.131 The absorption bands centred 
at 470 nm confirm the presence of the N(amidate) atom of the hydrazone ligand (Scheme 
4.2). Kitamura et al. carried out an in-depth study of the coordination of ligand HL22 to Pd(II) 
– the study found that across 8 complexes, only those with an N(amidate) atom showed an 
absorption band in this region.161 The absorption band in the visible region is mainly 
attributed to the intraligand π – π* transition of the hydrazone ligand. The related Pd(II), 
Pt(II), Cu(II) and Ni(II) complexes containing N(amidate) atoms also showed a characteristic 
absorption band in this region, attributed to the intraligand transition.157,158,161 
 
Figure 4.19: UV-Vis electronic absorption spectra of a-PtL22Cl and b-PtL22Cl in DCM at 298K. 
 
Scheme 4.2: Coordination sites in the hydrazide ligand L22. 
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Emission 
The emission spectra of the hydrazide based complexes were recorded in degassed 
DCM at room temperature (Figure 4.20). Complex a-PtL22Cl displays highly structured 
emission bands in the range 625 – 756 nm. The component band of highest intensity is the 
0-0 transition, suggesting little difference in geometry between the ground state and the 
emissive excited electron state. In contrast, weaker, less structured emission is displayed 
by b-PtL22Cl in the region 531 – 612 nm. The component band of highest intensity appears 
to be the 0—1 transition, with the 0 – 0 transition appearing as a shoulder, indicating a 
more significant difference in geometry between the ground and excited electronic state 
compared to a-PtL22Cl.55 This geometrical distortion of the molecule in the excited state 
can lead to efficient pathways to non-radiative decay. 
 
Figure 4.20: Normalised emission spectra of a-PtL22Cl and b-PtL22Cl in degassed DCM at 298 K. 
The emission lifetimes (τ) of the complexes are reported in Table 4.4. It is interesting 
to note that complex a-PtL22Cl shows susceptibility to quenching by dioxygen confirming 
that emission originates from a triplet state. The emission bimolecular rate constant for 
quenching by O2 (kq) of a-PtL22Cl is similar to the kq values (~108 to 109 mol-1 dm3 s-1) of 
luminescent Pt(II) complexes reported in the literature.89 Complex b-PtL22Cl however does 
not show susceptbility to quenching by dioxygen. The PLQY of a-PtL22Cl is 0.5%, whereas b-
PtL22Cl has a PLQY of 0.1%. The non-radiative rate constants are significantly higher than 
the radiative rate constants for both of the complexes. The radiative and non-radiative rate 
constant is lower in b-PtL22Cl than a-PtL22Cl. 
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Both the complexes show increased emission at 77K in butyronitrile (Figure 4.21). 
The complexes display highly structured emission, the emission λmax of complex a-PtL22Cl 
remains relatively unchanged. It is interesting to note this complex does not display the 
rigidochromic effect, MLCT states are very sensitive to the medium rigidity while the energy 
of ligand-centered excited states remain unchanged.162 A ligand-centered assignment is 
further supported by the highly structured vibrational profile of a-PtL22Cl.  In contrast, we 
observe an approximate 1000 cm-1 blue shift from the room temperature emission λmax of 
b-PtL22Cl. This shift is the largest of the complexes discussed so far and is indicative of a 
larger degree of distortion in solution at room temperature. The component band of 
highest intensity in b-PtL22Cl is the 0 – 1 transition, further indicating a significant degree 
of distortion in the excited state. 
 
Figure 4.21: Normalised emission spectra of a-PtL22Cl and b-PtL22Cl in butyronitrile rigid glass at 
77 K. 
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Table 4.4: Photophysical data for Complexes a-PtL22Cl and b-PtL22Cl 
  298 K   77 K 
Complex λ(abs) (nm) λ(em) (nm) τ * 
(μs)a  
Φ  
(%) 
kr 
(103 s-1) 
knr 
(105 s-1) 
kqd 
(mol-1 dm3 s-1) 
λ(em) 
 (nm) 
τ (μs) 
a-PtL22Cl 261, 317, 356(sh) , 478 625, 683, 756 0.4 (0.2) 0.5b 1.3 25 1.1 x 109 629, 688, 742 0.9 
b-PtL22Cl 293, 323(sh), 381, 471 531, 569, 612 1.5 (1.5) 0.1c 0.6 6.6 0 502, 541, 582 0.7 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±20% c ±30%  d Bimolecular 
rate constant for quenching by O2. *Χ2 values are located in appendix 7.3 
 
Table 4.5: Photophysical data for Complexes PtL25Cl 
  298 K   77 K solid state at 298 K  
Complex λ(abs) (nm) λ(em) (nm) τ * 
(ns)a  
Φb  
(%) 
kr 
(104 s-1) 
knr 
(106 s-1) 
kqc 
(mol-1 dm3 s-1) 
λ(em) 
 (nm) 
τ (µs) λ(em) 
 (nm) 
τ (ns) Φd  
(%) 
PtL23Cl 265, 331, 405 - - - - - - 475, 508, 546 8.3 523 770 1.6 
PtL24Cl 274, 341, 402 - - - - - - 491, 523, 564 5.3 575 1000 1.4 
PtL25Cl 268, 326, 416 627 48 (39) 0.1 2.1 2.1 1.6 x 109 560, 602, 654 0.1 - 100 ---e 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±30%.c Bimolecular rate 
constant for quenching by O2 c ±20%  d too weak to measure PLQY. *Χ2 values are located in appendix 7.3 
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4.1.5 Imide and Amide-based complexes 
Electronic Absorption Spectra 
  The imide-based complexes PtL23-25Cl are very poorly soluble in all common organic 
solvents. The absorption spectra of imide based complexes PtL23-25Cl were recorded in 
dilute (1.2 x 10-5  mol/dm3) DCM solution at room temperature (Figure 4.22). The complexes 
show strong absorption in the far UV and less intense bands at ~325 and ~400 nm. The 
absorption at approx. 270 nm is assigned to ligand based 1π – π* transitions due to the 
presence of this band in the ligand spectra.121 The absorptions in the low-energy region are 
assigned to bands of charge transfer character. 
 
Figure 4.22: UV-Vis electronic absorption spectra of PtL23-25Cl in DCM at 298K. 
Emission 
 The emission spectra of the complexes PtL23Cl – PtL25Cl were recorded in degassed 
DCM at room temperature. The imide-based complexes PtL23Cl and PtL24Cl are essentially 
non-emissive in fluid solution at room temperature. For the amide-based complex PtL25Cl 
we observe weak luminescence in solution at room temperature (φ = 0.1%).  The emission 
spectra are poorly structured and broad, typical of luminescence from states with a high 
degree of charge-transfer character (Figure 4.23). 
The emission lifetime (τ) is reported in Table 4.5. It is interesting to note that despite 
the relatively short lifetime of complex PtL25Cl, we observe susceptibility to quenching by 
dioxygen confirming that emission originates from a triplet state. The emission bimolecular 
rate constant for quenching by O2 (kq) of PtL25Cl is similar to the kq values (~108 to 109 mol-
1 dm3 s-1) of luminescent Pt(II) complexes reported in the literature.89 The non-radiative 
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rate constant is significantly higher than the radiative rate constant, resulting in weak 
emission. 
 
Figure 4.23: Emission spectra of PtL25Cl in degassed DCM at 298 K. 
 In dilute glassy solution at 77 K, all three of the complexes are weakly emissive, 
displaying more structured emission (Figure 4.24). The emission of PtL25Cl is blue shifted 
from the room temperature emission, although is is difficult to say to what extent as the 
0,0 band cannot be identified in the room temperature spectra. The component band of 
highest intensity appears to be the 0 – 1 transition for each of the complexes, indicating a 
significant degree of excited state distortion. 
 
Figure 4.24: Normalised emission spectra of PtL23Cl – PtL25Cl in EPA rigid glass at 77 K. 
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 The emission spectra of PtL23Cl – PtL25Cl were recorded in the solid state and all 
three of the complexes are weakly emissive. The imide-based complexes PtL23Cl and PtL24Cl 
display increased emission compared to the amide-based complex PtL25Cl, which was too 
weak to record a PLQY. Complex PtL23Cl displays broad, poorly structured emission, typical 
of luminescence from states with a high degree of charge-transfer character (Figure 4.25). 
The component band of highest intensity appears to be the 0—1 transition, with the 0 – 0 
transition appearing as a shoulder, suggesting a reasonable degree of difference in 
geometry between the ground and excited electronic state.55 PtL24Cl displays broad, 
structureless emission with a slightly reduced PLQY (1.4% vs. 1.6% for PtL23Cl). It is 
interesting to note the change in emission profile from the frozen solution spectrum of 
PtL24Cl; the emission has shifted from a highly structured profile to a broad structureless 
emission indicating there may be a change in the origin of emission. It is possible that the 
solid-state emission originates from aggregation effects, involving Pt-Pt interactions that 
give rise to low energy emitting states.   
 
Figure 4.25: Normalised emission spectra of PtL23Cl and PtL24Cl in the solid state at 298 K. 
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4.2 Tetradentate Pt(II) Complexes 
4.2.1 Hydrazone based complex 
Electronic Absorption Spectra 
The absorption spectrum of PtL27 was recorded in DCM at room temperature 
(Figure 4.26). The complex shows bands with high extinction coefficients in the far UV and 
less intense bands at ~420 nm. The absorption bands centred at ~420nm and 330 nm 
closely resemble the charge transfer bands of the parent tridentate complex PtL14Cl. The 
absorption bands below 300 nm are assigned to 1π – π* transitions localised on the ligand.  
 
Figure 4.26: UV-Vis electronic absorption spectra of PtL27 and PtL14Cl in DCM at 298K. 
Emission 
 The room-temperature and low-temperature (77 K) solution emission spectra were 
recorded for PtL27 and are shown in Figure 4.27. In contrast to the poorly structured 
emission profile of PtL14Cl, the room temperature emission of PtL27 is highly structured 
suggesting a greater ligand character of the lowest-energy triplet state. The component 
band of the highest intensity is the 0—1 transition, with the 0 – 0 transition appearing as a 
shoulder, suggesting a reasonable degree of difference in geometry between the ground 
and excited electronic state.55  
The PLQY in solution is 0.11 (degassed DCM, 298 K), a significant increase to that of 
the analogous tridentate PtL14Cl (0.017). The luminescence lifetime (τ = 11 µs) is also 
increased by a comparable order of magnitude from that of PtL14Cl (τ = 2.1 µs). This increase 
suggests that the improvement in PLQY is indeed due to a reduction in non-radiative decay 
N
N N
O
N
N N
O
Pt
Pt
Cl
PtL27
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pathways. The PLQY (0.11) luminescence lifetime (11 µs), kr (10 x 103 s-1) and knr (0.8 x 105 
s-1) of PtL27 are all comparable with PtL14C≡C-Ar (0.11, 9.3 µs, 12 x 103 s-1, 0.9 x 105 s-1, 
respectively). 
Complex PtL27 shows more intense emission at 77 K in frozen EPA glass and the 
estimated lifetime of emission remains in the range of microseconds, indicating 
phosphorescent emission. The emission is highly structured, with an approximate 
~500 cm-1 blue shift from the room temperature emission. The component band of highest 
intensity is the 0 – 0 transition, indicating a relatively small degree of excited state 
distortion. 
 
Figure 4.27: Normalised emission spectra of PtL27 at 298 K (in degassed DCM) and 77 K (in EPA 
rigid glass). 
Table 4.6: Photophysical data of complex PtL27. 
  298K 77K 
Complex λ(abs) (nm) λ(em) 
(nm) 
τ * 
(μs)a  
Φb  
(%) 
kr 
(103 s-1) 
knr 
(105 s-1) 
kqc 
(mol-1 dm3 s-1) 
λ(em) 
(nm) 
τ 
(μs) 
PtL27 257, 327, 
399(sh), 
419 
526, 
565, 
609 
11(0.3) 11 10 0.8 1.5 x 109 513, 
558, 
607, 
673 
51 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-
equilibrated solution are given in parentheses. b ±10%.c Bimolecular rate constant for 
quenching by O2. *Χ2 values are located in appendix 7.3 
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4.2.2 Pyrazole based complexes 
Electronic Absorption Spectra 
 The absorption spectra of pyrazole based complexes PtL29-31Cl were measured in 
DCM at room temperature (Figure 4.28).10 The high energy, intense absorptions (250 – 360 
nm) can be assigned as ligand based 1π – π* transitions. It is interesting to note that the 
charge transfer transition at ~400 nm is significantly weaker than the corresponding 
tridentate complex PtL21Cl, suggesting this transition is associated with the phenolate-Pt 
unit. 
 
Figure 4.28: UV-Vis electronic absorption spectra of PtL29-31Cl and PtL21Cl in DCM at 298K. 
Emission 
 The emission spectra of PtL29Cl and PtL30Cl – PtL31Cl were recorded in degassed DMF 
and DCM at room temperature, respectively. The complexes display highly structured 
emission bands in the range 502 – 592 nm (Figure 4.29), suggesting emission from a ligand-
centred state. The component band of highest intensity is the 0 – 0 transition, indicating 
little difference in geometry between the ground states and the emissive excited electronic 
states.  
 The emission lifetime (τ) of the complexes are reported in Table 4.7, it is interesting 
to note the complexes do not show susceptibility to quenching by dioxygen. The complexes 
display weak emission in solution at room temperature, the PLQY of PtL29Cl was too 
weak to measure. The non-radiative rate constants are significantly higher than the 
                                                          
10 Complex PtL32Cl was unsuitable for photophysical studies due to difficulties in purification of the complex. 
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radiative rate constants for both of the complexes. It is interesting to note the rates of non-
radiative decay in complexes PtL30Cl and PtL31Cl (~108 s-1) are significantly higher than all of 
the previously discussed complexes which are on the order of 105 – 106 s-1. This may be 
attributed to the freely rotating phenol ring providing an efficient route to non-radiative 
decay. 
 
Figure 4.29: Normalised emission spectra of PtL29Cl in degassed DMF and PtL30Cl – PtL31Cl in 
degassed DCM at 298 K. 
The emission spectra of PtL29Cl – PtL31Cl were recorded in the solid state and all 
three of the complexes are weakly emissive (Figure 4.30). The complexes PtL29Cl and PtL30Cl 
display increased emission compared to PtL31Cl, which was too weak to record a PLQY. The 
emission profile remains highly structured suggesting that the solid-state emission 
originates from the same state as the solution state emission. 
 
Figure 4.30: Normalised emission spectra of PtL30Cl and PtL31Cl in the solid state at 298 K. 
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Table 4.7: Photophysical data for complexes PtL29Cl – PtL31Cl. 
  298 K  solid state at 298 K  
Complex λ(abs) (nm) λ(em) (nm) τ * 
(ns)a  
Φb  
(%) 
kr 
(104 s-1) 
knr 
(107 s-1) 
λ(em) 
 (nm) 
τ (ns) Φ  
(%) 
PtL29Cl 283, 321, 336(sh), 360, 397, 
432 
502, 539, 
583 
26+11(55/45)(22+11(50/50))e ---d - - 513, 546, 
589 
1300 3.2 
PtL30Cl 284, 324, 359(sh), 396, 431 507, 544, 
590 
17(17) 0.3 18 59 509, 543, 
589 
410+130(75/25)e 0.23 
PtL31Cl 286, 297(sh), 323, 363(sh), 
397, 431 
512, 545, 
592 
40(40) 0.5 13 25 - 460+130 
(75/25)e 
---d 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±30%.c Bimolecular rate 
constant for quenching by O2. d too weak to measure PLQY. ebiexponential; relative weightings of components in parenthesis. *Χ2 values are located in 
appendix 7.3 
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4.3 Tridentate Ir(III) Complexes 
 
4.3.1 Hydrazone based complexes 
Electronic Absorption Spectra 
 The absorption spectra of tridentate Ir(III) complexes ([Ir(dpyx)(L14-17)]PF6, dpyx = 
1,3-Di(2-pyridyl)-4,6-dimethylbenzene) were recorded in MeCN at room temperature 
(Figure 4.31). The absorption spectra show very intense bands in the near-UV region 
between 240 – 300 nm, which are assigned to 1π-π* transitions from comparison to the 
literature.163 The weaker transitions extending into the visible region are attributed to 
transitions with charge transfer character. The MLCT transitions of the 4-OMe substituted 
complex are red-shifted with respect to the parent complex, which may be rationalised in 
terms of destabilisation of the HOMO as a result of the electron-donating nature of the 
substituent. 
 
 
Figure 4.31: UV-Vis electronic absorption spectra of [Ir(dpyx)(L14-17)]PF6 in MeCN at 298K. 
 
Emission 
 The emission spectra of the hydrazone based Ir(III) complexes were recorded in 
degassed DCM at room temperature (Figure 4.32). All of the complexes are luminescent in 
144 
 
solution at room temperature, with very little variation in the λmax (~600 nm). Complex 
[Ir(dpyx)(L15)]PF6 is shifted furthest into the red, mirroring the trend seen in the absorption. 
The emission spectra display poorly defined vibronic progression; the 0 – 1 band appears 
to be dominant with the exception of [Ir(dpyx)(HL15 )]PF6 where the 0 – 0 and 0 – 1 are 
equal.  
The PLQYs in degassed solution are in the range 0.05 – 0.09 (Table 4.8), the highest 
value is observed for the parent complex (Φlum = 0.09) which is the highest energy emitter. 
Complex [Ir(dpyx)(L17)]PF6 has the lowest PLQY of 5% and also the shortest lifetime (3.0 µs). 
Some insight into this may be obtained by considering the rate constants for radiative (kr) 
and nonradiative (knr) decay. The values in Table 4.8 indicate that the reduced PLQY and 
shorter lifetime of this complex are largely due to increased nonradiative decay. The 
radiative rate constants are similar for all four complexes. The PLQYs of these complexes 
are higher than that reported for the related [Ir(dpyx)(phbpy)]+, which has a PLQY of 
2.3%.164 Although the radiative rate constants of complexes [Ir(dpyx)(L14-17)]PF6 are a factor 
of ~10 smaller than for [Ir(dpyx)(phbpy)]+, this increase in PLQY can be attributed to a ~40-
fold decrease in the rates of non-radiative decay. This may be due to the increase in chelate 
ring size in complexes [Ir(dpyx)(L14-17)]PF6 from a 5,5 system in phbpy to a 5,6 system in L14-
17 relieving ring strain in the system. The emission life time (τ) of all the complexes show 
susceptibility to quenching by dioxygen confirming that emission originates from a triplet 
state.  
 
Figure 4.32: Emission spectra of complexes [Ir(dpyx)(L14-17)]PF6 in degassed DCM at 298K. 
145 
 
 
Table 4.8: Photophysical data for complexes [Ir(dpyx)(L14-17)]PF6 
  298K   
Complex λ(abs) (nm) λ(em) 
(nm) 
τ * 
(μs)a  
Φb  
(%) 
kr 
(103 s-1) 
knr 
(105 s-1) 
kqc 
(mol-1 dm3 s-1) 
[Ir(dpyx)(L14)]PF6 228 (sh), 248 (sh), 265, 285 (sh), 343 (sh), 370 (sh), 393, 416 
(sh)  
560, 600 5.4 (0.3) 9 16.7 1.7 1.4 x 109 
[Ir(dpyx)(L15)]PF6 229 (sh), 248, 277, 300 (sh), 346 (sh), 380, 434, 457 (sh) 615, 645 6.2 (0.2) 8 12.9 1.5 2.2 x 109 
[Ir(dpyx)(L16)]PF6 228 (sh), 246 (sh), 264, 285, 320 (sh), 346, 372, 395, 421 (sh) 575, 615 4.2 (0.3) 8 19.0 2.2 1.4 x 109 
[Ir(dpyx)(L17)]PF6 229 (sh), 245, 265, 299 (sh), 320 (sh), 350, 393, 429 (sh) 578, 620 3.0 (0.4) 5 16.7 3.2 9.8 x 108 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±10%.c Bimolecular rate 
constant for quenching by O2. *Χ2 values are located in appendix 7.3 
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Concluding Remarks 
 We have successfully synthesised and fully characterised a range of new tridentate 
Pt(II) complexes. We have explored the effect of pseudo-cyclometallating ligands of 
N^N^O— or N^N—^N – coordination. The proligands and corresponding complexes are all 
prepared using relatively mild conditions. The photophysical properties of the complexes 
have been discussed.  
 With the exception of the pyrazole-based complex, PtL21Cl, all of the tridentate 
complexes are weakly emissive in solution at room temperature. The PLQYs are in the range 
0.1 – 4%, a noteworthy improvement on the platinum terpyridiyl complex [Pt(tpy)Cl]+ 
which is essentially non-emissive in solution at room temperature. The Pt(II) complexes 
with N^N^O– ligands investigated in this work have higher PLQYs than those with N^N—^N 
ligands, suggesting the pseudo cyclometallating O- provides a stronger field than the N-. 
 Replacement of the chloride ligand in the imine-based PtL1Cl by a strong field 
acetylide was anticipated to raise the energy of deactivating d-d states, promoting 
luminescence over non-radiative decay. The exchange causes a small increase in PLQY 
(4.6% vs 4%), attributed to a reduction in knr rather than any beneficial effect on kr. 
Replacement of the chloride ligand in the hydrazone-based NMe PtL14Cl by an acetylide 
was more successful, raising the PLQY from 1.7% to 11% in PtL14C≡C-Ar.  
We have investigated the design of a more rigid structure based on the N^N^O- 
NMe hydrazone based proligands, extending them into tetradentate proligands with a 
C^N^N^O- coordination mode. The hydrazone-based NMe complex PtL27 has a PLQY of 
11%, with an emission lifetime, kr and knr of the same order as PtL14C≡C-Ar. The increase in 
PLQY can be attributed to a decrease in knr caused by the rigidification of the ligand in 
comparison to the parent complex PtL14Cl. 
 Extension of the pyrazole-based tridentate proligand was less successful. We 
successfully synthesised a series of tetradentate proligands offering a C^N^N^O- 
coordination mode, however complexation was only achieved in a tridentate C^N^N 
manner. The resulting complexes were only very weakly emission in solution at room 
temperature, due to high non-radiative decay constants likely caused by the free rotation 
of the phenol in solution providing efficient non-radiative decay pathways. 
147 
 
We have also investigated a series of Ir(III) complexes containing N^C^N and 
N^N^O- tridentate ligands. The photophysical properties of the complexes have been 
discussed. The PLQYs (5 – 9%) are higher than that reported for the related 
[Ir(dpyx)(phbpy)]+, which has a PLQY of 2.3%.  
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5 Multimetallic Complexes of Pt(II) and Ir(III) 
 
5.1 Introduction 
 Although the vast majority of complexes studied for photonic applications focus on 
monometallic species, in the past two decades there has been a growing interest in 
compounds incorporating more than one metal centre. There was an initially established 
view that multinuclear metal complexes give poor device performance due to the PLQYs of 
early examples of such complexes being considerably lower than for mononuclear 
analogues.165–167 However, more recent examples challenge this accepted view and 
establish that multinuclear complexes are not only viable for incorporation in OLEDs but 
may offer some intriguing benefits.167 
 Phosphorescent red and near-infrared emitters are required for full colour displays, 
however currently available red-emitting compounds are not able to match their high 
performing green counterparts.168 Many Ru(II) complexes have been studied for this 
purpose and more recently those of third-row metals such as Pt(II) and Ir(III).169 Examples 
of multinuclear systems have begun to emerge as an alternative approach to achieve red-
shifted emission. Pt(II) studies have utilised flexible or rigid linkers to bring together two 
square-planar units to promote d8—d8 interactions between the platinum centres or 
ligand—ligand (π-π) interactions. This typically results in an emission which is red-shifted 
from the 3MLCT emission of the mononuclear complex.170 In the case of Ir(III), many 
examples are individual mononuclear metal complexes linked through an ancillary or 
bridging ligand. This often results in compounds where the original properties of the 
mononuclear complex are retained.171  
 This chapter is by no means a comprehensive overview of the literature, but rather 
it is intended to give a flavour of the diversity of the field and highlight some interesting 
examples in recent literature. 
5.1.1 Pt(II) Complexes 
 Multinuclear Pt(II) complexes coordinated through multidentate nitrogen-donor 
ligands have been explored by a number of research groups. The use of pyrazolate bridges 
to introduce two or more metal centres in a face-to-face manner is of much interest. An 
early example of such complexes was provided by Gray and co-workers in 1993 who 
investigated the photophysics of binuclear complexes containing terpyridine ligands and 
149 
 
bridged by a variety of anionic N-N ligands; pyrazole, 7-azaindole, diphenylformamidine 
and arginine (Figure 5.1).172 Similar to the monometallic parent complex ([Pt(tpy)Cl]+), the 
new complexes failed to show emission in solution at room temperature although it was 
noted that in the solid state and 77K the emission maxima moved to lower energy with 
decreasing Pt—Pt separation. 
 
Figure 5.1: Binuclear Pt-terpyridine complex reported by by Gray and co-workers. 
 Che and co-workers, noting the extensive use of multidentate nitrogen-donor 
ligands in the assembly of cyclic supermolecules, reported the synthesis and photophysical 
study of a related set of Pt(II) complexes.173 The platinum-containing macrocycles utilised 
cyclometallated Pt(II) complexes bearing substituted pyridyl and 2,2’-bipyridyl ligands with 
various bidentate N-donor linkers; pyrazole, 7-azaindole and benzimidazole (Figure 5.2). 
Structured emissions were observed for complexes 2 – 5a in solution at room temperature 
although the multinuclear complexes have slightly lower PLQYs (3a = 0.18, 4a = 0.12, 5a = 
0.16) than the parent monometallic complex (2a = 0.19). In contrast to this, the remaining 
mono- and multinuclear complexes were either non or very weakly emissive. 
 
Figure 5.2: Multidentate nitrogen donor bridged Pt(II) complexes reported by Che and co-workers. 
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 Building upon these results, Thomspon and co-workers explored colour tuning in 
pyrazolate bridged Pt(II) binuclear complexes.174,175 The steric bulk of the bridging 
pyrazolate controls the degree of metal—metal interaction, giving compounds 6-8 which 
emit blue, green and red light, respectively (Figure 5.3). Efficient blue, green and red OLEDs 
were fabricated with these complexes and in combination allowed the fabrication of 
WOLEDs which showed high brightness and quantum efficiencies. 
 
Figure 5.3: Structure of the binuclear complexes used as phosphorescent dopants. 
 A number of other bridging ligands have been explored in order to bring two Pt(II) 
centres together in a face-to-face manner. Although a red shift in emission is consistently 
achieved, PLQYs are also consistently lower than their monometallic counterparts. In 2002, 
Che and co-workers utilised an isocyanide bridge to increase Pt—Pt interactions in complex 
9 (Figure 5.4) and reported a 100 nm red shift accompanied by a significant decrease in 
PLQY.176 This was attributed to a change in the nature of emission, from 3MLCT in the 
monometallic complex to an excimeric intraligand (3IL) excited state. In 2008, Williams and 
co-workers reported similar findings for  N^C^N-coordinated Pt(II) complexes linked 
through a xanthene core (Figure 5.4).177 
 
Figure 5.4: Binuclear Pt(II) complexes reported by Che and co-workers (9) and Williams and co-
workers (10). 
 An alternative strategy has been utilised by Kozhevnikov and co-workers, who 
synthesised a series of five dinuclear Pt(II) complexes based on diphenylpyrazine-based 
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bridging ligands (Figure 5.5).168 Rather than promoting Pt—Pt interactions or the formation 
of excimers, this approach is based on the general observation that the introduction of a 
second cyclometallated metal centre is accompanied by a red shift, due to the stabilisation 
of the LUMO.171 The study reveals that for all six ligands investigated, introduction of a 
second metal centre leads to significant stabilisation of the LUMO, while the HOMO 
remains relatively unaffected. Interestingly, for all of the systems, introducing a second 
metal ion increases the radiative rate constant kr, despite the red shift. This effect was 
attributed to the higher degree of spin-orbit coupling expected from the presence of a 
second Pt(II). 
 
Figure 5.5: Structure of the mononuclear and dinuclear Pt(II) complexes. 
Matsumura and co-workers recently reported the near-infrared luminescence of a 
bis(Pt-salen) complex.178 The photophysical properties of a fused Pt-salen complex (Pt215) 
were reported alongside two analogous mononuclear complexes 16 and 17 (Figure 5.6). 
The luminescence spectra showed the highest-energy maxima of Pt215, 16 and 17 were 
636, 558 and 574 nm, respectively, assigned to 3MLCT or 3ππ* emission (or possibly a 
mixture of the two).  
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Figure 5.6: Dinuclear complex Pt215 and structure of the mononuclear analogues 16 and 17. 
5.1.2 Ir(III) Complexes 
 In recent years, interest in multi-nuclear Ir(III) complexes has emerged from the 
intense and widely successful research into the application of iridium complexes as 
phosphors for light-emitting devices. In 2006, Monkman and co-workers reported the first 
incorporation of bridged diiridium complexes into electrophosphorescent OLEDs.167 The 
bis(μ-chloro)diiridium(III) complexes typically utilised to access cyclometallated 
mononuclear Ir(III) complexes are only weakly emissive at room temperature and 
unsuitable for OLEDs. However, their relative ease of synthesis is attractive for 
commercialisation purposes; Monkman and co-workers aimed to investigate the use of 
organic bridging ligands to produce dinuclear iridium complexes as phosphorescent 
dopants for OLEDs. They found that the traditional μ-chloro bridged dimers could be readily 
converted to diisocyanato-bridged species on reaction with tetrabutylammonium cyanate 
(Figure 5.7). Interestingly, despite emitting at the same energy (λmax = ~550 nm) the PLQY 
is increased considerably from 0.004 to 0.02, with a similar increase in lifetime τ. This 
increase in ɸ is attributed to a decrease in knr due to the stronger ligand field of the cyanate 
ligands increasing the energy gap between the emissive state and the deactivating d-d 
state. Complex 19 afforded OLEDs with EQE values of 0.8%, which although modest, began 
to challenge the perception that dinuclear species were not viable as dopants for 
electrophosphorescent OLEDs. 
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Figure 5.7: The conversion of chloro-bridged dimers to bis-μ-isocyanate-bridged dimers. 
 Similar to the success seen for Pt(II) complexes, pyrazole ligands have been 
employed to produce bridged dinuclear iridium complexes. In 2012, Chandrasekhar and co-
workers explored the use of different types of pyrazole ligands whose steric bulk was 
modulated by varying the number and nature of substituents on the 3 and 5 positions.179 
The treatment of a dichloro-bridged iridium dimer with sodium methoxide and a pyrazole 
(3,5-diphenylpyrazole (Ph2PzH) or 3(5)-methyl-5(3)-phenylpyrazole (PhMePzH)) resulted in 
the synthesis of binuclear iridium complexes bridged by one pyrazole ligand and one OH 
group (Figure 5.8). The phosphorescent emission for each of the bimetallic complexes is 
red shifted by approximately 50 nm compared to their monometallic counterparts. This is 
attributed to the π-donating nature of the bridging ligands, which pushes the electron 
density toward to Ir(III) centre. This raises the energy level of the HOMO, while leaving the 
LUMO (which is localised on the pyridyl rings of the ppy ligands) relatively unaffected.  
 
Figure 5.8: Conversion of chloro-bridged iridium dimers to pyrazole bridged dimers; water leads to 
the bridging OH groups. 
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 In the same year, Chandrasekhar and co-workers also reported the preparation of 
a series of dinuclear Ir(III) complexes utilising pyridine based linkers (Figure 5.9).180 The 
choice of ligands allowed for the variation of the spacer length to modulate the 
intermetallic distances and for variation in the extent of bridging ligand conjugation to 
modulate the degree of metal-metal interaction. The diiridium complexes all contain 
Ir(ppy)2 units bridged by the bis-pyridyl linkers; 1,2-bis(4-pyridyl)-ethane (bpa), 1,3-bis(4-
pyridyl)propane (bpp) and trans-1,2-bis(4-pyridyl)ethylene (bpe) afforded 
metallamacrocycles with two bridging linkers (complexes 23 – 25) whereas the use of N,N’-
bis(2-pyridyl)methylene-hydrazine (abp) and N,N’-(bis(2-pyridyl)formylidene)ethane-1,2-
diamine resulted in discrete dimers with only one bridging linker (complexes 26 and 27). 
For clarity, the ORTEP diagram of 23 and 26 can be seen in Figure 5.10. 
 
Figure 5.9: Bis-pyridyl linkers employed by Chandrasekhar and co-workers. 
 
Figure 5.10: ORTEP diagram (40 probability thermal ellipsoids) of the dicationic unit [{Ir(ppy)2}2(μ-
bpa)2] in 23 (left) and the dicationic unit [{Ir(ppy)2}2(μ-abp)] in 26. 
The emission properties of the complexes were investigated and all were found to 
be luminescent at room temperature. Complex 23 and 24 are very similar, both show blue 
emission (480 nm) with a PLQY of 0.45 and 0.48 respectively. The emissive state is 
attributed to one of 3LC character. The introduction of conjugation into the spacer in 
complex 25 causes a significant red shift in the emission (~60 nm) with the PLQY remaining 
relatively high (0.41). Compound 26 and 27 also show a similar red shift in emission; 
interestingly the PLQY of 26 is impressively high (0.51) whereas in complex 27 is it reduced 
to 0.12. This reduction in PLQY is thought to originate from an increase in knr; it is proposed 
that in solution the C-C bond in the bpfd linker can rotate to alternate between an anti- 
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and syn- configuration. The emission in complex 25 – 27 is attributed to states of 
predominantly 3MLCT character.  
Congrave et al. recently reported the study of diarylhydrazide bridging ligands to 
produce dinuclear iridium complexes (28 – 31), providing a short conjugative pathway 
between the two iridium centres (Figure 5.11).181 The diiridium complexes were 
synthesised via cleaving of the traditional bis(μ-chloro)-bridged intermediate with the 
hydrazide ligand in the presence of K2CO3. The resulting mixtures of meso (ɅΔ, a) and rac 
(ΔΔ/ɅɅ, b) diastereomers were separated and characterised separately. The 
phenylpyrazole complexes 28 and 29 were non emissive in solution at room temperature 
due to weaker crystal field strength of the ligands, a case commonly seen for non emissive 
homoleptic phenylpyrazole complexes.181 Complexes 30 and 31 were found to be weakly 
emissive in solution at room temperature (ɸPL < 1%), emitting in the turquoise and green 
regions, respectively. This weakness of the emission was attributed to unusually high knr. In 
line with the findings of Chandrasekhar and co-workers for complex 27, the highly flexible 
bridges are thought to facilitate nonradiative decay via intramolecular motion. 
Interestingly, when complexes 30 and 31 are doped into poly(methylmethacrylate) 
(PMMA) the knr rates decrease by 2-3 orders of magnitude due to suppression of the 
intramolecular motion, causing the PLQYs to also increase by 2-3 orders of magnitude.  
Noting the high values of nonradiative decay in flexible bridged diiridium 
complexes, Zhou and co-workers have investigated the properties of a series of diiridium 
complexes with a rigid pyrimidine bridge (Figure 5.12).182 The electron-deficient character 
of the pyrimidine ring is also thought to make a good electron acceptor to facilitate the 
MLCT processes. One mononuclear and two dinuclear Ir(III) complexes can be prepared in 
a one-pot reaction using 2-phenylpyrimidine-type ligands. The diiridium complexes possess 
higher HOMO and lower LUMO levels when compared with their mono-iridium 
counterparts, resulting in an approximate 80 nm red shift in emission. The emission in all 
cases mainly originates from the 3MLCT transitions and there is very little difference in λmax 
of diiridium complexes 34 – 37 despite the presence of electron-withdrawing fluorine. This 
is attributed to neither the HOMO nor the LUMO being localised on the phenyl ring of the 
phenylpyrimidine unit. The PLQY is close to unity for the mononuclear complexes whereas 
the diiridium complexes have lower PLQY in the range of 0.36 – 0.68. It is interesting to 
note that complexes 36 and 37 have the higher ɸPL of 0.68 which is amongst the highest 
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PLQYs for dinuclear Ir(III) complexes. The solution-processed device based on complex 35 
exhibited an outstanding EQE of 17.9%. 
 
Figure 5.11: Structures of the diiridium complexes (a = ɅΔ meso diastereomers; b = ΔΔ/ɅɅ rac 
diastereomers) studied by Congrave et al.
 
 
Figure 5.12: Mono- and di-nuclear complexes studied by Zhou and co-workers. 
5.1.3 Mixed Heavy Metal Complexes 
 Although there has been an increased interest in recent years in multinuclear 
complexes for OLED applications, the vast majority of research has been carried out on 
systems which compromise more than one atom of the same metal. Noting the absence of 
mixed-metal polymetallic, cyclometalated complexes having both Pt(II) and Ir(III) present 
in one luminophore, Williams and co-workers reported an early example of a rigid 
polynuclear cyclometalated complex incorporating one Ir(III) and two Pt(II) centres using a 
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pyrimidine based ligand.171 The related monometallic and dinuclear Pt(II) complexes were 
also prepared for comparison (Figure 5.13). All four of the complexes were found to be 
highly luminescent, both in the solid state and in solution at room temperature. 
Incorporation of a second Pt(II) centre in complex 39 caused a red shift in the λmax of 
emission (513 to 550 nm) and changed the spectral profile substantially, indeed there are 
no detectable emission bands corresponding to the mononuclear unit. The monometallic 
Ir(III) complex 40 is red shifted once again (λmax = 585 nm) and incorporation of two Pt(II) 
centres to produce complex 41 causes the most significant red shift (λmax = 626 nm). Again 
there are no detectable emission bands corresponding to the mononuclear unit. The PLQYs 
are high for each of the complexes (0.31 – 0.54), it is particularly notable that unlike the 
systems discussed so far the PLQY does not fall off even for the most red-shifted complex 
41. Introduction of subsequent metal centres can be seen to increase the radiative rate 
constant despite the emission energy decreasing; the kr roughly doubles going from 38 to 
39 and likewise from 40 to 41.  
Figure 5.13: Mononuclear, dinuclear and trinuclear complexes studied by Williams and co-workers. 
Kozhevnikov and co-workers have built upon the success of this system to 
incorporate a third Pt(II) metal centre and in 2017 published an unprecedented 
heterometallic tetranuclear complex, 42 (Figure 5.14).183 The iridium centre is incorporated 
first by reaction of 4,6-bis-(4-t-butylphenyl)-pyrimidine (bppymH2) with Ir(acac)3 in the 
presence of o-phosphoric acid. The resulting mononuclear complex is then reacted with 
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K2PtCl4 in a mixture of acetic acid and acetonitrile at reflux, followed by treatment with an 
excess sodium acetylacetonate in acetone to give the target complex 42.  
 
Figure 5.14: Heterometallic tetranuclear complex. 
The photophysical study of complex 42 revealed intense red emission (λmax = 611 
nm) in solution at room temperature. The impressive PLQY of 0.76 renders it one of the 
brightest red-emitting complexes reported to date. The luminescence lifetime of complex 
42 is unusually short at 720 ns (e.g. fac-Ir(ppy)3, τ = 1.9 μs), indicating very fast radiative 
decay. This augmentation of kr is consistent with the effect of additional metal ions in the 
previously reported system by Williams and co-workers.171 
A number of alternative approaches to mixed multinuclear complexes have also 
seen success in recent years. Acknowledging the success of Ma et al. in the use of 1,1,2,2-
tetraacetylethane (tae) to assemble emissive Pt(II) dyads184, Bruce and co-workers 
reported a heteronuclear Pt–Ir dyad linked by the tae ligand.185 Complex 43 (Figure 5.15) 
exhibits intense emission (λmax = 588 nm, ɸ = 0.46, τ = 4.9 μs in CH2Cl2 at 298 K), similar to 
the homometallic Ir dimer 44 (λmax = 586 nm, ɸ = 0.55). There is no evidence of emission 
from the Pt(II) unit at room temperature but at 77 K the main iridium based band is 
accompanied by an additional set of weak bands that emerge at higher energy, consistent 
with emission from the Pt(II) unit. Presumably, at room temperature, energy transfer from 
the higher-energy Pt unit to the lower-energy Ir moiety must be substantially faster than 
radiative decay of the Pt(ppy) unit.  
 Zysman-Colman and co-workers reported hetero-bi- and trimetallic Pt(II) and Ir(III) 
species linked by a conjugated rigid spacer.186 The complexes 45 and 46 exhibit red-shifted 
low energy bands, similar to the Ir-monometallic species with higher absorptivities 
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associated with the presence of the Pt-monometallic species (Figure 5.16). Complex 45 
PLQY is quasi identical to that of the Pt(II) monometallic complex at 8.3% whereas addition 
of the second Ir(III) centre in complex 46 causes a large increase in PLQY to 31.9%. 
Interestingly, this is attributed to a large decrease in knr rather than an increase in kr. 
  
Figure 5.15: Heteronuclear Pt–Ir dyad reported by Bruce and co-workers.  
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Figure 5.16: Structures of the bi- and trimetallic species reported by Zysman-Colman and co-
workers. 
From the small number of systems reviewed here it is clear to see that there is a 
large number of structural variations possible when introducing more than one metal into 
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a luminophore. Very different properties emerge depending on the bridging ligand and 
recent literature successfully dispels the myth that multinuclear metal complexes give poor 
device performance or that they necessarily have inferior PLQYs compared to their 
mononuclear analogues. 
5.2 Synthesis of Bimetallic Complexes 
 Due to recent reports in the literature debunking the myth that multinuclear 
systems are unsuitable for application in OLED devices, some of the tridentate ligand 
systems developed in chapter 3 were chosen for exploration into this emerging field. In 
particular the work by Kozhevnikov168,171,183,187 was persuasive and our intention was to 
build upon the reported success of rigidly linking two or more metals together using the 
easily accessed pseudo-cyclometallating systems discussed in chapter 3. 
5.2.1 Hydrazide Bridged Complexes 
 Nakajima and co-workers reported the formation of hydrazonato-bridged 
heterodimetallic Ru(III)-M(II) (M = Mn, Fe, Co, Ni, Cu, Zn and Pd) complexes which attracted 
our attention due to the mild conditions used to access the complexes.142,188 The reported 
palladium(II)-ruthenium(II) complex 47 (Figure 5.17) was synthesised from the 
monometallic Pd(II) complex and an equimolar amount of [RuCl2(PPh3)3] in DCM at room 
temperature.   
 
Figure 5.17: Pd(II)-Ru(II) complex reported by Nakajima and co-workers. 
 We found the tridentate Pt(II) complex a-PtL22Cl is a similarly good precursor to 
form a mixed metallic complex using mild conditions. a-PtL22Cl was reacted with one 
equivalent of [RuCl2(PPh3)3] in DCM at room temperature, the resulting solution was 
concentrated and hexane added to cause precipitation of a dark green solid in an 81% yield 
(Scheme 5.1). 
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Scheme 5.1: Synthetic procedure to form a-PtCl(μ-L22)RuCl2(PPh3)2. 
The identity of the complex was confirmed by 1H and 13C NMR spectroscopy, 
electrospray ionisation (ESI) mass spectrometry and elemental analysis. The 1H NMR 
spectrum of a-PtCl(μ-L22)RuCl2(PPh3)2 in CDCl3 showed a small upfield shift (0.2 ppm) of 
proton a + b upon complexation of the second metal centre and proton c is significantly 
shifted upfield from 7.58 to 6.15 ppm. These observations coincide with those reported by 
Nakajima and co-workers upon synthesis of complex 47. 
The tridentate Pt(II) complex a-PtL22Cl also proved to be a successful precursor to 
form a mixed Pt(II)-Ir(III) complex. a-PtL22Cl was reacted with 0.5 equivalents of [Ir(ppy)2Cl]2 
in a mixture of MeOH:DCM at 65°C for 1.5 hours. The resulting solution was evaporated to 
dryness, dissolved in the minimum amount of MeCN/H2O and pipetted into KPF6 (sat. aq.) 
to isolate a dark green solid (Scheme 5.2). 
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Scheme 5.2: Synthetic procedure to form [a-PtCl(μ-L22)Ir(ppy)2]PF6. 
The identity of the complex was confirmed by 1H and 13C NMR spectroscopy and by 
electrospray ionisation (ESI) mass spectrometry.  
5.2.2 Imide Bridged Complex 
 Building upon our success with hydrazide bridged complexes, the imide 
based Pt(II) complex PtL23Cl was investigated as a precursor to form a mixed Pt(II)-Ir(III) 
complex. PtL23Cl was reacted with 0.5 equivalents of [Ir(ppy)2Cl]2 in a mixture of 
MeOH:DCM at 65°C for 2 hours. The resulting solution was evaporated to dryness, 
dissolved in the minimum amount of DMSO and pipetted into KPF6 to isolate a bright yellow 
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solid in a 21% yield (Scheme 5.3). The resulting complex [PtCl(μ-L23)Ir(ppy)2]PF6 was very 
poorly soluble in common solvents, although a weak 1H NMR in deuterated DMSO did 
support formation of the desired product. The identity of the complex was confirmed by 
atmospheric pressure solids analysis probe ionisation (ASAP) and accurate mass 
spectrometry; the measured mass 954.0870 m/z is consistent with the empirical formula 
C34H24N5O2ClIrPt with an accuracy of 2.0 ppm. We interpret this as the molecular ion 
[C34H24N5O2ClIrPt]+. 
 
Scheme 5.3: Synthetic procedure to form [PtCl(μ-L23)Ir(ppy)2]PF6. 
5.2.3 Pyrimidine Bridged Complexes 
 The N^N^O hydrazone (NMe) based proligand HL14 has been extended into a 
pyrimidine bridged proligand which features potential ditopic N^N^O–N^N^O 
coordination. A series of such proligands has been synthesised using the synthetic strategy 
summarised in scheme 5.4.  
N N
NN N N
HOOH
N N
ClCl
N N
NNH2N NH2MeNHNH2
HO
O
R
R'
R
R'
H2L36 R,R' = H (74%)
H2L37 R = t-Bu, R' = H (74%)
H2L38 R,R' = t-Bu (81%)
MeOH 2
 
Scheme 5.4: Synthetic procedure to form ligands H2L36-H2L38. 
The key intermediate is 4,6-di(1-methylhydrazino)pyrimidine, from which a variety 
of bridging bis-terdentate N^N^O-N^N^O proligands can be prepared in one step simply by 
reaction with an appropriate salicylaldehyde. For example t-butyl groups were 
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incorporated into H2L37 and H2L38 in order to improve the solubility of the final product, 
since one of the drawbacks of rigid ligands is often poor solubility of products.187 The 
reaction invariably produces a fine white powder which can be isolated by filtration in high 
yields over the two steps.  
Condensation of the aldehyde and the hydrazine results in a significant upfield shift 
of the N=C-H proton in the 1H NMR spectra. For instance, in H2L36 this proton resonates at 
8.49 ppm in CDCl3 compared to 9.90 ppm for salicylaldehyde. The aromatic and phenolic 
protons are largely unaffected, nor is there a significant shift of the N-Me protons. 
Crystals of proligands H2L36 and H2L38 were obtained by slow evaporation of 
chloroform solutions. The structures obtained confirm the identities of the compounds 
(Figure 5.14). The molecules adopt a spiral configuration, similar to that found in fascinating 
pyrimidine dihydrazone compounds.189 The torsional angles between the plane defined by 
the hydrazone group and the pyrimidine ring is larger in H2L38 (22°) than H2L36 (13°) as is 
the angle between the phenol rings, 61 and 23°, respectively.  
In the first instance, we explored the complexation chemistry of the proligand HL36 
with Pt(II). Due to our successful complexation of proligands HL14 – HL20 using K2PtCl4, we 
initially attempted to synthesise a bimetallic Pt(II) complex using the same method. K2PtCl4 
and the proligand H2L36 in a 2:1 molar ratio were refluxed in a EtOH:H2O mixture for 2 hours. 
The resulting mixture was cooled to ambient temperature and filtered to yield the crude 
product. Initial analysis of the crude reaction material revealed a complex mixture of 
products in which the predominant product was a monometallic Pt(II) complex in which 
only one of the N^N^O coordination sites was occupied. Purification of this mixture proved 
challenging and we were unable to isolate PtHL36Cl. In an alternative procedure the 
mononuclear complex was successfully obtained by refluxing a mixture of the proligand 
H2L36, 2.1 equivalents of Pt(COD)Cl2 and an excess of NEt3 in MeCN (Scheme 5.5). The highly 
insoluble yellow precipitate was collected by hot filtration to give complex PtHL36Cl in a 
yield of 52%.  
Incorporation of a single Pt(II) ion resulted in a loss of symmetry in the 1H NMR 
spectrum. Upon complexation there is a downfield shift of the N-Me protons nearest to the 
metal (a) whereas the resonance of the N-Me protons (a’) is less affected (see labelling in 
Scheme 5.5). For instance, the N-Me protons resonate at 3.61 ppm in DMSO-d6 in the 
proligand H2L36 compared to 3.88 and 3.66 ppm in complex PtHL6Cl for NMe (a) and NMe 
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(a’) respectively. We observe an upfield shift of the remaining phenolic O-H proton, from 
10.98 to 10.24 ppm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14: Crystal structure and packing of H2L36 (above) and H2L38 (below) ; T = 120 K. 
Hydrogen atoms are omitted for clarity. 
Scheme 5.5: Synthesis of PtHL36Cl 
A number of unsuccessful attempts were made to synthesise the dinuclear Pt(II) 
complex of H2L36, which we attribute to the highly insoluble nature of PtHL36Cl preventing 
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further reaction. Incorporation of t-butyl groups into H2L37 and H2L38 was anticipated to 
increase the solubility of the resulting product and facilitate the formation of a dinuclear 
Pt(II) complex but we found that the solubility of the resulting proligands was decreased in 
MeCN and we were unable to form even their corresponding mononuclear Pt(II) 
complexes. 
We have also explored the complexation chemistry of the proligands H2L36 – H2L39 
with iridium(III), synthesising a series of mono- and dinuclear complexes (Scheme 5.6). The 
tridentate proligand dpyxH is known to react with IrCl3.3H2O in ethoxyethanol/water to 
give a dichloro-bridged dimer [Ir(dpyx)Cl(μ-Cl)2]2.98 Reaction of the di-chloro bridged 
iridium dimer with proligands H2L36 – H2L39 was carried out in ethylene glycol at 195°C for 
90 minutes, leading to the corresponding mono or dinuclear complexes depending on the 
stoichiometry used. The chloride counter anion was exchanged for PF6 by precipitation in 
aq. sat. KPF6. The complexes were purified by column chromatography followed by 
recrystallization from acetonitrile/ether.  
 
Scheme 5.6: Synthesis of dinuclear and mononuclear Ir(III) complexes.  
2 [Ir(dpyx)Cl(μ-Cl)]2 
[Ir(dpyx)Cl(μ-Cl)]2 
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 The identity of the complexes was confirmed by 1H and 13C NMR spectroscopy and 
by electrospray ionisation (ESI) mass spectrometry. Crystals of [{Ir(dpyx)}2L36]2PF6 and 
[{Ir(dpybx)}2L37]2PF6 suitable for X-ray diffraction were obtained from a MeCN solution by 
slow evaporation of the solvent (Figure 5.15 and Figure 5.16, respectively). A summary of 
important bond lengths and angles are shown in Table 5.1.  
Table 5.1: Selected Bond Distances (Å) and Angles (deg) for the Iridium Complexes 
[Ir(dpybx)2L36]2PF6 and [Ir(dpybx)2L37]2PF6 
  
[Ir(dpybx)2L36]2PF6 [Ir(dpybx)2L37]2PF6 
Bond Lengths Ir1-O1 2.013(7) 2.026(4)  
Ir1-N1 2.066(8) 2.079(5)  
Ir1-N3 2.017(7) 2.027(5)  
Ir1-N4 2.049(9) 2.045(5)  
Ir1-N5 2.023(8) 2.051(5)  
Ir1-C19 1.971(10) 1.952(5)  
Ir2-O2 2.036(7) 2.029(4)  
Ir2-N6 2.007(8) 2.029(5)  
Ir2-N8 2.074(7) 2.079(5)  
Ir2-N9 2.051(8) 2.053(5)  
Ir2-N10 2.073(8) 2.055(5)  
Ir2-C45 1.966(9) 1.947(5) 
Bond Angles O1-Ir1-N3 172.1(3) 171.58(17)  
N1-Ir1-C19 177.7(4) 176.0(2)  
N5-Ir1-N4 161.3(4) 160.87(19)  
O2-Ir2-N6 171.5(3) 171.44(17)  
N8-Ir2-C45 176.2(3) 178.2(2)  
N9-Ir2-N10 161.2(3) 160.42(18) 
Distances Ir1-Ir2 5.984 6.021 
 
 In both of the structures the iridium atoms are hexacoordinated in a distorted 
octahedral mode. The intermetallic distance is 5.984 and 6.021 Å in [{Ir(dpyx)}2L36]2PF6 and 
[{Ir(dpyx)}2L37]2PF6, respectively and the mean values of the Ir-C (1.959 Å) and Ir-N (2.05 Å) 
bonds in the Ir(dpyx) unit are within the normal ranges expected for such cyclometalated 
complexes.163 The mean values of the Ir-N(hydrazone) (2.0745 Å), Ir-N(pyridine) (2.02 Å) 
and Ir-O (2.026 Å) are similar to those reported for the monometallic complex 
[Ir(dpyx)L15]PF6 discussed earlier in the text.  
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Figure 5.15: Crystal Structure and Packing of Iridium Complex [{Ir(dpyx)}2L36]2PF6; T = 120 K. 
Hydrogen atoms are omitted for clarity.  
 
Figure 5.16: Crystal Structure and Packing of Iridium Complex [{Ir(dpyx)}2L37]2PF6; T = 120 K. 
Hydrogen atoms are omitted for clarity. 
The successful formation of both Pt(II) and Ir(III) monometallic complexes with 
these ditopic ligands led us to explore the formation of a mixed metal binuclear complex. 
Owing to the harsh conditions required for the preparation of [Ir(dpyx)HL36]PF6 – 
[Ir(pyxHL38]PF6, we tried incorporating the iridium centre first, to be followed by the 
introduction of the platinum ions. We made several unsuccessful attempts to introduce a 
platinum ion before altering our strategy and attempting to incorporate the platinum 
centre first, to be followed by the introduction of the iridium ion. The monometallic Pt(II) 
complex, PtHL36Cl, was reacted with the dichloro-bridged dimer [Ir(dpyx)Cl(μ-Cl)2]2  in 
ethylene glycol at 195 °C. The chloride counter anion was exchanged for PF6 by precipitation 
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in aq. sat. KPF6. Initial analysis of the crude reaction material revealed a complex mixture 
of products in which the predominant product was the desired mixed multinuclear complex 
[Ir(dpybx)(L36)PtCl]PF6 (Figure 5.17). The identity of the complex was confirmed by 
electrospray ionisation (ESI) mass spectrometry and accurate mass spectrometry; the 
measured mass of 1053.1658 m/z is consistent with the empirical formula C38H33N8O2ClIrPt 
with an accuracy of 0.9 ppm. We interpret this as the molecular ion [C38H33N8O2ClIrPt]+. 
Purification of this mixture proved challenging and we were unable to isolate the complex 
in sufficient purity for further studies. 
 
Figure 5.17: Mixed Pt(II)-Ir(III) multinuclear complex [Ir(dpybx)(L36)PtCl]PF6. 
5.3 Photophysical Properties of Bimetallic Complexes 
5.3.1 Hydrazide Bridged Complexes 
Electronic Absorption Spectra 
 The absorption spectra of complexes a-PtCl(μ-L22)RuCl2(PPh3)2 and [a-PtCl(μ-
L22)Ir(ppy)2]PF6 were recorded in DCM at room temperature (Figure 5.18). 
 
Figure 5.18: UV-Vis electronic absorption spectra of a-PtCl(μ-L22)RuCl2(PPh3)2, 
[a-PtCl(μ-L22)Ir(ppy)2]PF6 and a-PtL22Cl in DCM at 298 K. 
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 The key transitions in the UV-Vis electronic absorption spectra of a-PtL22Cl are 
retained in a-PtCl(μ-L22)RuCl2(PPh3)2, with the presence of an additional broad transition 
centred at ~700 nm attributed to a MLCT band related to the RuCl2(PPh3)2 unit.131 The UV-
Vis electronic absorption spectra of [a-PtCl(μ-L22)Ir(ppy)2]PF6 is markedly different from 
that of a-PtL22Cl. The intense bands centred at approximately 400 nm are attributed to 
1MLCT transitions and the band centred at ~600 nm is attributed to the 3MLCT transition of 
the Pt unit. 
Emission 
 Complexes a-PtCl(μ-L22)RuCl2(PPh3)2 and [a-PtCl(μ-L22)Ir(ppy)2]PF6 display no 
observable emission at ambient temperature in solution or the solid state. In glassy 
solution at 77 K, the complexes are weakly emissive, displaying a structurally well resolved 
luminescence spectrum. 
The emission of a-PtCl(μ-L22)RuCl2(PPh3)2 is similar to that of a-PtL22Cl (Figure 5.19). 
The emission of a-PtCl(μ-L22)RuCl2(PPh3)2 is therefore thought to originate from states 
involving the Pt(II) centre suggesting minimal excited-state interactions between the Pt(II) 
and Ru(II) centres.  The estimated lifetime of emission is in the range of microseconds, 
indicating phosphorescent emission (Table 5.2). 
 
Figure 5.19: Normalised emission spectra of a-PtCl(μ-L22)RuCl2(PPh3)2 in butyronitrile rigid glass at 
77 K and a-PtL22Cl in EPA rigid glass at 77 K. 
 The 77 K emission spectra of [a-PtCl(μ-L22)Ir(ppy)2]PF6 appears to display dual 
emission, with bands attributable to the Ir(III) and Pt(II) components appearing 
simultaneously. The bands around 496 nm are attributed to the Ir(III) component whereas 
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the bands around 659 nm are attributed to the Pt(II) component. Again, there appears to 
be minimal excited-state interactions. 
 
Figure 5.20: Normalised emission spectra of [a-PtCl(μ-L22)Ir(ppy)2]PF6 in butyronitrile rigid glass 
at 77 K and a-PtL22Cl in EPA rigid glass at 77 K. 
5.3.2 Imide Bridged Complexes 
Photophysical Properties 
Complex [PtCl(μ-L23)Ir(ppy)2]PF6 is very poorly soluble in all common organic 
solvents. The absorption spectrum of complex [PtCl(μ-L23)Ir(ppy)2]PF6 was recorded DCM 
at room temperature (Figure 5.21). It can be seen that spectrum is very similar to that of  
PtL23Cl, although the extinction coefficients are greatly increased, by a factor of around 2, 
throughout the spectrum. The lowest energy band is slightly blue-shifted in [PtCl(μ-
L23)Ir(ppy)2]PF6, from 405 nm in PtL23Cl to 396 nm in [PtCl(μ-L23)Ir(ppy)2]PF6. There is no 
observable emission at ambient temperature or 77 K in solution or in the solid state. 
 
Figure 5.21: UV-Vis electronic absorption spectra of [PtCl(μ-L23)Ir(ppy)2]PF6 and PtL23Cl in DCM at 
298 K. 
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Table 5.2: Photophysical data for complexes a-PtL22Cl, a-PtCl(μ-L22)RuCl2(PPh3)2 and [a-PtCl(μ-L22)Ir(ppy)2]PF6 
  298 K   77 K 
Complex λ(abs) (nm) λ(em) 
(nm) 
τ * 
(μs)a  
Φb  
(%) 
kr 
(103 s-1) 
knr 
(105 s-1) 
kqc 
(mol-1 dm3 s-1) 
λ(em) 
 (nm) 
τ (μs) 
a-PtL22Cl 261, 317, 356(sh) , 478 625, 683, 756 
0.4 
(0.2) 0.5 1.3 25 1.1 x 10
9 629, 688, 742 0.9 
a-PtCl(μ-
L22)RuCl2(PPh3)2 
290(sh), 348, 455, 692 - - - - - - 601, 660, 722 16+4(75/25)d 
[a-PtCl(μ-
L22)Ir(ppy)2]PF6 
258, 297(sh), 389, 423, 
469, 501, 602 - - - - - - 
462, 479, 496, 515, 
537, 602, 659, 715 
(λ = 496) 12 
(λ = 659) 
=15+3(80/20)d 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±20%.c Bimolecular rate constant for 
quenching by O2. dbiexponential; relative weightings of components in parenthesis. *Χ2 values are located in appendix 7.3 
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5.3.3 Pyrimidine Bridged Complexes 
Pt(II) Complexes 
Electronic Absorption Spectra 
The absorption spectrum of PtHL36Cl was recorded in DCM at room temperature 
(Figure 5.22). It can be seen that the absorption of PtHL36Cl is red-shifted compared to 
PtL14Cl, which may be attributed to the increased conjugation in the proligand HL36 or the 
change from a pyridine to a pyrimidine ring. The absorption bands below 300 nm are 
assigned to 1π – π* transitions localised on the ligand. The absorption bands centred at 
~430 nm and in the region 300 – 375 nm closely resemble the charge transfer bands of the 
parent tridentate complex PtL14Cl and thus are assigned similarly.  
 
Figure 5.22: UV-Vis electronic absorption spectra of PtHL36Cl and PtL14Cl in DCM at 298 K. 
Emission 
The complex PtHL36Cl is essentially non-emissive in solution at room temperature, 
however in dilute glassy solution at 77 K we observe highly structured emission (Figure 
5.23). The λmax emission is slightly red-shifted compared to PtL14Cl, by approximately 
300 cm-1. It is notable that the 0 – 0 vibrational component is higher than the 0 – 1 in 
PtHL36Cl, suggesting less excited-state distortion than for PtL14Cl, although the value of 0.91 
is still indicative of a large degree of distortion. The luminescence lifetime τ of complex 
PtHL36Cl is 33 µs, comparable to the of PtL14Cl (36 µs) and indicating phosphorescent 
emission. 
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Figure 5.23: Normalised emission spectra of PtHL36Cl in butyronitrile and PtL14Cl in frozen EPA glass 
at 77 K. 
Ir(III) Complexes 
Electronic Absorption Spectra 
 The absorption spectra of the monometallic [Ir(dpyx)HL36]PF6 — [Ir(dpyx)HL38]PF6 
were recorded in DCM at room temperature (Figure 5.24). It can be seen that there is very 
little variation in the absorption of each of the complexes, although there does appear to 
be a slight red shift of the lowest energy band with the addition of increasing numbers of 
t-butyl groups. Comparison with the absorption spectrum of [Ir(dpyx)L14]PF6 shows a red 
shift in the whole spectrum which may be attributed to the increased conjugation in the 
proligand HL36 or the change from a pyridine to a pyrimidine ring. The bands between 300 
– 400 nm can thus be attributed to 1π-π* transitions and the weaker transition extending 
to 450 nm are attributed to transitions with charge transfer character. 
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Figure 5.24: UV-Vis electronic absorption spectra of [Ir(dpyx)HL36]PF6 – [Ir(dpyx)HL38]PF6 in DCM at 
298 K (top) and [Ir(dpyx)HL36]PF6 and [Ir(dpyx)L14]PF6 (bottom). 
The absorption spectra of bimetallic [{Ir(dpyx)}2L36]2PF6 and [{Ir(dpybx)}2L37]2PF6 
were recorded in DCM at room temperature (Figure 5.25). It can be seen that once again 
there is very little variation in the absorption of both of the complexes, although there does 
appear to be a slight red-shift of the lowest energy band with the addition of the t-butyl 
groups. It can be seen that the absorption of [{Ir(dpyx)}2L36]2PF6 is strongly red-shifted 
compared to [Ir(dpyx)HL36]PF6 and the extinction coefficient of the lowest energy band is 
greatly increased. 
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Figure 5.25: UV-Vis electronic absorption spectra of [{Ir(dpyx)}2L36]2PF6 and [{Ir(dpybx)}2L37]2PF6 in 
DCM at 298 K (top) and [{Ir(dpyx)}2L36]2PF6 and [Ir(dpyx)HL36]PF6 (bottom). 
Emission 
 The emission spectra of the monometallic [Ir(dpyx)HL36]PF6 - [Ir(dpyx)HL38]PF6 were 
recorded in degassed DCM at room temperature (Figure 5.26). All of the complexes are 
luminescent in solution at room temperature. There is a ~10 nm red-shift of what appears 
to be the 0 – 0 band on the addition of increasing numbers of t-butyl groups. The emission 
spectra display poorly defined vibronic progression. It is noteworthy that the emission 
(λmax) observed for [Ir(dpyx)HL36]PF6 and the earlier reported monometallic complex 
[Ir(dpyx)L14]PF6 are identical, both showing emission maxima at 560 and 600 nm. 
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The PLQYs in degassed solution at 298 K are in the range 0.006 – 0.016 (Table 5.3). 
Some insight into this may be obtained by considering the rate constants for radiative (kr) 
and nonradiative (knr) decay. The ‘parent’ complex [Ir(dpyx)HL36]PF6 has a PLQY of 0.6%, 
which is increased in [Ir(dpyx)HL37]PF6 to 1.6% due to an increase in kr accompanied by a 
decrease in knr. The PLQY of [Ir(dpyx)HL38]PF6 is reduced to 0.2% which can be attributed to 
a decrease in kr while knr appears unaffected from the parent complex. In comparison to 
the earlier reported monometallic complexes, [Ir(dpyx)L14]PF6 – [Ir(dpyx)L17]PF6, there is a 
tenfold decrease in the rate of radiative decay. Interestingly, the rates of non-radiative 
decay are of the same order in both series. 
The emission life time (τ) of all the complexes show susceptibility to quenching by 
dioxygen confirming that emission originates from a triplet state. The emission bimolecular 
rate constant for quenching by O2 (kq) of [Ir(dpyx)HL36]PF6 - [Ir(dpyx)HL38]PF6 are of the same 
order as the previously dicussed monometallic complexes, [Ir(dpyx)L14]PF6 – 
[Ir(dpyx)L17]PF6. 
 
Figure 5.26: Normalised emission spectra of [Ir(dpyx)HL36]PF6 - [Ir(dpyx)HL38]PF6 in degassed DCM 
at 298 K. 
All complexes show increased emission at 77K in frozen butyronitrile and the 
estimated lifetimes of the emissions remain in the range of microseconds, indicating 
phosphorescent emission. All of the complexes displayed highly structured spectra, with an 
approximate 800 cm-1 blue-shift of the 0,0 band from the room temperature emission 
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(Figure 5.27). The 0,0 band is dominant, suggesting a relatively small degree of distortion 
in the excited state. 
 
Figure 5.27: Normalised emission spectra of [Ir(dpyx)HL36]PF6 - [Ir(dpyx)HL38]PF6 in butyronitrile 
glass at 77 K. 
The emission spectra of the bimetallic [{Ir(dpyx)}2L36]2PF6 and [{Ir(dpybx)}2L37]2PF6 
were recorded in degassed DCM at room temperature (Figure 5.28). Both of the complexes 
are luminescent in solution at room temperature. There is a small red-shift in emission 
(~6 nm) compared to [Ir(dpyx)HL36]PF6 and [Ir(dpyx)HL37]PF6 with the addition of a second 
Ir(III) centre. As we observed for the monometallic complexes [Ir(dpyx)HL36]PF6 - 
[Ir(dpyx)HL38]PF6, there is a ~10 nm red-shift in the emission from [{Ir(dpyx)}2L36]2PF6 
(566 nm) to [{Ir(dpybx)}2L37]2PF6 (576 nm) with the addition of the t-butyl group.  
Although there is a relatively small effect on the energy of emission with the 
addition of the second Ir(III) centre, there is a significant effect on the PLQY of 
luminescence. There is a 6-fold increase in the PLQY for each of the complexes with the 
addition of the second Ir(III) centre (Table 5.3). The ‘parent’ complex [{Ir(dpyx)}2L36]2PF6 
has a PLQY of 3.7%, which is increased to 11% in [{Ir(dpybx)}2L37]2PF6, which is attributed 
to a significant decrease in the non-radiative rate constant of [{Ir(dpybx)}2L37]2PF6. 
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Figure 5.28: Normalised emission spectra of [{Ir(dpyx)}2L36]2PF6 and [{Ir(dpybx)}2L37]2PF6 in 
degassed DCM at 298 K. 
Both complexes show increased emission at 77K in frozen butyronitrile and the 
estimated lifetimes of the emissions remain in the range of microseconds, indicating 
phosphorescent emission. Both of the complexes displayed highly structured spectra, with 
an approximate 800 cm-1 blue-shift of the 0,0 band from the room temperature emission 
(Figure 5.29). The 0,0 band is dominant, suggesting a relatively small degree of distortion 
in the excited state. 
 
Figure 5.29: Normalised emission spectra of [{Ir(dpyx)}2L36]2PF6 and [{Ir(dpybx)}2L37]2PF6 in 
butyronitrile at 77 K. 
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Table 5.3: Photophysical data for complexes [Ir(dpyx)HL36]PF6 - [Ir(dpyx)HL38]PF6 and [{Ir(dpyx)}2L36]2PF6 - [{Ir(dpyx)}2L37]2PF6. 
  298 K   77 K 
Complex λ(abs) (nm) λ(em) (nm) τ * 
(μs)a  
Φ  
(%) 
kr 
(103 s-1) 
knr 
(105 s-1) 
kqe 
(mol-1 dm3 s-1) 
λ(em) 
 (nm) 
τ 
(μs) 
Monometallic          
[Ir(dpyx)HL36]PF6 303, 318(sh), 340(sh), 370(sh), 
428, 450(sh) 
560(sh), 599 4.6(0.3) 0.6b 1.3 2.2 1.4 x 109 535, 581, 636, 
708 
18 
[Ir(dpyx)HL37]PF6 305(sh), 320, 378(sh), 430, 445(sh) 570(sh), 608 6.4(0.3) 1.6b 2.5 1.5 1.5 x 109 537, 584, 643, 
709 
15 
[Ir(dpyx)HL38]PF6 305(sh), 325, 384(sh), 436, 463(sh) 578(sh), 612 5.0(0.3) 0.2c 0.4 2.0 1.4 x 109 539, 587, 642, 
716 
18 
Bimetallic          
[{Ir(dpyx)}2L36]2PF6 275, 289, 339, 385(sh), 446(sh), 
476 
566, 606(sh) 0.9(0.2) 3.7d 41 11 1.8 x 109 536, 586, 645, 
717 
15 
[{Ir(dpyx)}2L37]2PF6 276, 289, 341, 385(sh), 448(sh), 
484 
576, 618(sh) 4.0(0.2) 11d 28 2.2 2.2 x 109 545, 597, 655, 
728 
18 
a Luminescence lifetime in degassed DCM solution; corresponding values in air-equilibrated solution are given in parentheses. b ±20% c ±30% d ±10% 
e Bimolecular rate constant for quenching by O2. *Χ2 values are located in appendix 7.3 
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Concluding Remarks 
 We have successfully synthesised and characterised a range of novel bimetallic 
complexes, incorporating a combination of Pt(II), Ir(III) and Ru(II) centres.  
We began by exploring the coordination of a second metal centre to two of our 
previously prepared monometallic complexes. The hydrazide-based complex a-PtL22Cl 
provided a N^O- donor set of which we explored the coordination to Ru(II) and Ir(III) whilst 
the imide-based complex PtL23Cl provided a O^O- donor set of which we explored the 
coordination to Ir(III).  
The hydrazide-bridged complexes a-PtCl(μ-L22)RuCl2(PPh3)2 and [a-PtCl(μ-
L22)Ir(ppy)2]PF6 have high extinction coefficients over a wide range of the UV-Visible 
spectrum, a-PtCl(μ-L22)RuCl2(PPh3)2 in particular absorbs strongly from 250 to 900 nm. Both 
complexes are non-emissive at room temperature. Measurements at 77 K reveal structured 
emission from the Pt(II) unit in both complexes and the Ir(III) unit in [a-PtCl(μ-
L22)Ir(ppy)2]PF6. There appears to be minimal ground state interactions between the Pt(II) 
and Ru(II)/Ir(III) unit in each of the complexes. 
The imide-bridged complex [PtCl(μ-L23)Ir(ppy)2]PF6 has a UV-Visible profile very 
similar to that of the parent monometallic Pt(II) complex and we observed no emission in 
solution at 298 K or 77 K or in the solid state. 
We have extended the hydrazone-based proligand HL14 into the proligands H2L36 – 
H2L38, offering two N^N^O-coordination sites bridged by a central pyrimidine ring. The 
coordination chemistry with Pt(II) and Ir(III) has been explored, preparing a monometallic 
Pt(II) complex alongside monometallic and bimetallic Ir(III) complexes. We were 
unsuccessful in our attempts to synthesise a bimetallic Pt(II) or a mixed Pt(II)/Ir(III) complex. 
The monometallic Pt(II) complex, PtHL36Cl, is non-emissive in solution at room 
temperature and in the solid state, although at 77 K weak emission is observed. The 
monometallic Ir(III) complexes are weakly emissive in solution at room temperature (0.2 – 
1.6%), notably weaker than the corresponding monometallic [Ir(dpyx)L14]PF6 (9%). 
Comparison of the rates of radiative and non-radiative decay reveal this decrease in PLQY 
is attributable to a ten-fold decrease in kr. 
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Coordination of the second Ir(III) centre causes a significant red-shift in the lowest 
energy absorption and the emission is shifted further into the red region by a small degree. 
The bimetallic Ir(III) complexes, [{Ir(dpyx)}2L36]2PF6 and [{Ir(dpyx)}2L37]2PF6, both show 
increased emission in solution at ambient temperature in comparison to their 
monometallic counterparts, with PLQYs of 3.7 and 11%, respectively. The increase in the 
PLQY of [{Ir(dpyx)}2L36]2PF6 compared to the monometallic [Ir(dpyx)HL36]PF6 is attributed 
to a large increase in kr whilst the increased emission of [{Ir(dpyx)}2L37]2PF6 is attributed to 
a large decrease in knr. 
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6 Experimental 
6.1 Synthesis: general remarks 
Materials. 
Reagents were obtained from commercial sources and used without further 
purification unless stated otherwise. Tetrabutylammonium hexafluorophosphate was 
recrystallized multiple times using ethanol. All solvents used in preparative work were at 
least Analar grade and water was purified using the PuriteSTILL plusTM system. Dry solvents 
were obtained from HPLC grade solvent that had been passed through a Pure Solv 400 
solvent purification system and stored over activated 3 or 4Å molecular sieves. For 
procedures involving dry solvent, glassware was oven-dried for at least 8 hours prior to use. 
Dedicated oxygen-free argon cylinders (BOC, UK) were used to provide an inert 
atmosphere.  
Physical Measurements. 
NMR spectra were recorded on a Bruker Avance-400 (400 MHz 1H and 100 MHz 13C) 
spectrometer. Two-dimensional NMR (COSY, NOESY, HSQC and HMBC) were acquired by 
the solution state NMR service at University of Durham on Varian VNMRS-600 (600 MHz) 
or VNMRS-700 (700 MHz) instruments. Chemical shifts (δ) are in ppm, referenced to 
residual protio-solvent resonances, and coupling constants are given in Hertz.  
ES-MS data (positive and negative ionisation modes) were obtained on a Waters 
TQD mass spectrometer interfaced with an Acquity UPLC system with acetonitrile as the 
carrier solvent. ASAP experiments were performed on Waters Xevo QToF mass 
spectrometer. MALDI experiments were performed on Autoflex II ToF/ToF mass 
spectrometer (Bruker Daltonik GmBH) with a trans-2-[3-(4-tert-Butylphenyl)-2-methyl-2-
propenylidene]malononitrile (DCTB) matrix. 
Thin-layer chromatography (TLC) was carried out using silica plates (MerckArt 5554) 
which were fluorescent upon irradiation at 254nm and preparative column 
chromatography was carried out using silica (Merck Silica Gel 60, 230-400 mesh). Analytical 
and preparative HPLC was performed by the chromatography service at Durham University. 
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 Elemental analysis was performed by either Mr Stephen Boyer (London 
Metropolitan University elemental analysis service) or Dr. Emily Unsworth using an Exeter 
CE-440 Elemental Analyser device (University of Durham elemental analysis service). 
Electronic spectra were recorded on a PerkinElmer Lambda 900 spectrophotometer 
or a Biotek Instruments EVIKON XS spectrometer operating with LabPower software. 
Diﬀuse-reﬂectance spectra were obtained by ﬁxed-angle oblique illumination of the sample 
using an Energetiq LDLS EQ99 broad-band lamp and collection perpendicular to the face of 
the sample using an Ocean Optics Maya Pro 2000 spectrometer. Data were recorded using 
the Ocean Optics software, and integration times were adjusted to aﬀord maximum 
response of the spectrometer without saturation of the detector. NaCl was used as the 
white standard. 
 Solution-based emission were acquired on a Jobin Yvon Spex Fluoromax-2 
spectrometer. All samples were contained within quartz cuvettes of 1 cm path length. 
Samples that were to be measured in the absence of air were degassed within the cuvette 
by three freeze-pump-thaw cycles. Emission was recorded at 90◦ to the excitation source, 
and appropriate ﬁlters were used when required to remove second-order peaks. All 
emission spectra were corrected after acquisition for dark count and for the spectral 
response of the detector. 
The PLQY were determined relative to a reference an aqueous solution of 
[Ru(bpy)3]Cl3. The PLQY of this complex is well established in air-equilibrated H2O to be 
0.028.190 To measure the PLQY, a sample of the complex was prepared so that the 
absorbance at the excitation wavelength was below 0.1 and a solution of [Ru(bpy)3]Cl3 with 
a similar intensity was prepared. The emission spectra of the complex and reference were 
measured under identical conditions and the PLQY was determined by equation 6.1. 
Φ =  Φ௦௧×
𝐼
𝐼௦௧
×
𝐴௦௧
𝐴
×
𝑛ଶ
𝑛௦௧ଶ
 
φ represents the PLQY, I the overall integrated intensity, A the 
absorbance at the excitation wavelength and n2 the refractive index of the solvent, the 
subscript st denotes the standard and all other values the sample. 
The potential for error is always present in any measurement and a discussion of 
the potential sources of error in this method are warranted.  
(6.1) 
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The absorbance of the two solutions must be appropriately dilute (typically A < 0.1) 
in order to avoid internal filter effects and errors arising from uneven distribution of the 
excited species in the detected volume.191 The measurement of the absorption spectrum 
of a compound has associated errors, such as instrumental noise, accuracy of the 
wavelength scale and accuracy of the intensity scale. This can result in a variation of 
absorbance values for a sample. The error is greater when reading off a slope, so a flat 
portion of the spectrum is always preferred to give a more accurate measurement. The use 
of equation 6.1 is restricted to comparison of compounds which can be excited at a 
common wavelength, so on occasion a compromise must be made and the absorbance 
value cannot always be read from a flat part of the spectrum for both compounds. 
For measurements in deoxygenated solutions, particular care must be taken to 
ensure oxygen is completely removed from the solution. This is achieved via freeze-pump-
thaw cycles which, if performed without care while using a volatile solvent, may lead to the 
loss of solvent and alter the solution concentration. Due to instrument design, we were 
unable to measure the absorbance after degassing a solution and therefore cannot confirm 
the concentration was unaffected. 
A number of factors affect the quality of the emission spectra, which may influence 
the spectral shape, position and intensity.192 Sources of uncertainty include; the 
wavelength accuracy of the instruments excitation and/or emission channel and the range 
of linearity of the instruments detection system.192 The availability of high quality 
spectrofluorimeters and correction file for the specific fluorimeter and detector reduces 
the error assocated with the measurement of emission spectra, however the response of 
the detector may change over time and this is generally more significant in the red region 
of the spectrum.  
The emission of a compound may show a temperature dependence, although the 
effect of this error is minimised by measuring the emission of the compound and the 
standard in quick succession. Additionally, although the spectrum is corrected for the 
baseline, the brightness of a compound will affect the signal to noise ratio and hence 
reduce the error associated with brighter compounds. 
The equation itself makes a number of assumptions. For the compound and the 
reference it is assumed that; reflection losses are the same, internal reflection effects are 
equal, reabsorption and reemission are negligible and the integrated luminescence 
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intensity is proportional to the fraction of light absorbed.193 Additionally, all of the 
literature values are assumed to be correct. 
A systematic examination of this method of PLQY determination by Resch-Genger 
and co-workers in 2011 concluded that relative uncertainties of 3 – 5% for absolute 
quantum yield measurements seem to be accomplishable with well-trained personnel 
utilising six independent measurements of the sample and the standard.194 Resch and co-
workers later expanded this discussion and moved to recommend the following 
uncertainties: ±4% for PLQY > 0.4, ±10% for 0.2 > PLQY > 0.02, ±20% for 0.02 > PLQY > 0.005 
and ±30% for PLQY < 0.005.192 
Lifetimes were determined using an Edinburgh Instruments OB 920 ﬂuorimeter. 
Luminescence lifetimes of the complexes up to approximately 10 µs were measured by 
time-correlated single-photon counting (TCSPC) method, using an EPL375 pulsed-diode 
laser as excitation source (374 nm excitation, pulse length of 60 ps). The laser repetition 
rate was selected so that the pulse period was at least 5-10 times longer than the complex 
lifetime. The emission was detected at 90◦ to the excitation source, after passage through 
a monochromator, using a Peltier-cooled R928. Lifetimes in excess of 10 µs were measured 
by multichannel scaling, and a xenon ﬂash lamp was used as the excitation source 
(excitation wavelength matched to a suitable absorption band of the complex, pulse length 
of 2 µs). TCSPC is widely accepted as one of the most accurate methods of lifetime 
determination due factors such as; shot noise-limited detection, high photon economy, low 
temporal jitter, higher temperal precision and high dynamic range.195 
The lifetimes were obtained by least-squares ﬁtting to a mono-exponential decay 
and goodness-of-ﬁt was assessed from the residuals (Χ2). Low temperature (77 K) 
experiments were performed using a glass vacuum cold ﬁnger apparatus built in house. A 
small amount of sample was dissolved in either a 2:2:1 solvent mix of 
ether/isopentane/ethanol (EPA) or butyronitrile and placed into a glass tube. The cold 
ﬁnger was ﬁlled with liquid nitrogen and the tube containing the sample was inserted.  
Electrochemical measurements were carried out using a Palm Emstat2 potentiostat 
with a three-electrode cell equipped with a platinum auxiliary electrode, a glassy carbon 
working electrode, and either a Ag/AgNO3 or a platinum reference electrode (CH2Cl2). 
Potentials are reported with reference to an internal standard ferrocenium/ferrocene 
(Fc+/0). 
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Magnetic susceptibility data were recorded using a SQUID magnetometer (MPMS7, 
Quantum Design) in a 1 T external field. Data were corrected for underlying diamagnetism 
using tabulated Pascal’s constants and ﬁt using julX (Dr. E. Bill). EPR measurements were 
carried out at the EPSRC National UK EPR Facility and Service in the Photon Science Institute 
at The University of Manchester. X-Band spectra were collected using a Bruker EMX Micro 
spectrometer. Simulations were performed using Bruker’s Xsophe software package (Dr. S. 
Sproules).196 
Melting points were taken on a Gallenkamp melting point apparatus. 
Crystallography. 
Single-crystal X-ray data was collected on a Bruker D8Venture diffractometer (IμS 
microfocus sources, focusing mirrors, CMOS Photon100 detector) using λMoKα (λ = 
0.71073Å) radiation, equipped with Cryostream (Oxford Cryosystems) open-flow nitrogen 
cryostates, the temperature on the crystals was maintained at 120.0 K. All structures were 
solved by direct methods and refined by full-matrix least squares on F2 for all data using 
SHELXTL197 and OLEX2198 software by Dr. D. S. Yufit (University of Durham). 
Density Functional Theory. 
DFT geometry optimisations, frequency, stability and TD-DFT excitation calculations 
were performed using Gaussian 09. The geometry optimizations of the complexes were 
performed at the B3LYP level of DFT152–154 and LANL2DZ basis set for all atoms. 
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6.2 Synthesis: Chapter 1 
H(Mabiq) was synthesized as previously described,36,37 with the following modification; 
4,4′-dihydroxy-2,2′-biquinazoline was synthesized by heating oxalylbis(anthranilamide) in a 
round bottom flask, under vacuum, at ~350 °C, using a heating mantle. The resultant dark 
brown solid was recrystallized from DMF (61% yield) and the product was confirmed by 
comparison of the IR to previously reported data.37 
 
Co(Mabiq)Cl2 (1).  
 
CoCl2·6H2O (66 mg, 0.28 mmol) was added to an aerated solution of H(Mabiq) (100 mg, 
0.18 mmol) and triethylamine (24 µL, 0.19 mmol) in CH2Cl2 (10 mL). The solution was left 
to stir overnight, filtered through celite and the solvent removed in vacuo, leaving a dark 
brown solid. The product was recrystallized by slow evaporation of a solution of 1 in CH2Cl2 
(97 mg, 0.14 mmol, 78% yield). 
1H NMR (400 MHz, CDCl3): δ= 9.19 (dd, J = 8.3, 0.8 Hz, 2H), 8.53 (d, J = 8.3 Hz, 2H), 8.10 
(ddd, j = 8.5, 7.0, 1.5 Hz, 2H), 7.89 (ddd, j = 8.2, 7.0, 1.1 Hz, 2H), 6.49 (s, 1H), 1.51 (s, 12H), 
1.48 (s, 12H). 13C NMR (101 MHz, CDCl3): δ= 186.8, 177.9, 159.3, 156.7, 151.05, 135.7, 
129.5, 129.2, 126.5, 124.2, 94.06, 51.9, 51.7, 24.3, 23.4. ASAP-MS(+) (m/z): 670 [M]+, 635 
[M-Cl]+, 600 [M-2Cl]+. UV-Vis λmax (nm (ε, M-1 cm-1)) in CH2Cl2: 273 (8.0 x 104), 322 (3.5 x 
104), 381 (2.3 x 104), 432 (8.0 x 103), 484 (1.2 x 104), 514 (2.7 x 104). IR (cm-1): 2978 w, 2930 
vw, 1603 m, 1572 m, 1561 m, 1510 s, 1488 m (sh), 1463 s, 1409 m, 1364 s, 1322 w, 1302 
w, 1268 m, 1257 w (sh), 1232 m, 1199 w (sh), 1190 w, 1166 s, 1125 m, 1092 s, 1065 s, 1032 
m (sh), 1000 m (sh), 963 m, 910 w, 893 m, 878 w, 866 w, 826 m, 813 w, 778 s, 758 m, 737 
m (sh), 728 s, 718 m (sh), 697 m, 687 s, 663 w, 638 w, 628 m, 610 s. Anal. Calcd for 
C34H35Cl4CoN8: C, 53.99; H, 4.66; N, 14.81. Found: C, 53.85; H, 4.71; N, 14.74. 
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Co(Mabiq)Cl (2).  
 
CoCl2 (24 mg, 0.18 mmol) was added to a solution of H(Mabiq) (100 mg, 0.18 mmol) and 
triethylamine (24 µL, 0.19 mmol) in CH2Cl2 (10 mL). The solution was stirred overnight, the 
resultant green solution was filtered through celite and the solvent removed in vacuo, 
leaving a dark green solid (107 mg, 94.4% yield). Single crystals were obtained by slow 
evaporation of a concentrated solution of 2 in CH2Cl2.  
ASAP-MS(+) (m/z): 601 [M-Cl]+, 543 [M-CoCl]+. UV-Vis λmax (nm (ε, M-1 cm-1)) in MeOH:  
253 (2.9 x 104), 271 (2.2 x 104), 318 (1.9 x 104), 348 (1.7 x 104), 427 (7.0 x 103), 442 (7.2 x 
103), 480 (3.6 x 103), 576 (2.1 x 103), 618 (2.2 x 103), 668 (1.7 x 103). IR (cm-1): 2973 w, 1597 
m, 1571 s, 1558 m (sh), 1544 w (sh), 1509 s, 1484 m, 1461 s, 1412 m, 1365 m, 1339 w, 1324 
w, 1302 w, 1296 w (sh), 1270 m, 1255 w, 1242 m, 1195 w, 1167 m, 1123 s, 1097 vs, 1078 
vs, 1031 w, 1017 w, 1006 w, 966 w, 958 w, 893 w, 866 w, 813 w, 811 w, 780 s, 763 m, 736 
m, 719 w (sh), 702 w (sh), 668 m, 675 w, 663 w, 646 w, 634 w, 630 w, 611 m. Anal. Calcd 
for C33H33CoClN8: C, 62.31; H, 5.23; N, 17.62. Found: C, 62.19; H, 5.39; N, 17.52.  
 
Co2(Mabiq)Cl3 (3).  
 
CoCl2 (103 mg, 0.79 mmol) was added to a solution of HMabiq (200 mg, 0.37 mmol) and 
triethylamine (48 µL, 0.38 mmol) in THF (10 mL). The mixture was stirred overnight, and 
the resultant green precipitate was filtered and washed with THF and hexane to give the 
dark green solid 3 (269 mg, 94.6% yield).  
ASAP-MS(+) (m/z): 601 [M-CoCl3]+. UV-Vis λmax (nm (ε, M-1 cm-1)) in MeOH: 253 (5.1 x 104), 
271 (4.2 x 104), 318 (3.7 x 104), 348 (3.0 x 104), 427 (1.5 x 104), 442 (1.6 x 104), 480 (7.4 x 
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103), 576 (4.5 x 103), 618 (4.6 x 103), 668 (3.5 x 103).  IR Spectrum (cm-1): 2967 w, 1560 s, 
1502 m, 1488 m, 1474 s (sh), 1460 s, 1431 m (sh), 1409 s, 1378 m, 1362 m, 1306 w, 1276 
w, 1257 w, 1228 m, 1200 w, 1169 m, 1125 m, 1094 s, 1072 s, 974 w, 956 w, 897 m. Anal. 
Calcd for C33H33Co2Cl3N8: C, 51.75; H, 4.34; N, 14.63. Found: C, 51.75; H, 4.28 N, 14.48. 
 
Co(Mabiq) (4).  
 
Cp2Co (8.6 mg, 0.046 mmol) was added to a suspension of 2 (29 mg, 0.046 mmol) in THF 
(5mL), upon which the mixture immediately turned a deep purple. The reaction was stirred 
overnight, filtered through celite and the solvent removed in vacuo, yielding a purple solid 
(22 mg, 79.6% yield). Single crystals were obtained by slow evaporation of a concentrated 
solution of 4 in THF.  
1H NMR (400 MHz, CDCl3): δ= 9.06 (dd, J = 8.2, 0.9 Hz, 2H), 8.37 (d, J = 8.1 Hz, 2H), 8.19 (td, 
j = 7.6, 2H), 7.64 (td, j = 7.6, 2H), 7.54 (s, 1H), 1.55 (s, 12H), 1.39 (s, 12H). ASAP-MS(+) (m/z): 
600 [M]+ . IR (cm-1): 2971 w, 2906 w, 1608 w, 1591 vw (sh), 1564 m, 1548 m, 1506 m, 1480 
m, 1463 w, 1446 m, 1414 m, 1388 w, 1374 m, 1364 m (sh), 1354 m, 1325 w, 1280 m, 1253 
w, 1222 m, 1187 vw, 1164 m, 1149 m, 1136 s, 1109 m (sh), 1016 w, 967 w, 954 vw, 896 w, 
867 m, 819 w (sh), 813 m, 792 vw, 765 vs, 748 s, 696 m, 690 m, 673 m, 632 m, 625 m, 612 
m. UV-Vis λmax (nm (ε, M-1 cm-1)) in THF: 268 (1.4 x 104), 324 (3.5 x 104), 335 (3.7 x 104), 392 
(1.9 x 104), 403 (2.4 x 104), 523 (1.3 x 104), 533 (1.4 x 104), 913 (2.8 x 103), 1048 (2.0 x 103), 
1210 (2.1 x 103). Anal. Calcd for C33H33CoN8: C, 65.99; H, 5.54; N, 18.66. Found: C, 66.16; H, 
5.62; N, 18.34. 
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6.3 Synthesis: Chapter 3 
HL1 
 
8-aminoquinoline (0.1 g, 0.7 mmol) and salicylaldehyde (85 mg, 0.7 mmol) were placed 
under vacuum and heated to 65°C with stirring. After 6 hours, an 87% conversion rate was 
achieved. The resulting orange oil was used in the next step with no purification. The 
experimental data obtained were in good agreement with that reported in literature.199 
 
HL2 
 
8-aminoquinoline (0.1 g, 0.7 mmol) and 2-hydroxy-5-methoxybenzaldehyde (107 mg, 0.7 
mmol) were placed under vacuum and heated to 65°C for 2 hours with stirring. The 
resulting orange oil was used in the next step with no purification. The experimental data 
obtained were in good agreement with that reported in literature.111 
HL3 
 
8-aminoquinoline (0.1 g, 0.7 mmol) and 2-hydroxy-5-(trifluoromethoxy)benzaldehyde (144 
mg, 0.7 mmol) were placed under vacuum and heated to 65°C for 2 hours with stirring. The 
resulting orange oil was used in the next step with no purification.  
 
 
 
 
191 
 
HL4 
 
8-aminoquinoline (0.1 g, 0.7 mmol) and 2-hydroxy-5-fluorobenzaldehyde (98 mg, 0.7 
mmol) were placed under vacuum and heated to 65°C for 2 hours with stirring. The 
resulting orange oil was used in the next step with no purification. The experimental data 
obtained were in good agreement with that reported in literature.111 
 
HL5 
 
Salicylaldehyde (1 ml, 9 mmol) was added drop wise to a solution of hydrazinopyridine (1 
g, 9 mmol) in 30ml of anhydrous methanol. A cream precipitate formed on addition and 
the resulting lemon suspension was stirred at reflux for 1 hour. The cream powder was 
isolated and washed with ethanol. The product was dried under high vacuum to give 1.58 
g (7.4 mmol, 82% yield).  
1H NMR (DMSO-d6, 400 MHz): 10.89 (1H, s), 10.54 (1H, br s), 8.28 (1H, s), 8.12 (1H, ddd, J = 
5, 2 and 1), 7.65 (1H, ddd, J = 8, 7 and 2), 7.57 (1H, dd, J = 8 and 2), 7.19 (1H, ddd, J = 8, 7 
and 2), 7.04 (1H, dt, J = 8 and 1), 6.89-6.85 (2H, m), 6.78 (1H, ddd, J = 7, 5 and1). 13C NMR 
(DMSO-d6, 101 MHz): 156.4, 155.9, 148.0, 138.6, 138.0, 129.7, 127.2, 120.5, 119.4, 116.0, 
115.0, 106.1. MS (ES+): m/z 214 [M+H]+.141,200  
 
HL6 
 
Experimental performed by Jack Fradgley. 2-Hydroxy-4-methylbenzaldehyde (125 mg, 0.92 
mmol) was added slowly to a stirred solution of 2-hydrazinopyridine (100 mg, 0.92 mmol) 
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in MeOH (8 ml) to produce a thick white slurry. The mixture was heated to reflux and stirred 
for 1 hour. The resulting white slurry was allowed to cool to ambient temperature, filtered 
and washed with hexane to afford 128 mg of a white solid (61% yield). 
1H NMR (DMSO-d6, 600 MHz): 10.82 (1H, s, HNH), 10.51 (1H, s, HOH), 8.23 (1H, s, Himine), 8.11 
(1H, ddd, J = 5, 2, 1, H3), 7.63 (1H, ddd, J = 9, 7, 2, H5), 7.42 (1H, d, J = 8, H3’), 6.99 (1H, d, J = 
8.5, H6), 6.75 (1H, ddd, J = 7, 5, 1, H4), 6.71 (1H. s. H6’), 6.69 (1H, d, J = 8, H4’), 2.25 (3H, s, 
HMe). 13C NMR (DMSO-d6, 151 MHz): 156.3 (C2), 156.0 (C1’), 148.0 (C3), 139.1 (C5’), 139.4 
(Cimine), 138.0 (C5), 127.4 (C3’), 120.4 (C4’), 117.7 (C2’), 116.4 (C6’), 114.9 (C4), 106.0 (C6), 21.1 
(CMe). MS (ES-): m/z 226 [M-H]-.  
 
HL7 
 
3,5-dichlorosalicylaldehyde (361 mg, 1.89 mmol) was added slowly to a stirred solution of 
2-hydrazinopyridine (206 mg, 1.89 mmol) in MeOH (30ml) to produce a thick yellow slurry. 
The mixture was heated to reflux and stirred for 1 hour. The resulting yellow slurry was 
allowed to cool to ambient temperature, filtered and washed with hexane. The product 
was dried under high vacuum to afford 471 mg of a yellow solid (1.67 mmol, 89% yield). 
The experimental data obtained were in good agreement with that reported in 
literature.201  
 
HL8 
 
Experimental performed by Jack Fradgley. 2-hydroxy-5-nitrobenzaldehyde (154 mg, 0.93 
mmol) was added slowly to a stirred solution of 2-hydrazinopyridine (100 mg, 0.92 mmol) 
in MeOH (8ml) to produce a thick yellow slurry. The mixture was heated to reflux and 
stirred for 1 hour. The resulting yellow slurry was allowed to cool to ambient temperature, 
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filtered and washed with hexane to afford 188 mg of a bright yellow solid (0.73 mmol, 79% 
yield). 
1H NMR (DMSO-d6, 600 MHz): 11.77 (1H, s, HOH), 11.14 (1H, s, HNH), 8.55 (1H, d, J = 3, H3’), 
8.31 (1H, s, Himine), 8.14 (1H, d, J = 5, H3), 8.07 (1H, dd, J = 9 and 3, H5’), 7.68 (1H, ddd, J = 9, 
7 and 2, H4), 7.16 (1H, d, J = 8, H6), 7.06 (1H, d, J = 9, H6’), 6.81 (1H, dd, J = 7 and 5, H5). 13C 
NMR (DMSO-d6, 151 MHz): 161.2 (COH), 156.3 (C2), 147.9 (C3), 140.1 (C4’), 138.1 (C4), 134.2 
(Cimine), 125.0 (C5’), 122.0 (C2’), 121.4 (C3’), 116.5 (C6’), 115.5 (C5), 106.5 (C6). MS (ES-): m/z 
257 [M-H]-.200 
 
HL9  
 
Experimental performed by Jack Fradgley. 5-fluorosalicylaldehyde (133 mg, 0.95 mmol) 
was added slowly to a stirred solution of 2-hydrazinopyridine (100 mg, 0.92 mmol) in MeOH 
(8ml) to produce a thick yellow slurry. The mixture was heated to reflux and stirred for 1 
hour. The resulting yellow slurry was allowed to cool to ambient temperature, filtered and 
washed with hexane to afford 109 mg of a bright yellow solid (0.47 mmol, 51% yield). 
1H NMR (DMSO-d6, 700 MHz): 10.97 (1H, s, HOH), 10.22 (1H, s, HNH), 8.24 (1H, s, Himine), 8.12 
(1H, dd, J = 5 and 1, H3), 7.64 (1H, ddd, J = 8, 7 and 2, H5), 7.43 (1H, dd, J = 10 and 3, H3’), 
7.14 (1H, d, J = 8, H6), 7.00 (1H, td, J = 9 and 3, H5’), 6.86 (1H, dd. J = 9 and 5, H6’), 6.77 (1H, 
ddd, J = 7, 5 and 1, H4). 13C NMR (DMSO-d6, 176 MHz): 156.5 (COH), 155.0 (C2), 151.90 (C2’), 
147.8 (C3), 138.0 (C5), 136.0 (Cimine), 122.1 (C4’), 117.1 (C6’), 115.9 (C5’), 115.2 (C5), 111.5 (C3’), 
106.4 (C6). MS (ES-): m/z 230 [M-H]-; HRMS (ES+) m/z = 232.0884 [M+H]+; calculated for 
[C12H11N3OF]+ 232.0886. Mp. = 226-227°C. 
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HL10 
 
Experimental performed by Jack Fradgley. 5-chlorosalicylaldehyde (151 mg, 0.96 mmol) 
was added slowly to a stirred solution of 2-hydrazinopyridine (104 mg, 0.95 mmol) in MeOH 
(8ml) to produce a thick white slurry. The mixture was heated to reflux and stirred for 1 
hour. The resulting white slurry was allowed to cool to ambient temperature, filtered and 
washed with hexane to afford 165 mg of a white solid (0.67 mmol, 70% yield). 
1H NMR (DMSO-d6, 700 MHz): 11.00 (1H, s, HOH), 10.52 (1H, s, HNH), 8.23 (1H, s, Himine), 8.12 
(1H, ddd, J = 5, 2 and 1, H3), 7.67 (1H, d, J = 3, H5), 7.64 (1H, ddd, J = 8, 7 and 2, H3’), 7.18 
(1H, dd, J = 9 and 3, H5’), 7.13 (1H, d, J = 8, H6), 6.89 (1H, d, J = 7, H6’), 6.78 (1H, ddd, J = 7, 5 
and 1, H4). 13C NMR (DMSO-d6, 176 MHz): 156.4 (COH), 154.4 (C2), 147.8 (C3), 138.0 (C3’), 
135.6 (Cimine), 128.9 (C5’), 125.1 (C5), 123.1 (C4’), 122.8 (C2’), 117.7 (C6’), 115.2 (C4), 106.4 
(C6). MS (ES-): m/z 246 [M-H]-.200 
 
HL11 
 
Experimental performed by Jack Fradgley. 2,4-dihydroxybenzaldehyde (134 mg, 0.97 
mmol) was added slowly to a stirred solution of 2-hydrazinopyridine (106 mg, 0.97 mmol) 
in MeOH (8ml) to produce a pale orange slurry. The mixture was heated to reflux and 
stirred for 1 hour. The resulting orange slurry was allowed to cool to ambient temperature, 
placed in the fridge overnight, filtered and washed with hexane to afford 97 mg of an 
orange solid (0.42 mmol, 44% yield). 
1H NMR (DMSO-d6, 700 MHz): 10.66 (2H, s, HOH), 9.69 (1H, s, HNH), 8.16 (1H, s, Himine), 8.10 
(1H, ddd, J = 5, 2 and 1, H3), 7.61 (1H, ddd, J = 8, 7 and 2, H5), 7.31 (1H, d, J = 8, H3’), 6.92 
(1H, d, J = 8, H6), 6.72 (1H, ddd, J = 7, 5 and 1, H4), 6.32 – 6.30 (2H, m, H6’ and H4’). 13C NMR 
(DMSO-d6, 176 MHz): 159.3 (C5’), 157.7 (C1’), 156.4 (C2), 147.9 (C3), 140.4 (Cimine), 137.9 (C5), 
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129.0 (C3’), 114.5 (C4), 111.9 (C2’), 107.5 (C6’), 105.7 (C6), 102.5 (C4’). MS (ES-): m/z 228 [M-
H]-.202 
 
HL13 
 
Experimental performed by Jack Fradgley. 2-hydroxy-5-methoxybenzaldehyde (150 mg, 
0.98 mmol) was added slowly to a stirred solution of 2-hydrazinopyridine (102 mg, 0.94 
mmol) in MeOH (8ml) to produce a white slurry. The mixture was heated to reflux and 
stirred for 1 hour. The resulting white slurry was allowed to cool to ambient temperature, 
filtered and washed with hexane to afford 133 mg of a white solid (0.55 mmol, 58% yield). 
1H NMR (CDCl3, 700 MHz): 10.25 (1H, br s, HOH), 9.10 (1H, br s, HNH), 8.18 (1H, d, J = 5, H3), 
7.91 (1H, s, Himine), 7.66 (1H, t, J = 8, H5), 7.09 (1H, d, J = 8, H6), 6.94 (1H, d, J = 9, H3’), 6.87 
– 6.84 (2H, m, H4 and H5’), 6.71 (1H, d, J = 3, H6’), 3.79 (3H, s, HOMe). 13C NMR (CDCl3, 176 
MHz): 155.6 (C2), 152.8 (C4’), 151.5 (C1’), 147.5 (C3), 142.9 (Cimine), 139.0 (C5), 118.3 (C2’), 
117.5 (C3’), 117.1 (C5’), 116.5 (C4), 114.2 (C6’), 107.0 (C6). MS (ES+):  m/z 244 [M+H]+.112 
 
HL14 
 
2-Hydroxy-1-napthaldehyde (230 mg, 1.34 mmol) was added to a solution of 2-
hydrazinopyridine (146 mg, 1.34 mmol) in MeOH (5ml). The resulting bright yellow slurry 
was refluxed for 30 mins before allowing to cool to ambient temperature. The mixture was 
filtered and the solid washed with methanol and hexane. The isolated solid was dried in 
vacuo to give 301 mg of a bright yellow solid (1.14 mmol, 85% yield). The experimental data 
obtained was good agreement with that reported in literature.203 
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2-(1-methylhydrazinyl)pyridine 
 
Bromopyridine (3.3 g, 21 mmol) was added under a stream of argon to methyl hydrazine 
(14.5 g, 315 mmol) to form a pale-yellow solution which was refluxed for 4 hours. The 
solvent was removed in vacuo to produce a yellow oil, which was washed with 40ml sat. 
Na2CO3 solution and extracted into EtOAc. The organic layer was washed with 2 x 40ml sat. 
NaCl and dried over magnesium sulphate. The solvent was removed in vacuo to give 1.19 g 
of a yellow oil (9.66 mmol, 69% yield). The experimental data obtained were in accord with 
that reported in literature.204  
 
HL14 
 
Salicylaldehyde (1.77 g, 14.5 mmol) was added to a solution of 2-(1-
methylhydrazinyl)pyridine (1.78 g, 14.5 mmol) in 20ml methanol. The bright yellow solution 
was refluxed for 1 hour before allowing to cool to ambient temperature. The solvent was 
slowly removed in vacuo until a precipitate formed and the flask was placed in an ice bath 
for 30 min. The slurry was filtered and washed with hexane to give 2.63 g of a cream solid 
(11.57 mmol, 80% yield). 
1H NMR (DMSO-d6, 600 MHz): 10.38 (1H, s, HOH), 8.23 (1H, d, J = 5, H3), 8.05 (1H, s, Himine), 
7.71 (2H, t, J = 8, H3’ and H5), 7.47 (1H, d, J = 9, H6), 7.19 (1H, t, J = 8, H5’), 6.85-6.92 (3H, m, 
H4, H4’ and H6’), 3.61 (3H, s, HNMe). 13C NMR (DMSO-d6, 151 MHz): 156.8 (C2), 155.7 (COH), 
147.2 (C3), 138.1 (C5), 134.1 (Cimine), 129.5 (C5’), 127.0 (C3’), 121.2 (C2’), 119.4 (C6’), 116.0 
(C4’), 115.6 (C4), 108.5 (C6), 29.3 (CMe). MS (ES+): m/z 228 [M+H]+, 108 [M – C7H6NO+H]+; 
HRMS (ES+): m/z = 228.1130 [M+H]+; calculated for [C12H14N3O]+ 228.1137. Mp. = 99-101°C. 
Anal. Cacld for C13H13N3O: C, 68.70; H, 5.77; N, 18.49. Found: C, 68.55; H, 5.76; N, 18.49. 
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HL15 
 
2-hydroxy-5-methoxybenzaldehyde (93 mg, 0.61 mmol) was added to a stirring solution of 
2-(1-methylhydrazinyl)pyridine (75 mg, 0.61 mmol) in 3ml methanol to form a yellow 
solution. The solution was heated to 40°C for a period of 30 minutes and the resulting 
lemon slurry was allowed to cool to room temperature before filtering and washing with 
cold methanol to give 104mg of a white solid (0.40 mmol, 66% yield). 
1H NMR (CDCl3, 700 MHz): 10.77 (1H, s, HOH), 8.27 (1H, dd, J = 8 and 1, H3), 7.76 (1H, s, 
Himine), 7.63 (1H, ddd, J = 8.5, 7 and 2, H5), 7.27 (1H, d, J = 8.5, H6), 6.93 (1H, d, J = 9, H3’), 
6.85-6.83 (2H, m, H5’ and H4), 6.80 (1H, d, J = 3, H6’), 3.80 (3H, s, HOMe), 3.71 (3H, s, HNMe). 
13C NMR (CDCl3, 176 MHz): 156.6 (C2), 152.8 (C4’), 151.0 (C1’), 147.5 (C3), 138.3 (C5), 138.0 
(Cimine), 119.3 (C2’), 117.3 (C3’), 116.4 (C4 or C5’), 116.3 (C4 or C5’), 114.5 (C6’), 108.8 (C6), 56.1 
(COMe), 29.6 (CNMe). MS (ES+): m/z 258 [M+H]+. Mp. = 110-111°C. 
 
HL16 
 
2-Hydroxy-5-(trifluoromethoxy)benzaldehyde (343 mg, 1.66 mmol) was added to a stirring 
solution of 2-(1-methylhydrazinyl)pyridine (205 mg, 1.66 mmol) in 2ml MeOH to form a 
yellow solution which was heated to reflux for a period of 30 minutes before being placed 
in the fridge overnight. The resulting yellow slurry was filtered and washed with cold 
methanol to isolate 192 mg of a lemon solid (0.62 mmol, 37% yield). 
1H NMR (CDCl3, 600 MHz): 11.23 (1H, s, HOH), 8.29 (1H, ddd, J = 5, 2 and 1, H3), 7.74 (1H, s, 
Himine), 7.65 (1H, ddd, J = 8.5, 7 and 2, H5), 7.25 (1H, d, J = 8.5, H6), 7.14 (1H, d, J = 2.5, H3’), 
7.09 (1H, dd, J = 9 and 2.5, H5’ or H6’), 6.98 (1H, d, J = 9, H5’ or H6’), 6.87 (1H, ddd, J = 7, 5 
and 1,H4), 3.71 (3H, s, HNMe). 13C NMR (CDCl3, 151 MHz): 156.4 (C2), 155.4 (C1’), 147.7 (C3), 
141.8 (C4’), 138.4 (C5), 136.6 (Cimine), 122.8 (C5’ or C6’), 122.4 (C3’), 121.6 (COCF3), 119.8 (C2’), 
117.7 (C5’ or C6’), 116.7 (C4), 108.7 (C6), 29.7 (CNMe). MS (ES-): m/z 310 [M-H]-; HRMS (ES-): 
m/z 310.0798 [M-H]-; calculated for [C14H11N3O2F3]- 310.0803. Mp. = 95-96°C.  
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HL17 
 
3,5-dichlorosalicylaldehyde (150 mg, 0.79 mmol) was added to a stirring solution of 2-(1-
methylhydrazinyl)pyridine (95 mg, 0.77 mmol) in 5ml MeOH to form a yellow solution 
which precipitated rapidly to form a lemon slurry. The solution was heated to reflux for a 
period of 30 minutes, before cooling to room temperature. The slurry was filtered and 
washed with cold methanol to isolate 169 mg of a white solid (0.57 mmol, 74% yield). 
1H NMR (CDCl3, 700 MHz): 11.85 (1H, s, HOH), 8.29 (1H, ddd, J = 9.5, 2 and 1, H3). 7.68 (1H, 
s, Himine), 7.66 (1H, ddd, J = 9, 7 and 2, H5), 7.31 (1H, d, J = 2, H5’), 7.28 (1H, d, J = 8.5, H6), 
7.18 (1H, d, J = 2.5, H3’), 6.90 (1H, ddd, J = 7, 5 and 1, H4), 3.71 (3H, s, HNMe). 13C NMR (CDCl3, 
176 MHz): 156.1 (C2), 151.3 (C1’), 147.7 (C3), 138.6 (C5), 135.5 (Cimine), 129.4 (C5’), 127.7 (C3’), 
124.3 (C2’), 122.2 (C6’), 121.3 (C4’), 117.2 (C4), 108.9 (C6), 29.9 (CNMe). MS (ES+): m/z 296 
[M+H]+; HRMS (ES+): m/z  296.0362 [M+H]+; calculated for [C13H12N3OCl2]+ 296.0357. Mp. 
= 169-169°C. 
 
HL18 
 
2-Hydroxy-1-napthaldehyde (105 mg, 0.61 mmol) was added to a stirring solution of 2-(1-
methylhydrazinyl)pyridine (75 mg, 0.61 mmol) in 3ml MeOH to form a lemon slurry which 
was heated to reflux for a period of 30 minutes, before cooling to room temperature. The 
slurry was filtered and washed with cold methanol to isolate 148 mg of a cream solid (0.53 
mmol, 87% yield).  
1H NMR (CDCl3, 700 MHz): 12.43 (1H, s, HOH), 8.67 (1H, s, Himine), 8.30 (1H, ddd, J = 5, 2 and 
1, H3), 8.11 (1H, d, J = 8.5, H4’), 7.81 (1H, d, J = 8, H7’), 7.76 (1H, d, J = 9, H9’), 7.67 (1H, ddd, 
J = 8.5, 7 and 2, H5), 7.54 (1H, ddd, J = 8.5, 7 and 1, H6’), 7.38 (1H, ddd, J = 8, 7 and 1, H5’), 
7.35 (1H, d, J = 8.5, H6), 7.25 (1H, d, J = 8, H10’), 6.86 (1H, dd, J = 7, 5 and 1, H4), 3.83 (3H, s, 
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HNMe). 13C NMR (CDCl3, 176 MHz): 156.6 (C2), 156.5 (C1’), 147.6 (C3), 138.4 (C5), 134.9 (Cimine), 
132.0 (C8’), 131.2 (C9’), 129.3 (C7’), 128.6 (C3’), 127.2 (C6’), 123.4 (C5’), 120.2 (C4’), 119.1 (C10’), 
116.3 (C4), 109.8 (C2’), 108.6 (C6). MS (ES-): m/z 276 [M-H]-. Mp. = 148-149°C. 
 
4-methoxy-2-(1-methylhydrazinyl)pyridine 
N
N NH2
MeO
 
2-Chloro-4-methoxypyridine (126 mg, 0.88 mmol) was stirred under reflux in methyl 
hydrazine (3ml) for a period of 24 hours. The resulting pale-yellow solution was allowed to 
cool to room temperature before being diluted with water (10ml) and extracted into Et2O 
(3 x 30ml). The organic layers were combined, dried over MgSO4 and the solvent removed 
in vacuo to yield 130 mg of a pale orange oil (0.85 mmol, 97% yield).  
1H NMR (CDCl3, 400 MHz): 7.98 (1H, d, J = 6), 6.49 (1H, d, J = 6), 6.24 (1H, dd, J = 6 and 2), 
4.02 (2H, br s), 3.83 (3H, s), 3.27 (3H, s).  
 
HL19 
 
Salicylaldehyde (130 mg, 1.06 mmol) was added to a stirring solution of 4-methoxy-2-(1-
methylhydrazinyl)pyridine (120 mg, 0.78 mmol) in MeOH (2.5ml) and the resulting orange 
solution was stirred for 3 hours at reflux. The solution was allowed to cool to ambient 
temperature and placed in the fridge overnight. The resulting white crystals were collected 
by filtration and washed with cold methanol to yield 51 mg of a white solid (0.20 mmol, 
19% yield).  
1H NMR (CDCl3, 700 MHz): 11.19 (1H, s, HOH), 8.08 (1H, d, J = 6, H3), 7.80 (1H, s, Himine), 7.27-
7.23 (2H, m, H4’ and H5’), 7.00 (1H, d, J = 8, H6’), 6.93 (1H, td, J = 7.5, H3’), 6.75 (1H, d, J = 2, 
H6), 6.44 (1H, dd, J = 6, 2), 3.89 (3H, s, HOMe), 3.70 (3H, s, HNMe). 13C NMR (CDCl3, 176 MHz): 
167.8 (C4), 158.6 (C2), 157.0 (C1’), 148.4 (C3), 138.4 (Cimine), 130.2 (C4’ or C5’), 130.0 (C4’ or 
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C5’), 119.7 (C3’), 119.4 (C2’), 116.7 (C2’), 105.2 (C5), 92.6 (C6), 55.3 (COMe), 29.9 (CNMe). Mp. = 
100-101°C. 
                                                                                                                                                                                                          
2-(1-methylhydrazinyl)-4-(trifluoromethyl)-pyridine 
 
2-Bromo-4-(trifluoromethyl)pyridine (200 mg, 0.88 mmol) was stirred under reflux in 
methyl hydrazine (3ml) for a period of 24 hours. The resulting pale-yellow solution was 
allowed to cool to room temperature before being diluted with water (10ml) and extracted 
into Et2O (3 x 30ml). The organic layers were combined, dried over MgSO4 and the solvent 
removed in vacuo to yield 100 mg of a pale-yellow oil (0.48 mmol, 59% yield).  
1H NMR (CDCl3, 400 MHz): 8.22 (1H, d, J = 5), 7.30-7.28 (1H, m), 6.72 (1H, dd, J = 5 and 1), 
4.00 (2H, br s), 3.32 (3H, s). 
 
HL20 
 
Salicylaldehyde (105 mg, 0.89 mmol) was added to a stirring solution of 2-(1-
methylhydrazinyl)-4-(trifluoromethyl)-pyridine (169 mg, 0.86 mmol) in MeOH (2.5ml) and 
the resulting yellow solution was stirred for 3 hours at reflux. The solution was allowed to 
cool to ambient temperature and placed in the fridge overnight. The resulting white 
crystals were collected by filtration and washed with cold methanol to yield 188 mg of a 
white solid (0.60 mmol, 72% yield).  
1H NMR (CDCl3, 700 MHz): 10.83 (1H, br s, HOH), 8.40 (1H, d, J = 5, H?), 7.89 (1H, s, H3), 7.43 
(1H, s, Himine), 7.28-7.25 (2H, m, H4’ and H5’), 7.04-7.00 (2H, m, H6’ and H3’), 6.93 (1H, td, J = 
7.5 and 1, H5), 3.73 (3H, d, J = 1, HNMe).  13C NMR (CDCl3, 176 MHz): 156.8, 148.7, 140.4, 
130.5, 130.4, 125.2 , 123.6, 122.1, 119.6, 118.7, 116.7, 111.2, 104.4, 29.7.  MS (ES+): m/z 
296 [M+H]+; HRMS (ES+): m/z = 296.1011 [M+H]+; calculated for [C14H13F3N3O]+ = 296.2672.  
Mp = 117.5-119.0oC. 
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3-(dimethylamino)-1-(2-hydroxyphenyl)-prop-2-en-1-one 
 
A mixture of 2’-hydroxyacetophenone (0.68 g, 5.0 mmol) and N,N-dimethylformamide 
dimethyl acetal (2.1 g, 17.5 mmol) was stirred at 75°C in DMF (25ml) for 30 minutes. The 
mixture was allowed to cool to ambient temperature before being poured into a beaker 
with brine (100ml) causing a yellow precipitate to form. The mixture was filtered and the 
solid dried under high vacuum at 50°C to afford 0.92 g of a bright yellow solid (0.48 mmol, 
96% yield). The experimental data obtained was good agreement with that reported in 
literature.114 
 
2-(1H-pyrazol-5-yl)phenol 
 
Hydrazine monohydrate (0.63ml, 12.6 mmol) was added to a suspension of 3-
(dimethylamino)-1-(2-hydroxyphenyl)-prop-2-en-1-one (0.4 g, 2.1 mmol) in EtOH (10ml) 
and the mixture was refluxed for 6 hours to afford a white suspension. The suspension was 
filtered to remove the white solid and the solvent removed in vacuo to afford a beige 
residue. The residue was washed with H2O, extracted into EtOAc and the solvent removed 
in vacuo to afford 0.21 g of a white solid (1.3 mmol, 62% yield). The experimental data 
obtained were in accord with that reported in literature.129 
 
HL21 
 
A mixture of 2-(1H-pyrazol-5-yl)phenol (150 mg, 0.94 mmol), 2-bromopyridine (178 mg, 
1.12 mmol), trans-1,2-diaminocyclohexane (22 mg, 0.19 mmol), copper iodide (9 mg, 0.05 
mmol), K2CO3 (273 mg, 1.97 mmol) in dry 1,4-dioxane (2ml) was degassed via freeze-pump-
thaw (3 cycles). The mixture was heated at reflux with stirring for 24 hours. After cooling 
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to ambient temperature, the mixture was diluted with EtOAc (6ml) and filtered through 
celite and washed through with EtOAc (40ml). The crude product was purified by 
chromatography with silica gel (hexane/DCM, 50:50) to provide 123 mg of a white solid 
(0.52 mmol, 55% yield). The experimental data obtained were in good agreement with that 
reported in literature.205 
 
2-(Hydrazinocarbonyl)pyridine 
 
Hydrazine monohydrate (1ml) was added dropwise to a solution of ethyl 2-picolinate (560 
mg, 3.7 mmol) in EtOH (3ml). The mixture was heated at reflux overnight before cooling to 
ambient temperature. The solvent was removed in vacuo to afford 421 mg of a white solid 
(3.07 mmol, 83% yield). The experimental data obtained were in accord with that reported 
in literature.161 
 
HL22 
 
2-Pyridine carboxaldehyde (78 mg, 0.73 mmol) was added dropwise under a steam of argon 
to a solution of 2-(hydrazinocarbonyl)pyridine (101 mg, 0.73 mmol) in MeOH (2ml). The 
resulting solution was refluxed for two hours before cooling to ambient temperature. The 
solvent was removed in vacuo and the resulting brown residue was recrystallized from 
DCM/hexane to afford 72 mg of a white crystalline solid (0.32 mmol, 44% yield). The 
experimental data obtained were in good agreement with that reported in literature.161 
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2,4,6-Tris(2-pyridyl)-s-triazine (200 mg, 0.64 mmol) and Cu(NO3).3H2O (155 mg, 0.64 mmol) 
were dissolved in a mixture of deionised water (7ml) and EtOH (5ml). The dark green 
solution was refluxed for a period of 2 hours and the resulting blue solution was transferred 
to a petri-dish and heated gently to cause crystallisation. The bright blue crystals were 
collected by filtration and then dissolved in chloroform (10ml). The resulting blue solution 
was added to a stirring solution of Ethylenediaminetetraacetic acid disodium salt dihydrate 
(390 mg, 1.05 mmol) in deionised water (15ml). The resulting biphasic mixture was stirred 
vigorously for a period of 4 hours. The organic layer was then extracted with chloroform (3 
x 30ml), dried over MgSO4 and the solvent removed in vacuo to yield 101 mg of a white 
solid (0.44 mmol, 69% yield). The experimental data obtained were in accord with that 
reported in literature.206  
 
2,4,6-Tris(2-pyrimidyl)-1,3,5-triazine 
 
2-Cyanopyrimidine (600 mg, 5.71 mmol) was heated with stirring in a stoppered flask at 
150°C for 48h. The solidified product was suspended in Et2O and filtered to obtain 477 mg 
of a cream coloured solid (1.51 mmol, 79% yield). The experimental data obtained were in 
good agreement with that reported in literature.120 
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Cu(NO3)2.3H2O (268 mg, 1.11 mmol) in H2O (10ml) was added to a suspension of 2,4,6-
Tris(2-pyrimidyl)-1,3,5-triazine (350 mg, 1.11 mmol) in EtOH (10ml) to form a dark green 
slurry which was refluxed for a period of 2 hours. The resulting blue solution was poured 
into a petri dish and allowed to stand for 4 hours. The blue crystals were isolated by 
filtration and dried in vacuo. The blue crystals were then added to a biphasic mixture of 
aqueous Na2H2EDTA (745 mg, 2.00 mmol, 30ml H2O) in chloroform (20ml) and the stirred 
at room temperature for a period of 5 hours. The organic layer was extracted with 
chloroform (3 x 50ml), dried over magnesium sulfate and the solvent removed in vacuo to 
yield 148 mg of a white solid (0.65 mmol, 58% yield). 
 
HL25 
 
A mixture of ethyl 2-picolinate (302 mg, 2.00 mmol), 2-(methylamino)pyridine (238 mg, 
2.20 mmol) and anhydrous 1,4-dioxane (1.4ml) was sealed in a microwave vial and heated 
at 180°C for 1 hour. The resulting yellow solution was diluted with deionised water (30ml) 
and extracted into DCM (2 x 30ml). The organic layers were washed with brine, dried over 
MgSO4 and the solvent removed in vacuo to yield a crude yellow liquid which was purified 
by column chromatography (5% MeOH in DCM) to yield 96 mg of a fine white powder (0.45 
mmol, 23% yield). The experimental data obtained were in accord with that reported in 
literature.207 
 
 
 
 
205 
 
2-Bromo-6-phenylpyridine 
 
A solution of nBuLi (1.6M in hexane, 24ml, 38.4 mmol) was added dropwise at 0°C to a 
solution of 2-(dimethylamino)ethanol (1.7 g, 19.2 mmol) in 19ml hexane resulting in a pale 
yellow solution. After 30 min stirring at 0°C, a solution of 2-phenylpyridine (1.0 g, 6.4 mmol) 
in 6.5ml hexane was added dropwise resulting in an orange solution. The solution was 
stirred at 0°C for 1 hour and then cooled to -78°C before the addition of CBr4 (7.4 g, 22.4 
mmol) in 22.5ml hexane. The resulting mixture was allowed to stir at -78°C for 1 hour 
before it was allowed to warm to room temperature overnight. Hydrolysis was then 
performed at 0°C by the addition of 25ml of H2O. The organic layer was extracted into 
EtOAc, dried over MgSO4 and concentrated to give an orange oil. The crude product was 
purified by chromatography with silica gel (hexane/EtOAc, 95:5) to provide 877 mg of a 
pale yellow solid (3.75 mmol, 59% yield). The experimental data obtained were in accord 
with that reported in literature.208 
 
2-hydrazino-6-phenyl-pyridine 
 
2-Bromo-6-phenylpyridine (260 mg, 1.10 mmol) was refluxed under argon in 20ml 
hydrazine hydrate for 22 hours before cooling to room temperature. The excess hydrazine 
hydrate was removed in vacuo, the residue dissolved in chloroform and stirred with K2CO3 
(300 mg, 2.2 mmol) for 20 minutes. The suspension was filtered through celite and the 
solvent removed in vacuo to afford 0.184 g of an orange air sensitive oil (0.99 mmol, 90% 
yield). The resulting orange oil was used in the next step with no formal isolation. 
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2-hydrazino-6-phenyl-pyridine (87 mg, 0.47 mmol) and salicylaldehyde (143 mg, 1.20 
mmol) were refluxed with stirring in MeOH (3ml) under argon for 40 minutes. The resulting 
yellow slurry was filtered, washed with hexane and purified by chromatography with silica 
gel (hexane/EtOAc, 90:10) to provide 53 mg of a white solid (0.18 mmol, 39% yield). 
1H NMR (CDCl3, 600 MHz): 10.75 (1H, s, HOH), 9.19 (1H, s, HNH), 7.98 (2H, d, J = 8, H2’), 7.74 
(1H, t, J = 8, H4), 7.59 (1H, s, Himine), 7.46 (2H, t, J = 8, H3’), 7.37 (1H, t, J = 7, H4’), 7.29 (1H, d, 
J = 8, H5), 7.24 (1H, t, J = 8, H4’’), 7.02 (1H, d, J = 8, H3), 7.00 (1H, d, J = 8, H3’’), 6.98 (1H, d, J 
= 8, H6’’), 6.88 (1H, t, J = 8, H5’’). 13C NMR (CDCl3, 151 MHz): 157.3 (COH), 156.2 (C1’), 155.8 
(C6), 142.9 (Cimine), 139.5 (C4), 139.2 (C2), 130.5 (C4’’), 130.0 (C3’’), 129.3 (C4’), 129.0 (C3’), 
127.1 (C2’), 119.6 (C5’’), 118.4 (C2’’), 116.7 (C6’’), 113.3 (C5), 105.2 (C3). MS (ES+): m/z 290 
[M+H]+; HRMS (ES+): m/z 290.1290 [M+H]+; calculated for [C18H16N3O]+ 290.1293.  
 
2-(1-methylhydrazino)-6-phenyl-pyridine 
 
2-Bromo-6-phenylpyridine (100 mg, 0.43 mmol) was refluxed under argon in 6ml 
methylhydrazine for 2 hours before cooling to room temperature. The mixture was diluted 
with 10ml water and the product extracted into diethyl ether. The organic layer was dried 
over MgSO4 and the solvent removed in vacuo to yield 85 mg of a yellow oil (0.43 mmol, 
100% yield). The experimental data obtained were in good agreement with that reported 
in literature.189  
 
207 
 
HL27 
4
5
6
N
2
3
1'
2'
3'
4'
N N
2''
1''
6''
5''
4''
3''
HO
 
2-(1-methylhydrazino)-6-phenyl-pyridine (88 mg, 0.44 mmol) and salicylaldehyde (54 mg, 
0.44 mmol) were refluxed with stirring in MeOH (6ml) under argon for 2 hours. The 
resulting white slurry was allowed to cool to ambient temperature, filtered and washed 
with cold methanol to give 98 mg of a white solid (0.32 mmol, 73% yield).  
1H NMR (CDCl3, 400 MHz): 11.32 (1H, s, HOH), 8.09 - 8.06 (2H, m, H2’), 7.88 (1H, s, Himine), 
7.74 (1H, dd, J = 8.5 and 8, H4), 7.53 – 7.42 (3H, m, H3’, H4’ and H5), 7.36 – 7.24 (3H, m, H4’, 
H3 and H3’’), 7.04 (1H, d, J = 8, H6’’), 6.97 (1H, td, J = 7.5 and 1, H5’’), 3.85 (3H, m, HNMe). 13C 
NMR (CDCl3, 101 MHz): 156.9, 156.2, 155.1, 139.3, 139.1, 138.3, 126.9, 119.7, 119.4, 116.7, 
112.7, 107.1, 29.5. MS (ES+): m/z 304 [M+H]+. 
 
2-{[2-(3-bromophenyl)hydrazinylidene]methyl}phenol 
 
Salicylaldehyde (235 mg, 1.9 mmol) was added to a solution of 3-Bromophenylhydrazine 
(300 mg, 1.6 mmol) in MeOH (4ml). The resulting yellow solution was refluxed for 2 hours 
to produce a yellow slurry. The mixture was allowed to cool to ambient temperature and 
then filtered and washed with hexane to yield 277 mg of a beige solid (0.95 mmol, 60% 
yield).  
1H NMR (CDCl3, 700 MHz): 10.54 (1H, s, HNH), 10.25 (1H, s, HOH), 8.18 (1H, s, Himine), 7.62 
(1H, d, J = 8, H6’), 7.17 (2H, t, J = 8, H5 and H5’), 7.14 (1H, t, J = 2, H2), 6.94 (1H, d, J = 8, H6), 
6.90 (1H, d, J = 8, H4), 6.89-6.85 (2H, m, H3’ and H4’). 13C NMR (CDCl3, 176 MHz): 155.6 (COH), 
146.5 (C1), 137.5 (Cimine), 131.2 (C5 or C5’), 129.6 (C5 or C5’), 126.8 (C6’), 122.5 (C3), 121.0 (C4), 
120.6 (C2’), 119.4 (C3’ or C4’), 115.9 (C3’ or C4’), 113.8 (C2), 110.8 (C6). MS (ES+): m/z 291 
[M+H]+. 
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A mixture of 2-{[2-(3-bromophenyl)hydrazinylidene]methyl}phenol (300 mg, 1.57 mmol), 
Lithium Chloride (348 mg, 8.21 mmol), 2-(tributylstannyl)pyridine (480 mg, 1.30 mmol) and 
Pd(PPh3)4 (51 mg, 0.04 mmol) in anhydrous toluene (7ml) was degassed via freeze-pump-
thaw (3 cycles). The mixture was heated at reflux with stirring for 48 hours. After cooling 
to ambient temperature, a solution of saturated aqueous KF (12ml) was added and stirring 
was continued for 1 hour. The resulting slurry was filtered via celite, washed through with 
toluene (40ml) and the solvent removed in vacuo to afford a brown oil. The crude oil was 
washed with 5% aq. NaHCO3 solution (2 x 75ml) and extracted into DCM. The organic layer 
was dried over potassium carbonate and the solvent removed in vacuo to afford an orange 
oil. The crude product was purified by chromatography with silica gel (hexane/EtOAc, 
70:30) to provide 72 mg of a white solid (0.25 mmol, 19% yield). 
1H NMR (CDCl3, 600 MHz): 10.87 (1H, s, HOH), 8.70 (1H, d, J = 5, H6), 7.86 (1H, s, Himine), 7.73-
7.78 (3H, m, H3, H5 and HNH), 7.61 (1H, t, J = 2, H2’’), 7.50 (1H, d, J = 8, H4’’), 7.40 (1H, t, J = 8, 
H5’’), 7.22-7.25 (2H, m, H4 and H4’), 7.14 (1H, dd, J = 8 and 2, H6’), 7.08 (1H, dd, J = 8 and 2, 
H6’’), 7.00 (1H, d, J = 8, H3’), 6.90 (1H, t, J = 8, H5’). 13C NMR (CDCl3, 151 MHz): 157.2 (COH and 
C2), 149.7 (C6), 144.1 (C3’’), 141.6 (Cimine), 140.7 (C1’’), 137.1 (C3 or C5), 130.2 (C4 or C4’), 130.2 
(C5’’), 129.6 (C6’), 122.5 (C4 or C4’), 120.9 (C3 and C5), 119.6 (C5’), 119.6 (C4’), 118.6 (C2’), 116.7 
(C3’), 113.3 (C6’’), 111.4 (C2’’). MS (ES-): m/z 288 [M-H]-; HRMS (ES+): m/z 290.1302 [M+H]+; 
calculated for [C18H16N3O]+ 290.1293.  
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A mixture of 2-(1H-pyrazol-5-yl)phenol (150 mg, 0.94 mmol), 2-Bromo-6-phenylpyridine 
(263 mg, 1.12 mmol), trans-1,2-diaminocyclohexane (21.5 mg, 0.19 mmol), copper iodide 
(9 mg, 0.05 mmol), K2CO3 (273 mg, 1.97 mmol) in dioxane (2ml) was degassed via freeze-
pump-thaw (3 cycles). The mixture was heated at reflux with stirring for 24 hours. After 
cooling to ambient temperature, the mixture was diluted with EtOAc (6ml) and filtered 
through celite and washed through with EtOAc (40ml). The crude product was purified by 
chromatography with silica gel (hexane/DCM, 50:50) to provide 267 mg of a white solid 
(91% yield). 
1H NMR (CDCl3, 600 MHz): 10.76 (1H, s, HOH), 8.82 (1H, d, J = 3, H3’), 8.11 - 8.08 (2H, m, H3’’’), 
7.93 (1H, t, J = 8, H4), 7.82 (1H, dd, J = 8 and 1, H3), 7.69 – 7.65 (2H, m, H5 and H6’’), 7.54 – 
7.45 (3H, m, H2’’’ and H4’’’), 7.31 - 7.27 (1H, m, H4’’), 7.09 (1H, dd, J = 8 and 1, H3’’), 6.97 (1H, 
td, J = 8 and 1, H5’’), 6.90 (1H, d, J = 3, H4’). 13C NMR (CDCl3, 151 MHz): 104.9 (C4’), 110.3 (C3), 
116.3 (C2’’), 117.3 (C3’’), 118.1 (C5), 119.6 (C5’’), 127.1 (C3’’’ and C6’’), 128.3 (C3’), 129.0 (C2’’’), 
129.7 (C4’’’), 130.1 (C4’’), 138.3 (C1’’’), 139.9 (C4), 150.4 (C6), 154.0 (C2), 156.3 (C5’ and COH). 
MS (ES+): m/z 314 [M+H]+; HRMS (ES+): m/z 314.1294 [M+H]+; calculated for [C20H16N3O]+ 
314.1293. Mp = 137-139°C. Anal. Cacld for C20H15N3O: C, 76.66; H, 4.83; N, 13.41. Found: C, 
76.53; H, 4.85; N, 13.38. 
 
3-(dimethylamino)-1-(2-methoxyphenyl)-2-propen-1-one 
 
A mixture of 2’-methoxyacetophenone (0.64 g, 5.10 mmol) and N,N-dimethylformamide 
dimethyl acetal (2.2 g, 18.1 mmol) was refluxed in DMF (24ml) overnight. The mixture was 
allowed to cool to ambient temperature before being washed with brine (100ml), extracted 
into EtOAc (3 x 75ml) and dried over MgSO4. The solvent was removed in vacuo to yield 
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1.03 g of a viscous orange oil (5.0 mmol, 99% yield). The experimental data obtained were 
in accord with that reported in literature.209 
 
3-(2-methoxyphenyl)pyrazole 
 
Hydrazine monohydrate (3ml, 61.5 mmol) was added to a suspension of 3-
(dimethylamino)-1-(2-methoxyphenyl)-2-propen-1-one (1.032 g, 5.03 mmol) in EtOH (5ml) 
and the mixture was refluxed for 48 hours to afford a yellow solution. The solvent was 
removed in vacuo to afford a crude brown oil which was purified by chromatography with 
silica gel (hexane/EtOAc, 40:60) to provide 562 mg of a yellow solid (3.2 mmol, 64% yield). 
The experimental data obtained were in accord with that reported in literature.210 
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A mixture of 3-(2-methoxyphenyl)pyrazole (100 mg, 0.57 mmol), 2-Bromo-6-
phenylpyridine (161 mg, 0.69 mmol), trans-1,2-diaminocyclohexane (13.3 mg, 0.12 mmol), 
copper iodide (6 mg, 0.03 mmol), K2CO3 (167 mg, 1.2 mmol) in dioxane (2ml) was degassed 
via freeze-pump-thaw (3 cycles). The mixture was heated at reflux with stirring for 24 
hours. After cooling to ambient temperature, the mixture was diluted with EtOAc (6ml), 
filtered through celite and washed through with EtOAc (40ml). The crude product was 
purified by chromatography with silica gel (hexane/DCM, 50:50) to provide 180 mg of a 
white solid (0.55 mmol, 96% yield). 
1H NMR (CDCl3, 600 MHz): 8.76 (1H, d, J = 3, H3’), 8.13 (1H, dd, J = 8 and 2, H6’’), 8.10 (2H, d, 
J = 7, H2’’’), 8.05 (1H, d, J = 8, H3), 7.88 (1H, t, J = 8, H4), 7.63 (1H, d, J = 8, H5), 7.51 (2H, t, J = 
8, H3’’’), 7.45 (1H, tt, J = 7 and J = 1, H4’’’), 7.35 (1H, ddd, J = 9, 7 and 2, H5’’), 7.07 (1H, td, J = 
8 and 1, H4’’), 7.04 (1H, d, J = 3, H4’), 7.02 (1H, d, J = 8, H3’’), 3.95 (3H, s, HOMe). 13C NMR 
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(CDCl3, 151 MHz): 157.4 (C1’’), 155.8 (C6), 151.8 (C2), 151.1 (C5’), 139.5 (C4), 138.7 (C1’’’), 
129.5 (C5’’), 129.4 (C4’’’), 129.0 (C6’’), 128.9 (C3’’’), 127.5 (C3’), 127.0 (C2’’’), 122.2 (C2’’), 121.0 
(C4’’), 117.5 (C5), 111.6 (C3’’), 110.9 (C3), 109.5 (C4’), 55.7 (COMe). MS (ES+): m/z 328 [M+H]+; 
HRMS (ES+): m/z 328.1444 [M+H]+; calculated for [C21H18N3O]+ 328.1450. 
 
4-tert-butylphenylpyridine 
 
A mixture of 2-bromopyridine (500 mg, 3.16 mmol), 4-tert-butylphenylboronic acid (739 
mg, 4.15 mmol), sodium carbonate (3.00 g, 28.3 mmol) in toluene (12ml), distilled water 
(12ml) and ethanol (2.4ml) was degassed via freeze-pump-thaw (3 cycles). Pd(PPh3)4 (150 
mg, 0.13 mmol) was added and the resulting mixture was heated at reflux with stirring for 
24 hours. After cooling to ambient temperature, the mixture was diluted with distilled 
water (60ml) and extracted with DCM (3 x 75ml). The organic layer was washed with brine 
(80ml) and dried over magnesium sulphate to give a brown oil. The crude product was 
purified by chromatography with silica gel (hexane/EtOAc, 95:5) to provide 599 mg of an 
off-white solid (2.83 mmol, 90% yield). The experimental data obtained were in accord with 
that reported in literature.211 
 
2-bromo-6-(4-tert-butylphenyl)pyridine 
 
A solution of nBuLi (1.6M in hexane, 11ml, 17.6 mmol) was added dropwise at 0°C to a 
solution of 2-(dimethylamino)ethanol (757 mg, 8.49 mmol) in 8.5ml hexane resulting in a 
pale yellow solution. After 30 min stirring at 0°C, a solution of 4-tert-butylphenylpyridine 
(599 mg, 2.83 mmol) in 3ml hexane was added dropwise resulting in an orange solution. 
212 
 
The solution was stirred at 0°C for 1 hour and then cooled to -78°C before the addition of 
CBr4 (3.28 g, 9.90 mmol) in 10ml hexane. The resulting mixture was allowed to stir at -78°C 
for 1 hour before it was allowed to warm to room temperature overnight. Hydrolysis was 
then performed at 0°C by the addition of 25ml of H2O. The organic layer was extracted into 
EtOAc, dried over MgSO4 and concentrated to give an orange oil. The crude product was 
purified by chromatography with silica gel (hexane/EtOAc, 95:5) followed by a second 
chromatography with silica gel (hexane/DCM, 80:20) to provide 490 mg of a white solid 
(1.69 mmol, 60% yield). The experimental data obtained were in accord with that reported 
in literature.212 
 
HL31 
 
A mixture of 2-(1H-pyrazol-5-yl)phenol (133 mg, 0.83 mmol), 2-bromo-6-(4-tert-
butylphenyl)pyridine (200 mg, 0.69 mmol), trans-1,2-diaminocyclohexane (15.8 mg, 0.14 
mmol), copper iodide (9 mg, 0.05 mmol), K2CO3 (200 mg, 1.50 mmol) in dioxane (2ml) was 
degassed via freeze-pump-thaw (3 cycles). The mixture was heated at reflux with stirring 
for 24 hours. After cooling to ambient temperature, the mixture was diluted with EtOAc 
(6ml) and filtered through celite and washed through with EtOAc (40ml). The crude product 
was purified by chromatography with silica gel (hexane/DCM, 50:50) to provide 170 mg of 
a white solid (0.46 mmol, 67% yield). 
1H NMR (CDCl3, 600 MHz): 10.77 (1H, s, HOH), 8.81 (1H, d, J = 3, H3’), 8.02 (2H, d, J = 8, H3’’’), 
7.90 (1H, t, J = 8, H4), 7.79 (1H, d, J = 8, H3), 7.67-7.65 (2H, m, H6’’ and H5), 7.54 (2H, d, J = 8, 
H2’’’), 7.29 (1H, t, J = 8, H5’’), 7.09 (1H, d, J = 8, H3’’), 6.97 (1H, t, J = 7, H4’’), 6.89 (1H, d, J = 3, 
H4’), 1.39 (9H, s, H6’’’). 13C NMR (CDCl3, 151 MHz): 156.3 (C2), 156.2 (COH), 153.9 (C5’), 153.0 
(C4’’’), 150.3 (C6), 139.7 (C4), 135.6 (C1’’’), 130.1 (C5’’), 128.2 (C3’), 127.0 (C6’’), 126.8 (C3’’’), 
125.9 (C2’’’), 119.6 (C4’’), 117.9 (C5), 117.3 (C3’’), 116.3 (C2’’), 109.9 (C3), 104.8 (C4’), 34.9 (C5’’’), 
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31.4 (C6’’’). MS (ES+): m/z 370 [M-H]+; HRMS (ES+): m/z 370.1912 [M+H]+; calculated for 
[C24H24N3O]+ 370.1919. 
 
2-bromo-6-phenoxy-pyridine 
 
A mixture of phenol (620 mg, 6.6 mmol), NaH (164 mg, 6.8 mmol) and DMF (10ml) was 
stirred over ice for a period of 10 minutes. A solution of 2,6-dibromopyridine (620 mg, 2.6 
mmol) in DMF (6ml) was added slowly and the ice bath was maintained for a further 10 
minute period. The solution was then heated to 100°C and stirred overnight under argon. 
The resulting brown solution was allowed to cool to ambient temperature, quenched with 
sat. aq. NaHCO3 and extracted into EtOAc. The organic layer was washed with brine, dried 
over MgSO4 and the solvent removed in vacuo to yield a brown oil. The crude product was 
purified by chromatography with silica gel (100% hexane to hexane/EtOAc, 95:5) to provide 
580 mg of a white solid (2.3 mmol, 89% yield). The experimental data obtained were in 
accord with that reported in literature.130 
 
HL31 
 
A mixture of 2-(1H-pyrazol-5-yl)phenol (45 mg, 0.28 mmol), 2-bromo-6-phenoxy-pyridine 
(59 mg, 0.24 mmol), trans-1,2-diaminocyclohexane (9 mg, 0.08 mmol), copper iodide (3 
mg, 0.02 mmol), K2CO3 (70 mg, 0.5 mmol) in dioxane (1ml) was degassed via freeze-pump-
thaw (3 cycles). The mixture was heated at reflux with stirring for 72 hours. After cooling 
to ambient temperature, the mixture was diluted with EtOAc (6ml) and filtered through 
celite and washed through with EtOAc (40ml). The crude product was purified by 
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chromatography with silica gel (100% hexane) to provide 24 mg of a white solid (0.07 mmol, 
30% yield). 
1H NMR (CDCl3, 700 MHz): 10.66 (1H, s, HOH), 8.27 (1H, d, J = 3, H3’), 7.83 (1H, t, J = 8, H4), 
7.60 (1H, dd, J = 8 and 1.5, H6’’), 7.54 (1H, d, J = 8, H3 or H5), 7.45 (2H, t, J = 8, H3’’’), 7.28-
7.25 (2H, m, H4’’ and H4’’’), 7.21 (2H, d, J = 8, H2’’’), 7.07 (1H, d, J = 8, H3’’), 6.95 (1H, t, J = 8, 
H5’’), 6.77-6.76 (2H, m, H4’ and H3 or H5). 13C NMR (CDCl3, 176 MHz): 162.8 (C2), 156.2 (C1’’), 
154.1 (C5’), 153.8 (C1’’’), 148.8 (C6), 142.2 (C4), 130.2 (C4’’), 129.8 (C3’’’), 128.4 (C3’), 127.1 
(C6’’), 125.2 (C4’’’), 121.5 (C2’’’), 119.6 (C5’’), 117.3 (C3’’), 116.2 (C2’’), 108.3 (C3 or C5), 105.5 (C3 
or C5), 104.9 (C4’). MS (ES+): m/z 330 [M-H]+. 
 
Methyl 6-phenylpicolinate 
 
A mixture of methyl-6-bromopicolinate (200 mg, 0.93 mmol), phenylboronic acid (136 mg, 
1.12 mmol), 1 M Na2CO3 (aq) (4ml) in THF (8ml) was degassed via freeze-pump-thaw (3 
cycles). Pd(PPh3)4 (32 mg, 0.028 mmol) was added and the resulting mixture was heated at 
reflux with stirring for 24 hours. After cooling to ambient temperature, the mixture was 
diluted with distilled water (10ml) and extracted with DCM (3 x 40ml). The organic layer 
was washed with brine (50ml) and dried over magnesium sulphate to give a yellow oil. The 
crude product was purified by chromatography with silica gel (hexane/EtOAc, 80:20) to 
provide 186 mg of an off-white solid (0.87 mmol, 94% yield). The experimental data 
obtained were in accord with that reported in literature.213  
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6-phenyl-pyridine-2-carboxylic acid hydrazide 
 
Methyl 6-phenylpicolinate (180 mg, 0.84 mmol) was refluxed under argon in 6ml hydrazine 
hydrate for 3 hours before cooling to room temperature. The mixture was diluted with 
10ml water and the product extracted into diethyl ether. The organic layer was dried over 
MgSO4 and the solvent removed in vacuo to yield 172 mg of an off-white solid (0.81 mmol). 
Due to the air-sensitive nature of the material it was used in the next step with no formal 
isolation. 
1H NMR (CDCl3, 400 MHz): 9.17 (1H, br s), 8.13 (1H, dd, J = 7 and 1), 8.02 3 – 8.01 (2H, m), 
7.97 – 7.90 (2H, m), 7.55 – 7.45 (3H, m), 7.25 – 7.21 (1H, m).  
 
HL33  
 
6-phenyl-pyridine-2-carboxylic acid hydrazide (172 mg, 0.81 mmol) and 2-pyridine 
carboxyaldehyde (89 mg, 0.83 mmol) were refluxed in MeOH (4ml) for a period of 2 hours 
before allowing to cool to ambient temperature. The solvent was removed in vacuo and 
successive DCM//hexane recrystallizations afforded 42 mg of a white solid (0.14 mmol, 17% 
yield).  
HL33 (Z isomer) 
1H NMR (CDCl3, 600 MHz): 11.28 (1H, s, HNH), 8.82 (1H, d, J = 5, H6’), 8.30 (1H, dd, J = 7 and 
2, H4), 8.28 – 8.25 (2H, m, H3’’), 7.97 – 7.94 (2H, m, H5 and H3), 7.90 (1H, td, J = 8 and 2, H4’), 
7.63 (1H, s, Himine), 7.59 – 7.54 (2H, m, H2’’), 7.54 – 7.51 (2H, m, H3’ and H4’’), 7.38 (1H, ddd, 
J = 8, 5 and 1, H5’). 13C NMR (CDCl3, 151 MHz): 162.9 (C2), 156.1 (C6), 152.6 (C2’), 149.7 (CC=O), 
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148.7 (C6’), 139.6 (Cimine), 138.8 (C1’’), 138.3 (C3), 137.7 (C4’), 129.7 (C4’’), 128.9 (C3’’), 127.3 
(C2’’), 126.1 (C3’), 124.1 (C5’), 123.4 (C5), 122.0 (C4). MS (ES-): m/z 301 [M-H]+. 
 
PtL1Cl 
 
A bright red mixture of HL1 (50 mg, 0.20 mmol), Pt(1,5-COD)Cl2 (75 mg, 0.20 mmol) and 
anhydrous NEt3 (20 mg, 0.20 mmol) in anhydrous MeCN (1ml) was stirred overnight at 
reflux under Argon. The mixture was allowed to cool to ambient temperature, filtered and 
washed with MeCN (2 x 1ml) to yield 78 mg of a red solid (0.16 mmol, 82% yield). 
1H NMR (DMSO-d6, 600 MHz): 9.80 (1H, s, Himine), 9.62 (1H, dd, J = 5.5 and 1, H9), 8.86 (1H, 
d, J = 8, H8), 8.78 (1H, d, J = 8, H4), 8.06 (1H, d, J = 8, H6), 7.92 (1H, t, J = 8, H5), 7.85 – 7.83 
(2H, m, H10 and H3’), 7.56 (1H, ddd, J = 9, 6 and 2, H5’), 6.97 (1H, d, J = 9, H6’), 6.76 (1H, t, J = 
7, H4’). 13C NMR (DMSO-d6, 151 MHz): 163.7 (C1’), 152.6 (C9), 149.9 (Cimine), 146.7 (C2), 144.2 
(C3), 139.8 (C8), 135.9 (C5’), 135.7 (C10 orC3’), 129.6 (C7), 129.2 (C5), 128.3 (C6), 124.2 (C10 or 
C3’), 122.1 (C2’), 121.8 (C6’), 119.6 (C4), 117.4 (C4’). MS (ASAP): m/z 478 [M+H]+. 
 
PtL2Cl 
 
 
A bright red mixture of HL2 (31 mg, 0.11 mmol), Pt(1,5-COD)Cl2 (42 mg, 0.11 mmol) and 
anhydrous NEt3 (20 mg, 0.20 mmol) in anhydrous MeCN (1ml) was stirred overnight at 
reflux under Argon. The mixture was allowed to cool to ambient temperature, filtered and 
washed with MeCN (2 x 1ml) to yield 43 mg of a purple-red solid (0.08 mmol, 73% yield). 
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1H NMR (DMSO-d6, 700 MHz): 9.74 (1H, s, Himine), 9.60 (1H, dd, J = 5 and 1, H9), 8.84 (1H, 
dd, J = 8 and 1, H8), 8.71 (1H, d, J = 8, H4), 8.03 (1H, d, J = 8, H6), 7.91 (1H, t, J = 8, H5), 7.82 
(1H, dd, J = 8 and 5, H10), 7.27 – 7.25 (2H, m, H3’ and H5’), 6.91 (1H, d, J = 9, H6’), 3.76 (3H, s, 
HOMe). 13C NMR (DMSO-d6, 176 MHz): 159.2 (C1’), 152.1 (C9), 150.0 (C4’), 148.4 (Cimine), 146.3 
(C3), 146.3 (C2), 143.6 (C8), 139.3 (C8), 129.1 (C7), 128.8 (C5), 127.6 (C6), 126.5 (C3’), 123.7 
(C10), 122.4 (C6’), 120.2 (C2’), 118.7 (C4), 113.1 (C5’). MS (ES-): m/z 507 [M-H]+. 
 
PtL3Cl 
 
A bright red mixture of HL3 (37 mg, 0.11 mmol), Pt(1,5-COD)Cl2 (42 mg, 0.11 mmol) and 
anhydrous NEt3 (20 mg, 0.20 mmol) in anhydrous MeCN (1ml) was stirred overnight at 
reflux under Argon. The mixture was allowed to cool to ambient temperature, filtered and 
washed with MeCN (2 x 1ml) to yield 35 mg of an orange-red solid (0.06 mmol, 57% yield). 
1H NMR (DMSO-d6, 600 MHz): 9.85 (1H, s, Himine), 9.57 (1H, d, J = 5, H9), 8.84 (1H, d, J = 8, 
H8), 8.70 (1H, d, J = 8, H4), 8.06 (1H, d, J = 8, H6), 7.91 (1H, t, J = 8, H5), 7.84 – 7.79 (2H, m, 
H10 and H3’), 7.53 (1H, dd, J = 9 and 3, H5’), 7.00 (1H, d, J = 9, H6’). 13C NMR (DMSO-d6, 151 
MHz): 161.6 (C1’), 152.2 (C9), 149.1 (Cimine), 145.9 (C3), 143.7 (C2), 139.5 (C8), 138.5 (C4’), 
129.1 (C7), 128.8 (C5), 128.6 (C5’), 128.3 (C6), 125.8 (C10 or C3’), 123.8 (C10 or C3’), 123.0 (C6’), 
121.0 (C2’), 119.3 (C4). MS (ES+): m/z 562 [M-H]+; HRMS (ES+): m/z 561.0106 [M+H]+; 
calculated for [C17H11N2O2F3ClPt]+ 561.0088. 
 
PtL4Cl 
 
A bright red mixture of HL4 (29 mg, 0.11 mmol), Pt(1,5-COD)Cl2 (42 mg, 0.11 mmol) and 
anhydrous NEt3 (20 mg, 0.20 mmol) in anhydrous MeCN (1ml) was stirred overnight at 
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reflux under Argon. The mixture was allowed to cool to ambient temperature, filtered and 
washed with MeCN (2 x 1ml) to yield 28 mg of an orange-red solid (0.06 mmol, 57% yield). 
1H NMR (DMSO-d6, 600 MHz): 9.74 (1H, s, Himine), 9.54 (1H, dd, J = 5 and 1, H9), 8.81 (1H, 
dd, J = 8.5 and 1, H8), 8.67 (1H, d, J = 8, H4), 8.02 (1H, d, J = 8.5, H6), 7.88 (1H, t, J = 8, H5), 
7.79 (1H, dd, J = 8 and 5.5, H10), 7.54 (1H, dd, J = 9.5 and 3, H3’), 7.44 (1H, ddd, J = 9.5, 8 and 
3, H4’), 6.91 (1H, dd, J = 9 and 5, H6’). 13C NMR (DMSO-d6, 151 MHz): 160.0 (C1’), 152.6 (C4’), 
152.1 (C9), 148.5 (Cimine), 145.9 (C3), 143.6 (C2), 139.3 (C8), 129.1 (C7), 128.8 (C5), 128.0 (C6), 
123.7 (C5’), 122.8 (C10), 120.3 (C6’), 119.1 (C2’), 117.0 (C3’). MS (ES+): m/z 496 [M-H]+ 
 
PtL1C≡C-Ar 
 
A mixture of PtL1Cl (30 mg, 0.06 mmol), CuI (5 mg, 0.03 mmol), 1-ethynyl-3,5-
bis(trifluoromethyl)benzene (23 mg, 0.1 mmol) and anhydrous NEt3 (0.3ml) in anhydrous 
DCM (3ml) was refluxed for a period of 48 hours under argon. The solvent was removed in 
vacuo and the residue purified by column chromatography (gradient from 80 Hex: 20 DCM 
to 20 Hex: 80 DCM) to yield 21 mg of a red solid (0.03 mmol, 50% yield). 
1H NMR (DMSO-d6, 700 MHz): 9.80 (1H, d, J = 5, H10), 9.15 (1H, s, Himine), 8.49 (1H, d, J = 8, 
H8), 8.23 (1H, d, J = 7.5, H4), 7.96 (2H, s, H2’’), 7.79 (1H, d, J = 8, H6), 7.74 (1H, t, J = 8, H5), 
7.70 (1H, s, H4’’), 7.52-7.47 (3H, m, H9, H3’ and H5’), 7.06 (1H, d, J = 9, H6’), 6.67 (1H, t, J = 7, 
H4’). 13C NMR (DMSO-d6, 176 MHz): 165.5 (C3), 154.9 (C10), 149.7 (Cimine), 146.4 (C1’), 145.3 
(C2), 138.7 (C5), 136.0 (C3’ or C5’), 135.4 (C3’ or C5’), 132.4 (C2’’), 131.5 (CCF3), 130.2 (C8), 129.0 
(C5), 127.6 (C6), 124.8 (C1’’’), 123.9 (C9), 123.2 (C6’ and C2’’’), 119.1 (C4’’), 117.7 (C2), 117.5 
(C4’), 101.3 (C2’), 96.5 (C1’’). MS (ES+): m/z 679 [M+H]+; HRMS (ES+): m/z 679.0731 [M+H]+; 
calculated for [C26H15N2OF6Pt]+ 679.0715. 
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PtL5Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L5 (26 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
pink solution was refluxed for 4 hours. The resulting mustard yellow slurry was isolated by 
centrifuge and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green 
solid. The crude product was then extracted into hot MeCN, filtered through celite and the 
solvent removed in vacuo to produce 32 mg of a yellow solid (0.07 mmol, 60% yield).141  
1H NMR (DMSO-d6, 700 MHz): 8.86 (1H, ddd, J = 6, 2 and 1, H3), 8.70 (1H, s, Himine), 7.97 (1H, 
ddd, J = 8.5, 7 and 1.5, H5) 7.70 (1H, dd, J = 8 and 2, H3’), 7.45 (1H, ddd, J = 8.5, 6.5 and 2, 
H4’),  7.23 (1H, t, J = 8.5, H6), 7.09 (1H, d, J = 8.5, H6’), 7.01 (1H, ddd, J = 7, 6 and 1, H4), 6.77 
(1H, ddd, J = 8, 7 and 1, H5’). 13C NMR (DMSO-d6, 176 MHz): 159.2 (C1’), 153.8 (C2), 145.2 
(C3), 138.4 (C5), 138.3 (Cimine), 132.8 (C3’), 132.3 (C4’), 120.7 (C6’), 118.6 (C2’), 116.0 (C5’), 115.2 
(C4), 107.0 (C6). MS (ES+): m/z 442 [M+H]+; HRMS (ES+): m/z 442.0206 [M+H]+; calculated 
for [C12H11N3OPtCl]+ 442.0217. 
 
PtL6Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L6 (25 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
pink solution was refluxed for 4 hours. The resulting orange-brown slurry was isolated by 
centrifuge and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate 32 mg 
of a green-brown solid (0.07 mmol, 58% yield).  
1H NMR (DMSO-d6, 700 MHz): 8.83 (1H, ddd, J = 6, 2, and 1, H3), 8.61 (1H, s, Himine), 7.95 
(1H, ddd, J = 9, 7 and 2, H5), 7.57 (1H, d, J = 8, H3’), 7.20 (1H, ddd, J = 9, 2 and 1, H6), 6.99 
(1H, ddd, J = 7, 6 and 1, H4), 6.91 (1H, s, H6’), 6.61 (1H, dd, J = 8 and 2, H4’), 2.19 (3H, s, HMe). 
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13C NMR (DMSO-d6, 176 MHz): 159.6 (C1’), 153.8 (C2), 145.2 (C3), 142.7 (C2’), 138.3 (C5), 
138.1 (Cimine), 132.6 (C3’), 120.5 (C6’), 118.0 (C4’), 116.3 (C5’), 115.1 (C4), 106.9 (C6). MS (ES-): 
m/z 456 [M-H]- 
 
PtL7Cl 
 
A solution of potassium tetrachloroplatinate (303 mg, 0.73 mmol) in deionised water (5ml) 
was added to a solution of L7 (200 mg, 0.71 mmol) in EtOH (15ml) and the resulting pale 
pink solution was heated at 80°C for 4 hours. The resulting yellow slurry was isolated by 
centrifuge and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate 300 
mg of a mustard yellow solid. The crude material was recrystallized in DMF to isolate 223 
mg of a bright yellow solid (0.44 mmol, 61% yield).     
1H NMR (DMSO-d6, 600 MHz): 8.84 (1H, d, J = 6, H3), 8.72 (1H, s, Himine), 7.99 (1H, ddd, J = 
8.5, 7 and 1.5, H5), 7.88 (1H, d, J = 3, H3’), 7.72 (1H, d, J = 3, H5’), 7.24 (1H, d, J = 8.5, H6), 7.03 
(1H, t, J = 6.5, H4). 13C NMR (DMSO-d6, 151 MHz): 154.3 (COH), 152.8 (C2), 145.3 (C3), 138.7 
(C5), 137.4 (Cimine), 130.8 (C5’), 130.3 (C3’), 125.7 (C4’ or C6’), 120.5 (C2’), 118.2 (C4’ or C6’), 
115.4 (C4), 107.3 (C6). MS (ES-): m/z 510 [M-H]-. 
 
PtL8Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L8 (31 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
pink solution was refluxed for 4 hours. The resulting orange-yellow slurry was isolated by 
centrifuge and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate 44 mg 
of an orange solid (0.09 mmol, 75% yield).141 
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1H NMR (DMSO-d6, 700 MHz): 8.88 (1H, s, Himine or H3’), 8.87 (1H, s, Himine or H3’), 8.80 (1H, 
d, J = 6, H3), 8.22 (1H, dd, J = 9 and 3, H5’), 7.98 (1H, ddd, J = 8, 7 and 1, H5), 7.23 (1H, d, J = 
8, H6), 7.16 (1H, d, J = 9, H6’), 7.01 (1H, t, J = 7, H4). 13C NMR (DMSO-d6, 176 MHz): 163.7 
(COH), 154.9 (C2), 145.3 (C3), 138.9 (C5), 137.9 (Cimine), 137.0 (C4’), 130.7 (C3’), 125.6 (C5’), 
121.7 (C6’), 118.9 (C2’), 115.2 (C4), 107.4 (C6). MS (ES-): m/z 486 [M-H]- 
 
PtL9Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L9 (27 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
pink solution was refluxed for 4 hours. The resulting orange slurry was isolated by 
centrifuge and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate 41 mg 
of a yellow solid (0.09 mmol, 73% yield). 
1H NMR (DMSO-d6, 700 MHz): 8.86 (1H, ddd, J = 6, 1.5 and 1, H3), 8.68 (1H, s, Himine), 7.98 
(1H, ddd, J = 9, 7 and 1.5, H5), 7.61 (1H, dd, J = 10 and 3, H3’), 7.34 (1H, ddd, J = 11, 7 and 2, 
H5’), 7.23 (1H, d, J = 8.5, H6), 7.09 (1H, dd, J = 9 and 5, H6’), 7.03 (1H, ddd, J = 7, 6 and 1, H4). 
13C NMR (DMSO-d6, 176 MHz): 156.6 (C1’), 154.2 (C2), 152.8 (C4’), 145.7 (C3), 138.9 (C5), 
137.9 (Cimine), 122.3 (C6’), 120.7 (C5’), 118.1 (C2’), 116.2 (C3’), 115.8 (C4’), 107.6 (C6).  MS (ES+): 
m/z 460 [M+H]+; HRMS (ES+): m/z 460.0113 [M+H]+; calculated for [C12H10N3OFPtCl]+ 
460.0123. 
 
PtL10Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L10 (29 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
pink solution was refluxed for 4 hours. The resulting yellow slurry was isolated by centrifuge 
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and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate 43 mg of a yellow 
solid (0.09 mmol, 75% yield). 
1H NMR (DMSO-d6, 700 MHz): 8.82 (1H, d, J = 6, H3), 8.67 (1H, s, Himine), 7.95 (1H, ddd, J = 
9, 7 and 1, H5), 7.84 (1H, d, J = 3, H3’), 7.41 (1H, dd, J = 9 and 3, H5’), 7.20 (1H, d, J = 9, H6), 
7.07 (1H, d, J = 9, H6’), 7.00 (1H, t, J = 7, H4). 13C NMR (DMSO-d6, 176 MHz): 158.5 (COH), 
154.5 (C2), 145.7 (C3), 138.9 (C5), 137.8 (Cimine), 132.0 (C5’), 131.3 (C3’), 123.0 (C6’), 120.1 (C4’ 
or C2’), 119.6 (C4’ or C2’), 115.7 (C4), 107.6 (C6). MS (ES-): m/z 476 [M-H]-. 
 
PtL11Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L11 (27 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
pink solution was refluxed for 4 hours. The resulting brown slurry was isolated by centrifuge 
and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate 20 mg of a green 
solid (0.04 mmol, 36% yield). 
1H NMR (DMSO-d6, 700 MHz): 13.50 (1H, br s, HNH), 9.94 (1H, s, HOH), 8.78 (1H, ddd, J = 6, 2 
and 1, H3), 8.45 (1H, s, Himine), 7.92 (1H, ddd, J = 9, 7 and 2, H5), 7.48 (1H, d, J = 9, H6’), 7.15 
(1H, dt, J = 9 and 1, H6), 6.94 (1H, ddd, J = 7, 6 and 1, H4), 6.43 (1H, d, J = 3, H4’), 6.31 (1H, 
dd, J = 9 and 2, H3’). 13C NMR (DMSO-d6, 176 MHz): 161.8 (C5’), 161.6 (C1’), 153.8 (C2), 145.2 
(C3), 138.20 (Cimine), 138.1 (C5), 134.2 (C6’), 114.7 (C4), 112.0 (C2’), 107.6 (C3’), 106.7 (C6), 
104.4 (C4’). MS (ES-): m/z 458 [M-H]- 
 
PtL12Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L12 (29 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
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pink solution was refluxed for 4 hours. The resulting yellow slurry was isolated by centrifuge 
and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate 41 mg of a yellow 
solid (0.09 mmol, 72% yield). 
1H NMR (DMSO-d6, 700 MHz): 8.86 (1H, ddd, J = 6, 2 and 1, H3), 8.68 (1H, s, Himine), 7.97 (1H, 
ddd, J = 9, 7 and 2, H5), 7.23-7.22 (2H, m, H6 and H3’), 7.14 (1H, dd, J = 9 and 3, H5’), 7.04 
(1H, d, J = 9, H6’), 7.01 (1H, ddd, J = 7, 6 and 1, H4), 3.75 (1H, s, HOMe). 13C NMR (DMSO-d6, 
176 MHz): 154.9 (C1’), 153.6 (C2), 149.6 (C4’), 145.2 (C3), 138.2 (C5), 137.8 (Cimine), 122.4 (C5’), 
121.5 (C6’), 117.3 (C2’), 115.1 (C4), 112.6 (C3’), 107.0 (C6), 55.7 (COMe). MS (ES-): m/z 471 [M-
H]- 
 
 PtL13Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L13 (29 mg, 0.11mmol) in EtOH (2.5ml) and the solution was 
refluxed for 4 hours. The resulting green slurry was allowed to cool to ambient 
temperature. The mixture was centrifuged and the collected solid washed with water (5ml), 
EtOH (5ml) and Et2O (5ml) before being dried in vacuo to yield 37 mg of a green solid (0.08 
mmol, 68% yield).   
1H NMR (DMSO-d6, 400 MHz): 9.65 (1H, s), 8.86 (1H, d, J = 6), 8.08 (1H, d, J = 8.5), 7.99 (1H, 
ddd, J = 8.5, 7 and 1.5), 7.93 (1H, d, J = 9), 7.89 (1H, d, J = 8), 7.65 (1H, t, J = 8), 7.38 (1H, t, 
J = 8), 7.33 – 7.30 (2H, m), 7.02 (1H, t, J = 7). The material was not sufficiently soluble to 
obtain a 13C NMR spectrum. 
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PtL14Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1ml) 
was added to a solution of L14 (27 mg, 0.12 mmol) in EtOH (2.5ml) and the resulting pale 
pink solution was refluxed for 4 hours. The resulting mustard yellow slurry was isolated by 
centrifuge and washed with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green 
solid. The crude product was then extracted into DCM, filtered through celite and the 
solvent removed in vacuo to produce 45 mg of a yellow solid (0.10 mmol, 82% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.06 (1H, ddd, J = 6, 2 and 0.5, H3), 8.94 (1H, s, Himine), 8.07 
(1H, ddd, J = 9, 7 and 2, H5), 7.82 (1H, dd, J = 8 and 2, H3’), 7.48 (1H, d, J = 9, H6), 7.45 (1H, 
ddd, J = 8.5, 6.5 and 2, H6’), 7.09 (2H, m, H4  and H5’), 6.79 (1H, ddd, J = 8, 7 and 1, H4’), 3.91 
(3H, s, HNMe). 13C NMR (DMSO-d6, 176 MHz): 159.3 (C2), 152.9 (C1’), 145.9 (C3), 138.7 (C5), 
137.6 (Cimine), 133.7 (C3’), 132.5 (C5’), 120.5 (C6’), 118.8 (C2’), 116.1 (C4’), 115.8 (C4’), 108.7 
(C6), 34.03 (CNMe). MS (ES+): m/z 462 [M-Cl+MeCN]+; HRMS (ES+): m/z 461.0865 [M+H]+; 
calculated for [C15H15N4OPt]+ 461.0878. 
 
PtL15Cl 
 
A solution of potassium tetrachloroplatinate (75 mg, 0.18 mmol) in deionised water (1.5ml) 
was added to a solution of L15 (44 mg, 0.17 mmol) in EtOH (4ml) and the resulting pale pink 
solution was refluxed for 4 hours. The resulting dark green slurry was filtered washed with 
water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green solid. The crude product 
was then recrystallized in hot DMF to produce 36 mg of a yellow solid (0.07 mmol, 43% 
yield).  
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1H NMR (DMSO-d6, 700 MHz): 9.09 (1H, d, J = 6), 8.96 (1H, s), 8.08 (1H, ddd, J = 9, 7 and 2), 
7.50 (1H, d, J = 9), 7.37 (1H, d, J = 3), 7.15 (1H, dd, J = 9 and 3), 7.10 (1H, t, J = 7), 7.05 (1H, 
d, J = 9). The material was not sufficiently soluble to obtain a 13C NMR spectrum. MS (ES+): 
m/z 487 [M+H]+. 
 
PtL16Cl 
 
A solution of potassium tetrachloroplatinate (100 mg, 0.24 mmol) in deionised water (2ml) 
was added to a solution of L16 (62 mg, 0.20 mmol) in EtOH (5ml) and the resulting pale pink 
solution was refluxed for 4 hours. The resulting dark green slurry was filtered washed with 
water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green solid. The crude product 
was then recrystallized in hot DMF to produce 47 mg of a bright yellow solid (0.09 mmol, 
43% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.03 (1H, dd, J = 6 and 1, H3), 9.00 (1H, s, Himine), 8.07 (1H, 
ddd, J = 9, 7 and 1.5, H5), 7.88 (1H, d, J = 3, H3’), 7.49 (1H, d, J = 9, H6), 7.43 (1H, dd, J = 9 and 
3, H5’), 7.13 (1H, d, J = 9, H6’), 7.09 (1H, ddd, J = 7, 6 and 1, H4), 3.91 (3H, s, HNMe). 13C NMR 
(DMSO-d6, 176 MHz): 157.8 (C1’), 152.9 (C2), 145.9 (C3), 138.8 (C5), 137.9 (C2’), 136.9 (Cimine), 
125.6 (C4’), 124.8 (C5’), 121.9 (C3’), 119.7 (COCF3), 118.5 (C6’), 116.0 (C4), 108.8 (C6). MS (ES+): 
m/z 541 [M+H]+; HRMS (ES+): m/z 540.0207 [M+H]+; calculated for [C14H12N3O2F3PtCl]+ 
540.0197. 
 
PtL17Cl 
 
A solution of potassium tetrachloroplatinate (291 mg, 0.7 mmol) in deionised water (5ml) 
was added to a solution of L17 (200 mg, 0.68 mmol) in EtOH (15ml) and the resulting pale 
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pink solution was refluxed for 4 hours. The resulting dark green slurry was filtered washed 
with water (2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green solid. The crude 
product was then recrystallized in hot DMF to produce 114 mg of a bright yellow solid (0.22 
mmol, 32% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.03 (1H, dd, J = 6 and 1, H3), 8.98 (1H, s, Himine), 8.09 (1H, 
ddd, J = 9, 7 and 1.5, H5), 7.92 (1H, d, J = 3, H3’), 7.71 (1H, d, J = 3, H5’), 7.79 (1H, d, J = 9, H6), 
7.11 (1H, ddd, J = 7, 6 and 1, H4), 3.87 (3H, s, HNMe). The material was not sufficiently soluble 
to obtain a 13C NMR spectrum. MS (ES+): m/z 531 [M-Cl+MeCN]+. 
 
PtL18Cl 
 
A solution of potassium tetrachloroplatinate (75 mg, 0.18 mmol) in deionised water (1.5ml) 
was added to a solution of L18 (50 mg, 0.17 mmol) in EtOH (4ml) and the resulting pale pink 
solution was refluxed for 4 hours. The resulting green slurry was filtered washed with water 
(2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green solid. The crude product was 
then recrystallized in hot DMF to produce 30 mg of a yellow solid (0.06 mmol, 35% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.45 (1H, s), 9.06 (1H, d, J = 7), 8.41 (1H, d, J = 8.5), 8.08 (1H, 
t, J = 8), 7.92 (1H, d, J = 9), 7.85 (1H, d, J = 8), 7.61 (1H, t, J = 7.5), 7.56 (1H, d, J = 9), 7.36 
(1H, t, J = 7), 7.30 (1H, d, J = 9), 7.10 (1H, t, J = 6). The material was not sufficiently soluble 
to obtain a 13C NMR spectrum. MS (ES+): m/z 507 [M+H]+ 
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PtL19Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1.5ml) 
was added to a solution of L19 (28 mg, 0.11 mmol) in EtOH (4ml) and the resulting pale pink 
solution was refluxed for 4 hours. The resulting green slurry was filtered washed with water 
(2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green solid. The crude product was 
then recrystallized in hot DMF to produce 17 mg of a yellow solid (0.03 mmol, 32% yield).  
1H NMR (DMSO-d6, 700 MHz): 8.85 (1H, s, Himine), 8.75 (1H, d, J = 7, H3), 7.75 (1H, dd, J = 8 
and 2, H3’), 7.40 (1H, ddd, J = 8.5, 7 and 2, H5), 7.02 (1H, d, J = 8, H6’), 6.88 (1H, d, J = 2.5, 
H6), 6.76 – 6.72 (2H, m, H5 and H4’), 3.94 (3H, s, HOMe), 3.86 (3H, s, HNMe). 13C NMR (DMSO-
d6, 176 MHz): 166.8 (C4), 159.4 (C1’), 154.7 (C2), 146.6 (C3), 137.3 (Cimine), 133.7 (C3’), 132.4 
(C5’), 120.5 (C6’), 118.9 (C2’), 115.9 (C4’), 105.5 (C5), 91.6 (C6). MS (ES+): m/z 492 [M+H]+; 
HRMS (ES+): m/z 491.0976 [M+H]+; calculated for [C16H17N4O2PtCl]+ 491.0978. 
 
PtL20Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1.5ml) 
was added to a solution of L20 (29 mg, 0.11 mmol) in EtOH (4ml) and the resulting pale pink 
solution was refluxed for 4 hours. The resulting green slurry was filtered washed with water 
(2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green solid. The crude product was 
then recrystallized in hot DMF to produce 22 mg of a yellow solid (0.04 mmol, 38% yield). 
1H NMR (DMSO-d6, 700 MHz): 9.31 (1H, d, J = 6), 9.07 (1H, s), 7.88 (1H, s), 7.86 (1H, dd, J = 
8 and 1.5), 7.48 (1H, ddd, J = 85, 7 and 2), 7.40 (1H, dd, J = 6.5 and 1.5), 7.13 (1H, d, J = 8), 
6.82 (1H, t, J = 7). The material was not sufficiently soluble to obtain a 13C NMR spectrum. 
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MS (ES+): m/z 530 [M+H]+; HRMS (ES+): m/z 529.0762 [M]+; calculated for 
[C16H14N4OF3PtCl]+ 529.0746. 
 
PtL14C≡C-Ar 
 
A mixture of PtL14Cl (37 mg, 0.08 mmol), CuI (5 mg, 0.03 mmol), 1-ethynyl-3,5-
bis(trifluoromethyl)benzene (30 mg, 0.12 mmol) and anhydrous NEt3 (0.4ml) in anhydrous 
DCM (7ml) was refluxed for a period of 48 hours under argon. The resulting slurry was 
filtered and wash with small volumes of DCM to yield 20 mg of a bright yellow solid (0.03 
mmol, 38% yield). 
1H NMR (DMSO-d6, 600 MHz): 9.26 (1H, dd, J = 6 and 1, H3), 8.91 (1H, s, Himine), 8.10 (1H, 
ddd, J = 9, 7 and 1.5, H5), 8.00 (2H, s, H2’’), 7.88 (1H, s, H4’’), 7.82 (1H, dd, J = 8 and 2, H3’), 
7.54 (1H, d, J = 9, H6), 7.46 (1H, ddd, J = 8.5, 7 and 2, H5’), 7.17 (1H, d, J = 8, H6’), 7.08 (1H, t, 
J = 6.5, H4), 6.81 (1H, t, J = 7, H4’), 3.94 (3H, s, HNMe). 13C NMR (DMSO-d6, 151 MHz): 159.8, 
153.0, 149.1, 138.5, 138.4, 134.1, 132.3, 131.7, 130.5, 130.2, 124.2, 122.4, 121.1, 118.8, 
116.3, 115.7, 109.1, 104.1, 33.6, 30.7, 7.2. MS (ES+): m/z 659 [M+H]+. 
 
PtL21Cl 
 
A solution of potassium tetrachloroplatinate (50 mg, 0.12 mmol) in deionised water (1.5ml) 
was added to a solution of L21 (26 mg, 0.11 mmol) in EtOH (4ml) and the resulting pale pink 
solution was refluxed for 4 hours. The resulting green slurry was filtered washed with water 
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(2 x 5ml), EtOH (2 x 5ml) and Et2O (5ml) to isolate a green solid. The crude product was 
then recrystallized in hot DMF to produce 46 mg of a yellow solid (0.10 mmol, 90% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.42 (1H, d, J = 3, H3’), 9.12 (1H, d, J = 6, H6’’), 8.47 (1H, ddd, 
J = 8, 7 and 1.5, H4’’), 8.39 (1H, d, J = 8.5, H3’’), 8.07 (1H, dd, J = 8 and 2, H3), 7.82 (1H, d, J = 
3, H4’), 7.64 (1H, ddd, J = 7, 6 and 1, H5’’), 7.35 (1H, ddd, J = 8.5, 7 and 2, H5), 7.18 (1H, dd, J 
= 8.5 and 1, H6), 6.85 (1H, ddd, J = 8, 7 and 1, H4). 13C NMR (DMSO-d6, 176 MHz): 159.6 (C2), 
148.3 (C6’’), 147.8 (C1’’’), 141.2 (C2’’), 140.6 (C4’’), 130.9 (C3’), 130.6 (C5), 128.3 (C3), 122.8 
(C5’’), 121.8 (C6), 116.0 (C4), 113.4 (C5’), 111.5 (C3’’), 105.7 (C4’). MS (ASAP): m/z 467 [M+H]+. 
 
a-PtL22Cl and b-PtL22Cl 
 
A solution of L22 (91 mg, 0.4 mmol), Pt(COD)Cl2 (150 mg, 0.4 mmol) and NEt3 (41 mg, 0.4 
mmol) in MeCN (6ml) was refluxed under argon for a period of 48 hours. The resulting dark 
red mixture was filtered to yield 143 mg of a purple solid. The crude material was separated 
by column chromatography (5% MeOH in DCM) to yield 51 mg (0.11 mmol, 28% yield) of a-
PtL22Cl and 27 mg (0.06 mmol, 15% yield) of b-PtL22Cl. 
a-PtL22Cl: 1H NMR (DMSO-d6, 600 MHz): 10.0 (1H, d, J = 6, H6’), 9.39 (1H, d, J = 6, H6), 8.29 
– 8.26 (2H, m, H4 and H4’), 7.98 (1H, dd, J = 8 and 1, H3’), 7.89 (1H, dd, J = 8 and 1, H3), 7.81 
(1H, ddd, J = 7.5, 6 and 1.5, H5), 7.73 (1H, s, Himine), 7.55 (1H, ddd, J = 7, 6 and 1.5, H5’). 13C 
NMR (DMSO-d6, 151 MHz): 170.3 (CC=O), 151.9 (C6’), 149.4 (C2’), 149.3 (C6), 141.7 (C4’ or C4), 
140.1 (C4’ or C4), 136.7 (C2), 136.7 (Cimine), 129.6 (C3), 129.1 (C5), 126.3 (C3’), 124.9 (C5’). MS 
(ES+): m/z 457 [M+H]+ 
b-PtL22Cl: 1H NMR (CDCl3, 400 MHz): 9.97 (1H, dd, J = 6 and 1.5), 9.39 (1H, d, J = 6), 9.04 
(1H, dd, J = 8.5 and 2), 8.36 (1H, s), 8.10 (1H, dt, J = 8 and 2), 7.90 (1H, dt, J = 8 and 1.5), 
7.50 – 7.44 (2H, m), 7.32 (1H, ddd, J = 8, 6 and 1.5). The material was not sufficiently soluble 
to obtain a 13C NMR spectrum. MS (ES+): m/z 457 [M+H]+ 
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PtL23Cl 
 
Pt(COD)Cl2 (83 mg, 0.22 mmol) and NEt3 (22 mg, 0.22 mmol) was added to a stirring solution 
of L23 (50 mg, 0.22 mmol) in MeCN (2ml) and the resulting yellow solution was stirred 
overnight at 60°C under argon. The resulting yellow slurry was filtered and washed with 
MeCN to yield 65 mg of a bright yellow solid (0.14 mmol, 64% yield). The experimental data 
obtained were in accord with that reported in literature.143 
 
PtL24Cl 
 
L24 (150 mg, 0.65 mmol) and K2PtCl4 (272 mg, 0.65 mmol) were stirred in DMF (10ml) at 
60°C for a period of 24 hours. The resulting orange slurry was filtered and the filtrates were 
diluted with H2O and extracted into DCM. The solvent was removed in vacuo to yield the 
crude product. The dark orange solid was recrystallized in DMSO to yield 10 mg of a yellow 
solid (0.02 mmol, 3% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.32 (2H, m), 7.96 (4H, m). The material was not sufficiently 
soluble to obtain a 13C NMR spectrum. MS (ES+): m/z 459 [M+H]+.  
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PtL25Cl 
 
Pt(COD)Cl2 (53 mg, 0.14 mmol) and NEt3 (14 mg, 0.14 mmol) was added to a stirring solution 
of L25 (30 mg, 0.14 mmol) in MeCN (2ml) and the resulting yellow solution was stirred 
overnight at 60°C under argon. The resulting yellow slurry was filtered and washed with 
MeCN to yield 24mg of a bright yellow solid (0.06 mmol, 41% yield).  
1H NMR (CDCl3, 700 MHz): 9.13 (1H, d, J = 5.5, H6’), 9.02 (1H, d, J = 5.5, H6), 8.02 (1H, td, J = 
8 and 1.5, H5), 7.94 (1H, td, J = 8 and 1.5, H5’), 7.81 (1H, d, J = 8, H3), 7.48 (1H, ddd, J = 8, 5.5 
and 2, H4), 7.42 (1H, d, J = 8, H3’), 7.30 (1H, t, J = 7, H4’), 5.07 (2H, s, HCH2). 13C NMR (CDCl3, 
176 MHz): 169.5 (C2’), 168.4 (CC=O), 157.9 (C2), 150.0 (C6’), 149.5 (C6), 139.9 (C5), 138.7 (C5’), 
127.2 (C4), 125.7 (C3), 123.7 (C9’), 122.3 (C3’), 55.0 (CCH2). MS (ES+): m/z 443 [M+H]+; HRMS 
(ES+): m/z 442.0227 [M+H]+; calculated for [C12H11N3OPtCl]+ 442.0217.214  
 
PtL27 
 
A mixture of L27 (30 mg, 0.10 mmol) and K2PtCl4 (46 mg, 0.11 mmol) in acetic acid (2ml) was 
degassed via three freeze-pump-thaw cycles and the resulting mixture was refluxed for 5 
days before cooling to ambient temperature. The resulting green-yellow slurry was filtered 
to yield 15 mg of a green-yellow solid (0.03 mmol, 30% yield). 
1H NMR (DMSO-d6, 700 MHz): 8.94 (1H, s), 8.03 (1H, dd, J = 8.5 and 7.5), 7.79 – 7.76 (2H, 
m), 7.56 – 7.53 (2H, m), 7.44 (1H, ddd, J = 8.5, 6.5 and 2), 7.31 – 7.26 (3H, m), 7.11 (1H, td, 
J = 7.5 and 1), 6.77 (1H, ddd, J = 8, 7 and 1), 3.94 (3H, s). The material was not sufficiently 
soluble to obtain a 13C NMR spectrum. MS (ES+): m/z 497 [M]+. 
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PtL29Cl 
 
A mixture of L29 (137 mg, 0.44 mmol) and K2PtCl4 (200 mg, 0.48 mmol) in an acetic acid and 
water mix (3ml, 9:1) was degassed via 3 freeze-pump-thaw cycles. The resulting slurry was 
sealed in a microwave vial and heated to 160°C for 3 hours. The product was isolated via 
centrifuge and washed with H2O, EtOH and Et2O to yield 185 mg of a green solid (0.34 
mmol, 71% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.98 (1H, s, HOH), 9.08 (1H, d, J = 3, H3’), 8.23 (1H, t, J = 8, H4), 
7.95 (1H, d, J = 8, H3), 7.83 (1H, d, J = 8, H5), 7.66 (1H, dd, J = 7.5 and 1.5, H6’’), 7.63 (1H, dd, 
J = 8 and 1, H3’’’), 7.60 (1H, dd, J = 7.5 and 1, H6’’’), 7.25 (1H, ddd, J = 8, 7 and 1.5, H4’’), 7.14 
(1H, d, J = 3, H4’), 7.12 (1H, td, J = 7 and 1, H5’’’), 7.07 (1H, td, J = 7.5 and 1, H4’’’), 6.92 (1H, 
dd, J = 8 and 0.5, H3’’), 6.83 (1H, td, J = 7.5 and 1, H5’’). 13C NMR (DMSO-d6, 176 MHz): 163.1 
(C2), 155.6 (C1’’), 155.5 (C5’), 148.1 (C6), 145.5 (C1’’’), 140.9 (C4), 137.2 (C2’’’), 133.2 (C6’’’), 132.9 
(C6’’), 132.3 (C3’), 131.1 (C4’’), 129.7 (C5’’’), 124.7 (C3’’’), 123.7 (C4’’’), 118.5 (C5’’), 115.6 (C2’’), 
115.2 (C5), 115.1 (C3’’), 112.5 (C4’), 107.6 (C3). MS (ES+): m/z 543 [M+H]+. 
 
PtL30Cl 
 
A mixture of L30 (36 mg, 0.11 mmol) and K2PtCl4 (20 mg, 0.12 mmol) in acetic acid (2ml) was 
degassed via three freeze-pump-thaw cycles and the resulting mixture was refluxed for 3 
days before cooling to ambient temperature. The resulting green-yellow slurry was filtered 
to yield 17 mg of a green-yellow solid (0.03 mmol, 28% yield). 
1H NMR (DMSO-d6, 400 MHz): 9.13 (1H, d, J = 3), 8.27 (1H, t, J = 8), 7.98 (1H, d, J = 8), 7.87 
(1H, d, J = 7.5), 7.66 (1H, dd, J = 7 and 1.5), 7.63 (1H, dd, J = 7.5 and 2), 7.58 (1H, dd, J = 8 
and 1), 7.45 (1H, ddd, J = 8, 7.5 and 2), 7.18 – 7.06 (4H, m), 7.02 (1H, td, J = 7.5 and 1), 3.83 
(3H, s). 13C NMR (DMSO-d6, 101 MHz): 163.2, 157.2, 148.2, 145.6, 141.0, 133.3, 132.6, 
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132.5, 131.4, 129.8, 124.8, 123.8, 119.9, 117.4, 115.4, 112.4, 110.9, 107.8, 55.5. MS (ES+): 
m/z 558 [M+H]+. 
 
PtL31Cl 
 
A mixture of L31 (55 mg, 0.15 mmol) and K2PtCl4 (75 mg, 0.18 mmol) in acetic acid (3ml) was 
degassed via three freeze-pump-thaw cycles and the resulting mixture was refluxed for 3 
days before cooling to ambient temperature. The resulting green-yellow slurry was filtered 
to yield 8 mg of a yellow solid (0.01 mmol, 9% yield). 
1H NMR (DMSO-d6, 400 MHz): 10.01 (1H, s), 9.10 (1H, d, J = 3), 8.23 (1H, t, J = 8), 7.94, (1H, 
d, J = 8), 7.80 (1H, d, J = 8), 7.72 – 7.70 (2H, m), 7.56 (1H, d, J = 8), 7.27 (1H, ddd, J = 8, 7.5 
and 2), 7.17 (1H, d, J = 3), 7.13 (1H, dd, J = 8 and 2), 6.94 (1H, dd, J = 8 and 1), 6.85 (1H, td, 
J = 7.5 and 1), 1.27 (9H, s). Insufficient material was produced to obtain a 13C NMR 
spectrum. ASAP: m/z 563 [M-Cl]+. 
 
PtL32Cl 
 
 
A mixture of L32 (28 mg, 0.09 mmol) and K2PtCl4 (42 mg, 0.10 mmol) in acetic acid (3ml) was 
degassed via three freeze-pump-thaw cycles and the resulting mixture was refluxed for 3 
days before cooling to ambient temperature. The resulting green slurry was filtered to yield 
7 mg of a green-yellow solid (0.01 mmol, 14% yield). 
1H NMR (DMSO-d6, 400 MHz): 9.81 (1H, s), 9.22 (1H, d, J = 3), 8.42 (1H, t, J = 8), 8.13 (1H, d, 
J = 8), 8.03 (1H, d, J = 8), 7.42 (1H, d, J = 7.5), 7.37 (1H, d, J = 8.5), 7.26 (1H, t, J = 8), 7.06 – 
234 
 
7.04 (3H, m), 6.91 – 6.86 (2H, m), 6.82 (1H, t, J = 7.5). Insufficient material was produced to 
obtain a 13C NMR spectrum. ASAP: m/z 524 [M-Cl]+. 
 
[Ir(dpyx)L14]PF6 
 
A mixture of L14 (24 mg, 0.11 mmol) and [Ir(dpyx)Cl(µ-Cl)2]2 (50 mg, 0.05 mmol) in ethylene 
glycol (1.5ml) was heated to 195°C for 90 mins under argon. The resulting brown slurry was 
diluted with H2O (2ml) and pipetted into sat. aq. KPF6 to produce a bright yellow solid. The 
crude product was isolated by centrifuge and washed with H2O. The crude product was 
recrystallized in acetone/hexane to yield 31 mg of a bright yellow solid (0.04 mmol, 34% 
yield).  
1H NMR (DMSO-d6, 700 MHz): 9.01 (1H, s), 8.21 (2H, d, J = 2.5, H6’’), 7.87 (2H, t, J = 8, H5’’), 
7.79 – 7.78 (3H, m, H3’’ or H3), 7.64 (1H, ddd, J = 9, 7 and 1.5, H4’), 7.48 (1H, d, J = 9, H3’), 
7.15 (1H, s, H4’’’), 7.11 (2H, t, J = 6.5, H4’’), 7.00 (1H, ddd, J = 8, 7 and 2, H5), 6.86 (1H, d, J = 
6, H6’), 6.62 (1H, t, J = 7, H4), 6.57 (1H, t, J = 7), 6.43 (1H, d, J = 8.5), 4.20 (3H, s, HNMe), 2.85 
(6H, s, HMe). 13C NMR (DMSO-d6, 176 MHz): 178.7, 168.9, 160.8, 154.5, 150.4, 149.6, 139.8, 
139.2, 138.0, 137.9, 137.6, 135.0, 131.5, 131.4, 123.8, 123.2, 121.8, 119.5, 116.6, 115.1, 
109.3, 33.7, 21.9. MS (ES+): m/z 678 [M]+. 
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[Ir(dpyx)L15]PF6 
 
A mixture of L15 (25 mg, 0.11 mmol) and [Ir(dpyx)Cl(µ-Cl)2]2 (50 mg, 0.05 mmol) in ethylene 
glycol (1.5ml) was heated to 195°C for 90 mins under argon. The resulting brown slurry was 
diluted with H2O (2ml) and pipetted into sat. aq. KPF6 to produce a bright yellow solid. The 
crude product was isolated by centrifuge and washed with H2O. The crude product was 
recrystallized in MeCN/Et2O to yield 55 mg of a bright yellow solid (0.06 mmol, 59% yield).  
1H NMR (CD3CN, 700 MHz): 8.83 (1H, s, Himine), 8.21 (1H, d, J = 2, H6’’), 7.79 (2H, ddd, J = 9, 
7 and 2, H5’’), 7.68 (2H, ddd, J = 6, 2 and 1, H3’’), 7.58 – 7.56 (1H, m, H5), 7.24 (1H, d, J = 3, 
H3’), 7.19 (1H, d, J = 9, H6), 7.16 (1H, s, H4’’’), 7.01 (2H, ddd, J = 7.5, 6 and 1, H4’’), 6.99 (1H, 
ddd, J = 6, 2 and 1, H3), 6.77 (1H, dd, J = 9 and 3, H5’), 6.47 (1H, ddd, J = 7, 6 and 1, H4), 6.39 
(1H, d, J = 9, H6’), 4.11 (3H, s, HNMe), 3.77 (3H, s, HOMe), 2.88 (6H, s, HMe). 13C NMR (CD3CN, 
176 MHz): 179.6, 170.6, 157.3, 156.0, 151.4, 151.3, 150.7, 140.6, 139.7, 139.5, 139.0, 138.7, 
125.0, 123.8, 123.4, 122.4, 119.3, 117.5, 116.4, 110.1, 56.5, 34.7, 22.5. MS (ES+): m/z 708 
[M]+; HRMS (ES+): m/z 706.1912 [M]+; calculated for [C32H29N5O2Ir]+ 706.1927. 
 
[Ir(dpyx)L16]PF6 
 
A mixture of L16 (30 mg, 0.11 mmol) and [Ir(dpyx)Cl(µ-Cl)2]2 (50 mg, 0.05 mmol) in ethylene 
glycol (1.5ml) was heated to 195°C for 90 mins under argon. The resulting brown slurry was 
diluted with H2O (2ml) and filtered to yield a mustard yellow solid. The crude product was 
dissolved in hot DMSO and pipetted into sat. aq. KPF6 to produce a bright yellow solid. The 
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crude product was isolated by centrifuge and washed with H2O to yield 47 mg of a bright 
yellow solid (0.05 mmol, 47% yield).  
1H NMR (CD3CN, 700 MHz): 8.81 (1H, s, Himine), 8.23 (2H, d, J = 8.5, H6’’), 7.82 (2H, ddd, J = 
8, 7.5 and 1.5, H5’’), 7.70 – 7.68 (3H, m, H3’ and H3’’), 7.80 (1H, ddd, J = 8.5, 7 and 1.5, H5), 
7.22 (1H, d, J = 9, H6), 7.18 (1H, s, H4’’’), 7.05 – 7.00 (4H, m, H3, H5’ and H4’’), 6.50 (1H, ddd, J 
= 8, 6 and 1, H4), 6.47 (1H, d, J = 9, H6’), 4.11 (3H, s, HNMe), 2.89 (6H, s, HMe). 13C NMR (CD3CN, 
176 MHz): 177.7, 169.5, 159.9, 150.4, 139.8, 138.8, 138.0, 137.9, 137.8, 131.8, 126.1, 125.0, 
124.1, 122.9, 119.3, 117.5, 117.3, 109.4, 33.8, 21.5. MS (ES+): m/z 762 [M]+; HRMS (ES+): 
m/z 760.1632 [M]+; calculated for [C32H26N5O2F3Ir]+ 760.1645. 
 
[Ir(dpyx)L16]PF6 
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A mixture of L17 (12 mg, 0.04 mmol) and [Ir(dpyx)Cl(µ-Cl)2]2 (20 mg, 0.02 mmol) in ethylene 
glycol (1.5ml) was heated to 195°C for 90 mins under argon. The resulting brown slurry was 
diluted with H2O (2ml) and filtered to yield a mustard yellow solid. The crude product was 
dissolved in hot DMSO and pipetted into sat. aq. KPF6 to produce a bright yellow solid. The 
crude product was isolated by centrifuge and washed with H2O to yield 18 mg of a bright 
yellow solid (0.02 mmol, 99% yield).  
1H NMR (DMSO-d6, 600 MHz): 9.10 (1H, s, Himine), 8.24 (2H, d, J = 8, H6’’), 7.98 (1H, d, J = 3, 
H5’), 7.92 (2H, t, J = 8, H5’’), 7.83 (2H, dd, J = 6 and 1, H3’’), 7.70 (1H, ddd, J = 9, 7 and 1.5, H5), 
7.55 (1H, d, J = 9, H6), 7.35 (1H, d, J = 3, H3’), 7.18 (1H, s, H4’’’), 7.15 (1H, ddd, J = 7.5, 6 and 
1, H4’’), 6.85 (1H, dd, J = 6 and 1, H3), 6.65 (1H, t, J = 7, H4), 4.21 (3H, s, HNMe), 2.88 (6H, s, 
HMe). 13C NMR (DMSO-d6, 151 MHz): 177.7, 168.8, 154.7, 153.9, 150.6, 149.6, 140.1, 138.3, 
128.1, 138.0, 137.4, 132.4, 131.8, 130.1, 126.3, 123.8, 123.3, 121.7, 118.1, 117.2, 117.1, 
109.6, 34.0, 30.7, 21.9. MS (ES+): m/z 746 [M]+; HRMS (ES+): m/z 744.1039 [M]+; calculated 
for [C31H25N5O2Cl2Ir]+ 744.1042. 
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6.3 Synthesis: Chapter 5 
a-PtCl(μ-L22)RuCl2(PPh3)2 
 
A solution of a-PtL22Cl (20 mg, 0.04 mmol) and RuCl2(PPh3)3 (42 mg, 0.04 mmol) in DCM 
(7ml) was stirred for 4 hours. The solution was reduced to approximately 2.5ml and hexane 
(9ml) was added to cause precipitation. The slurry was filtered to yield 41 mg of a dark 
green solid (0.03 mmol, 75%). 
1H NMR (CDCl3, 600 MHz): 10.06 (1H, d, J = 6.5), 9.41 (1H, d, J = 6), 7.92 (1H, td, J = 8 and 
1), 7.85 (1H, d, J = 3), 7.71 (1H, td, J = 7.5 and 1), 7.67 – 7.64 (6H, m), 7.55 (1H, d, J = 8), 7.49 
(1H, ddd, J = 7.5, 5.5 and 1), 7.47 – 7.43 (6H, m), 7.25 – 7.22 (6H, m), 7.20 (1H, ddd, J = 7, 6 
and 1.5), 7.16 – 7.13 (6H, m), 7.06 – 7.02 (6H, m), 6.13 (1H, d, J = 8). The material was not 
sufficiently stable in solution to obtain a 13C spectrum. MS (ES+): m/z 1117 [M(– Cl)+H]+; 
HRMS (ES+): m/z 1112.0632 [M(-Cl)]+; calculated for [C48H39N4OP2Cl2RuPt]+ 1112.0662. 
Anal. Calcd for C48H39N4OP2Cl3RuPt: C, 49.21; H, 3.42; N, 5.12. Found: C, 50.03; H, 3.41; N, 
4.86. 
 
[a-PtCl(μ-L22)Ir(ppy)2]PF6 
N O
N N
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[Ir(ppy)2Cl]2 (12 mg, 0.011 mmol) and a-PtL22Cl (10 mg, 0.022 mmol) were heated to 65°C 
in a MeOH:DCM (1.2:1, 2.2ml) mixture for a period of two hours. The solvent was removed 
in vacuo and the residue dissolved in the minimum amount of MeCN/H2O mix. The solution 
was pipetted into sat. aq. H2O, centrifuged and washed with H2O to isolate 20 mg of a green 
solid (0.018, 82% yield). 
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1H NMR ((CD3)2CO, 600 MHz): 10.17 (1H, dd, J = 8 and 1.5), 9.54 (1H, ddd, J = 6, 1.5 and 0.5), 
8.80 (1H, ddd, J = 6, 1.5 and 1), 8.67 (1H, ddd, J = 6, 1.5 and 1), 8.39 (1H, td, J = 8 and 1.5), 
8.29 (1H, td, J = 8 and 1.5), 8.27 – 8.25 (2H, m), 8.22 (1H, dd, J = 8 and 1.5), 8.07 – 8.04 (2H, 
m), 8.01 (1H, ddd, J = 8, 6 and 1.5), 7.85 (2H, td, J = 8 and 1), 7.73 (1H, ddd, J = 7.5, 6 and 
1.5), 7.48 (1H, dd, J = 8 and 1.5), 7.39 (1H, ddd, J = 7, 6 and 1.5), 7.34 (1H, ddd, J = 7.5, 6 
and 1.5), 7.30 (1H, s), 7.01 (1H, td, J = 7.5 and 1), 6.97 (1H, td, J = 7.5 and 1), 6.87 (1H, td, J 
= 7.5 and 1), 6.83 (1H, td, J = 7.5 and 1), 6.32 (1H, dd, J = 8 and 1), 6.18 (1H, dd, J = 7.5 and 
1). 13C NMR ((CD3)2CO, 151 MHz): 167.8, 166.9, 158.3, 153.4, 150.9, 150.2, 149.3, 147.9, 
147.6, 144.9, 144.0, 142.3, 140.9, 139.8, 139.2, 139.0, 133.0, 132.4, 131.7, 130.3, 130.1, 
129.5, 128.0, 127.8, 124.9, 124.4, 123.5, 122.7, 122.5, 119.9, 119.6. MS (ES+): m/z 956 [M]+; 
HRMS (ES+): m/z 955.1071 [M]+; calculated for [C34H25N6OClPtIr]+ 955.1033 
 
[PtCl(μ-L25)Ir(ppy)2]PF6 
 
[Ir(ppy)2Cl]2 (12 mg, 0.011 mmol) and PtL2Cl (10 mg, 0.022 mmol) were heated to 65°C in a 
MeOH:DCM (1.2:1, 2.2ml) mixture for a period of two hours. The solvent was removed in 
vacuo and the residue dissolved in the minimum amount of hot DMSO. The solution was 
pipetted into sat. aq. H2O, centrifuged and washed with H2O to isolate 5 mg of a yellow 
solid (0.004, 21% yield). 
1H NMR (DMSO-d6, 400 MHz): 9.50, 6.06, 8.45 – 8.40, 8.28, 8.02, 7.94 – 7.89, 7.71, 7.06, 
6.92, 5.92. The material was not sufficiently soluble to obtain a 13C NMR spectrum. MS 
(ES+): m/z 956 [M]+; HRMS (ES+): m/z 954.0870 [M]+; calculated for [C34H24N5O2ClPtIr]+ 
954.0851. 
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4,6-di(1-methylhydrazino)pyrimidine 
 
4,6-Dichloropyrimidine (720 mg, 4.83 mmol) was stirred in methylhydrazine (10ml) at 
reflux under argon for 2 hours. The resulting solution was diluted with 20ml water and the 
product extracted into DCM. The organic layer was dried over MgSO4 and the solvent 
removed in vacuo to yield 702 mg of a cream solid (4.17 mmol, 86% yield). The 
experimental data obtained were in accord with that reported in literature.189 
 
H2L36 
 
Salicylaldehyde (254 mg, 2.08 mmol) was added slowly to a solution of 4,6-di(1-
methylhydrazino)pyrimidine (175 mg, 1.04 mmol) in MeOH (5ml). The yellow solution was 
stirred under argon at reflux for 1 hour before cooling to ambient temperature. The 
resulting lemon slurry was filtered and washed with cold methanol to yield 295 mg of a 
cream powder (0.78 mmol, 75% yield).  
1H NMR (CDCl3, 700 MHz): 10.98 (2H, s, HOH), 8.48 (1H, s, H6), 7.90 (2H, s, Himine), 7.28-7.26 
(4H, m, H3’ + H4’), 7.04 (2H, d, J = 9, H6’), 6.91 (2H, td, J = 7.5 and 1, H5’), 6.80 (1H, s, H3), 3.66 
(6H, s, HNMe). 13C NMR (CDCl3, 176 MHz): 162.0 (C6), 157.6 (C1’), 157.3 (C6), 141.6 (Cimine), 
130.7 (C3’ and C4’), 119.5 (C5’), 118.8 (C2’), 117.1 (C6’), 85.7 (C3), 30.0 (CNMe). MS (ES-): m/z 
375 [M-H]-; HRMS (ES-): m/z 375.1583 [M-H]-; calculated for [C20H19N6O2]+ 601.4230.  
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H2L37 
 
5-tert-Butyl-2-hydroxybenzaldehyde (210 mg, 1.18 mmol) was added slowly to a stirring 
solution of 4,6-di(1-methylhydrazino)pyrimidine (100 mg, 0.59 mmol) in MeOH (6ml). The 
yellow solution was stirred under argon at reflux for 1 hour before cooling to ambient 
temperature. The resulting lemon slurry was filtered and washed with cold methanol to 
yield 247 mg of a cream powder (0.51 mmol, 86% yield).  
1H NMR (CDCl3, 700 MHz): 10.80 (2H, s, HOH), 8.49 (1H, d, J = 7, H6), 7.96 (2H, s, Himine), 7.31 
(2H, dd, J = 8.5 and 2.5, H5’), 7.27 (1H, s, H3’), 6.98 (2H, d, J = 9, H6’), 6.84 (1H, d, J = 1, H3), 
3.70 (6H, s, HNMe), 1.33 (18H, s, Ht-butyl). 13C NMR (CDCl3, 176 MHz): 162.1 (C2), 155.4 (C6), 
142.3 (C1’), 142.2 (Cimine), 128.2 (C5’), 127.3 (C3’), 125.3 (C4’), 118.0 (C2’), 116.7 (C6’), 85.79 
(C3), 34.2 (C7’), 31.6 (Ct-butyl), 30.1 (CNMe). MS (ES+): m/z 489 [M+H]+ 
 
H2L38 
 
 
3,5-di-tert-Butyl-2-hydroxybenzaldehyde (84 mg, 0.36 mmol) was added slowly to a stirring 
solution of 4,6-di(1-methylhydrazino)pyrimidine (30 mg, 0.18 mmol) in MeOH (1ml). The 
yellow solution was stirred under argon at reflux for 1 hour before cooling to ambient 
temperature. The resulting lemon slurry was filtered and washed with cold methanol to 
yield 68mg of a white powder (0.11 mmol, 61% yield).  
1H NMR (CDCl3, 700 MHz): 11.50 (2H, s, HOH), 8.54 (1H, s, H3), 7.99 (2H, s, Himine), 7.33 (2H, 
d, J = 2.5, H5’), 7.11 (2H, d, J = 2.5, H3’), 6.78 (1H, s, H6), 3.67 (6H, s, HNMe), 1.41 (18H, s, H8’), 
1.33 (18H, s, H10’). 13C NMR (CDCl3, 176 MHz): 162.2 (C2), 157.6 (C6), 154.5 (C1’), 143.6 
(Cimine), 140.9 (C4’), 136.8 (C6’), 125.8 (C5’), 125.5 (C3’), 117.9 (C2’), 86.2 (C3), 35.3 (C9’), 34.3 
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(C7’), 31.7 (C10’), 30.4 (CNMe), 29.8 (C8’). MS (ES+): m/z 601 [M+H]+; HRMS (ES+): m/z 
601.4253 [M+H]+; calculated for [C36H53N6O2]+ 601.4230.  
 
PtHL36Cl 
 
H2L36 (44 mg, 0.12 mmol), Pt(COD)Cl2 (110 mg, 0.29 mmol) and NEt3 (24 mg, 0.23 mmol) 
were refluxed in MeCN (4 ml) for a period of 24 hours under argon. The slurry was allowed 
to cool to ambient temperature before being filtered. The crude material was suspended 
in MeCN (2ml) at reflux for one hour before hot filtration to yield 17 mg of a yellow-green 
solid (0.028 mmol, 24% yield).  
1H NMR (DMSO-d6, 700 MHz): 9.03 (1H, s), 8.95 (1H, s), 8.33 (1H, s), 8.04 (1H, d, J = 7), 7.80 
(1H, d, J = 8), 7.43 (1H, ddd, J = 9, 7 and 1.5), 7.28 (1H, ddd, J = 8, 7 and 1.5), 7.04 (1H, d, J 
= 8), 7.00 (1H, s), 6.95 – 6.92 (2H, m), 6.76 (1H, t, J = 7), 3.89 (3H, s), 3.69 (3H, s). The 
material was not sufficiently soluble to obtain a 13C NMR spectrum. MALDI-TOF: m/z 606 
[M+H]+. 
 
[Ir(dpyx)HL36]PF6 
 
H2L36 (36 mg, 0.096 mmol) and [Ir(dpyx)Cl(µ-Cl]2 (50 mg, 0.048 mmol) were heated to 195°C 
in ethylene glycol (1.5ml) for 90 minutes under argon. The resulting slurry was allowed to 
cool to ambient temperature before adding 5ml H2O and filtering to obtain an orange-
brown solid. The crude material was dissolved in the minimum volume of hot DMSO, 
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pippeted into sat. aq. H2O, centrifuged and washed with H2O to yield 22 mg of a yellow 
solid (0.023 mmol, 24% yield).  
1H NMR (CD3CN, 700 MHz): 10.41 (1H, s), 8.90 (1H, s), 8.25 (2H, d, J = 9), 8.16 (1H, s), 7.85 
– 7.82 (4H, m), 7.72 (1H, dd, J = 8 and 1.5), 7.51 (1H, d, J = 8), 7.34 (1H, t, J = 8), 7.18 (1H, 
s), 7.11 – 7.06 (4H, m), 7.00 – 6.98 (2H, m), 6.69 (1H, t, J = 7), 6.62 (1H, s), 6.42 (1H, d, J = 
8), 4.10 (3H, s), 3.48 (3H, s), 2.91 (6H, s). 13C NMR (CD3CN, 176 MHz): 179.7, 178.0, 175.0, 
170.7, 162.8, 159.1, 158.1, 151.6, 141.1, 140.6, 139.8, 139.0, 136.2, 133.5, 132.5, 131.9, 
125.1, 123.8, 123.0, 120.9, 120.5, 119.8, 118.3, 117.4, 116.8, 85.1, 41.4, 33.9, 30.6, 22.5. 
MS (ES+): m/z 827 [M+H]+. 
 
[Ir(dpyx)HL37]PF6 
 
H2L37 (90 mg, 0.184 mmol) and [Ir(dpyx)Cl(µ-Cl]2 (87 mg, 0.084 mmol) were heated to 195°C 
in ethylene glycol (1.5ml) for 90 minutes under argon. The resulting slurry was allowed to 
cool to ambient temperature before adding 5ml H2O and filtering to obtain an orange-
brown solid. The crude material was dissolved in the minimum volume of hot DMSO, 
pippeted into sat. aq. H2O, centrifuged and washed with H2O to yield 64 mg of a yellow 
solid (0.059 mmol, 32% yield).  
1H NMR (CD3CN, 700 MHz): 10.29 (1H, s), 8.92 (1H, s), 8.23 (2H, d, J = 8), 8.14 (1H, s), 7.83 
– 7.80 (5H, m), 7.71 (1H, d, J = 3), 7.50 (1H, d, J = 2), 7.34 (1H, dd, J = 8.5 and 2), 7.19 (1H, 
dd, J = 9 and 2.5), 7.15 (1H, s), 7.07 (2H, ddd, J = 7, 6 and 1), 7.03 (1H, d, J = 0.5), 6.89 (1H, 
d, J = 9), 6.58 (1H, s), 6.36 (1H, d, J = 9), 4.08 (3H, s), 3.45 (3H, s), 2.89 (6H, s), 1.30 (9H, s), 
1.29 (9H, s). 13C NMR (CD3CN, 176 MHz): 178.2, 170.8, 161.0, 159.8, 159.8, 159.0, 158.8, 
155.9, 151.5, 143.7, 141.4, 140.6, 139.7, 139.1, 139.0, 132.6, 131.9, 131.7, 129.8, 128.7, 
125.1, 123.8, 122.6, 119.3, 119.0, 118.3, 117.0, 85.0, 41.36, 34.7, 34.3, 33.9, 30.6, 22.5. MS 
(ES+): m/z 940 [M+H]+. 
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[Ir(dpyx)HL38]PF6 
 
H2L38 (30 mg, 0.05 mmol) and [Ir(dpyx)Cl(µ-Cl]2 (26 mg, 0.025 mmol) were heated to 195°C 
in ethylene glycol (1.5ml) for 90 minutes under argon. The resulting slurry was allowed to 
cool to ambient temperature before adding 5ml H2O and filtering to obtain an orange-
brown solid. The crude material was dissolved in the minimum volume of hot DMSO, 
pippeted into sat. aq. H2O, centrifuged and washed with H2O to yield 29 mg of a yellow 
solid (0.024 mmol, 48% yield).  
1H NMR (CD3CN, 700 MHz): 11.37 (1H, s), 8.92 (1H, s), 8.20 (2H, d, J = 8), 8.16 (1H, s), 7.82 
– 7.78 (4H, m), 7.55 (1H, d, J = 2.5), 7.42 (1H, d, J = 2), 7.32 (1H, d, J = 2), 7.22 (1H, d, J = 3), 
7.15 (1H, s), 7.11 (1H, s), 7.04 (2H, ddd, J = 7, 5 and 1), 6.58 (1H, s), 4.10 (3H, s), 3.48 (3H, 
s), 1.49 (9H, s), 1.30 (18H, s), 0.70 (9H, s). 13C NMR (CD3CN, 176 MHz): 171.2, 159.9, 159.6, 
159.4, 158.9, 155.3, 151.4, 142.6, 141.8, 141.6, 140.4, 139.3, 139.2, 137.6, 137.3, 132.3, 
130.1, 128.6, 127.5, 127.3, 124.6, 123.5, 119.3, 118.7, 118.3, 84.77, 35.9, 35.8, 34.9, 34.6, 
33.6, 31.7, 31.7, 30.6, 29.8, 29.2, 22.5. MS (ES+): m/z 1052 [M+H]+; HRMS (ES+): m/z 
1049.4940 [M]+; calculated for [C54H66N8O2Ir]+ 1049.4915. 
 
[Ir(dpyx)2L36]2PF6 
 
H2L36 (22 mg, 0.058 mmol) and [Ir(dpyx)Cl(µ-Cl]2 (61 mg, 0.058 mmol) were heated to 195°C 
in ethylene glycol (1.5ml) for 90 minutes under argon. The resulting slurry was allowed to 
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cool to ambient temperature before diluting with 2ml H2O. The filtrates were pippeted into 
sat. aq. H2O, centrifuged and washed with H2O to isolate the crude product. The product 
was purified by recystallisation in MeCN/Et2O to yield 4 mg of a yellow solid (0.003 mmol, 
5% yield).  
1H NMR (CD3CN, 700 MHz): 8.83 (2H, s, Himine), 8.01 (4H, d, J = 8, H3’’), 7.70 (4H, ddd, J = 8, 
7.5 and 1.5, H4’’), 7.64 (2H, dd, J = 8 and 2, H3’), 7.53 (4H, dd, J = 6 and 1, H6’’), 7.15 (2H, s, 
H4’’’), 7.04 (2H, ddd, J = 9, 7 and 2, H5’), 6.87 (4H, ddd, J = 7.5, 5.5 and 1), 6.63 (2H, ddd, J = 
8, 7 and 1), 6.46 (1H, s, H6), 6.28 (2H, d, J = 9, H6’), 5.97 (1H, s, H3), 4.10 (6H, s, HNMe), 2.88 
(12H, s, HMe). 13C NMR (CD3CN, 176 MHz): 175.7 (C1’’’), 170.0 (C2’’), 163.0 (C1’), 162.1 (C2’’’), 
156.2 (C2), 151.6 (C6’’), 142.4 (Cimine), 140.6 (C4’’), 139.0 (C3’’’), 138.50 (C2’’’), 136.3 (C3’), 134.0 
(C5’), 133.5 (C4’’’), 124.5 (C3’’), 123.5 (C5’’), 122.9 (C6’), 119.9 (C2’), 117.1 (C4’), 84.65 (C6), 34.70 
(CNMe), 23.0 (CMe). MS (ES+): m/z 639 [M]2+. 
 
[Ir(dpyx)2L37]2PF6 
 
H2L37 (24 mg, 0.048 mmol) and [Ir(dpyx)Cl(µ-Cl]2 (50 mg, 0.048 mmol) were heated to 195°C 
in ethylene glycol (1.5ml) for 90 minutes under argon. The resulting slurry was allowed to 
cool to ambient temperature before diluting with 2ml H2O. The filtrates were pippeted into 
sat. aq. H2O, centrifuged and washed with H2O to isolate the crude product. The product 
was purified by column chromatography (5% MeOH in DCM) to yield 8 mg of a yellow solid 
(0.006 mmol, 12% yield).  
1H NMR (CD3CN, 700 MHz): 8.87 (2H, s, Himine), 8.02 (4H, d, J = 8, H3’’), 7.71 (4H, ddd, J = 8, 
7.5 and 1.5, H4’’), 7.64 (2H, d, J = 2.5, H3’), 7.53 (4H, ddd, J = 6, 2 and 0.5, H6’’), 7.16 – 7.14 
(4H, m, H5’ and H4’’’), 6.89 (4H, ddd, J = 7, 6 and 1, H5’’), 6.45 (1H, s, H6), 6.25 (2H, d, J = 9, 
H6’), 5.97 (1H, s, H3), 4.12 (6H, s, HNMe), 2.89 (12H, s, HMe), 1.26 (18H, s, Hbutyl). 13C NMR 
(CD3CN, 176 MHz): 175.9 (C1’’’), 170.0 (C2’’’), 162.1 (C3), 161.2 (C1’), 156.0 (C2), 151.5 (C6’’), 
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142.7 (Cimine), 140.6 (C4’’), 139.5 (C4’), 139.0 (C3’’’), 138.5 (C2’’), 133.4 (C5’ or C4’’’), 132.2 (C5’ 
or C4’’’), 131.9 (C3’), 124.5 (C3’’), 123.5 (C5’’), 122.4 (C6’), 118.9 (C2’), 84.5 (C6), 34.7 (CNMe), 
34.3 (C7’), 31.6 (Cbutyl), 23.0 (CMe). MS (ES+): m/z 695 [M]2+; HRMS (ES+): m/z 694.2226 [M]2+; 
calculated for [C64H62N10O2Ir2]+ 694.2188. 
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7 Appendix 
7.1 Publications arising from work discussed in this thesis 
 
A Series of [Co(Mabiq)Cl2–n] (n = 0, 1, 2) Compounds and Evidence for the Elusive Bimetallic 
Form 
Emma V. Puttock, Priyabrata Banerjee, Manuel Kaspar, Liam Drennen, Dmitry S. Yufit, 
Eckhard Bill, Stephen Sproules, and Corinna R. Hess 
Inorg. Chem., 2015, 54 (12), pp 5864–5873 
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7.2 Crystal structure data 
 
Crystal data and structure refinement for Co(Mabiq)Cl2 (1), 13srv204 
Empirical formula  C33H33Cl2CoN8 x CH3OH 
Formula weight  703.55 
Temperature/K  120 
Crystal system  triclinic 
Space group  P-1 
a/Å  9.9013(10) 
b/Å  15.0390(14) 
c/Å  22.641(2) 
α/°  96.477(3) 
β/°  99.828(3) 
γ/°  102.058(3) 
Volume/Å3  3209.9(5) 
Z  4 
ρcalcmg/mm3  1.456 
m/mm-1  0.744 
F(000)  1464.0 
Crystal size/mm3  0.397 × 0.089 × 0.059 
2Θ range for data collection  4.28 to 54° 
Index ranges  -12 ≤ h ≤ 12, -19 ≤ k ≤ 18, -23 ≤ l ≤ 28 
Reflections collected  28168 
Independent reflections  13951[R(int) = 0.0849] 
Data/restraints/parameters  13951/1/850 
Goodness-of-fit on F2  0.969 
Final R indexes [I>=2σ (I)]  R1 = 0.0642, wR2 = 0.1045 
Final R indexes [all data]  R1 = 0.1454, wR2 = 0.1252 
Largest diff. peak/hole / e Å-3  0.69/-0.62 
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Crystal data and structure refinement for Co(Mabiq)Cl (2), 13srv319 
Empirical formula  C33H33ClCoN8 x 2 CH2Cl2 
Formula weight  805.91 
Temperature/K  120 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  11.6266(8) 
b/Å  21.9485(15) 
c/Å  15.0135(10) 
α/°  90.00 
β/°  108.541(2) 
γ/°  90.00 
Volume/Å3  3632.4(4) 
Z  4 
ρcalcmg/mm3  1.474 
m/mm-1  0.879 
F(000)  1660.0 
Crystal size/mm3  0.364 × 0.145 × 0.104 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  4.3 to 57° 
Index ranges  -15 ≤ h ≤ 15, -29 ≤ k ≤ 29, -20 ≤ l ≤ 20 
Reflections collected  50205 
Independent reflections  9196 [Rint = 0.0519, Rsigma = 0.0436] 
Data/restraints/parameters  9196/0/590 
Goodness-of-fit on F2  1.011 
Final R indexes [I>=2σ (I)]  R1 = 0.0501, wR2 = 0.1288 
Final R indexes [all data]  R1 = 0.0750, wR2 = 0.1434 
Largest diff. peak/hole / e Å-3  0.85/-1.21 
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Crystal data and structure refinement for Co2(Mabiq)Cl3 (3), 13srv319* 
Empirical formula  C33H33Cl3Co2N8O0.25 
Formula weight  769.88 
Temperature/K  120 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  14.387(5) 
b/Å  10.175(4) 
c/Å  23.559(9) 
α/°  90.00 
β/°  98.012(4) 
γ/°  90.00 
Volume/Å3  3415(2) 
Z  4 
 
*limited details are available as data was not of a publishable quality 
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Crystal data and structure refinement for Co(Mabiq) (4), 13srv326 
Empirical formula  C33H33CoN8 
Formula weight  600.60 
Temperature/K  120 
Crystal system  orthorhombic 
Space group  Pbca 
a/Å  10.199(3) 
b/Å  20.351(6) 
c/Å  26.781(8) 
α/°  90.00 
β/°  90.00 
γ/°  90.00 
Volume/Å3  5559(3) 
Z  8 
ρcalcmg/mm3  1.435 
m/mm-1  0.608 
F(000)  2512.0 
Crystal size/mm3  0.05 × 0.02 × 0.01 
Radiation  synchrotron (λ = 0.68890) 
2Θ range for data collection  3.88 to 46° 
Index ranges  -11 ≤ h ≤ 11, -23 ≤ k ≤ 23, -29 ≤ l ≤ 30 
Reflections collected  36358 
Independent reflections  4231 [Rint = 0.0984, Rsigma = 0.0611] 
Data/restraints/parameters  4231/0/511 
Goodness-of-fit on F2  1.054 
Final R indexes [I>=2σ (I)]  R1 = 0.0484, wR2 = 0.1132 
Final R indexes [all data]  R1 = 0.0743, wR2 = 0.1267 
Largest diff. peak/hole / e Å-3  0.35/-0.53 
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Crystal data and structure refinement for HL5, 14srv209 
Empirical formula  C12H11N3O 
Formula weight  213.24 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  4.617(2) 
b/Å  20.615(9) 
c/Å  10.849(5) 
α/°  90.00 
β/°  94.341(12) 
γ/°  90.00 
Volume/Å3  1029.7(8) 
Z  4 
ρcalcg/cm3  1.376 
μ/mm-1  0.092 
F(000)  448.0 
Crystal size/mm3  0.41 × 0.04 × 0.03 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  5.46 to 54.98 
Index ranges  -5 ≤ h ≤ 5, -26 ≤ k ≤ 26, -14 ≤ l ≤ 14 
Reflections collected  13285 
Independent reflections  2341 [Rint = 0.2352, Rsigma = 0.2108] 
Data/restraints/parameters  2341/0/146 
Goodness-of-fit on F2  0.957 
Final R indexes [I>=2σ (I)]  R1 = 0.0862, wR2 = 0.1569 
Final R indexes [all data]  R1 = 0.2259, wR2 = 0.2023 
Largest diff. peak/hole / e Å-3  0.26/-0.32 
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Crystal data and structure refinement for HL29, 14srv219 
Empirical formula  C20H15N3O 
Formula weight  313.35 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  16.1462(11) 
b/Å  6.0429(5) 
c/Å  16.3394(15) 
α/°  90.00 
β/°  104.725(8) 
γ/°  90.00 
Volume/Å3  1541.9(2) 
Z  4 
ρcalcg/cm3  1.350 
μ/mm-1  0.086 
F(000)  656.0 
Crystal size/mm3  0.51 × 0.07 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  5.16 to 56 
Index ranges  -21 ≤ h ≤ 21, -7 ≤ k ≤ 7, -21 ≤ l ≤ 21 
Reflections collected  23998 
Independent reflections  3711 [Rint = 0.0985, Rsigma = 0.0680] 
Data/restraints/parameters  3711/0/277 
Goodness-of-fit on F2  1.033 
Final R indexes [I>=2σ (I)]  R1 = 0.0542, wR2 = 0.0918 
Final R indexes [all data]  R1 = 0.0928, wR2 = 0.1057 
Largest diff. peak/hole / e Å-3  0.23/-0.23 
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Crystal data and structure refinement for HL30, 15srv130 
Empirical formula  C21H17N3O 
Formula weight  327.38 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  9.8507(5) 
b/Å  8.5210(5) 
c/Å  19.7284(10) 
α/°  90.00 
β/°  103.807(2) 
γ/°  90.00 
Volume/Å3  1608.11(15) 
Z  4 
ρcalcg/cm3  1.352 
μ/mm-1  0.085 
F(000)  688.0 
Crystal size/mm3  0.51 × 0.15 × 0.09 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.26 to 58 
Index ranges  -13 ≤ h ≤ 13, -11 ≤ k ≤ 11, -26 ≤ l ≤ 26 
Reflections collected  24051 
Independent reflections  4279 [Rint = 0.0628, Rsigma = 0.0518] 
Data/restraints/parameters  4279/0/294 
Goodness-of-fit on F2  1.021 
Final R indexes [I>=2σ (I)]  R1 = 0.0458, wR2 = 0.1029 
Final R indexes [all data]  R1 = 0.0706, wR2 = 0.1161 
Largest diff. peak/hole / e Å-3  0.27/-0.28 
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Crystal data and structure refinement for PtL1Cl, 14srv227 
Empirical formula  C16H11ClN2OPt x CH2Cl2 
Formula weight  562.73 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  7.8778(6) 
b/Å  8.8726(8) 
c/Å  13.2483(10) 
α/°  75.787(7) 
β/°  72.823(7) 
γ/°  74.302(8) 
Volume/Å3  837.79(12) 
Z  2 
ρcalcg/cm3  2.231 
μ/mm-1  8.859 
F(000)  532.0 
Crystal size/mm3  0.17 × 0.06 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.84 to 57 
Index ranges  -10 ≤ h ≤ 10, -11 ≤ k ≤ 11, -17 ≤ l ≤ 17 
Reflections collected  17866 
Independent reflections  4252 [Rint = 0.0856, Rsigma = 0.0783] 
Data/restraints/parameters  4252/0/217 
Goodness-of-fit on F2  0.990 
Final R indexes [I>=2σ (I)]  R1 = 0.0388, wR2 = 0.0645 
Final R indexes [all data]  R1 = 0.0535, wR2 = 0.0693 
Largest diff. peak/hole / e Å-3  1.23/-1.20 
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Crystal data and structure refinement for PtL1C≡C-Ar, 16srv273 
Empirical formula  C26H14F6N2OPt x 2 C2H6OS 
Formula weight  835.74 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  16.5452(7) 
b/Å  18.5441(7) 
c/Å  9.7467(4) 
α/°  90 
β/°  91.0751(14) 
γ/°  90 
Volume/Å3  2989.9(2) 
Z  4 
ρcalcg/cm3  1.857 
μ/mm-1  4.906 
F(000)  1632.0 
Crystal size/mm3  0.11 × 0.1 × 0.06 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.392 to 60 
Index ranges  -22 ≤ h ≤ 23, -26 ≤ k ≤ 26, -13 ≤ l ≤ 13 
Reflections collected  65412 
Independent reflections  8719 [Rint = 0.0488, Rsigma = 0.0328] 
Data/restraints/parameters  8719/7/405 
Goodness-of-fit on F2  1.039 
Final R indexes [I>=2σ (I)]  R1 = 0.0243, wR2 = 0.0399 
Final R indexes [all data]  R1 = 0.0389, wR2 = 0.0429 
Largest diff. peak/hole / e Å-3  0.65/-0.63 
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Crystal data and structure refinement for PtL6Cl, 16srv140 
Empirical formula  C13H12ClN3OPt x C3H7NO 
Formula weight  529.89 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  14.4735(9) 
b/Å  14.4419(9) 
c/Å  8.3539(5) 
α/°  90.00 
β/°  96.170(2) 
γ/°  90.00 
Volume/Å3  1736.06(18) 
Z  4 
ρcalcg/cm3  2.027 
μ/mm-1  8.253 
F(000)  1016.0 
Crystal size/mm3  0.12 × 0.01 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4 to 58 
Index ranges  -19 ≤ h ≤ 19, -19 ≤ k ≤ 19, -11 ≤ l ≤ 11 
Reflections collected  21653 
Independent reflections  4619 [Rint = 0.0703, Rsigma = 0.0571] 
Data/restraints/parameters  4619/0/220 
Goodness-of-fit on F2  1.026 
Final R indexes [I>=2σ (I)]  R1 = 0.0334, wR2 = 0.0658 
Final R indexes [all data]  R1 = 0.0533, wR2 = 0.0720 
Largest diff. peak/hole / e Å-3  2.65/-1.52 
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Crystal data and structure refinement for PtL8Cl, 15srv223 
Empirical formula  C12H9ClN4O3Pt x C2H6SO 
Formula weight  565.90 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  7.0662(2) 
b/Å  23.0266(5) 
c/Å  11.1435(3) 
α/°  90.00 
β/°  106.773(2) 
γ/°  90.00 
Volume/Å3  1736.02(8) 
Z  4 
ρcalcg/cm3  2.165 
μ/mm-1  8.384 
F(000)  1080.0 
Crystal size/mm3  0.36 × 0.03 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  5.2 to 58 
Index ranges  -9 ≤ h ≤ 9, -31 ≤ k ≤ 31, -15 ≤ l ≤ 15 
Reflections collected  34017 
Independent reflections  4619 [Rint = 0.0784, Rsigma = 0.0528] 
Data/restraints/parameters  4619/0/228 
Goodness-of-fit on F2  1.204 
Final R indexes [I>=2σ (I)]  R1 = 0.0408, wR2 = 0.0718 
Final R indexes [all data]  R1 = 0.0539, wR2 = 0.0749 
Largest diff. peak/hole / e Å-3  1.47/-3.15 
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Crystal data and structure refinement for PtL12Cl, 15srv232 
Empirical formula  C13H14ClN3O3Pt 
Formula weight  490.81 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  8.5021(7) 
b/Å  8.6034(7) 
c/Å  10.4411(8) 
α/°  66.850(2) 
β/°  88.962(3) 
γ/°  86.218(3) 
Volume/Å3  700.68(10) 
Z  2 
ρcalcg/cm3  2.326 
μ/mm-1  10.216 
F(000)  464.0 
Crystal size/mm3  0.29 × 0.06 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.8 to 60 
Index ranges  -11 ≤ h ≤ 11, -12 ≤ k ≤ 12, -14 ≤ l ≤ 14 
Reflections collected  15145 
Independent reflections  4080 [Rint = 0.0387, Rsigma = 0.0374] 
Data/restraints/parameters  4080/0/194 
Goodness-of-fit on F2  1.059 
Final R indexes [I>=2σ (I)]  R1 = 0.0187, wR2 = 0.0401 
Final R indexes [all data]  R1 = 0.0222, wR2 = 0.0410 
Largest diff. peak/hole / e Å-3  1.77/-1.14 
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Crystal data and structure refinement for PtL14Cl, 15srv096 
Empirical formula  C13H12ClN3OPt 
Formula weight  456.80 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  11.1945(5) 
b/Å  9.5950(4) 
c/Å  12.2845(5) 
α/°  90.00 
β/°  105.6722(14) 
γ/°  90.00 
Volume/Å3  1270.44(9) 
Z  4 
ρcalcg/cm3  2.388 
μ/mm-1  11.248 
F(000)  856.0 
Crystal size/mm3  0.16 × 0.09 × 0.06 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  5.46 to 60 
Index ranges  -15 ≤ h ≤ 15, -13 ≤ k ≤ 13, -17 ≤ l ≤ 17 
Reflections collected  27170 
Independent reflections  3706 [Rint = 0.0275, Rsigma = 0.0158] 
Data/restraints/parameters  3706/0/174 
Goodness-of-fit on F2  1.082 
Final R indexes [I>=2σ (I)]  R1 = 0.0114, wR2 = 0.0232 
Final R indexes [all data]  R1 = 0.0142, wR2 = 0.0240 
Largest diff. peak/hole / e Å-3  0.71/-0.48 
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Crystal data and structure refinement for PtL17Cl, 15srv291 
Empirical formula  C13H10Cl3N3OPt x C3H7NO 
Formula weight  598.78 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  8.5082(7) 
b/Å  8.8816(7) 
c/Å  13.2120(11) 
α/°  108.748(2) 
β/°  100.964(3) 
γ/°  97.584(3) 
Volume/Å3  907.91(13) 
Z  2 
ρcalcg/cm3  2.190 
μ/mm-1  8.189 
F(000)  572.0 
Crystal size/mm3  0.19 × 0.04 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.96 to 60 
Index ranges  -11 ≤ h ≤ 11, -12 ≤ k ≤ 12, -18 ≤ l ≤ 18 
Reflections collected  18871 
Independent reflections  5283 [Rint = 0.0418, Rsigma = 0.0460] 
Data/restraints/parameters  5283/0/238 
Goodness-of-fit on F2  1.044 
Final R indexes [I>=2σ (I)]  R1 = 0.0230, wR2 = 0.0457 
Final R indexes [all data]  R1 = 0.0296, wR2 = 0.0474 
Largest diff. peak/hole / e Å-3  1.73/-1.59 
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Crystal data and structure refinement for PtL19Cl, 16srv451 
Empirical formula  C14H14ClN3O2Pt 
Formula weight  486.82 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  8.3913(5) 
b/Å  8.2576(5) 
c/Å  19.9601(11) 
α/°  90 
β/°  92.4713(19) 
γ/°  90 
Volume/Å3  1381.79(14) 
Z  4 
ρcalcg/cm3  2.340 
μ/mm-1  10.355 
F(000)  920.0 
Crystal size/mm3  0.11 × 0.05 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  5.19 to 59.994 
Index ranges  -11 ≤ h ≤ 11, -11 ≤ k ≤ 11, -28 ≤ l ≤ 28 
Reflections collected  22080 
Independent reflections  4032 [Rint = 0.0527, Rsigma = 0.0432] 
Data/restraints/parameters  4032/0/192 
Goodness-of-fit on F2  1.041 
Final R indexes [I>=2σ (I)]  R1 = 0.0268, wR2 = 0.0427 
Final R indexes [all data]  R1 = 0.0465, wR2 = 0.0461 
Largest diff. peak/hole / e Å-3  1.28/-0.88 
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Crystal data and structure refinement for PtL27, 16srv209 
 
Empirical formula  C19H15N3OPt x C2H6SO 
Formula weight  574.56 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  19.3076(8) 
b/Å  19.5130(8) 
c/Å  10.4261(5) 
α/°  90 
β/°  105.2760(10) 
γ/°  90 
Volume/Å3  3789.2(3) 
Z  8 
ρcalcg/cm3  2.014 
μ/mm-1  7.539 
F(000)  2224.0 
Crystal size/mm3  0.21 × 0.08 × 0.06 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  2.186 to 59.998 
Index ranges  -27 ≤ h ≤ 27, -27 ≤ k ≤ 27, -14 ≤ l ≤ 14 
Reflections collected  50787 
Independent reflections  11044 [Rint = 0.0594, Rsigma = 0.0528] 
Data/restraints/parameters  11044/0/511 
Goodness-of-fit on F2  1.034 
Final R indexes [I>=2σ (I)]  R1 = 0.0402, wR2 = 0.0943 
Final R indexes [all data]  R1 = 0.0600, wR2 = 0.1047 
Largest diff. peak/hole / e Å-3  3.49/-2.32 
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Crystal data and structure refinement for PtL31Cl, 15srv149 
Empirical formula  C24H22ClN3Opt (x 3 CH3COOH?) 
Formula weight  598.99 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  10.0432(7) 
b/Å  10.8058(7) 
c/Å  13.7861(9) 
α/°  71.4105(19) 
β/°  71.8564(19) 
γ/°  84.038(2) 
Volume/Å3  1347.55(16) 
Z  2 
ρcalcg/cm3  1.476 
μ/mm-1  5.322 
F(000)  580.0 
Crystal size/mm3  0.16 × 0.05 × 0.01 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.26 to 55 
Index ranges  -14 ≤ h ≤ 14, -15 ≤ k ≤ 15, -20 ≤ l ≤ 19 
Reflections collected  24197 
Independent reflections  6151 [Rint = 0.0708, Rsigma = 0.1241] 
Data/restraints/parameters  6151/0/275 
Goodness-of-fit on F2  1.062 
Final R indexes [I>=2σ (I)]  R1 = 0.0424, wR2 = 0.0882 
Final R indexes [all data]  R1 = 0.0569, wR2 = 0.0911 
Largest diff. peak/hole / e Å-3  1.14/-2.15 
 
 
 
 
 
264 
 
Crystal data and structure refinement for [PtL29]OTf, 16srv012 
Empirical formula  C23H20N3O2Pt x CF3O3S 
Formula weight  714.58 
Temperature/K  120.0 
Crystal system  orthorhombic 
Space group  Pbca 
a/Å  10.5032(4) 
b/Å  14.8938(5) 
c/Å  30.1011(10) 
α/°  90.00 
β/°  90.00 
γ/°  90.00 
Volume/Å3  4708.8(3) 
Z  8 
ρcalcg/cm3  2.016 
μ/mm-1  6.116 
F(000)  2768.0 
Crystal size/mm3  0.53 × 0.07 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.72 to 56 
Index ranges  -13 ≤ h ≤ 13, -19 ≤ k ≤ 19, -39 ≤ l ≤ 39 
Reflections collected  73151 
Independent reflections  5676 [Rint = 0.1696, Rsigma = 0.0678] 
Data/restraints/parameters  5676/31/331 
Goodness-of-fit on F2  1.029 
Final R indexes [I>=2σ (I)]  R1 = 0.0556, wR2 = 0.1362 
Final R indexes [all data]  R1 = 0.0825, wR2 = 0.1564 
Largest diff. peak/hole / e Å-3  2.88/-1.54 
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Crystal data and structure refinement for [Ir(dpyx)L15]PF6, 16srv479 
Empirical formula  C32H29IrN5O2 x PF6 x CH3CN 
Formula weight  893.83 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  11.4532(5) 
b/Å  15.8034(7) 
c/Å  18.1543(8) 
α/°  90.00 
β/°  95.0909(16) 
γ/°  90.00 
Volume/Å3  3273.0(2) 
Z  4 
ρcalcg/cm3  1.814 
μ/mm-1  4.206 
F(000)  1760.0 
Crystal size/mm3  0.25 × 0.21 × 0.08 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.8 to 60 
Index ranges  -16 ≤ h ≤ 16, -22 ≤ k ≤ 22, -25 ≤ l ≤ 25 
Reflections collected  71211 
Independent reflections  9548 [Rint = 0.0310, Rsigma = 0.0174] 
Data/restraints/parameters  9548/0/456 
Goodness-of-fit on F2  1.054 
Final R indexes [I>=2σ (I)]  R1 = 0.0161, wR2 = 0.0348 
Final R indexes [all data]  R1 = 0.0214, wR2 = 0.0367 
Largest diff. peak/hole / e Å-3  0.81/-1.01 
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Crystal data and structure refinement for H2L36, 16srv249 
Empirical formula  C20H20N6O2 
Formula weight  376.42 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  I2/c 
a/Å  15.5025(12) 
b/Å  10.4734(8) 
c/Å  11.3532(9) 
α/°  90 
β/°  93.231(7) 
γ/°  90 
Volume/Å3  1840.4(3) 
Z  4 
ρcalcg/cm3  1.359 
μ/mm-1  0.092 
F(000)  792.0 
Crystal size/mm3  0.32 × 0.1 × 0.06 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.696 to 57.986 
Index ranges  -21 ≤ h ≤ 21, -14 ≤ k ≤ 14, -15 ≤ l ≤ 15 
Reflections collected  15142 
Independent reflections  2446 [Rint = 0.1019, Rsigma = 0.0686] 
Data/restraints/parameters  2446/0/133 
Goodness-of-fit on F2  1.020 
Final R indexes [I>=2σ (I)]  R1 = 0.0565, wR2 = 0.1088 
Final R indexes [all data]  R1 = 0.1101, wR2 = 0.1299 
Largest diff. peak/hole / e Å-3  0.26/-0.22 
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Crystal data and structure refinement for H2L38, 16srv303 
Empirical formula  C36H52N6O2 
Formula weight  600.83 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  12.1186(12) 
b/Å  12.2241(10) 
c/Å  12.9851(11) 
α/°  72.172(3) 
β/°  77.714(3) 
γ/°  88.934(3) 
Volume/Å3  1787.0(3) 
Z  2 
ρcalcg/cm3  1.117 
μ/mm-1  0.070 
F(000)  652.0 
Crystal size/mm3  0.32 × 0.11 × 0.05 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.79 to 58 
Index ranges  -16 ≤ h ≤ 16, -16 ≤ k ≤ 16, -17 ≤ l ≤ 17 
Reflections collected  28016 
Independent reflections  9488 [Rint = 0.0442, Rsigma = 0.0629] 
Data/restraints/parameters  9488/2/417 
Goodness-of-fit on F2  1.021 
Final R indexes [I>=2σ (I)]  R1 = 0.0556, wR2 = 0.1208 
Final R indexes [all data]  R1 = 0.0964, wR2 = 0.1369 
Largest diff. peak/hole / e Å-3  0.35/-0.32 
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Crystal data and structure refinement for [Ir(dpyx)2L36]2PF6, 16srv305 
Empirical formula  C56H48Ir2N10O2 x 2 PF6 x 4 CH3CN 
Formula weight  1731.60 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  12.7200(11) 
b/Å  14.3155(12) 
c/Å  19.9170(17) 
α/°  86.983(3) 
β/°  79.538(3) 
γ/°  78.218(2) 
Volume/Å3  3490.9(5) 
Z  2 
ρcalcg/cm3  1.647 
μ/mm-1  3.939 
F(000)  1700.0 
Crystal size/mm3  0.12 × 0.09 × 0.02 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.216 to 55 
Index ranges  -17 ≤ h ≤ 17, -19 ≤ k ≤ 19, -27 ≤ l ≤ 27 
Reflections collected  74344 
Independent reflections  16016 [Rint = 0.1680, Rsigma = 0.2280] 
Data/restraints/parameters  16016/914/872 
Goodness-of-fit on F2  0.958 
Final R indexes [I>=2σ (I)]  R1 = 0.0735, wR2 = 0.1514 
Final R indexes [all data]  R1 = 0.1517, wR2 = 0.1700 
Largest diff. peak/hole / e Å-3  3.38/-1.40 
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Crystal data and structure refinement for [Ir(dpyx)2L37]2PF6, 16srv324 
Empirical formula  2(C64H64Ir2N10O2) x 3 (PF6) x (CH3OH) x 6 (CH3CN) 
Formula weight  3492.57 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  12.2674(11) 
b/Å  16.3422(15) 
c/Å  21.227(2) 
α/°  75.235(3) 
β/°  76.582(3) 
γ/°  87.493(3) 
Volume/Å3  4002.2(6) 
Z  1 
ρcalcg/cm3  1.449 
μ/mm-1  3.422 
F(000)  1733.0 
Crystal size/mm3  0.16 × 0.15 × 0.06 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.24 to 57.998 
Index ranges  -16 ≤ h ≤ 16, -22 ≤ k ≤ 22, -28 ≤ l ≤ 28 
Reflections collected  83046 
Independent reflections  21245 [Rint = 0.0351, Rsigma = 0.0362] 
Data/restraints/parameters  21245/64/891 
Goodness-of-fit on F2  1.053 
Final R indexes [I>=2σ (I)]  R1 = 0.0484, wR2 = 0.1054 
Final R indexes [all data]  R1 = 0.0674, wR2 = 0.1166 
Largest diff. peak/hole / e Å-3  4.91/-3.05 
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7.3 Χ2 values 
 
Complex Χ2 
Degassed Aerated 77K 
PtL1Cl 0.993 1.038 1.170 
PtL2Cl 0.983 1.134 1.002 
PtL3Cl 0.952 1.044 1.176 
PtL4Cl 1.100 0.872 1.338 
PtL1C≡C-Ar 1.082 0.957 1.342 
PtL14Cl 1.078 1.042 1.324 
PtL15Cl 1.086 1.147 1.263 
PtL16Cl 0.947 0.932 1.159 
PtL17Cl 1.068 1.168 1.334 
PtL18Cl 0.995 1.034 1.329 
PtL19Cl 1.012 0.891 1.137 
PtL20Cl 1.039 1.169 1.206 
PtL14C≡C-Ar 1.028 1.065 1.258 
a-PtL22Cl 1.117 1.039 1.225 
b-PtL22Cl 0.977 1.049 1.139 
PtL23Cl n/a n/a 1.212 
PtL24Cl n/a n/a 0.977 
PtL25Cl 1.064 1.016 1.272 
PtL27 0.928 0.985 1.313 
PtL29Cl 0.997 1.222 n/a 
PtL30Cl 1.189 1.220 1.213 
PtL31Cl 0.968 0.980 1.279 
[Ir(dpyx)L14]PF6 0.982 1.182 1.246 
[Ir(dpyx)L15]PF6 1.110 1.034 1.303 
[Ir(dpyx)L16]PF6 1.071 1.186 0.993 
[Ir(dpyx)L17]PF6 1.279 1.043 1.234 
a-PtCl(µ-
L22)RuCl2(PPh3)2 
n/a n/a 1.025 
[a-PtCl(µ-
L22)Ir(ppy)2]PF6 
n/a n/a (496) 1.213 (659) 
1.298 
[Ir(dpyx)HL36]PF6 1.059 1.120 1.303 
[Ir(dpyx)HL37]PF6 1.076 0.984 1.165 
[Ir(dpyx)HL38]PF6 1.114 0.961 1.204 
[{Ir(dpyx)}2L36]2PF6 1.266 0.960 1.198 
[{Ir(dpyx)}2L37]2PF6 10.92 1.024 1.275 
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